case_id,submitter_id,project_id,age_at_index,days_to_birth,days_to_death,demographic_id,ethnicity,gender,race,state,submitter_id,updated_datetime,vital_status,year_of_birth,year_of_death,age_at_diagnosis,ajcc_pathologic_m,ajcc_pathologic_n,ajcc_pathologic_stage,ajcc_pathologic_t,ajcc_staging_system_edition,classification_of_tumor,days_to_last_follow_up,diagnosis_id,icd_10_code,morphology,primary_diagnosis,prior_malignancy,prior_treatment,progression_or_recurrence,site_of_resection_or_biopsy,state,submitter_id,synchronous_malignancy,tissue_or_organ_of_origin,created_datetime,state,submitter_id,treatment_id,treatment_or_therapy,treatment_type,updated_datetime,tumor_grade,tumor_stage,updated_datetime,year_of_diagnosis
a123dc45-e427-461e-8d60-c51307aa498c,TCGA-D5-6535,TCGA-COAD,80,-29278,--,aaf1b252-c510-57c5-8061-2a9f082b8430,not hispanic or latino,female,white,released,TCGA-D5-6535_demographic,2019-07-31T18:33:41.312933-05:00,Alive,1930,--,29278,MX,N1,Stage IIIB,T3,7th,not reported,460,c2a3df3d-44b3-54fd-ab0d-dbe3fd9922a4,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6535_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6535_treatment,1997b351-0a08-5ded-ab56-892b39f2fda9,no,"Radiation Therapy, NOS",2019-07-31T18:33:41.312933-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2010
a123dc45-e427-461e-8d60-c51307aa498c,TCGA-D5-6535,TCGA-COAD,80,-29278,--,aaf1b252-c510-57c5-8061-2a9f082b8430,not hispanic or latino,female,white,released,TCGA-D5-6535_demographic,2019-07-31T18:33:41.312933-05:00,Alive,1930,--,29278,MX,N1,Stage IIIB,T3,7th,not reported,460,c2a3df3d-44b3-54fd-ab0d-dbe3fd9922a4,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6535_diagnosis,No,"Colon, NOS",2019-04-28T11:18:41.421158-05:00,released,TCGA-D5-6535_treatment_1,bf2b530c-09d8-5654-b070-2e1bc931ef3f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:41.312933-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2010
b107565b-7558-4745-952b-689178367e1c,TCGA-AA-3525,TCGA-COAD,90,-32871,--,e1bc0cb3-dda3-5cdc-a89e-82e8d96ea93d,not reported,male,not reported,released,TCGA-AA-3525_demographic,2019-07-31T18:34:57.084754-05:00,Alive,1917,--,32871,M0,N1,Stage IIIB,T3,6th,not reported,1,113cd34a-f9f5-56a9-b96d-2e63ccd8405b,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3525_diagnosis,Not Reported,Ascending colon,2019-04-28T11:19:42.608628-05:00,released,TCGA-AA-3525_treatment_1,afdd6411-e528-5071-bf08-d748bc6f8fcf,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:57.084754-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2007
b107565b-7558-4745-952b-689178367e1c,TCGA-AA-3525,TCGA-COAD,90,-32871,--,e1bc0cb3-dda3-5cdc-a89e-82e8d96ea93d,not reported,male,not reported,released,TCGA-AA-3525_demographic,2019-07-31T18:34:57.084754-05:00,Alive,1917,--,32871,M0,N1,Stage IIIB,T3,6th,not reported,1,113cd34a-f9f5-56a9-b96d-2e63ccd8405b,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3525_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3525_treatment,c908071f-33bb-591f-9a5b-12d346b5ce21,no,"Radiation Therapy, NOS",2019-07-31T18:34:57.084754-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2007
1ad0b9b9-7ded-4281-b114-9dcc6138c037,TCGA-AA-3530,TCGA-COAD,80,-29402,--,d032a0e6-fefa-5d34-8abe-fb6f0f722890,not reported,male,not reported,released,TCGA-AA-3530_demographic,2019-07-31T18:24:32.066469-05:00,Alive,1927,--,29402,M0,N0,Stage I,T2,6th,not reported,580,59bdc21a-274f-57c7-9198-1283cf91adeb,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AA-3530_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3530_treatment,6fa0c5e6-18a2-5d89-a8a2-11ab988ad8c5,no,"Radiation Therapy, NOS",2019-07-31T18:24:32.066469-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2007
1ad0b9b9-7ded-4281-b114-9dcc6138c037,TCGA-AA-3530,TCGA-COAD,80,-29402,--,d032a0e6-fefa-5d34-8abe-fb6f0f722890,not reported,male,not reported,released,TCGA-AA-3530_demographic,2019-07-31T18:24:32.066469-05:00,Alive,1927,--,29402,M0,N0,Stage I,T2,6th,not reported,580,59bdc21a-274f-57c7-9198-1283cf91adeb,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AA-3530_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:11:03.929960-05:00,released,TCGA-AA-3530_treatment_1,ddabffe9-f3e3-5a62-a31c-702e96786553,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:32.066469-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2007
a6f98ee5-9638-4ebe-804b-fba54aea9f90,TCGA-CK-6746,TCGA-COAD,84,-30957,--,081d4edc-baf1-5a8d-9204-a75b7d834226,not hispanic or latino,female,white,released,TCGA-CK-6746_demographic,2019-07-31T18:42:29.067202-05:00,Alive,1925,--,30957,MX,N0,Stage IIB,T4b,6th,not reported,--,9bc052df-134d-58e4-8232-5559f0050918,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CK-6746_diagnosis,No,Cecum,2019-04-28T11:26:04.277106-05:00,released,TCGA-CK-6746_treatment_1,24641e42-0a5b-5072-958c-9786ba075db7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:29.067202-05:00,not reported,stage iib,2019-08-08T16:36:28.485406-05:00,2009
a6f98ee5-9638-4ebe-804b-fba54aea9f90,TCGA-CK-6746,TCGA-COAD,84,-30957,--,081d4edc-baf1-5a8d-9204-a75b7d834226,not hispanic or latino,female,white,released,TCGA-CK-6746_demographic,2019-07-31T18:42:29.067202-05:00,Alive,1925,--,30957,MX,N0,Stage IIB,T4b,6th,not reported,--,9bc052df-134d-58e4-8232-5559f0050918,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CK-6746_diagnosis,No,Cecum,--,released,TCGA-CK-6746_treatment,96200a23-3168-5df2-946a-b458ea688f7e,not reported,"Radiation Therapy, NOS",2019-07-31T18:42:29.067202-05:00,not reported,stage iib,2019-08-08T16:36:28.485406-05:00,2009
fac2c617-8149-45bb-b766-fbe13dc3c425,TCGA-DM-A1D7,TCGA-COAD,82,-30142,405,c3252fed-01e9-5b34-a6ce-862a6d69b7eb,not hispanic or latino,male,white,released,TCGA-DM-A1D7_demographic,2019-07-31T18:40:53.587553-05:00,Dead,1918,--,30142,M0,N0,Stage IIA,T3,--,not reported,405,c7b03e7d-f7a6-5cab-ba53-b6a1a2994e67,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-DM-A1D7_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A1D7_treatment,60a456a3-d828-566c-bd58-48c07f33ab7e,not reported,"Radiation Therapy, NOS",2019-07-31T18:40:53.587553-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
fac2c617-8149-45bb-b766-fbe13dc3c425,TCGA-DM-A1D7,TCGA-COAD,82,-30142,405,c3252fed-01e9-5b34-a6ce-862a6d69b7eb,not hispanic or latino,male,white,released,TCGA-DM-A1D7_demographic,2019-07-31T18:40:53.587553-05:00,Dead,1918,--,30142,M0,N0,Stage IIA,T3,--,not reported,405,c7b03e7d-f7a6-5cab-ba53-b6a1a2994e67,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-DM-A1D7_diagnosis,No,Sigmoid colon,2019-04-28T11:24:41.950974-05:00,released,TCGA-DM-A1D7_treatment_1,19f05386-bead-5369-9f23-ed5c345920e5,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:53.587553-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
bf69a4ce-ec7e-4752-a86d-dcc80e3c9a57,TCGA-AZ-4615,TCGA-COAD,84,-30908,--,cc77fb95-c41f-5007-9efe-4bef1de2595f,not hispanic or latino,male,white,released,TCGA-AZ-4615_demographic,2019-07-31T18:35:52.835712-05:00,Alive,1925,--,30908,M0,N1,Stage IIIB,T3,--,not reported,1002,6c96bf54-d1a3-533f-9afd-1ec606635abf,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4615_diagnosis,No,Cecum,--,released,TCGA-AZ-4615_treatment,7a193ef0-be86-58b3-a8fc-6613588d5b46,no,"Radiation Therapy, NOS",2019-07-31T18:35:52.835712-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2009
bf69a4ce-ec7e-4752-a86d-dcc80e3c9a57,TCGA-AZ-4615,TCGA-COAD,84,-30908,--,cc77fb95-c41f-5007-9efe-4bef1de2595f,not hispanic or latino,male,white,released,TCGA-AZ-4615_demographic,2019-07-31T18:35:52.835712-05:00,Alive,1925,--,30908,M0,N1,Stage IIIB,T3,--,not reported,1002,6c96bf54-d1a3-533f-9afd-1ec606635abf,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4615_diagnosis,No,Cecum,2019-04-28T11:20:29.488974-05:00,released,TCGA-AZ-4615_treatment_1,a62b9452-0c1a-58b1-938b-36ed75f26f2d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:52.835712-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2009
fa83dfb5-7386-4a35-9861-aa866478d5f1,TCGA-D5-6533,TCGA-COAD,68,-24971,--,7aaf445d-bbc8-5b31-8aeb-539c75be4914,not hispanic or latino,female,white,released,TCGA-D5-6533_demographic,2019-07-31T18:40:50.645120-05:00,Alive,1942,--,24971,M0,N0,--,T4b,7th,not reported,775,ff22c401-7194-5812-bddd-d94ab958bdbe,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-D5-6533_diagnosis,No,Transverse colon,--,released,TCGA-D5-6533_treatment,b2ad1e59-9b27-56d4-b554-5cf22487b875,no,"Radiation Therapy, NOS",2019-07-31T18:40:50.645120-05:00,not reported,not reported,2019-08-08T16:36:52.154454-05:00,2010
fa83dfb5-7386-4a35-9861-aa866478d5f1,TCGA-D5-6533,TCGA-COAD,68,-24971,--,7aaf445d-bbc8-5b31-8aeb-539c75be4914,not hispanic or latino,female,white,released,TCGA-D5-6533_demographic,2019-07-31T18:40:50.645120-05:00,Alive,1942,--,24971,M0,N0,--,T4b,7th,not reported,775,ff22c401-7194-5812-bddd-d94ab958bdbe,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-D5-6533_diagnosis,No,Transverse colon,2019-04-28T11:24:39.497738-05:00,released,TCGA-D5-6533_treatment_1,c19fbb0a-9a79-5e19-b803-6075e82e4860,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:50.645120-05:00,not reported,not reported,2019-08-08T16:36:52.154454-05:00,2010
fb4cc403-694c-421f-b360-3108b6d57ad5,TCGA-AU-3779,TCGA-COAD,80,-29460,--,21465ab2-e1bd-5f0a-b29e-d2b79d69bf66,not hispanic or latino,female,white,released,TCGA-AU-3779_demographic,2019-07-31T18:40:59.819475-05:00,Alive,1930,--,29460,M0,N0,Stage IIA,T3,7th,not reported,441,7db57a70-92d5-5aad-bd3e-634d32ac5706,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AU-3779_diagnosis,No,Sigmoid colon,2019-04-28T11:24:47.025345-05:00,released,TCGA-AU-3779_treatment_1,4921ebe4-4c06-5c20-928c-71fbce49aa60,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:59.819475-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2010
fb4cc403-694c-421f-b360-3108b6d57ad5,TCGA-AU-3779,TCGA-COAD,80,-29460,--,21465ab2-e1bd-5f0a-b29e-d2b79d69bf66,not hispanic or latino,female,white,released,TCGA-AU-3779_demographic,2019-07-31T18:40:59.819475-05:00,Alive,1930,--,29460,M0,N0,Stage IIA,T3,7th,not reported,441,7db57a70-92d5-5aad-bd3e-634d32ac5706,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AU-3779_diagnosis,No,Sigmoid colon,--,released,TCGA-AU-3779_treatment,acd90055-f9a4-5541-8379-8495ab5c8f69,no,"Radiation Therapy, NOS",2019-07-31T18:40:59.819475-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2010
c0b8c55c-b993-481d-aeea-9ebfa64ee20e,TCGA-CM-4746,TCGA-COAD,61,-22403,--,ced2e2cd-e651-5e65-bbf3-2e35ccfed507,not hispanic or latino,male,black or african american,released,TCGA-CM-4746_demographic,2019-07-31T18:36:01.855387-05:00,Alive,1948,--,22403,M0,N0,Stage I,T2,--,not reported,1126,65e9bac1-1b43-5c30-b825-3ac0d6b5f5b9,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-4746_diagnosis,No,Sigmoid colon,2019-04-28T11:20:36.900392-05:00,released,TCGA-CM-4746_treatment_1,d249a047-44e1-5ce5-a6fd-a70b26a45e88,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:01.855387-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2009
c0b8c55c-b993-481d-aeea-9ebfa64ee20e,TCGA-CM-4746,TCGA-COAD,61,-22403,--,ced2e2cd-e651-5e65-bbf3-2e35ccfed507,not hispanic or latino,male,black or african american,released,TCGA-CM-4746_demographic,2019-07-31T18:36:01.855387-05:00,Alive,1948,--,22403,M0,N0,Stage I,T2,--,not reported,1126,65e9bac1-1b43-5c30-b825-3ac0d6b5f5b9,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-4746_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-4746_treatment,261c5cc0-4a33-5ec4-9113-3b6213bcef3b,no,"Radiation Therapy, NOS",2019-07-31T18:36:01.855387-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2009
192da41f-f0a5-494e-8eb9-96bcdae56ff8,TCGA-AA-3819,TCGA-COAD,41,-15280,--,cf2ba3b2-7136-503b-90c6-bea2e7cb21f4,not reported,female,not reported,released,TCGA-AA-3819_demographic,2019-07-31T18:41:27.084688-05:00,Alive,1967,--,15280,M0,N0,Stage IIA,T3,6th,not reported,761,ff935da5-4205-5313-a792-5170d914b30a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3819_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3819_treatment,831969d1-7133-5848-a8f1-ba659fa23114,no,"Radiation Therapy, NOS",2019-07-31T18:41:27.084688-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
192da41f-f0a5-494e-8eb9-96bcdae56ff8,TCGA-AA-3819,TCGA-COAD,41,-15280,--,cf2ba3b2-7136-503b-90c6-bea2e7cb21f4,not reported,female,not reported,released,TCGA-AA-3819_demographic,2019-07-31T18:41:27.084688-05:00,Alive,1967,--,15280,M0,N0,Stage IIA,T3,6th,not reported,761,ff935da5-4205-5313-a792-5170d914b30a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3819_diagnosis,No,"Colon, NOS",2019-04-28T11:25:09.397794-05:00,released,TCGA-AA-3819_treatment_1,d6d51539-ea0b-5b11-a883-6cb3b8693db1,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:27.084688-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
28033279-cc74-4775-afdf-2497f6ddb55c,TCGA-AA-3506,TCGA-COAD,77,-28275,--,3cd15173-8bda-5f0b-8803-cede5957b0e2,not reported,male,not reported,released,TCGA-AA-3506_demographic,2019-07-31T18:25:32.285478-05:00,Alive,1927,--,28275,M0,N0,Stage I,T2,5th,not reported,1765,04ac8afc-47cc-5e72-a683-525297d73da0,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3506_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3506_treatment,c4f8a138-4fcb-5b22-9d1b-709db4028d2d,no,"Radiation Therapy, NOS",2019-07-31T18:25:32.285478-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2004
28033279-cc74-4775-afdf-2497f6ddb55c,TCGA-AA-3506,TCGA-COAD,77,-28275,--,3cd15173-8bda-5f0b-8803-cede5957b0e2,not reported,male,not reported,released,TCGA-AA-3506_demographic,2019-07-31T18:25:32.285478-05:00,Alive,1927,--,28275,M0,N0,Stage I,T2,5th,not reported,1765,04ac8afc-47cc-5e72-a683-525297d73da0,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3506_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:11:54.420660-05:00,released,TCGA-AA-3506_treatment_1,77d10805-2fb4-5b65-b887-36c0804a8e43,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:32.285478-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2004
8368d745-c74d-4236-ba75-16ca7aaeb3ca,TCGA-AA-3502,TCGA-COAD,73,-26724,--,b4df3e14-47e0-57b9-8238-816b2fc3dc85,not reported,male,not reported,released,TCGA-AA-3502_demographic,2019-07-31T18:31:45.872081-05:00,Alive,1930,--,26724,M0,N0,Stage I,T2,5th,not reported,1065,ab4301d9-1fa8-5d79-8ae0-cb94b90d7828,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3502_diagnosis,No,"Colon, NOS",2019-04-28T11:17:05.549390-05:00,released,TCGA-AA-3502_treatment_1,0e938c7a-b219-5baf-a48f-03debf5de4c0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:45.872081-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2003
8368d745-c74d-4236-ba75-16ca7aaeb3ca,TCGA-AA-3502,TCGA-COAD,73,-26724,--,b4df3e14-47e0-57b9-8238-816b2fc3dc85,not reported,male,not reported,released,TCGA-AA-3502_demographic,2019-07-31T18:31:45.872081-05:00,Alive,1930,--,26724,M0,N0,Stage I,T2,5th,not reported,1065,ab4301d9-1fa8-5d79-8ae0-cb94b90d7828,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3502_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3502_treatment,1af39fb9-f38d-5d91-a310-84b8ff18e8c2,no,"Radiation Therapy, NOS",2019-07-31T18:31:45.872081-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2003
a5e14add-1552-4606-9ffe-3a03bcf76640,TCGA-4T-AA8H,TCGA-COAD,42,-15494,--,32ecfa6f-246a-5098-9c2c-523bfb0795e7,not hispanic or latino,female,black or african american,released,TCGA-4T-AA8H_demographic,2019-07-31T18:33:56.520315-05:00,Alive,1971,--,15494,MX,N0,Stage IIA,T3,7th,not reported,385,9c203708-a70d-59cc-8a6d-4163fc4f7645,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-4T-AA8H_diagnosis,No,Descending colon,2019-04-28T11:18:53.124462-05:00,released,TCGA-4T-AA8H_treatment_1,dc1d07dc-3969-5cee-b595-de5e68bb6af6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:56.520315-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2013
a5e14add-1552-4606-9ffe-3a03bcf76640,TCGA-4T-AA8H,TCGA-COAD,42,-15494,--,32ecfa6f-246a-5098-9c2c-523bfb0795e7,not hispanic or latino,female,black or african american,released,TCGA-4T-AA8H_demographic,2019-07-31T18:33:56.520315-05:00,Alive,1971,--,15494,MX,N0,Stage IIA,T3,7th,not reported,385,9c203708-a70d-59cc-8a6d-4163fc4f7645,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-4T-AA8H_diagnosis,No,Descending colon,--,released,TCGA-4T-AA8H_treatment,e25b10e1-2774-51e3-90fd-df4c03d66a5a,no,"Radiation Therapy, NOS",2019-07-31T18:33:56.520315-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2013
e3ca9046-9634-4332-b19f-88b18110f941,TCGA-CM-4751,TCGA-COAD,62,-22891,--,49eb8bfc-7fea-5feb-af97-b973c300850a,not hispanic or latino,male,white,released,TCGA-CM-4751_demographic,2019-07-31T18:39:07.802275-05:00,Alive,1947,--,22891,M0,N1b,Stage IIIB,T3,7th,not reported,822,af83fcc1-98a9-5b9f-9b3d-e5023da9048d,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-4751_diagnosis,No,Cecum,--,released,TCGA-CM-4751_treatment,96f10618-8648-54df-9ea2-ba85e6564ce8,no,"Radiation Therapy, NOS",2019-07-31T18:39:07.802275-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2009
e3ca9046-9634-4332-b19f-88b18110f941,TCGA-CM-4751,TCGA-COAD,62,-22891,--,49eb8bfc-7fea-5feb-af97-b973c300850a,not hispanic or latino,male,white,released,TCGA-CM-4751_demographic,2019-07-31T18:39:07.802275-05:00,Alive,1947,--,22891,M0,N1b,Stage IIIB,T3,7th,not reported,822,af83fcc1-98a9-5b9f-9b3d-e5023da9048d,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-4751_diagnosis,No,Cecum,2019-04-28T11:23:13.901996-05:00,released,TCGA-CM-4751_treatment_1,8b7074e7-222e-5002-a50c-789be99b74d1,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:07.802275-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2009
3334201d-a3c0-45ec-a9ed-cf48cc8c38e8,TCGA-AZ-4614,TCGA-COAD,71,-26267,172,b0163ff6-e4db-5f02-997b-344c5a316b82,not hispanic or latino,female,white,released,TCGA-AZ-4614_demographic,2019-07-31T18:26:25.647975-05:00,Dead,1937,2008,26267,M1,N1,Stage IVA,T4a,--,not reported,--,7a98a635-deab-5375-a629-3f9b94559c70,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4614_diagnosis,No,Cecum,2019-04-28T11:12:39.180249-05:00,released,TCGA-AZ-4614_treatment_1,8c183581-0da4-50e3-9f76-8fb58e9a68a6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:25.647975-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2008
3334201d-a3c0-45ec-a9ed-cf48cc8c38e8,TCGA-AZ-4614,TCGA-COAD,71,-26267,172,b0163ff6-e4db-5f02-997b-344c5a316b82,not hispanic or latino,female,white,released,TCGA-AZ-4614_demographic,2019-07-31T18:26:25.647975-05:00,Dead,1937,2008,26267,M1,N1,Stage IVA,T4a,--,not reported,--,7a98a635-deab-5375-a629-3f9b94559c70,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4614_diagnosis,No,Cecum,--,released,TCGA-AZ-4614_treatment,7cac437a-b8b9-5e6e-ad28-78b10d939f30,no,"Radiation Therapy, NOS",2019-07-31T18:26:25.647975-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2008
e75985cb-357e-4072-b047-eea37965d70c,TCGA-DM-A282,TCGA-COAD,60,-22265,--,c02ac2d2-68f4-5094-9aa6-5157ffe3d6f9,not hispanic or latino,female,white,released,TCGA-DM-A282_demographic,2019-07-31T18:39:30.779527-05:00,Alive,1940,--,22265,M0,N0,Stage IIA,T3,6th,not reported,4233,898c13b3-4b86-5fcc-a27a-e8b29e70f496,C18.3,8480/3,Mucinous adenocarcinoma,no,No,not reported,Hepatic flexure of colon,released,TCGA-DM-A282_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:23:34.099835-05:00,released,TCGA-DM-A282_treatment_1,c16eb6cd-f5db-56f7-b7a1-f351907b3322,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:30.779527-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
e75985cb-357e-4072-b047-eea37965d70c,TCGA-DM-A282,TCGA-COAD,60,-22265,--,c02ac2d2-68f4-5094-9aa6-5157ffe3d6f9,not hispanic or latino,female,white,released,TCGA-DM-A282_demographic,2019-07-31T18:39:30.779527-05:00,Alive,1940,--,22265,M0,N0,Stage IIA,T3,6th,not reported,4233,898c13b3-4b86-5fcc-a27a-e8b29e70f496,C18.3,8480/3,Mucinous adenocarcinoma,no,No,not reported,Hepatic flexure of colon,released,TCGA-DM-A282_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-DM-A282_treatment,5d8d8581-bd05-55f6-8e72-5bec14d31db9,not reported,"Radiation Therapy, NOS",2019-07-31T18:39:30.779527-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
41658cf8-0de1-4a97-bb60-0f0107c84e00,TCGA-AA-3675,TCGA-COAD,84,-30801,--,4dcaccea-0265-5160-bc7a-babc193e4cd4,not reported,male,not reported,released,TCGA-AA-3675_demographic,2019-07-31T18:27:34.274889-05:00,Alive,1922,--,30801,M0,N0,Stage II,T3,5th,not reported,1431,b69ce59a-de84-593e-9392-9c404c4c90d2,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AA-3675_diagnosis,No,Ascending colon,2019-04-28T11:13:36.785987-05:00,released,TCGA-AA-3675_treatment_1,6bd49918-ae28-5617-b4c6-0504bdcf8cdd,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:34.274889-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2006
41658cf8-0de1-4a97-bb60-0f0107c84e00,TCGA-AA-3675,TCGA-COAD,84,-30801,--,4dcaccea-0265-5160-bc7a-babc193e4cd4,not reported,male,not reported,released,TCGA-AA-3675_demographic,2019-07-31T18:27:34.274889-05:00,Alive,1922,--,30801,M0,N0,Stage II,T3,5th,not reported,1431,b69ce59a-de84-593e-9392-9c404c4c90d2,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AA-3675_diagnosis,No,Ascending colon,--,released,TCGA-AA-3675_treatment,7b2966c5-6ba1-58b0-b27c-2464868288fa,no,"Radiation Therapy, NOS",2019-07-31T18:27:34.274889-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2006
613aa3e8-a70b-45a9-9c08-0c2346c8bf00,TCGA-AD-A5EJ,TCGA-COAD,74,-27180,--,2449f775-9b98-5f75-9d41-a91f13de2606,not hispanic or latino,female,black or african american,released,TCGA-AD-A5EJ_demographic,2019-07-31T18:41:47.741064-05:00,Alive,1938,--,27180,MX,N0,Stage IIA,T3,7th,not reported,--,6df8610a-2989-59b6-8ab7-4e722d492f72,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AD-A5EJ_diagnosis,No,Cecum,2019-04-28T11:25:28.371644-05:00,released,TCGA-AD-A5EJ_treatment_1,fde1a8e5-a617-5483-9e18-99255cd1f46c,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:47.741064-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2012
613aa3e8-a70b-45a9-9c08-0c2346c8bf00,TCGA-AD-A5EJ,TCGA-COAD,74,-27180,--,2449f775-9b98-5f75-9d41-a91f13de2606,not hispanic or latino,female,black or african american,released,TCGA-AD-A5EJ_demographic,2019-07-31T18:41:47.741064-05:00,Alive,1938,--,27180,MX,N0,Stage IIA,T3,7th,not reported,--,6df8610a-2989-59b6-8ab7-4e722d492f72,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AD-A5EJ_diagnosis,No,Cecum,--,released,TCGA-AD-A5EJ_treatment,84dc5401-f316-5926-806b-40080642b62e,not reported,"Radiation Therapy, NOS",2019-07-31T18:41:47.741064-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2012
01ad5016-f691-4bca-82a0-910429d8d25b,TCGA-AA-3561,TCGA-COAD,72,-26420,--,a15d5cf9-ccf7-593a-9e1c-548b9884ae7e,not reported,male,not reported,released,TCGA-AA-3561_demographic,2019-07-31T18:22:19.487538-05:00,Alive,1937,--,26420,M0,N0,Stage IIA,T3,6th,not reported,424,e959a688-d3ff-5c8f-93fb-bd3d180b8178,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3561_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3561_treatment,4e687d5b-f5ad-5af9-ae0f-488c1ae75686,no,"Radiation Therapy, NOS",2019-07-31T18:22:19.487538-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2009
01ad5016-f691-4bca-82a0-910429d8d25b,TCGA-AA-3561,TCGA-COAD,72,-26420,--,a15d5cf9-ccf7-593a-9e1c-548b9884ae7e,not reported,male,not reported,released,TCGA-AA-3561_demographic,2019-07-31T18:22:19.487538-05:00,Alive,1937,--,26420,M0,N0,Stage IIA,T3,6th,not reported,424,e959a688-d3ff-5c8f-93fb-bd3d180b8178,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3561_diagnosis,No,"Colon, NOS",2019-04-28T11:09:15.006001-05:00,released,TCGA-AA-3561_treatment_1,373fe496-9007-59b7-bc09-b0ae0eb512b5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:19.487538-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2009
ac6a3df9-41b1-4e5a-a15e-f44481384c23,TCGA-AA-3860,TCGA-COAD,53,-19449,--,610cfbc3-cf71-53f5-981f-cc5f1216fb68,not reported,female,not reported,released,TCGA-AA-3860_demographic,2019-07-31T18:34:29.888668-05:00,Alive,1956,--,19449,M0,N1,Stage IIIB,T3,6th,not reported,945,5b291082-1fe8-5a10-82c1-220d3368f172,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3860_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3860_treatment,1aca079c-bf56-5bae-8be2-aa4c38a642a4,no,"Radiation Therapy, NOS",2019-07-31T18:34:29.888668-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
ac6a3df9-41b1-4e5a-a15e-f44481384c23,TCGA-AA-3860,TCGA-COAD,53,-19449,--,610cfbc3-cf71-53f5-981f-cc5f1216fb68,not reported,female,not reported,released,TCGA-AA-3860_demographic,2019-07-31T18:34:29.888668-05:00,Alive,1956,--,19449,M0,N1,Stage IIIB,T3,6th,not reported,945,5b291082-1fe8-5a10-82c1-220d3368f172,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3860_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:19:19.814826-05:00,released,TCGA-AA-3860_treatment_1,0252d725-b2c8-5d00-b479-322320c12c8c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:29.888668-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
5498d5ef-ad24-4034-9750-7c996c5355e1,TCGA-AA-3875,TCGA-COAD,78,-28640,--,0466a597-764b-5690-b97f-a6b926a9dd1d,not reported,female,not reported,released,TCGA-AA-3875_demographic,2019-07-31T18:28:25.647569-05:00,Alive,1929,--,28640,M0,N0,Stage I,T1,6th,not reported,549,0a2addcc-c767-5584-b773-ab048078e1d1,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3875_diagnosis,No,Ascending colon,2019-04-28T11:14:19.164384-05:00,released,TCGA-AA-3875_treatment_1,6c779f40-7031-549b-8d87-206cd394bf0d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:25.647569-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
5498d5ef-ad24-4034-9750-7c996c5355e1,TCGA-AA-3875,TCGA-COAD,78,-28640,--,0466a597-764b-5690-b97f-a6b926a9dd1d,not reported,female,not reported,released,TCGA-AA-3875_demographic,2019-07-31T18:28:25.647569-05:00,Alive,1929,--,28640,M0,N0,Stage I,T1,6th,not reported,549,0a2addcc-c767-5584-b773-ab048078e1d1,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3875_diagnosis,No,Ascending colon,--,released,TCGA-AA-3875_treatment,8fe82b6a-1b60-535a-b474-46e4c3f06697,no,"Radiation Therapy, NOS",2019-07-31T18:28:25.647569-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
750770db-53cf-4021-a8c2-5e0ddb97fef5,TCGA-AA-3994,TCGA-COAD,69,-25323,--,df93ca80-c97f-5583-8462-8582dbec31f8,not reported,male,not reported,released,TCGA-AA-3994_demographic,2019-07-31T18:30:43.006907-05:00,Alive,1939,--,25323,M0,N1,Stage IIIB,T3,6th,not reported,822,4ee499b4-f7bc-5ba2-a884-ae1c1adac3d8,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3994_diagnosis,No,"Colon, NOS",2019-04-28T11:16:13.699898-05:00,released,TCGA-AA-3994_treatment_1,e76cc591-9fc7-5084-a4ce-530aa7446090,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:43.006907-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2008
750770db-53cf-4021-a8c2-5e0ddb97fef5,TCGA-AA-3994,TCGA-COAD,69,-25323,--,df93ca80-c97f-5583-8462-8582dbec31f8,not reported,male,not reported,released,TCGA-AA-3994_demographic,2019-07-31T18:30:43.006907-05:00,Alive,1939,--,25323,M0,N1,Stage IIIB,T3,6th,not reported,822,4ee499b4-f7bc-5ba2-a884-ae1c1adac3d8,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3994_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3994_treatment,f0efbc27-487c-53e1-a28d-ffdc08e25841,no,"Radiation Therapy, NOS",2019-07-31T18:30:43.006907-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2008
62d39be5-f029-4eb8-8b00-46470e06a755,TCGA-AA-A00Q,TCGA-COAD,66,-24199,--,041cf0af-1896-5ca7-bd8e-8a3501a8820e,not reported,female,not reported,released,TCGA-AA-A00Q_demographic,2019-07-31T15:47:31.276344-05:00,Alive,1942,--,24199,M0,N1,Stage IIIB,T4,6th,not reported,1278,aff4f604-fbee-507c-b299-03279bb4998b,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00Q_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A00Q_treatment,59386e60-f97a-570b-b76b-54a98a04c1f2,no,"Radiation Therapy, NOS",2019-07-31T15:47:31.276344-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2008
62d39be5-f029-4eb8-8b00-46470e06a755,TCGA-AA-A00Q,TCGA-COAD,66,-24199,--,041cf0af-1896-5ca7-bd8e-8a3501a8820e,not reported,female,not reported,released,TCGA-AA-A00Q_demographic,2019-07-31T15:47:31.276344-05:00,Alive,1942,--,24199,M0,N1,Stage IIIB,T4,6th,not reported,1278,aff4f604-fbee-507c-b299-03279bb4998b,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00Q_diagnosis,No,Sigmoid colon,2019-04-28T09:03:49.765581-05:00,released,TCGA-AA-A00Q_treatment_1,4f2e18a9-8951-5902-a510-01191e47f3fc,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:47:31.276344-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2008
cbe23011-93b7-4e9f-b934-bd0122f91f54,TCGA-F4-6463,TCGA-COAD,51,-18804,--,25c689fe-a441-5342-879a-08d0ee7acb06,not hispanic or latino,male,white,released,TCGA-F4-6463_demographic,2019-07-31T18:37:19.412043-05:00,Alive,1960,--,18804,M0,N0,Stage IIA,T3,7th,not reported,1087,1ba63f4b-58a5-5af3-a992-fbf15023d65b,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-F4-6463_diagnosis,No,Transverse colon,--,released,TCGA-F4-6463_treatment,d942e7be-2b05-5352-b2ab-f48cbbbe3456,no,"Radiation Therapy, NOS",2019-07-31T18:37:19.412043-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
cbe23011-93b7-4e9f-b934-bd0122f91f54,TCGA-F4-6463,TCGA-COAD,51,-18804,--,25c689fe-a441-5342-879a-08d0ee7acb06,not hispanic or latino,male,white,released,TCGA-F4-6463_demographic,2019-07-31T18:37:19.412043-05:00,Alive,1960,--,18804,M0,N0,Stage IIA,T3,7th,not reported,1087,1ba63f4b-58a5-5af3-a992-fbf15023d65b,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-F4-6463_diagnosis,No,Transverse colon,2019-04-28T11:21:39.418430-05:00,released,TCGA-F4-6463_treatment_1,d376b638-dc94-5cb3-a581-5c99a7688adc,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:19.412043-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
a72dd578-3a6f-4807-a843-4a942500944e,TCGA-AA-A01K,TCGA-COAD,74,-27029,--,3a070acf-87de-58bc-8423-82015f5af52e,not reported,female,not reported,released,TCGA-AA-A01K_demographic,2019-07-31T18:33:59.679235-05:00,Alive,1935,--,27029,M0,N2,Stage IIIC,T3,6th,not reported,943,157a7626-4402-56c7-9d4a-64dc79318045,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01K_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A01K_treatment,37df7182-0e4c-5066-b781-480e3b0bd3fa,no,"Radiation Therapy, NOS",2019-07-31T18:33:59.679235-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2009
a72dd578-3a6f-4807-a843-4a942500944e,TCGA-AA-A01K,TCGA-COAD,74,-27029,--,3a070acf-87de-58bc-8423-82015f5af52e,not reported,female,not reported,released,TCGA-AA-A01K_demographic,2019-07-31T18:33:59.679235-05:00,Alive,1935,--,27029,M0,N2,Stage IIIC,T3,6th,not reported,943,157a7626-4402-56c7-9d4a-64dc79318045,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01K_diagnosis,No,Sigmoid colon,2019-04-28T11:18:55.682171-05:00,released,TCGA-AA-A01K_treatment_1,b85c48e6-7381-5130-b42d-54ffe14bf0f9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:59.679235-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2009
cee553c8-460d-436b-b55d-8f41624816cc,TCGA-G4-6317,TCGA-COAD,51,-18822,--,8ab6a76c-f78c-5524-ab62-b76badcf91da,not hispanic or latino,female,white,released,TCGA-G4-6317_demographic,2019-07-31T18:37:37.040159-05:00,Alive,1957,--,18822,MX,N2,Stage IIIC,T3,6th,not reported,1095,b7922aa1-5b26-5ed2-86d0-6a25da7b15da,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6317_diagnosis,No,Sigmoid colon,2019-04-28T11:21:54.437248-05:00,released,TCGA-G4-6317_treatment_1,4fab38ba-ab7b-5012-bec3-721c2e157bfa,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:37.040159-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2008
cee553c8-460d-436b-b55d-8f41624816cc,TCGA-G4-6317,TCGA-COAD,51,-18822,--,8ab6a76c-f78c-5524-ab62-b76badcf91da,not hispanic or latino,female,white,released,TCGA-G4-6317_demographic,2019-07-31T18:37:37.040159-05:00,Alive,1957,--,18822,MX,N2,Stage IIIC,T3,6th,not reported,1095,b7922aa1-5b26-5ed2-86d0-6a25da7b15da,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6317_diagnosis,No,Sigmoid colon,--,released,TCGA-G4-6317_treatment,b7024056-8533-5bc3-9327-402b53af84c8,no,"Radiation Therapy, NOS",2019-07-31T18:37:37.040159-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2008
95d4f0c4-5997-4ffb-b876-0ddfeee972bb,TCGA-A6-4105,TCGA-COAD,79,-29097,442,ba979bea-2687-5b6b-b1d2-7cae8d1842f6,not hispanic or latino,male,white,released,TCGA-A6-4105_demographic,2019-07-31T18:32:55.661866-05:00,Dead,1931,2011,29097,M0,N0,Stage IIA,T3,7th,not reported,--,5237b12c-b558-5d27-a19c-7bc99561a195,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-A6-4105_diagnosis,Not Reported,Ascending colon,--,released,TCGA-A6-4105_treatment,bed4e335-ee3e-5006-ad0b-08ffefc4245a,no,"Radiation Therapy, NOS",2019-07-31T18:32:55.661866-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
95d4f0c4-5997-4ffb-b876-0ddfeee972bb,TCGA-A6-4105,TCGA-COAD,79,-29097,442,ba979bea-2687-5b6b-b1d2-7cae8d1842f6,not hispanic or latino,male,white,released,TCGA-A6-4105_demographic,2019-07-31T18:32:55.661866-05:00,Dead,1931,2011,29097,M0,N0,Stage IIA,T3,7th,not reported,--,5237b12c-b558-5d27-a19c-7bc99561a195,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-A6-4105_diagnosis,Not Reported,Ascending colon,2019-04-28T11:18:04.248809-05:00,released,TCGA-A6-4105_treatment_1,4238cfe4-00fc-5c5e-89e1-14f22b7ed3b9,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:55.661866-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
e7dbfca1-9657-4952-8e0d-dec6373dda5b,TCGA-G4-6321,TCGA-COAD,60,-21921,--,85302259-be61-5216-8b2e-ae5ec2d0ac75,not hispanic or latino,female,white,released,TCGA-G4-6321_demographic,2019-07-31T18:39:37.561873-05:00,Alive,1949,--,21921,MX,N1,Stage III,T2,6th,not reported,672,a2bfb093-e2f4-5759-b1a1-5e03c116efc1,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6321_diagnosis,Not Reported,Cecum,--,released,TCGA-G4-6321_treatment,28112b51-aa1c-591d-9fe4-7a113bf181e0,no,"Radiation Therapy, NOS",2019-07-31T18:39:37.561873-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2009
e7dbfca1-9657-4952-8e0d-dec6373dda5b,TCGA-G4-6321,TCGA-COAD,60,-21921,--,85302259-be61-5216-8b2e-ae5ec2d0ac75,not hispanic or latino,female,white,released,TCGA-G4-6321_demographic,2019-07-31T18:39:37.561873-05:00,Alive,1949,--,21921,MX,N1,Stage III,T2,6th,not reported,672,a2bfb093-e2f4-5759-b1a1-5e03c116efc1,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6321_diagnosis,Not Reported,Cecum,2019-04-28T11:23:39.404478-05:00,released,TCGA-G4-6321_treatment_1,94545279-dc82-5fb6-b901-7d0795ea6958,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:37.561873-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2009
f87c6dcc-1a9e-4df5-962c-1f946e2611f8,TCGA-AA-A01T,TCGA-COAD,63,-23192,--,905bb777-342e-533b-a3a4-3e093b1513f2,not reported,female,not reported,released,TCGA-AA-A01T_demographic,2019-07-31T18:40:38.632096-05:00,Alive,1941,--,23192,M0,N1,Stage III,T3,5th,not reported,1005,c5bd6379-4928-57e0-9532-996f77045c13,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01T_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A01T_treatment,c73cc96e-65b6-58ec-a5f2-852af1445e22,no,"Radiation Therapy, NOS",2019-07-31T18:40:38.632096-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
f87c6dcc-1a9e-4df5-962c-1f946e2611f8,TCGA-AA-A01T,TCGA-COAD,63,-23192,--,905bb777-342e-533b-a3a4-3e093b1513f2,not reported,female,not reported,released,TCGA-AA-A01T_demographic,2019-07-31T18:40:38.632096-05:00,Alive,1941,--,23192,M0,N1,Stage III,T3,5th,not reported,1005,c5bd6379-4928-57e0-9532-996f77045c13,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01T_diagnosis,No,Sigmoid colon,2019-04-28T11:24:29.379555-05:00,released,TCGA-AA-A01T_treatment_1,b65850bb-1154-50f5-a2dc-324e99b8b6f3,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:38.632096-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
14efca0c-882d-4fba-b15c-64af6e213b80,TCGA-AA-3976,TCGA-COAD,70,-25599,--,96d26f8d-129f-5e5a-a45f-8c3b37b9665c,not reported,male,not reported,released,TCGA-AA-3976_demographic,2019-07-31T18:24:10.024168-05:00,Alive,1939,--,25599,M0,N1,Stage IIIA,T2,6th,not reported,791,2fb760ba-3fe5-579b-8be8-86ecfb0a0d23,C19,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Rectosigmoid junction,released,TCGA-AA-3976_diagnosis,Not Reported,Rectosigmoid junction,2019-04-28T11:10:46.503643-05:00,released,TCGA-AA-3976_treatment_1,4cb389fd-e3a6-503e-a04e-0548088178c9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:10.024168-05:00,not reported,stage iiia,2019-08-08T16:35:04.140343-05:00,2009
14efca0c-882d-4fba-b15c-64af6e213b80,TCGA-AA-3976,TCGA-COAD,70,-25599,--,96d26f8d-129f-5e5a-a45f-8c3b37b9665c,not reported,male,not reported,released,TCGA-AA-3976_demographic,2019-07-31T18:24:10.024168-05:00,Alive,1939,--,25599,M0,N1,Stage IIIA,T2,6th,not reported,791,2fb760ba-3fe5-579b-8be8-86ecfb0a0d23,C19,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Rectosigmoid junction,released,TCGA-AA-3976_diagnosis,Not Reported,Rectosigmoid junction,--,released,TCGA-AA-3976_treatment,980fcca3-9a0c-5295-b2bd-fcc8a31f7355,no,"Radiation Therapy, NOS",2019-07-31T18:24:10.024168-05:00,not reported,stage iiia,2019-08-08T16:35:04.140343-05:00,2009
38d65618-4857-490e-86b3-0a3f772a9f60,TCGA-CK-5916,TCGA-COAD,71,-26024,643,9842c8e6-ccab-5d13-93a3-58120a201b81,not hispanic or latino,female,white,released,TCGA-CK-5916_demographic,2019-07-31T18:26:52.649539-05:00,Dead,1932,2004,26024,M0,N0,Stage I,T1,6th,not reported,--,51cf0de9-7a10-5e62-8cbe-f68ebf3fa9b2,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CK-5916_diagnosis,No,Ascending colon,2019-04-28T11:13:02.544602-05:00,released,TCGA-CK-5916_treatment_1,5f761851-d2a5-50fc-bda0-4ba679198d88,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:52.649539-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2003
38d65618-4857-490e-86b3-0a3f772a9f60,TCGA-CK-5916,TCGA-COAD,71,-26024,643,9842c8e6-ccab-5d13-93a3-58120a201b81,not hispanic or latino,female,white,released,TCGA-CK-5916_demographic,2019-07-31T18:26:52.649539-05:00,Dead,1932,2004,26024,M0,N0,Stage I,T1,6th,not reported,--,51cf0de9-7a10-5e62-8cbe-f68ebf3fa9b2,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CK-5916_diagnosis,No,Ascending colon,--,released,TCGA-CK-5916_treatment,4bc25f42-2195-5dd7-9700-66b782d30c04,no,"Radiation Therapy, NOS",2019-07-31T18:26:52.649539-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2003
dc22eba5-6fb7-4875-b30a-99fa00758301,TCGA-D5-6920,TCGA-COAD,77,-28124,--,764a04ef-80ff-521a-a303-ee8fcf85404d,not hispanic or latino,female,white,released,TCGA-D5-6920_demographic,2019-07-31T18:38:35.651519-05:00,Alive,1934,--,28124,M0,N0,Stage IIA,T3,7th,not reported,377,67137dc1-edb6-5a1b-91a8-c009c86752de,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6920_diagnosis,No,Sigmoid colon,2019-04-28T11:22:45.748665-05:00,released,TCGA-D5-6920_treatment_1,c4181451-cc56-5d08-bc5f-c397133be071,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:35.651519-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
dc22eba5-6fb7-4875-b30a-99fa00758301,TCGA-D5-6920,TCGA-COAD,77,-28124,--,764a04ef-80ff-521a-a303-ee8fcf85404d,not hispanic or latino,female,white,released,TCGA-D5-6920_demographic,2019-07-31T18:38:35.651519-05:00,Alive,1934,--,28124,M0,N0,Stage IIA,T3,7th,not reported,377,67137dc1-edb6-5a1b-91a8-c009c86752de,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6920_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6920_treatment,dda9b778-e481-59e4-8001-de8316fc0e95,no,"Radiation Therapy, NOS",2019-07-31T18:38:35.651519-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
eb191e71-4b6e-4c8d-8348-519be5a1e657,TCGA-DM-A1D6,TCGA-COAD,88,-32302,570,a0c8b02b-9f5e-50ab-b1e8-e7dcd5cd1211,not hispanic or latino,male,white,released,TCGA-DM-A1D6_demographic,2019-07-31T18:43:04.586219-05:00,Dead,1912,2004,32302,M0,N0,Stage IIA,T3,--,not reported,570,5c5f200a-02c0-538d-b1a9-a758ca14ea9b,C18.5,8480/3,Mucinous adenocarcinoma,no,No,not reported,Splenic flexure of colon,released,TCGA-DM-A1D6_diagnosis,No,Splenic flexure of colon,--,released,TCGA-DM-A1D6_treatment,8c7e4e2b-0041-5e57-bae5-afd2869ae2da,not reported,"Radiation Therapy, NOS",2019-07-31T18:43:04.586219-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
eb191e71-4b6e-4c8d-8348-519be5a1e657,TCGA-DM-A1D6,TCGA-COAD,88,-32302,570,a0c8b02b-9f5e-50ab-b1e8-e7dcd5cd1211,not hispanic or latino,male,white,released,TCGA-DM-A1D6_demographic,2019-07-31T18:43:04.586219-05:00,Dead,1912,2004,32302,M0,N0,Stage IIA,T3,--,not reported,570,5c5f200a-02c0-538d-b1a9-a758ca14ea9b,C18.5,8480/3,Mucinous adenocarcinoma,no,No,not reported,Splenic flexure of colon,released,TCGA-DM-A1D6_diagnosis,No,Splenic flexure of colon,2019-04-28T11:26:34.806001-05:00,released,TCGA-DM-A1D6_treatment_1,86d37584-e148-5335-b76d-c9df58655f0d,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:43:04.586219-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
568dbda7-88b5-4330-881f-dc5d6c7ce4ae,TCGA-G4-6307,TCGA-COAD,37,-13648,--,77af3a77-5a0c-5b9e-ba16-590cba3d54b2,not hispanic or latino,female,white,released,TCGA-G4-6307_demographic,2019-07-31T18:28:41.320756-05:00,Alive,1970,--,13648,M0,N1,Stage IIIB,T3,2nd,not reported,1674,956357f2-9c5f-5c6d-9371-5b6c7a0198d2,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6307_diagnosis,No,Sigmoid colon,2019-04-28T11:14:31.842259-05:00,released,TCGA-G4-6307_treatment_1,8420a802-696e-5e21-954c-d38f287c2e6e,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:41.320756-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2007
568dbda7-88b5-4330-881f-dc5d6c7ce4ae,TCGA-G4-6307,TCGA-COAD,37,-13648,--,77af3a77-5a0c-5b9e-ba16-590cba3d54b2,not hispanic or latino,female,white,released,TCGA-G4-6307_demographic,2019-07-31T18:28:41.320756-05:00,Alive,1970,--,13648,M0,N1,Stage IIIB,T3,2nd,not reported,1674,956357f2-9c5f-5c6d-9371-5b6c7a0198d2,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6307_diagnosis,No,Sigmoid colon,--,released,TCGA-G4-6307_treatment,0d639c64-bb66-5ef3-96b1-29afb95b258f,no,"Radiation Therapy, NOS",2019-07-31T18:28:41.320756-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2007
d9fb85c3-ade1-47bf-8159-170f81eb130f,TCGA-AA-3662,TCGA-COAD,80,-29554,--,78980cce-c5f7-5b89-82e2-70ab7cc6bcbc,not reported,female,not reported,released,TCGA-AA-3662_demographic,2019-07-31T18:38:23.780609-05:00,Alive,1925,--,29554,M1,N2,Stage IV,T4,5th,not reported,184,e3ade95d-c128-5fae-8a6c-3ea820c30c4f,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3662_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:22:35.806906-05:00,released,TCGA-AA-3662_treatment_1,68112583-82df-551e-8762-9757075f163d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:23.780609-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2005
d9fb85c3-ade1-47bf-8159-170f81eb130f,TCGA-AA-3662,TCGA-COAD,80,-29554,--,78980cce-c5f7-5b89-82e2-70ab7cc6bcbc,not reported,female,not reported,released,TCGA-AA-3662_demographic,2019-07-31T18:38:23.780609-05:00,Alive,1925,--,29554,M1,N2,Stage IV,T4,5th,not reported,184,e3ade95d-c128-5fae-8a6c-3ea820c30c4f,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3662_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3662_treatment,861dfd71-e5d7-5d02-a848-5f14fed6db94,no,"Radiation Therapy, NOS",2019-07-31T18:38:23.780609-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2005
043a4745-566b-4106-b159-99cb8b394b81,TCGA-AA-3877,TCGA-COAD,83,-30377,--,afeb6d8b-016d-5866-9a06-fa57cb03e820,not reported,female,not reported,released,TCGA-AA-3877_demographic,2019-07-31T18:22:34.409958-05:00,Alive,1924,--,30377,M0,N0,Stage I,T1,6th,not reported,943,7c64a78f-f0f8-5948-96a9-6385914267be,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-AA-3877_diagnosis,No,Transverse colon,2019-04-28T11:09:28.011600-05:00,released,TCGA-AA-3877_treatment_1,40ea7b0d-34dd-5baf-9d56-351dec55ce94,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:34.409958-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
043a4745-566b-4106-b159-99cb8b394b81,TCGA-AA-3877,TCGA-COAD,83,-30377,--,afeb6d8b-016d-5866-9a06-fa57cb03e820,not reported,female,not reported,released,TCGA-AA-3877_demographic,2019-07-31T18:22:34.409958-05:00,Alive,1924,--,30377,M0,N0,Stage I,T1,6th,not reported,943,7c64a78f-f0f8-5948-96a9-6385914267be,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-AA-3877_diagnosis,No,Transverse colon,--,released,TCGA-AA-3877_treatment,b0947078-60ad-553c-b7ad-0c2f1728f5bb,no,"Radiation Therapy, NOS",2019-07-31T18:22:34.409958-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
ddf69ed9-4c53-48b8-9f01-495bd60c3425,TCGA-AA-3514,TCGA-COAD,81,-29738,--,7a8f2e8e-f56c-5e68-b144-854b46a052d8,not reported,female,not reported,released,TCGA-AA-3514_demographic,2019-07-31T18:38:44.655149-05:00,Alive,1925,--,29738,M0,N0,Stage I,T2,6th,not reported,31,b2c0656f-311b-59ab-aefd-bf25cd66afcd,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3514_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3514_treatment,22e97da3-53cf-55e9-b2e8-c5f52782bcfa,no,"Radiation Therapy, NOS",2019-07-31T18:38:44.655149-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2006
ddf69ed9-4c53-48b8-9f01-495bd60c3425,TCGA-AA-3514,TCGA-COAD,81,-29738,--,7a8f2e8e-f56c-5e68-b144-854b46a052d8,not reported,female,not reported,released,TCGA-AA-3514_demographic,2019-07-31T18:38:44.655149-05:00,Alive,1925,--,29738,M0,N0,Stage I,T2,6th,not reported,31,b2c0656f-311b-59ab-aefd-bf25cd66afcd,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3514_diagnosis,No,"Colon, NOS",2019-04-28T11:22:53.269452-05:00,released,TCGA-AA-3514_treatment_1,6455f318-082a-51eb-a9d8-e7179e885d1f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:44.655149-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2006
4c6c8d3d-e4a3-490a-9211-cfbe7e6ee25b,TCGA-A6-5665,TCGA-COAD,84,-30915,--,ec8fb7f7-4585-5aa5-96be-7367b8226cd3,not hispanic or latino,female,white,released,TCGA-A6-5665_demographic,2019-07-31T18:28:05.162254-05:00,Alive,1926,--,30915,M0,N0,Stage IIA,T3,7th,not reported,671,8b065860-5850-5e13-9d3c-930da451c3bb,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-5665_diagnosis,No,Ascending colon,--,released,TCGA-A6-5665_treatment,e21825af-c3b3-5f46-a33f-c25ebe0864b2,no,"Radiation Therapy, NOS",2019-07-31T18:28:05.162254-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
4c6c8d3d-e4a3-490a-9211-cfbe7e6ee25b,TCGA-A6-5665,TCGA-COAD,84,-30915,--,ec8fb7f7-4585-5aa5-96be-7367b8226cd3,not hispanic or latino,female,white,released,TCGA-A6-5665_demographic,2019-07-31T18:28:05.162254-05:00,Alive,1926,--,30915,M0,N0,Stage IIA,T3,7th,not reported,671,8b065860-5850-5e13-9d3c-930da451c3bb,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-5665_diagnosis,No,Ascending colon,2019-04-28T11:14:01.938818-05:00,released,TCGA-A6-5665_treatment_1,26744759-4778-5baa-b97d-87f1cc418475,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:05.162254-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
f9b5e6a5-c2da-4a0d-9251-bb6f557b7b58,TCGA-AA-3660,TCGA-COAD,51,-18932,--,3ebb1aba-374f-5bf2-aad9-2d60e8084b73,not reported,female,not reported,released,TCGA-AA-3660_demographic,2019-07-31T18:40:47.698467-05:00,Alive,1954,--,18932,M0,N0,Stage II,T3,5th,not reported,2375,0c65cb46-40f0-59f1-898f-1726882ee790,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3660_diagnosis,No,"Colon, NOS",2019-04-28T11:24:37.050565-05:00,released,TCGA-AA-3660_treatment_1,58e82586-9e95-50f3-aa35-86ce548d60bf,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:47.698467-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
f9b5e6a5-c2da-4a0d-9251-bb6f557b7b58,TCGA-AA-3660,TCGA-COAD,51,-18932,--,3ebb1aba-374f-5bf2-aad9-2d60e8084b73,not reported,female,not reported,released,TCGA-AA-3660_demographic,2019-07-31T18:40:47.698467-05:00,Alive,1954,--,18932,M0,N0,Stage II,T3,5th,not reported,2375,0c65cb46-40f0-59f1-898f-1726882ee790,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3660_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3660_treatment,67987cc9-22df-5fe6-b7a5-c12589b19dbb,no,"Radiation Therapy, NOS",2019-07-31T18:40:47.698467-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
835c3e23-ac2b-4bc9-ac65-e3e81adecf77,TCGA-AA-3941,TCGA-COAD,84,-31015,--,341f720b-2dcd-5a10-a546-38aed255c011,not reported,female,not reported,released,TCGA-AA-3941_demographic,2019-07-31T18:31:43.058452-05:00,Alive,1926,--,31015,M1a,N1b,Stage IVA,T4,7th,not reported,730,b5c63aae-bc1d-5b49-ae43-4c43198a4641,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3941_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3941_treatment,0a5169f6-1369-54bb-a9d3-d9ae47428423,no,"Radiation Therapy, NOS",2019-07-31T18:31:43.058452-05:00,not reported,stage iva,2019-08-08T16:35:04.140343-05:00,2010
835c3e23-ac2b-4bc9-ac65-e3e81adecf77,TCGA-AA-3941,TCGA-COAD,84,-31015,--,341f720b-2dcd-5a10-a546-38aed255c011,not reported,female,not reported,released,TCGA-AA-3941_demographic,2019-07-31T18:31:43.058452-05:00,Alive,1926,--,31015,M1a,N1b,Stage IVA,T4,7th,not reported,730,b5c63aae-bc1d-5b49-ae43-4c43198a4641,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3941_diagnosis,No,"Colon, NOS",2019-04-28T11:17:03.184207-05:00,released,TCGA-AA-3941_treatment_1,b9fb7567-5254-5a3b-a352-997435e6ee7e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:43.058452-05:00,not reported,stage iva,2019-08-08T16:35:04.140343-05:00,2010
849031de-ac8a-4012-9362-d192512997f1,TCGA-AZ-6605,TCGA-COAD,77,-28485,159,e480900c-f32e-543a-b2de-6989eca3bc0a,not hispanic or latino,male,white,released,TCGA-AZ-6605_demographic,2019-07-31T18:31:48.834673-05:00,Dead,1931,2008,28485,M0,N1,Stage IIIB,T4,6th,not reported,--,19091e01-a122-53be-8a0b-ea9624523ced,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-6605_diagnosis,No,Ascending colon,--,released,TCGA-AZ-6605_treatment,366973aa-5847-502b-88d3-56ecded026ec,no,"Radiation Therapy, NOS",2019-07-31T18:31:48.834673-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2008
849031de-ac8a-4012-9362-d192512997f1,TCGA-AZ-6605,TCGA-COAD,77,-28485,159,e480900c-f32e-543a-b2de-6989eca3bc0a,not hispanic or latino,male,white,released,TCGA-AZ-6605_demographic,2019-07-31T18:31:48.834673-05:00,Dead,1931,2008,28485,M0,N1,Stage IIIB,T4,6th,not reported,--,19091e01-a122-53be-8a0b-ea9624523ced,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-6605_diagnosis,No,Ascending colon,2019-04-28T11:17:08.059273-05:00,released,TCGA-AZ-6605_treatment_1,e232ed5b-89ce-55c3-8c8d-afb4f6ef11ea,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:48.834673-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2008
e457344d-76fb-46bf-b362-61a6e811d131,TCGA-AA-A00N,TCGA-COAD,75,-27667,122,e5528d29-c1db-5e6b-9d91-a6ac56e88f21,not reported,male,not reported,released,TCGA-AA-A00N_demographic,2019-07-31T18:39:10.501456-05:00,Dead,1933,2008,27667,M0,N0,Stage IIB,T4,6th,not reported,--,64590599-9ebb-51e3-802d-94e0e3cc904f,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-A00N_diagnosis,No,Cecum,2019-04-28T11:23:16.540087-05:00,released,TCGA-AA-A00N_treatment_1,20c99f24-8d92-5a51-9678-f0126609e625,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:10.501456-05:00,not reported,stage iib,2019-08-08T16:35:04.140343-05:00,2008
e457344d-76fb-46bf-b362-61a6e811d131,TCGA-AA-A00N,TCGA-COAD,75,-27667,122,e5528d29-c1db-5e6b-9d91-a6ac56e88f21,not reported,male,not reported,released,TCGA-AA-A00N_demographic,2019-07-31T18:39:10.501456-05:00,Dead,1933,2008,27667,M0,N0,Stage IIB,T4,6th,not reported,--,64590599-9ebb-51e3-802d-94e0e3cc904f,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-A00N_diagnosis,No,Cecum,--,released,TCGA-AA-A00N_treatment,246008df-b04d-5635-a6eb-06109133a5af,not reported,"Radiation Therapy, NOS",2019-07-31T18:39:10.501456-05:00,not reported,stage iib,2019-08-08T16:35:04.140343-05:00,2008
32b77693-18e1-4692-8488-add1940c9e7c,TCGA-AU-6004,TCGA-COAD,69,-25259,--,62153c7a-2cf9-52f2-8e97-c8a496b7391c,not hispanic or latino,female,white,released,TCGA-AU-6004_demographic,2019-07-31T18:26:22.730006-05:00,Alive,1941,--,25259,M0,N0,Stage I,T2,7th,not reported,824,cd9b87fb-e8d2-56c0-a3c6-d3bd74294c70,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AU-6004_diagnosis,No,Cecum,2019-04-28T11:12:36.759509-05:00,released,TCGA-AU-6004_treatment_1,954779bb-0ba2-5a4c-8252-71a274b92197,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:22.730006-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2010
32b77693-18e1-4692-8488-add1940c9e7c,TCGA-AU-6004,TCGA-COAD,69,-25259,--,62153c7a-2cf9-52f2-8e97-c8a496b7391c,not hispanic or latino,female,white,released,TCGA-AU-6004_demographic,2019-07-31T18:26:22.730006-05:00,Alive,1941,--,25259,M0,N0,Stage I,T2,7th,not reported,824,cd9b87fb-e8d2-56c0-a3c6-d3bd74294c70,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AU-6004_diagnosis,No,Cecum,--,released,TCGA-AU-6004_treatment,a16d82e6-93ca-52b2-a858-23c8726f15ac,not reported,"Radiation Therapy, NOS",2019-07-31T18:26:22.730006-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2010
5da56982-6de7-4994-aa9e-3b01200b2959,TCGA-AA-3861,TCGA-COAD,72,-26602,--,e74c8b90-fe24-55f3-8100-8ae97bcd37a6,not reported,male,not reported,released,TCGA-AA-3861_demographic,2019-07-31T18:29:15.928818-05:00,Alive,1937,--,26602,M0,N0,Stage IIA,T3,6th,not reported,914,3ba9803b-07e1-5a4c-a6c2-3f9f63eb277f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3861_diagnosis,No,Cecum,2019-04-28T11:15:02.129675-05:00,released,TCGA-AA-3861_treatment_1,ae97c72d-fd02-54a5-ac3f-7eaa06a42a75,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:15.928818-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
5da56982-6de7-4994-aa9e-3b01200b2959,TCGA-AA-3861,TCGA-COAD,72,-26602,--,e74c8b90-fe24-55f3-8100-8ae97bcd37a6,not reported,male,not reported,released,TCGA-AA-3861_demographic,2019-07-31T18:29:15.928818-05:00,Alive,1937,--,26602,M0,N0,Stage IIA,T3,6th,not reported,914,3ba9803b-07e1-5a4c-a6c2-3f9f63eb277f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3861_diagnosis,No,Cecum,--,released,TCGA-AA-3861_treatment,e624d2c1-3d48-5177-8245-8997ff4d9707,no,"Radiation Therapy, NOS",2019-07-31T18:29:15.928818-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
7f6898e2-a840-4ad1-80f7-783f8b766fcc,TCGA-WS-AB45,TCGA-COAD,52,--,--,6b1fd853-a75e-52c0-a2a3-08bdc2d715a1,not hispanic or latino,female,black or african american,released,TCGA-WS-AB45_demographic,2019-07-31T18:31:24.849368-05:00,Alive,1956,--,--,MX,N0,Stage IIA,T3,6th,not reported,2130,8cb35400-b14c-5ee7-8723-afcd84a42ea0,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-WS-AB45_diagnosis,No,Cecum,--,released,TCGA-WS-AB45_treatment,7dcb75ff-8869-5f92-a85d-1fac0c2ffc37,no,"Radiation Therapy, NOS",2019-07-31T18:31:24.849368-05:00,not reported,stage iia,2019-08-08T16:37:44.165377-05:00,2008
7f6898e2-a840-4ad1-80f7-783f8b766fcc,TCGA-WS-AB45,TCGA-COAD,52,--,--,6b1fd853-a75e-52c0-a2a3-08bdc2d715a1,not hispanic or latino,female,black or african american,released,TCGA-WS-AB45_demographic,2019-07-31T18:31:24.849368-05:00,Alive,1956,--,--,MX,N0,Stage IIA,T3,6th,not reported,2130,8cb35400-b14c-5ee7-8723-afcd84a42ea0,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-WS-AB45_diagnosis,No,Cecum,2019-04-28T11:16:48.412551-05:00,released,TCGA-WS-AB45_treatment_1,e52050f9-4fd5-5a56-8479-32dce5c71f29,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:24.849368-05:00,not reported,stage iia,2019-08-08T16:37:44.165377-05:00,2008
94067eb7-98b7-4975-bab1-c09e1b454a25,TCGA-D5-5541,TCGA-COAD,63,-23109,--,6bace8fa-7f7f-5b3f-afa3-b5992d16f4e1,not hispanic or latino,male,white,released,TCGA-D5-5541_demographic,2019-07-31T18:32:49.712600-05:00,Alive,1947,--,23109,M0,N1a,Stage IIIB,T3,--,not reported,1701,a1d7f915-44f6-50c3-b690-3a61ec240a90,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-5541_diagnosis,No,Sigmoid colon,2019-04-28T11:17:59.504788-05:00,released,TCGA-D5-5541_treatment_1,cca769b3-cbf8-5581-baca-c2362dfdfabb,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:49.712600-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
94067eb7-98b7-4975-bab1-c09e1b454a25,TCGA-D5-5541,TCGA-COAD,63,-23109,--,6bace8fa-7f7f-5b3f-afa3-b5992d16f4e1,not hispanic or latino,male,white,released,TCGA-D5-5541_demographic,2019-07-31T18:32:49.712600-05:00,Alive,1947,--,23109,M0,N1a,Stage IIIB,T3,--,not reported,1701,a1d7f915-44f6-50c3-b690-3a61ec240a90,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-5541_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-5541_treatment,cb4216ad-e6ab-5f0d-beee-6be3d1ade480,no,"Radiation Therapy, NOS",2019-07-31T18:32:49.712600-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
c83d38fc-e011-4f75-a100-96513611f3e9,TCGA-QG-A5YV,TCGA-COAD,64,-23499,--,f925b2d3-22aa-5466-b920-a5e93a24ab81,not hispanic or latino,female,black or african american,released,TCGA-QG-A5YV_demographic,2019-07-31T15:26:52.331591-05:00,Alive,1947,--,23499,MX,N1a,Stage IIIC,T4b,7th,not reported,1301,b36a2c9a-a9c7-5d4a-816c-7c688bf79b37,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-QG-A5YV_diagnosis,No,Sigmoid colon,--,released,TCGA-QG-A5YV_treatment,deb10c46-927d-5f08-91c2-e15a2fc847ce,no,"Radiation Therapy, NOS",2019-07-31T15:26:52.331591-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2011
c83d38fc-e011-4f75-a100-96513611f3e9,TCGA-QG-A5YV,TCGA-COAD,64,-23499,--,f925b2d3-22aa-5466-b920-a5e93a24ab81,not hispanic or latino,female,black or african american,released,TCGA-QG-A5YV_demographic,2019-07-31T15:26:52.331591-05:00,Alive,1947,--,23499,MX,N1a,Stage IIIC,T4b,7th,not reported,1301,b36a2c9a-a9c7-5d4a-816c-7c688bf79b37,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-QG-A5YV_diagnosis,No,Sigmoid colon,2019-04-28T08:46:04.832089-05:00,released,TCGA-QG-A5YV_treatment_1,f2bb1ea1-a82f-5606-9c55-0b31f58dfad4,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:26:52.331591-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2011
dd7a53ee-cb08-40c4-9935-51d1ca17e9e8,TCGA-A6-A565,TCGA-COAD,34,-12526,494,71b2037e-0745-5b5d-b990-0559111356de,not reported,female,black or african american,released,TCGA-A6-A565_demographic,2019-07-31T15:54:22.209427-05:00,Dead,1974,2009,12526,MX,N2,Stage IIIC,T3,6th,not reported,--,543c73c4-4fed-5459-a732-a3cee12f433b,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-A6-A565_diagnosis,No,Transverse colon,--,released,TCGA-A6-A565_treatment,0b28aa5e-f038-598e-abcd-cf1b527996f4,no,"Radiation Therapy, NOS",2019-07-31T15:54:22.209427-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
dd7a53ee-cb08-40c4-9935-51d1ca17e9e8,TCGA-A6-A565,TCGA-COAD,34,-12526,494,71b2037e-0745-5b5d-b990-0559111356de,not reported,female,black or african american,released,TCGA-A6-A565_demographic,2019-07-31T15:54:22.209427-05:00,Dead,1974,2009,12526,MX,N2,Stage IIIC,T3,6th,not reported,--,543c73c4-4fed-5459-a732-a3cee12f433b,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-A6-A565_diagnosis,No,Transverse colon,2019-04-28T09:09:24.370420-05:00,released,TCGA-A6-A565_treatment_1,23b36149-60c6-56ba-a51d-62a16b429a6b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:54:22.209427-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
eb4e4e09-98b3-4e85-8dd2-75676ff2af14,TCGA-A6-5656,TCGA-COAD,74,-27184,--,71fa0c75-6370-5652-ae06-14f4082d3333,not hispanic or latino,male,white,released,TCGA-A6-5656_demographic,2019-07-31T15:40:49.085554-05:00,Alive,1936,--,27184,M0,N0,Stage I,T2,7th,not reported,1001,028a6c81-e6ad-54d6-b704-f2e221dc1175,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-5656_diagnosis,No,Sigmoid colon,2019-04-28T08:58:10.975715-05:00,released,TCGA-A6-5656_treatment_1,a4155406-552e-52d2-8697-3311c99a6dce,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:40:49.085554-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2010
eb4e4e09-98b3-4e85-8dd2-75676ff2af14,TCGA-A6-5656,TCGA-COAD,74,-27184,--,71fa0c75-6370-5652-ae06-14f4082d3333,not hispanic or latino,male,white,released,TCGA-A6-5656_demographic,2019-07-31T15:40:49.085554-05:00,Alive,1936,--,27184,M0,N0,Stage I,T2,7th,not reported,1001,028a6c81-e6ad-54d6-b704-f2e221dc1175,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-5656_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-5656_treatment,aa8e8952-5377-5f83-8641-26e7b45d2929,no,"Radiation Therapy, NOS",2019-07-31T15:40:49.085554-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2010
fce1fd5a-54d2-4260-b187-4eb7035e96e9,TCGA-CM-6675,TCGA-COAD,35,-12935,--,74318c8e-1db4-52c2-bec7-d3c26378b3db,not hispanic or latino,male,black or african american,released,TCGA-CM-6675_demographic,2019-07-31T18:41:09.062845-05:00,Alive,1976,--,12935,M1b,N2b,Stage IVB,T3,7th,not reported,397,d4767b82-2b32-57c6-b805-c54a60c2d221,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6675_diagnosis,No,Cecum,2019-04-28T11:24:54.570495-05:00,released,TCGA-CM-6675_treatment_1,23fdf036-f01a-5c46-b363-683d3135e1bd,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:09.062845-05:00,not reported,stage ivb,2019-08-08T16:36:28.485406-05:00,2011
fce1fd5a-54d2-4260-b187-4eb7035e96e9,TCGA-CM-6675,TCGA-COAD,35,-12935,--,74318c8e-1db4-52c2-bec7-d3c26378b3db,not hispanic or latino,male,black or african american,released,TCGA-CM-6675_demographic,2019-07-31T18:41:09.062845-05:00,Alive,1976,--,12935,M1b,N2b,Stage IVB,T3,7th,not reported,397,d4767b82-2b32-57c6-b805-c54a60c2d221,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6675_diagnosis,No,Cecum,--,released,TCGA-CM-6675_treatment,0afb1a2a-af33-5a35-848c-66fb6ffffb06,no,"Radiation Therapy, NOS",2019-07-31T18:41:09.062845-05:00,not reported,stage ivb,2019-08-08T16:36:28.485406-05:00,2011
36eaf209-c332-4321-b6aa-51a3368ecd79,TCGA-AA-3555,TCGA-COAD,81,-29617,--,44aef388-91be-5490-8bf7-0da9bf0aefce,not reported,female,not reported,released,TCGA-AA-3555_demographic,2019-07-31T18:26:46.449505-05:00,Alive,1927,--,29617,M0,N0,Stage IIA,T3,6th,not reported,911,25b239a7-ab82-5ab9-ae57-038444646fcf,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3555_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3555_treatment,f189f9c1-4468-5c56-a4ae-0fbf1d586bd3,no,"Radiation Therapy, NOS",2019-07-31T18:26:46.449505-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2008
36eaf209-c332-4321-b6aa-51a3368ecd79,TCGA-AA-3555,TCGA-COAD,81,-29617,--,44aef388-91be-5490-8bf7-0da9bf0aefce,not reported,female,not reported,released,TCGA-AA-3555_demographic,2019-07-31T18:26:46.449505-05:00,Alive,1927,--,29617,M0,N0,Stage IIA,T3,6th,not reported,911,25b239a7-ab82-5ab9-ae57-038444646fcf,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3555_diagnosis,No,"Colon, NOS",2019-04-28T11:12:57.322130-05:00,released,TCGA-AA-3555_treatment_1,f411ee46-7cb7-500e-bacb-ff6822da7f63,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:46.449505-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2008
9382987c-b5b3-48fe-8194-4d83fe340cd0,TCGA-F4-6807,TCGA-COAD,51,-18690,--,46a18ab6-d58a-5fdf-bdbb-151154cf05e3,not hispanic or latino,female,white,released,TCGA-F4-6807_demographic,2019-07-31T18:32:37.834512-05:00,Alive,1960,--,18690,M0,N2b,Stage IIIC,T3,7th,not reported,1309,58988d02-f71c-5dad-9321-038a10dd8344,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6807_diagnosis,No,"Colon, NOS",2019-04-28T11:17:49.204500-05:00,released,TCGA-F4-6807_treatment_1,5dc0e54a-7f74-56af-b9d2-521ef85081cb,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:37.834512-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2011
9382987c-b5b3-48fe-8194-4d83fe340cd0,TCGA-F4-6807,TCGA-COAD,51,-18690,--,46a18ab6-d58a-5fdf-bdbb-151154cf05e3,not hispanic or latino,female,white,released,TCGA-F4-6807_demographic,2019-07-31T18:32:37.834512-05:00,Alive,1960,--,18690,M0,N2b,Stage IIIC,T3,7th,not reported,1309,58988d02-f71c-5dad-9321-038a10dd8344,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6807_diagnosis,No,"Colon, NOS",--,released,TCGA-F4-6807_treatment,93f86c02-17cb-5724-9a5f-9389e91a9e27,no,"Radiation Therapy, NOS",2019-07-31T18:32:37.834512-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2011
0cb0dac8-4ce2-444a-b1ae-1550e065b4d9,TCGA-AA-A01V,TCGA-COAD,59,-21792,--,48da077c-9d18-5eff-8c46-337182c49ca1,not reported,male,not reported,released,TCGA-AA-A01V_demographic,2019-07-31T18:23:10.236755-05:00,Alive,1945,--,21792,M0,N0,Stage I,T2,5th,not reported,31,66a02deb-321a-5b9d-a215-3e12f6a6f5fb,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A01V_diagnosis,No,Cecum,2019-04-28T11:09:58.526601-05:00,released,TCGA-AA-A01V_treatment_1,1ab9847f-0c97-552e-8c8d-99791175146c,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:10.236755-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2004
0cb0dac8-4ce2-444a-b1ae-1550e065b4d9,TCGA-AA-A01V,TCGA-COAD,59,-21792,--,48da077c-9d18-5eff-8c46-337182c49ca1,not reported,male,not reported,released,TCGA-AA-A01V_demographic,2019-07-31T18:23:10.236755-05:00,Alive,1945,--,21792,M0,N0,Stage I,T2,5th,not reported,31,66a02deb-321a-5b9d-a215-3e12f6a6f5fb,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A01V_diagnosis,No,Cecum,--,released,TCGA-AA-A01V_treatment,da75f03d-ba5d-52fe-9d8f-28394aca4fed,not reported,"Radiation Therapy, NOS",2019-07-31T18:23:10.236755-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2004
e6ec5a68-7555-4f26-bd7e-9cdb4c5f7004,TCGA-AA-3549,TCGA-COAD,69,-25415,--,4e1df4e6-8694-52f0-9dab-50374df39a77,not reported,male,not reported,released,TCGA-AA-3549_demographic,2019-07-31T18:39:25.071028-05:00,Alive,1939,--,25415,M0,N0,Stage I,T2,6th,not reported,639,e2cf51cf-7393-5f02-b402-85a61bb1d6bc,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3549_diagnosis,No,"Colon, NOS",2019-04-28T11:23:29.203155-05:00,released,TCGA-AA-3549_treatment_1,c90bf09d-da9e-54f4-a6ed-68615def25ad,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:25.071028-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
e6ec5a68-7555-4f26-bd7e-9cdb4c5f7004,TCGA-AA-3549,TCGA-COAD,69,-25415,--,4e1df4e6-8694-52f0-9dab-50374df39a77,not reported,male,not reported,released,TCGA-AA-3549_demographic,2019-07-31T18:39:25.071028-05:00,Alive,1939,--,25415,M0,N0,Stage I,T2,6th,not reported,639,e2cf51cf-7393-5f02-b402-85a61bb1d6bc,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3549_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3549_treatment,9dde8b90-276d-5a7b-8421-04a5a80fdcb1,yes,"Radiation Therapy, NOS",2019-07-31T18:39:25.071028-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
4f786107-3cf5-4ab3-bba4-f399dee23f0e,TCGA-AA-3844,TCGA-COAD,78,-28521,--,63613bf9-e89e-5e95-98de-225f503dc73a,not reported,female,not reported,released,TCGA-AA-3844_demographic,2019-07-31T18:28:11.082544-05:00,Alive,1931,--,28521,M0,N2,Stage IIIC,T3,6th,not reported,454,a48b545d-d9f0-5838-959c-879dd4073190,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3844_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3844_treatment,70a33944-b1a3-53cb-a9f4-96c85f0f6cea,yes,"Radiation Therapy, NOS",2019-07-31T18:28:11.082544-05:00,not reported,stage iiic,2019-08-08T16:34:38.138144-05:00,2009
4f786107-3cf5-4ab3-bba4-f399dee23f0e,TCGA-AA-3844,TCGA-COAD,78,-28521,--,63613bf9-e89e-5e95-98de-225f503dc73a,not reported,female,not reported,released,TCGA-AA-3844_demographic,2019-07-31T18:28:11.082544-05:00,Alive,1931,--,28521,M0,N2,Stage IIIC,T3,6th,not reported,454,a48b545d-d9f0-5838-959c-879dd4073190,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3844_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:14:06.591888-05:00,released,TCGA-AA-3844_treatment_1,d27e1763-e78a-5a5f-a7c9-b251c5096520,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:11.082544-05:00,not reported,stage iiic,2019-08-08T16:34:38.138144-05:00,2009
cc53bf9e-5e27-4305-a08b-552120c10aa5,TCGA-AA-3950,TCGA-COAD,79,-29130,--,647747e6-769a-5fdc-888c-13d03910711d,not reported,female,not reported,released,TCGA-AA-3950_demographic,2019-07-31T18:37:28.224356-05:00,Alive,1931,--,29130,M0,N0,Stage IIA,T3,6th,not reported,730,49315af2-455b-5103-a293-115f4a86faa0,C18.2,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Ascending colon,released,TCGA-AA-3950_diagnosis,Not Reported,Ascending colon,2019-04-28T11:21:46.738416-05:00,released,TCGA-AA-3950_treatment_1,c1cfa321-b4b4-55a8-8957-93b499fc7eae,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:28.224356-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2010
cc53bf9e-5e27-4305-a08b-552120c10aa5,TCGA-AA-3950,TCGA-COAD,79,-29130,--,647747e6-769a-5fdc-888c-13d03910711d,not reported,female,not reported,released,TCGA-AA-3950_demographic,2019-07-31T18:37:28.224356-05:00,Alive,1931,--,29130,M0,N0,Stage IIA,T3,6th,not reported,730,49315af2-455b-5103-a293-115f4a86faa0,C18.2,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Ascending colon,released,TCGA-AA-3950_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3950_treatment,8df55038-5f7c-5d2c-b43b-19d123fe3ce5,no,"Radiation Therapy, NOS",2019-07-31T18:37:28.224356-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2010
f38d49b7-6cad-4460-abd0-3685a3b2d941,TCGA-AA-3814,TCGA-COAD,85,-31380,--,5f03ff67-868b-5d06-85c2-a2ef124dde5c,not reported,female,not reported,released,TCGA-AA-3814_demographic,2019-07-31T18:40:19.187259-05:00,Alive,1922,--,31380,M0,N0,Stage IIA,T3,6th,not reported,--,03e1152c-f492-54c3-ba21-9d88c5f45818,C18.9,8255/3,Adenocarcinoma with mixed subtypes,yes,No,not reported,"Colon, NOS",released,TCGA-AA-3814_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:24:14.162079-05:00,released,TCGA-AA-3814_treatment_1,760b3a0d-ded8-549d-abaf-338d2cae7b29,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:19.187259-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
f38d49b7-6cad-4460-abd0-3685a3b2d941,TCGA-AA-3814,TCGA-COAD,85,-31380,--,5f03ff67-868b-5d06-85c2-a2ef124dde5c,not reported,female,not reported,released,TCGA-AA-3814_demographic,2019-07-31T18:40:19.187259-05:00,Alive,1922,--,31380,M0,N0,Stage IIA,T3,6th,not reported,--,03e1152c-f492-54c3-ba21-9d88c5f45818,C18.9,8255/3,Adenocarcinoma with mixed subtypes,yes,No,not reported,"Colon, NOS",released,TCGA-AA-3814_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3814_treatment,76bdb056-05b4-5be7-9900-aea0a2032797,not reported,"Radiation Therapy, NOS",2019-07-31T18:40:19.187259-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
c48e2ce0-3806-4675-92f3-d38ff67c5efa,TCGA-DM-A28M,TCGA-COAD,63,-23043,--,155b98d4-01cf-527d-bfab-f482001d7542,not hispanic or latino,male,white,released,TCGA-DM-A28M_demographic,2019-07-31T18:36:19.731617-05:00,Alive,1940,--,23043,M0,N0,Stage IIA,T3,6th,not reported,2895,d6c89b75-58be-5023-b55a-a367d1330a70,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-DM-A28M_diagnosis,No,Descending colon,--,released,TCGA-DM-A28M_treatment,b9674b50-24a2-5d9a-b9e5-64be67c10752,not reported,"Radiation Therapy, NOS",2019-07-31T18:36:19.731617-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2003
c48e2ce0-3806-4675-92f3-d38ff67c5efa,TCGA-DM-A28M,TCGA-COAD,63,-23043,--,155b98d4-01cf-527d-bfab-f482001d7542,not hispanic or latino,male,white,released,TCGA-DM-A28M_demographic,2019-07-31T18:36:19.731617-05:00,Alive,1940,--,23043,M0,N0,Stage IIA,T3,6th,not reported,2895,d6c89b75-58be-5023-b55a-a367d1330a70,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-DM-A28M_diagnosis,No,Descending colon,2019-04-28T11:20:51.173605-05:00,released,TCGA-DM-A28M_treatment_1,46c7ae10-5016-5d5c-b043-338d75a077d9,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:19.731617-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2003
d5619045-060a-4b60-86e4-6a5774994fd4,TCGA-AA-3989,TCGA-COAD,84,-30712,242,8b62f224-eb71-58a3-befe-731d74dc3164,not reported,male,not reported,released,TCGA-AA-3989_demographic,2019-07-31T18:38:00.249306-05:00,Dead,1925,--,30712,M1,N2,Stage IV,T3,6th,not reported,--,1064fa3a-0e4c-50d0-9bb7-d39c97f03ddb,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3989_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3989_treatment,1aac6fb1-125c-59e4-a5da-d2a42415a7ae,no,"Radiation Therapy, NOS",2019-07-31T18:38:00.249306-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
d5619045-060a-4b60-86e4-6a5774994fd4,TCGA-AA-3989,TCGA-COAD,84,-30712,242,8b62f224-eb71-58a3-befe-731d74dc3164,not reported,male,not reported,released,TCGA-AA-3989_demographic,2019-07-31T18:38:00.249306-05:00,Dead,1925,--,30712,M1,N2,Stage IV,T3,6th,not reported,--,1064fa3a-0e4c-50d0-9bb7-d39c97f03ddb,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3989_diagnosis,No,"Colon, NOS",2019-04-28T11:22:15.051169-05:00,released,TCGA-AA-3989_treatment_1,4a21417e-d43d-53f9-b843-972150a269dc,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:00.249306-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
227f945f-76fd-4a63-9609-d4e730a3d22a,TCGA-CM-5349,TCGA-COAD,68,-24867,--,307a32ac-af84-50c5-abf2-70aaa605b264,not hispanic or latino,female,white,released,TCGA-CM-5349_demographic,2019-07-31T18:24:56.400495-05:00,Alive,1942,--,24867,M0,N0,Stage IIA,T3,7th,not reported,915,7b2e84ea-4f86-54a5-b17d-591de0310179,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5349_diagnosis,No,Cecum,--,released,TCGA-CM-5349_treatment,58c33e23-aec3-5d36-aee9-410f93b95ef3,no,"Radiation Therapy, NOS",2019-07-31T18:24:56.400495-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
227f945f-76fd-4a63-9609-d4e730a3d22a,TCGA-CM-5349,TCGA-COAD,68,-24867,--,307a32ac-af84-50c5-abf2-70aaa605b264,not hispanic or latino,female,white,released,TCGA-CM-5349_demographic,2019-07-31T18:24:56.400495-05:00,Alive,1942,--,24867,M0,N0,Stage IIA,T3,7th,not reported,915,7b2e84ea-4f86-54a5-b17d-591de0310179,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5349_diagnosis,No,Cecum,2019-04-28T11:11:24.221255-05:00,released,TCGA-CM-5349_treatment_1,86e60908-dab9-5a59-a042-79072913b77a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:56.400495-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
1a09207e-9184-4f32-bd07-a9f4dc6c825d,TCGA-AA-3833,TCGA-COAD,63,-23011,--,e5fdab11-8dde-59cf-a84c-57fd65f18822,not reported,female,not reported,released,TCGA-AA-3833_demographic,2019-07-31T18:24:28.920925-05:00,Alive,1945,--,23011,M0,N0,Stage IIA,T3,6th,not reported,485,a4824df2-8869-5301-8f21-61f56a500be7,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3833_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3833_treatment,a85620fc-c87d-5e17-b856-09029be77037,no,"Radiation Therapy, NOS",2019-07-31T18:24:28.920925-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
1a09207e-9184-4f32-bd07-a9f4dc6c825d,TCGA-AA-3833,TCGA-COAD,63,-23011,--,e5fdab11-8dde-59cf-a84c-57fd65f18822,not reported,female,not reported,released,TCGA-AA-3833_demographic,2019-07-31T18:24:28.920925-05:00,Alive,1945,--,23011,M0,N0,Stage IIA,T3,6th,not reported,485,a4824df2-8869-5301-8f21-61f56a500be7,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3833_diagnosis,No,"Colon, NOS",2019-04-28T11:11:01.514693-05:00,released,TCGA-AA-3833_treatment_1,2f613459-5c47-5d28-93ae-bfc4f5b4b806,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:28.920925-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
ba49b428-246d-46d2-b549-39a5fc8f7003,TCGA-AA-3554,TCGA-COAD,62,-22799,--,a55747ae-1a96-55d5-9a48-92ef135c18b4,not reported,female,not reported,released,TCGA-AA-3554_demographic,2019-07-31T18:35:29.542823-05:00,Alive,1946,--,22799,M0,N0,Stage IIA,T3,6th,not reported,546,809e48eb-e413-5032-b2d9-fab505bac342,C18.2,8140/3,"Adenocarcinoma, NOS",yes,Yes,not reported,Ascending colon,released,TCGA-AA-3554_diagnosis,Not Reported,Ascending colon,2019-04-28T11:20:09.124104-05:00,released,TCGA-AA-3554_treatment_1,e24adeb7-a4c6-5482-9d3d-c4b051a1cff5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:29.542823-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2008
ba49b428-246d-46d2-b549-39a5fc8f7003,TCGA-AA-3554,TCGA-COAD,62,-22799,--,a55747ae-1a96-55d5-9a48-92ef135c18b4,not reported,female,not reported,released,TCGA-AA-3554_demographic,2019-07-31T18:35:29.542823-05:00,Alive,1946,--,22799,M0,N0,Stage IIA,T3,6th,not reported,546,809e48eb-e413-5032-b2d9-fab505bac342,C18.2,8140/3,"Adenocarcinoma, NOS",yes,Yes,not reported,Ascending colon,released,TCGA-AA-3554_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3554_treatment,171d47af-b3f6-55d1-89e5-221d5c39ed16,no,"Radiation Therapy, NOS",2019-07-31T18:35:29.542823-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2008
1b0b0533-7c4f-4edd-a75e-8b56f49d54ab,TCGA-DM-A1D0,TCGA-COAD,79,-28875,--,cfb1446f-8a63-59f8-9594-fd12d9f4a3fa,not hispanic or latino,female,white,released,TCGA-DM-A1D0_demographic,2019-07-31T18:24:38.550258-05:00,Alive,1922,--,28875,M0,N0,Stage IIA,T3,--,not reported,3974,5e1c1fbd-bba8-589b-8727-5cee3e0b3662,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A1D0_diagnosis,No,Sigmoid colon,2019-04-28T11:11:08.725964-05:00,released,TCGA-DM-A1D0_treatment_1,3e33b9b1-1fcc-5bc8-8126-0ce718a23eaf,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:38.550258-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
1b0b0533-7c4f-4edd-a75e-8b56f49d54ab,TCGA-DM-A1D0,TCGA-COAD,79,-28875,--,cfb1446f-8a63-59f8-9594-fd12d9f4a3fa,not hispanic or latino,female,white,released,TCGA-DM-A1D0_demographic,2019-07-31T18:24:38.550258-05:00,Alive,1922,--,28875,M0,N0,Stage IIA,T3,--,not reported,3974,5e1c1fbd-bba8-589b-8727-5cee3e0b3662,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A1D0_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A1D0_treatment,04b741f1-f211-59e6-9547-a77d34025b0e,not reported,"Radiation Therapy, NOS",2019-07-31T18:24:38.550258-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1,TCGA-G4-6298,TCGA-COAD,90,-32872,--,0be19452-0a78-5c95-a0df-6b37aacd9c9a,not hispanic or latino,male,black or african american,released,TCGA-G4-6298_demographic,2019-07-31T18:34:17.660279-05:00,Dead,1915,2006,32872,MX,N1,Stage IIIB,T4a,6th,not reported,--,b19761bd-495c-5939-a8bb-388abefca808,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6298_diagnosis,Not Reported,Cecum,2019-04-30T16:18:11.450094-05:00,released,TCGA-G4-6298_treatment_1,125dd097-553a-5763-af5f-8732c8f09389,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:17.660279-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2005
ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1,TCGA-G4-6298,TCGA-COAD,90,-32872,--,0be19452-0a78-5c95-a0df-6b37aacd9c9a,not hispanic or latino,male,black or african american,released,TCGA-G4-6298_demographic,2019-07-31T18:34:17.660279-05:00,Dead,1915,2006,32872,MX,N1,Stage IIIB,T4a,6th,not reported,--,b19761bd-495c-5939-a8bb-388abefca808,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6298_diagnosis,Not Reported,Cecum,--,released,TCGA-G4-6298_treatment,9b34cc2a-df2d-5864-87dd-26a54f604da9,no,"Radiation Therapy, NOS",2019-07-31T18:34:17.660279-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2005
794131b8-f4be-4f15-b3b9-6f0b10a5a38b,TCGA-CA-6715,TCGA-COAD,63,-23075,--,d2ed8653-34a8-5eb5-9af0-7c23f482b9f2,not hispanic or latino,male,asian,released,TCGA-CA-6715_demographic,2019-07-31T18:31:03.894059-05:00,Alive,1947,--,23075,M0,N1,Stage IIIB,T3,6th,not reported,383,9d814031-9478-53a6-b1e6-5e51b9726c84,C18.7,8260/3,"Papillary adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CA-6715_diagnosis,No,Sigmoid colon,--,released,TCGA-CA-6715_treatment,180d7b1d-432c-528b-bd58-d4c3cfaee91d,no,"Radiation Therapy, NOS",2019-07-31T18:31:03.894059-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2010
794131b8-f4be-4f15-b3b9-6f0b10a5a38b,TCGA-CA-6715,TCGA-COAD,63,-23075,--,d2ed8653-34a8-5eb5-9af0-7c23f482b9f2,not hispanic or latino,male,asian,released,TCGA-CA-6715_demographic,2019-07-31T18:31:03.894059-05:00,Alive,1947,--,23075,M0,N1,Stage IIIB,T3,6th,not reported,383,9d814031-9478-53a6-b1e6-5e51b9726c84,C18.7,8260/3,"Papillary adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CA-6715_diagnosis,No,Sigmoid colon,2019-04-28T11:16:30.966052-05:00,released,TCGA-CA-6715_treatment_1,d548e4ce-e339-5c49-a6bb-ff719a15b95c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:03.894059-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2010
2c9996bb-af6e-4424-881a-e81b9c9aeb78,TCGA-AA-3688,TCGA-COAD,80,-29220,--,d3271579-0ecf-5d15-bf99-d174714ac108,not reported,male,not reported,released,TCGA-AA-3688_demographic,2019-07-31T18:25:59.026309-05:00,Alive,1927,--,29220,M1,N1,Stage IV,T3,6th,not reported,578,1f3c8a5e-0aad-5c4d-a0ff-9696ba52bd9d,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3688_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:12:17.047535-05:00,released,TCGA-AA-3688_treatment_1,bf0d774f-17b4-54e9-8c5f-eadc094c74e6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:59.026309-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2007
2c9996bb-af6e-4424-881a-e81b9c9aeb78,TCGA-AA-3688,TCGA-COAD,80,-29220,--,d3271579-0ecf-5d15-bf99-d174714ac108,not reported,male,not reported,released,TCGA-AA-3688_demographic,2019-07-31T18:25:59.026309-05:00,Alive,1927,--,29220,M1,N1,Stage IV,T3,6th,not reported,578,1f3c8a5e-0aad-5c4d-a0ff-9696ba52bd9d,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3688_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3688_treatment,44a0a985-87cc-50b6-a41a-ef83b1e63c7a,no,"Radiation Therapy, NOS",2019-07-31T18:25:59.026309-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2007
c46971a1-cbac-425d-bac2-f4142c92522e,TCGA-AA-3672,TCGA-COAD,90,-32872,--,0becb33d-603f-5e49-bd22-d32b9b28f05d,not reported,female,not reported,released,TCGA-AA-3672_demographic,2019-07-31T18:36:16.492804-05:00,Alive,1916,--,32872,M0,N1,Stage III,T3,5th,not reported,--,18573ba8-355f-51ed-9c59-d66bb6316be2,C18.4,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Transverse colon,released,TCGA-AA-3672_diagnosis,Not Reported,Transverse colon,--,released,TCGA-AA-3672_treatment,25e2cda8-5729-58fb-b73a-4e50fe4feb2c,no,"Radiation Therapy, NOS",2019-07-31T18:36:16.492804-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2006
c46971a1-cbac-425d-bac2-f4142c92522e,TCGA-AA-3672,TCGA-COAD,90,-32872,--,0becb33d-603f-5e49-bd22-d32b9b28f05d,not reported,female,not reported,released,TCGA-AA-3672_demographic,2019-07-31T18:36:16.492804-05:00,Alive,1916,--,32872,M0,N1,Stage III,T3,5th,not reported,--,18573ba8-355f-51ed-9c59-d66bb6316be2,C18.4,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Transverse colon,released,TCGA-AA-3672_diagnosis,Not Reported,Transverse colon,2019-04-30T16:18:14.047624-05:00,released,TCGA-AA-3672_treatment_1,32d2607a-0e44-51ee-ab21-f0ea4fe09f90,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:16.492804-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2006
01240896-3f3f-4bf9-9799-55c87bfacf36,TCGA-F4-6854,TCGA-COAD,77,-28272,--,b1e10863-67ed-5fe2-b38d-529e9c4f225c,not hispanic or latino,female,white,released,TCGA-F4-6854_demographic,2019-07-31T18:22:16.240216-05:00,Alive,1934,--,28272,M0,N0,Stage IIA,T3,7th,not reported,16,7ab667a5-24f1-521f-af07-009572bea810,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6854_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6854_treatment,c2edb8f2-f179-553e-b7a5-a3b40248bf6d,no,"Radiation Therapy, NOS",2019-07-31T18:22:16.240216-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
01240896-3f3f-4bf9-9799-55c87bfacf36,TCGA-F4-6854,TCGA-COAD,77,-28272,--,b1e10863-67ed-5fe2-b38d-529e9c4f225c,not hispanic or latino,female,white,released,TCGA-F4-6854_demographic,2019-07-31T18:22:16.240216-05:00,Alive,1934,--,28272,M0,N0,Stage IIA,T3,7th,not reported,16,7ab667a5-24f1-521f-af07-009572bea810,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6854_diagnosis,No,Sigmoid colon,2019-04-28T11:09:12.518807-05:00,released,TCGA-F4-6854_treatment_1,3226f0a2-4850-5dc2-aeac-6e3eacfc04b3,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:16.240216-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
b4c3cf95-a27c-4bcf-9321-38723473e83b,TCGA-AA-3855,TCGA-COAD,72,-26541,--,f227482e-59f9-5035-9dd2-e43860ca3caa,not reported,male,not reported,released,TCGA-AA-3855_demographic,2019-07-31T18:35:08.449189-05:00,Alive,1937,--,26541,M0,N0,Stage I,T2,6th,not reported,975,3bcea62f-d040-5e29-b658-1167db2407bc,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3855_diagnosis,No,"Colon, NOS",2019-04-28T11:19:52.316748-05:00,released,TCGA-AA-3855_treatment_1,a9e6c060-16e3-5f02-b7c3-17b3108a7360,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:08.449189-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
b4c3cf95-a27c-4bcf-9321-38723473e83b,TCGA-AA-3855,TCGA-COAD,72,-26541,--,f227482e-59f9-5035-9dd2-e43860ca3caa,not reported,male,not reported,released,TCGA-AA-3855_demographic,2019-07-31T18:35:08.449189-05:00,Alive,1937,--,26541,M0,N0,Stage I,T2,6th,not reported,975,3bcea62f-d040-5e29-b658-1167db2407bc,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3855_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3855_treatment,472ccc41-5466-5c24-ac99-c36ca3cd7d68,no,"Radiation Therapy, NOS",2019-07-31T18:35:08.449189-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
0f008098-d8aa-46dc-8445-cca59838c582,TCGA-AD-5900,TCGA-COAD,67,-24776,--,f351bbcb-3688-5c5b-a148-00a02eb56f83,not hispanic or latino,male,white,released,TCGA-AD-5900_demographic,2019-07-31T18:23:29.260255-05:00,Alive,1943,--,24776,MX,N0,Stage I,T2,7th,not reported,370,c69ecd47-0e8c-56be-a97a-082d041ab034,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AD-5900_diagnosis,No,Ascending colon,2019-04-28T11:10:12.670799-05:00,released,TCGA-AD-5900_treatment_1,3a44faf4-1178-56a9-ba96-703ef4796664,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:29.260255-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2010
0f008098-d8aa-46dc-8445-cca59838c582,TCGA-AD-5900,TCGA-COAD,67,-24776,--,f351bbcb-3688-5c5b-a148-00a02eb56f83,not hispanic or latino,male,white,released,TCGA-AD-5900_demographic,2019-07-31T18:23:29.260255-05:00,Alive,1943,--,24776,MX,N0,Stage I,T2,7th,not reported,370,c69ecd47-0e8c-56be-a97a-082d041ab034,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AD-5900_diagnosis,No,Ascending colon,--,released,TCGA-AD-5900_treatment,7e5cd073-f004-526d-85d5-75156172f229,no,"Radiation Therapy, NOS",2019-07-31T18:23:29.260255-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2010
2a7bbafe-d499-4241-ba3d-a52ba0a5db3c,TCGA-F4-6460,TCGA-COAD,51,-18637,972,31e0fc8b-807b-5b8b-b703-0774a2b0872e,not hispanic or latino,female,white,released,TCGA-F4-6460_demographic,2019-07-31T18:25:43.844085-05:00,Dead,1960,--,18637,M0,N1,Stage IIIB,T3,7th,not reported,407,d88794a7-88b5-5ecc-b191-3fd0ae42f848,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6460_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6460_treatment,37e1f12b-a154-524f-a1a9-9a9a18c6b6c4,no,"Radiation Therapy, NOS",2019-07-31T18:25:43.844085-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2011
2a7bbafe-d499-4241-ba3d-a52ba0a5db3c,TCGA-F4-6460,TCGA-COAD,51,-18637,972,31e0fc8b-807b-5b8b-b703-0774a2b0872e,not hispanic or latino,female,white,released,TCGA-F4-6460_demographic,2019-07-31T18:25:43.844085-05:00,Dead,1960,--,18637,M0,N1,Stage IIIB,T3,7th,not reported,407,d88794a7-88b5-5ecc-b191-3fd0ae42f848,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6460_diagnosis,No,Sigmoid colon,2019-04-28T11:12:05.488151-05:00,released,TCGA-F4-6460_treatment_1,d9aa12a0-847d-5278-ae52-73c0c657ecc9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:43.844085-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2011
7a70f061-9a6f-408e-a416-7f5295ceba3b,TCGA-CK-6751,TCGA-COAD,88,-32354,--,db017e5c-25b3-5114-92db-47929ecb5869,not hispanic or latino,female,white,released,TCGA-CK-6751_demographic,2019-07-31T18:31:12.647167-05:00,Alive,1914,--,32354,MX,N0,Stage I,T2,5th,not reported,518,2c6d5727-1971-5a01-8b3c-a28bc09200c6,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CK-6751_diagnosis,No,Ascending colon,2019-04-28T11:16:38.634000-05:00,released,TCGA-CK-6751_treatment_1,09ab8fbc-b2e6-579d-9604-392aea487d23,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:12.647167-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2002
7a70f061-9a6f-408e-a416-7f5295ceba3b,TCGA-CK-6751,TCGA-COAD,88,-32354,--,db017e5c-25b3-5114-92db-47929ecb5869,not hispanic or latino,female,white,released,TCGA-CK-6751_demographic,2019-07-31T18:31:12.647167-05:00,Alive,1914,--,32354,MX,N0,Stage I,T2,5th,not reported,518,2c6d5727-1971-5a01-8b3c-a28bc09200c6,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CK-6751_diagnosis,No,Ascending colon,--,released,TCGA-CK-6751_treatment,7bbb198e-5578-5137-81a3-ad457879284b,no,"Radiation Therapy, NOS",2019-07-31T18:31:12.647167-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2002
269e8ca8-722d-449b-ace1-6545bd72bdd6,TCGA-AA-3527,TCGA-COAD,90,-32871,--,066f0bd0-7461-5afd-a3f1-b5cdcb4d603e,not reported,female,not reported,released,TCGA-AA-3527_demographic,2019-07-31T18:25:18.135199-05:00,Alive,1917,--,32871,M0,N0,Stage IIA,T3,6th,not reported,--,00547ae8-edc7-56f8-8830-a24fdc718a86,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AA-3527_diagnosis,Not Reported,Cecum,--,released,TCGA-AA-3527_treatment,1ea9f8fb-7da3-5c39-9762-d5005686c1f5,not reported,"Radiation Therapy, NOS",2019-07-31T18:25:18.135199-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
269e8ca8-722d-449b-ace1-6545bd72bdd6,TCGA-AA-3527,TCGA-COAD,90,-32871,--,066f0bd0-7461-5afd-a3f1-b5cdcb4d603e,not reported,female,not reported,released,TCGA-AA-3527_demographic,2019-07-31T18:25:18.135199-05:00,Alive,1917,--,32871,M0,N0,Stage IIA,T3,6th,not reported,--,00547ae8-edc7-56f8-8830-a24fdc718a86,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AA-3527_diagnosis,Not Reported,Cecum,2019-04-28T11:11:41.635699-05:00,released,TCGA-AA-3527_treatment_1,9f8d3f97-1d52-5fd6-8229-a4f7bf906922,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:18.135199-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
381cf7f3-cd7b-4660-8175-ff8062f7bf78,TCGA-AA-A00L,TCGA-COAD,66,-24319,--,f76e1fa2-7120-5187-bd94-e2a0ef118984,not reported,male,not reported,released,TCGA-AA-A00L_demographic,2019-07-31T18:26:36.902616-05:00,Alive,1943,--,24319,M0,N0,Stage IIA,T3,6th,not reported,1157,62e4b5ec-00cf-578f-9a25-f9d15d6d709f,C18.4,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Transverse colon,released,TCGA-AA-A00L_diagnosis,Not Reported,Transverse colon,2019-04-28T11:12:49.662675-05:00,released,TCGA-AA-A00L_treatment_1,3d21ea88-f724-5c96-b0b0-2cdb8aa5e5fb,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:36.902616-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
381cf7f3-cd7b-4660-8175-ff8062f7bf78,TCGA-AA-A00L,TCGA-COAD,66,-24319,--,f76e1fa2-7120-5187-bd94-e2a0ef118984,not reported,male,not reported,released,TCGA-AA-A00L_demographic,2019-07-31T18:26:36.902616-05:00,Alive,1943,--,24319,M0,N0,Stage IIA,T3,6th,not reported,1157,62e4b5ec-00cf-578f-9a25-f9d15d6d709f,C18.4,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Transverse colon,released,TCGA-AA-A00L_diagnosis,Not Reported,Transverse colon,--,released,TCGA-AA-A00L_treatment,6b10dd43-c2ff-5e94-94d4-ad9ad2b40f06,no,"Radiation Therapy, NOS",2019-07-31T18:26:36.902616-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
d4da3298-3a02-44a6-bdcd-d260f38e520b,TCGA-AY-A71X,TCGA-COAD,54,-19904,--,001b5151-9bde-5439-bfc6-bbc239f967b0,not hispanic or latino,female,black or african american,released,TCGA-AY-A71X_demographic,2019-07-31T15:47:34.056841-05:00,Alive,1959,--,19904,M0,N0,Stage I,T2,7th,not reported,588,928c2749-43db-567e-82e1-d2a27b40fefd,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-A71X_diagnosis,No,Cecum,2019-04-28T09:03:52.302762-05:00,released,TCGA-AY-A71X_treatment_1,134c0f37-cec6-534a-87b0-3464e58feae2,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:47:34.056841-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2013
d4da3298-3a02-44a6-bdcd-d260f38e520b,TCGA-AY-A71X,TCGA-COAD,54,-19904,--,001b5151-9bde-5439-bfc6-bbc239f967b0,not hispanic or latino,female,black or african american,released,TCGA-AY-A71X_demographic,2019-07-31T15:47:34.056841-05:00,Alive,1959,--,19904,M0,N0,Stage I,T2,7th,not reported,588,928c2749-43db-567e-82e1-d2a27b40fefd,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-A71X_diagnosis,No,Cecum,--,released,TCGA-AY-A71X_treatment,2e710eac-f8cf-5cd2-acf4-6fdfc694019e,no,"Radiation Therapy, NOS",2019-07-31T15:47:34.056841-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2013
7a481097-14a3-4916-9632-d899c25fd284,TCGA-AA-A022,TCGA-COAD,88,-32446,--,42793c8e-4a71-5edc-bcef-bcbba950dd7e,not reported,female,not reported,released,TCGA-AA-A022_demographic,2019-07-31T15:21:04.951807-05:00,Alive,1917,--,32446,M0,N0,Stage II,T4,5th,not reported,--,a816f46f-85d6-5ae3-8d2f-737fcdfad5b8,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A022_diagnosis,No,Cecum,--,released,TCGA-AA-A022_treatment,8b681403-6c4e-5978-95a9-73ca979ea8a6,not reported,"Radiation Therapy, NOS",2019-07-31T15:21:04.951807-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2005
7a481097-14a3-4916-9632-d899c25fd284,TCGA-AA-A022,TCGA-COAD,88,-32446,--,42793c8e-4a71-5edc-bcef-bcbba950dd7e,not reported,female,not reported,released,TCGA-AA-A022_demographic,2019-07-31T15:21:04.951807-05:00,Alive,1917,--,32446,M0,N0,Stage II,T4,5th,not reported,--,a816f46f-85d6-5ae3-8d2f-737fcdfad5b8,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A022_diagnosis,No,Cecum,2019-04-28T08:41:06.799946-05:00,released,TCGA-AA-A022_treatment_1,fca6254d-530e-5718-a89c-61caab1a70c7,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T15:21:04.951807-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2005
7570761b-c333-40df-ac8c-9b7f94c58ef9,TCGA-G4-6586,TCGA-COAD,73,-27020,--,23b91af0-e835-52c1-8e82-89bf8e56d996,not hispanic or latino,female,white,released,TCGA-G4-6586_demographic,2019-07-31T18:41:59.829718-05:00,Alive,1935,--,27020,M0,N0,Stage IIA,T3,6th,not reported,1089,abce05cc-9253-55b8-b892-ca7aa911267f,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-G4-6586_diagnosis,Not Reported,Ascending colon,2019-04-28T11:25:38.656409-05:00,released,TCGA-G4-6586_treatment_1,c8fe8be3-658f-52f1-acb0-957303f050fe,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:59.829718-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2008
7570761b-c333-40df-ac8c-9b7f94c58ef9,TCGA-G4-6586,TCGA-COAD,73,-27020,--,23b91af0-e835-52c1-8e82-89bf8e56d996,not hispanic or latino,female,white,released,TCGA-G4-6586_demographic,2019-07-31T18:41:59.829718-05:00,Alive,1935,--,27020,M0,N0,Stage IIA,T3,6th,not reported,1089,abce05cc-9253-55b8-b892-ca7aa911267f,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-G4-6586_diagnosis,Not Reported,Ascending colon,--,released,TCGA-G4-6586_treatment,6dd058b6-a317-57b1-a506-18f230ef2756,no,"Radiation Therapy, NOS",2019-07-31T18:41:59.829718-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2008
df5ab6cc-6f68-4b6b-95e2-954c6b57ba9c,TCGA-CA-6718,TCGA-COAD,46,-17109,306,2efb540d-33a0-5cd3-b11d-5ed2f95596d6,not hispanic or latino,male,asian,released,TCGA-CA-6718_demographic,2019-07-31T18:38:53.448363-05:00,Dead,1964,--,17109,M0,N0,Stage IIA,T3,6th,not reported,3,0139fa7d-5570-579e-ba13-55f1ab069119,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-6718_diagnosis,No,"Colon, NOS",--,released,TCGA-CA-6718_treatment,30e47192-4ab4-5394-9e41-accc4da1f991,no,"Radiation Therapy, NOS",2019-07-31T18:38:53.448363-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
df5ab6cc-6f68-4b6b-95e2-954c6b57ba9c,TCGA-CA-6718,TCGA-COAD,46,-17109,306,2efb540d-33a0-5cd3-b11d-5ed2f95596d6,not hispanic or latino,male,asian,released,TCGA-CA-6718_demographic,2019-07-31T18:38:53.448363-05:00,Dead,1964,--,17109,M0,N0,Stage IIA,T3,6th,not reported,3,0139fa7d-5570-579e-ba13-55f1ab069119,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-6718_diagnosis,No,"Colon, NOS",2019-04-28T11:23:01.352285-05:00,released,TCGA-CA-6718_treatment_1,e5d15c0c-e479-5a46-8fad-8e21da01230f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:53.448363-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
300fff5a-0f61-402d-b845-3938ba7b1294,TCGA-QG-A5YX,TCGA-COAD,61,-22617,--,3118dc75-1508-5b38-a597-92fd1226425e,not hispanic or latino,female,black or african american,released,TCGA-QG-A5YX_demographic,2019-07-31T15:43:04.238536-05:00,Alive,1950,--,22617,MX,N0,Stage IIA,T3,7th,not reported,1003,1027744c-2dac-53e3-972b-e5e49cb32467,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-QG-A5YX_diagnosis,No,Sigmoid colon,2019-04-28T09:00:08.100254-05:00,released,TCGA-QG-A5YX_treatment_1,6010bdb9-94a0-51cb-ad7d-ad7391a18c90,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:43:04.238536-05:00,not reported,stage iia,2019-08-08T16:37:44.165377-05:00,2011
300fff5a-0f61-402d-b845-3938ba7b1294,TCGA-QG-A5YX,TCGA-COAD,61,-22617,--,3118dc75-1508-5b38-a597-92fd1226425e,not hispanic or latino,female,black or african american,released,TCGA-QG-A5YX_demographic,2019-07-31T15:43:04.238536-05:00,Alive,1950,--,22617,MX,N0,Stage IIA,T3,7th,not reported,1003,1027744c-2dac-53e3-972b-e5e49cb32467,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-QG-A5YX_diagnosis,No,Sigmoid colon,--,released,TCGA-QG-A5YX_treatment,c187020c-9685-53fc-a9b5-2537ea92faa3,no,"Radiation Therapy, NOS",2019-07-31T15:43:04.238536-05:00,not reported,stage iia,2019-08-08T16:37:44.165377-05:00,2011
3d8fd9b2-9aa2-4c81-8843-535ae66d6140,TCGA-AZ-4308,TCGA-COAD,47,-17321,--,37184007-26fe-5a75-b14c-071795a6b9f6,not hispanic or latino,female,white,released,TCGA-AZ-4308_demographic,2019-07-31T18:27:12.410842-05:00,Alive,1959,--,17321,M0,N1,Stage IIIB,T3,6th,not reported,3324,a55b6a19-0122-55ce-9350-986201bbc965,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AZ-4308_diagnosis,No,Sigmoid colon,2019-04-28T11:13:19.936137-05:00,released,TCGA-AZ-4308_treatment_1,49837d72-8d09-5d22-b616-36d8f2614eef,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:12.410842-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2006
3d8fd9b2-9aa2-4c81-8843-535ae66d6140,TCGA-AZ-4308,TCGA-COAD,47,-17321,--,37184007-26fe-5a75-b14c-071795a6b9f6,not hispanic or latino,female,white,released,TCGA-AZ-4308_demographic,2019-07-31T18:27:12.410842-05:00,Alive,1959,--,17321,M0,N1,Stage IIIB,T3,6th,not reported,3324,a55b6a19-0122-55ce-9350-986201bbc965,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AZ-4308_diagnosis,No,Sigmoid colon,--,released,TCGA-AZ-4308_treatment,92dea7bc-2211-5971-9774-3eb2f87d011c,no,"Radiation Therapy, NOS",2019-07-31T18:27:12.410842-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2006
93edb105-5dc9-4a4a-9fca-c91f0161fcc7,TCGA-AA-3511,TCGA-COAD,64,-23407,--,6fe6f432-eb61-576a-8bae-efb209861062,not reported,male,not reported,released,TCGA-AA-3511_demographic,2019-07-31T18:32:46.532835-05:00,Alive,1941,--,23407,M0,N0,Stage II,T4,5th,not reported,212,fe16d423-c653-5727-9c35-2f686e12a06a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3511_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3511_treatment,4890c558-6f77-5621-8aa7-74e1086952e2,no,"Radiation Therapy, NOS",2019-07-31T18:32:46.532835-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2005
93edb105-5dc9-4a4a-9fca-c91f0161fcc7,TCGA-AA-3511,TCGA-COAD,64,-23407,--,6fe6f432-eb61-576a-8bae-efb209861062,not reported,male,not reported,released,TCGA-AA-3511_demographic,2019-07-31T18:32:46.532835-05:00,Alive,1941,--,23407,M0,N0,Stage II,T4,5th,not reported,212,fe16d423-c653-5727-9c35-2f686e12a06a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3511_diagnosis,No,"Colon, NOS",2019-04-28T11:17:56.897151-05:00,released,TCGA-AA-3511_treatment_1,da8a0947-294a-5da3-a15b-7981e257be8d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:46.532835-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2005
c8de215d-53a4-4e6c-be58-5887a8094815,TCGA-AD-6965,TCGA-COAD,62,-22853,--,8a14f8cf-ab22-5a42-9614-6f07ee3162f8,not hispanic or latino,male,white,released,TCGA-AD-6965_demographic,2019-07-31T18:37:00.529762-05:00,Alive,1949,--,22853,M0,N2b,Stage IIIC,T4a,7th,not reported,805,aea31f5f-ca23-5540-b9e4-ab1600d78411,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AD-6965_diagnosis,No,Cecum,2019-04-28T11:21:24.461910-05:00,released,TCGA-AD-6965_treatment_1,c1476844-f207-5716-a44f-2478bef906e6,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:00.529762-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2011
c8de215d-53a4-4e6c-be58-5887a8094815,TCGA-AD-6965,TCGA-COAD,62,-22853,--,8a14f8cf-ab22-5a42-9614-6f07ee3162f8,not hispanic or latino,male,white,released,TCGA-AD-6965_demographic,2019-07-31T18:37:00.529762-05:00,Alive,1949,--,22853,M0,N2b,Stage IIIC,T4a,7th,not reported,805,aea31f5f-ca23-5540-b9e4-ab1600d78411,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AD-6965_diagnosis,No,Cecum,--,released,TCGA-AD-6965_treatment,f4fbd912-1389-559e-b4d9-fbdfffa3f4b9,no,"Radiation Therapy, NOS",2019-07-31T18:37:00.529762-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2011
a54b322b-80d3-435c-8d14-25841b741f6c,TCGA-5M-AATE,TCGA-COAD,76,-27870,--,d2b2e4d7-419d-5370-94f3-2adeb4606b07,hispanic or latino,male,black or african american,released,TCGA-5M-AATE_demographic,2019-07-31T18:42:26.162270-05:00,Alive,1935,--,27870,M0,N0,Stage IIA,T3,7th,not reported,1200,77253688-4400-5836-886d-80d5758d41c6,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-5M-AATE_diagnosis,No,Ascending colon,2019-04-28T11:26:01.824923-05:00,released,TCGA-5M-AATE_treatment_1,c7e9d153-dd06-5819-8f50-cd6a53b92cae,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:26.162270-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2011
a54b322b-80d3-435c-8d14-25841b741f6c,TCGA-5M-AATE,TCGA-COAD,76,-27870,--,d2b2e4d7-419d-5370-94f3-2adeb4606b07,hispanic or latino,male,black or african american,released,TCGA-5M-AATE_demographic,2019-07-31T18:42:26.162270-05:00,Alive,1935,--,27870,M0,N0,Stage IIA,T3,7th,not reported,1200,77253688-4400-5836-886d-80d5758d41c6,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-5M-AATE_diagnosis,No,Ascending colon,--,released,TCGA-5M-AATE_treatment,44ff7b56-834d-5e65-a072-0f8ca2e577fd,no,"Radiation Therapy, NOS",2019-07-31T18:42:26.162270-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2011
9d8c4693-8e36-473b-bb34-a7cdc04dd223,TCGA-CM-6170,TCGA-COAD,73,-26663,--,85d6210e-f994-5f0d-8a1b-a89ef3bf3c4f,not hispanic or latino,female,white,released,TCGA-CM-6170_demographic,2019-07-31T18:33:26.036329-05:00,Alive,1937,--,26663,M0,N0,Stage I,T2,7th,not reported,457,8ee5348d-d087-576b-8f53-79661e4d812a,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-CM-6170_diagnosis,No,Descending colon,--,released,TCGA-CM-6170_treatment,2fe16006-63fe-5e6f-af9d-4b07f6a133b4,no,"Radiation Therapy, NOS",2019-07-31T18:33:26.036329-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
9d8c4693-8e36-473b-bb34-a7cdc04dd223,TCGA-CM-6170,TCGA-COAD,73,-26663,--,85d6210e-f994-5f0d-8a1b-a89ef3bf3c4f,not hispanic or latino,female,white,released,TCGA-CM-6170_demographic,2019-07-31T18:33:26.036329-05:00,Alive,1937,--,26663,M0,N0,Stage I,T2,7th,not reported,457,8ee5348d-d087-576b-8f53-79661e4d812a,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-CM-6170_diagnosis,No,Descending colon,2019-04-28T11:18:29.051167-05:00,released,TCGA-CM-6170_treatment_1,c8c126bc-7399-53a1-9a0e-c48fd1b8e44b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:26.036329-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
0ec6ed47-db99-4273-9823-ffbde6a77091,TCGA-A6-6651,TCGA-COAD,55,-20110,--,2e06fcd0-87ea-5afe-85c9-2a8ae12bf1f9,not hispanic or latino,female,white,released,TCGA-A6-6651_demographic,2019-07-31T18:23:26.374276-05:00,Alive,1955,--,20110,MX,N1b,Stage IIIB,T3,7th,not reported,662,bc7fc12f-1aa5-5467-9098-a2a9d9299b10,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6651_diagnosis,No,"Colon, NOS",2019-04-28T11:10:10.150933-05:00,released,TCGA-A6-6651_treatment_1,35512bb1-1a6a-57bd-9ede-1cfa8896bc82,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:26.374276-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
0ec6ed47-db99-4273-9823-ffbde6a77091,TCGA-A6-6651,TCGA-COAD,55,-20110,--,2e06fcd0-87ea-5afe-85c9-2a8ae12bf1f9,not hispanic or latino,female,white,released,TCGA-A6-6651_demographic,2019-07-31T18:23:26.374276-05:00,Alive,1955,--,20110,MX,N1b,Stage IIIB,T3,7th,not reported,662,bc7fc12f-1aa5-5467-9098-a2a9d9299b10,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6651_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-6651_treatment,3f56a597-bd5b-5df5-9c20-7f9d0e0dcf8a,no,"Radiation Therapy, NOS",2019-07-31T18:23:26.374276-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
5e7074a6-5011-4dc5-950c-41365dbc6d09,TCGA-AD-6964,TCGA-COAD,58,-21457,331,0b41f9bc-126d-5ccc-9b07-ea28444dab15,not hispanic or latino,male,white,released,TCGA-AD-6964_demographic,2019-07-31T18:29:19.052383-05:00,Dead,1953,--,21457,--,N2b,--,T4a,7th,not reported,23,96ad3274-0170-5005-bccb-091022c50b91,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AD-6964_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AD-6964_treatment,79ede20e-e550-5c4f-9835-924b13dda327,no,"Radiation Therapy, NOS",2019-07-31T18:29:19.052383-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2011
5e7074a6-5011-4dc5-950c-41365dbc6d09,TCGA-AD-6964,TCGA-COAD,58,-21457,331,0b41f9bc-126d-5ccc-9b07-ea28444dab15,not hispanic or latino,male,white,released,TCGA-AD-6964_demographic,2019-07-31T18:29:19.052383-05:00,Dead,1953,--,21457,--,N2b,--,T4a,7th,not reported,23,96ad3274-0170-5005-bccb-091022c50b91,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AD-6964_diagnosis,Not Reported,Ascending colon,2019-04-28T11:15:04.519558-05:00,released,TCGA-AD-6964_treatment_1,68371f74-0021-524e-a8a6-154b33166705,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:19.052383-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2011
7b47489f-c3cc-4388-b5d7-c7c02790a5f6,TCGA-AA-3956,TCGA-COAD,65,-24045,--,01b00f5c-8c33-55c9-a193-f24eeefa58c6,not reported,male,not reported,released,TCGA-AA-3956_demographic,2019-07-31T18:31:18.685631-05:00,Alive,1942,--,24045,M0,N0,Stage IIA,T3,6th,not reported,1035,a27f3617-a5a9-5fb9-aff5-5d437ea56f6f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3956_diagnosis,No,Cecum,2019-04-28T11:16:43.559153-05:00,released,TCGA-AA-3956_treatment_1,3038e1c4-9bc9-59c8-a909-4b348f6479c1,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:18.685631-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2007
7b47489f-c3cc-4388-b5d7-c7c02790a5f6,TCGA-AA-3956,TCGA-COAD,65,-24045,--,01b00f5c-8c33-55c9-a193-f24eeefa58c6,not reported,male,not reported,released,TCGA-AA-3956_demographic,2019-07-31T18:31:18.685631-05:00,Alive,1942,--,24045,M0,N0,Stage IIA,T3,6th,not reported,1035,a27f3617-a5a9-5fb9-aff5-5d437ea56f6f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3956_diagnosis,No,Cecum,--,released,TCGA-AA-3956_treatment,724776c0-7e33-5c94-b954-18378fc18e1e,no,"Radiation Therapy, NOS",2019-07-31T18:31:18.685631-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2007
13eff2e5-e33a-485f-9ba4-8a7ccb3c7528,TCGA-AD-6888,TCGA-COAD,73,-26816,472,9a82f19a-d2cd-5c8f-8653-a80113db0203,not hispanic or latino,male,white,released,TCGA-AD-6888_demographic,2019-07-31T18:23:57.161274-05:00,Dead,1937,--,26816,M0,N1b,Stage IIIB,T3,7th,not reported,155,f76d0d13-206a-5617-b224-3d0715ec191c,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Hepatic flexure of colon,released,TCGA-AD-6888_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AD-6888_treatment,7ce2a86d-9ca0-5452-80e6-4ffb591d5d3c,no,"Radiation Therapy, NOS",2019-07-31T18:23:57.161274-05:00,not reported,stage iiib,2019-08-08T16:35:29.811838-05:00,2010
13eff2e5-e33a-485f-9ba4-8a7ccb3c7528,TCGA-AD-6888,TCGA-COAD,73,-26816,472,9a82f19a-d2cd-5c8f-8653-a80113db0203,not hispanic or latino,male,white,released,TCGA-AD-6888_demographic,2019-07-31T18:23:57.161274-05:00,Dead,1937,--,26816,M0,N1b,Stage IIIB,T3,7th,not reported,155,f76d0d13-206a-5617-b224-3d0715ec191c,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Hepatic flexure of colon,released,TCGA-AD-6888_diagnosis,Not Reported,Ascending colon,2019-04-28T11:10:35.548215-05:00,released,TCGA-AD-6888_treatment_1,b4c31251-1e77-5089-aa57-553387110e83,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:57.161274-05:00,not reported,stage iiib,2019-08-08T16:35:29.811838-05:00,2010
c085da47-d634-491a-80ea-514e5a231f70,TCGA-CK-5912,TCGA-COAD,81,-29938,1493,f5fecf0f-d8f4-5223-ba12-a183ab6a009a,not hispanic or latino,male,white,released,TCGA-CK-5912_demographic,2019-07-31T18:35:58.966674-05:00,Dead,1925,--,29938,MX,N0,Stage I,T2,6th,not reported,1466,bc4f42f3-9c31-5bc6-b90a-5ad1b9ee7067,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-CK-5912_diagnosis,Not Reported,Ascending colon,2019-04-28T11:20:34.386279-05:00,released,TCGA-CK-5912_treatment_1,2ecd6a9b-9f24-5558-8fd8-b1771704df5c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:58.966674-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2006
c085da47-d634-491a-80ea-514e5a231f70,TCGA-CK-5912,TCGA-COAD,81,-29938,1493,f5fecf0f-d8f4-5223-ba12-a183ab6a009a,not hispanic or latino,male,white,released,TCGA-CK-5912_demographic,2019-07-31T18:35:58.966674-05:00,Dead,1925,--,29938,MX,N0,Stage I,T2,6th,not reported,1466,bc4f42f3-9c31-5bc6-b90a-5ad1b9ee7067,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-CK-5912_diagnosis,Not Reported,Ascending colon,--,released,TCGA-CK-5912_treatment,65b59181-cce4-574f-9494-51f55fcf7bf7,no,"Radiation Therapy, NOS",2019-07-31T18:35:58.966674-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2006
23252dca-e836-47a0-b294-758ad60aa259,TCGA-G4-6299,TCGA-COAD,69,-25318,--,b216d1d0-54ad-58e2-b3a8-1aaa1df084ba,not hispanic or latino,male,white,released,TCGA-G4-6299_demographic,2019-07-31T18:24:59.672611-05:00,Alive,1936,--,25318,M0,N2,Stage IIIC,T3,6th,not reported,2268,ca62a6ee-c5b9-5405-aa95-12200788197f,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-G4-6299_diagnosis,No,Descending colon,2019-04-28T11:11:26.766785-05:00,released,TCGA-G4-6299_treatment_1,63072edd-300f-579f-bec3-19e4160bd73e,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:59.672611-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2005
23252dca-e836-47a0-b294-758ad60aa259,TCGA-G4-6299,TCGA-COAD,69,-25318,--,b216d1d0-54ad-58e2-b3a8-1aaa1df084ba,not hispanic or latino,male,white,released,TCGA-G4-6299_demographic,2019-07-31T18:24:59.672611-05:00,Alive,1936,--,25318,M0,N2,Stage IIIC,T3,6th,not reported,2268,ca62a6ee-c5b9-5405-aa95-12200788197f,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-G4-6299_diagnosis,No,Descending colon,--,released,TCGA-G4-6299_treatment,72c5c14c-3ddd-545b-a528-b691552e2bf0,no,"Radiation Therapy, NOS",2019-07-31T18:24:59.672611-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2005
e4c0d890-a634-48bd-9108-e674532b0d2e,TCGA-D5-6531,TCGA-COAD,75,-27633,--,e1f89dca-811b-52a5-ab47-c81986c3b972,not hispanic or latino,male,white,released,TCGA-D5-6531_demographic,2019-07-31T18:39:16.142647-05:00,Alive,1935,--,27633,M0,N0,Stage IIA,T3,--,not reported,540,78f1afd8-0517-58b8-b280-8ed353abf375,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-D5-6531_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:23:21.587102-05:00,released,TCGA-D5-6531_treatment_1,998ea534-961c-5ec7-9165-1cb63a4500f2,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:16.142647-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
e4c0d890-a634-48bd-9108-e674532b0d2e,TCGA-D5-6531,TCGA-COAD,75,-27633,--,e1f89dca-811b-52a5-ab47-c81986c3b972,not hispanic or latino,male,white,released,TCGA-D5-6531_demographic,2019-07-31T18:39:16.142647-05:00,Alive,1935,--,27633,M0,N0,Stage IIA,T3,--,not reported,540,78f1afd8-0517-58b8-b280-8ed353abf375,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-D5-6531_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-D5-6531_treatment,bf7e7fa2-2e18-579b-ad11-dee5b17f5f9d,no,"Radiation Therapy, NOS",2019-07-31T18:39:16.142647-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
88e64f45-adc4-4223-9838-4d7d45b8f0c0,TCGA-AA-3526,TCGA-COAD,57,-21123,--,5d7872b9-9b47-5e0e-ae7c-f475f58066b7,not reported,male,not reported,released,TCGA-AA-3526_demographic,2019-07-31T18:32:09.663758-05:00,Alive,1950,--,21123,M0,N0,Stage I,T2,6th,not reported,580,bc2b309c-0fcc-5322-9972-53d0049de1ab,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3526_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3526_treatment,772bc6c7-106f-597d-8abb-2bd87408f9df,no,"Radiation Therapy, NOS",2019-07-31T18:32:09.663758-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2007
88e64f45-adc4-4223-9838-4d7d45b8f0c0,TCGA-AA-3526,TCGA-COAD,57,-21123,--,5d7872b9-9b47-5e0e-ae7c-f475f58066b7,not reported,male,not reported,released,TCGA-AA-3526_demographic,2019-07-31T18:32:09.663758-05:00,Alive,1950,--,21123,M0,N0,Stage I,T2,6th,not reported,580,bc2b309c-0fcc-5322-9972-53d0049de1ab,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3526_diagnosis,No,Sigmoid colon,2019-04-28T11:17:26.383632-05:00,released,TCGA-AA-3526_treatment_1,47366cdf-eb91-5a64-bf0f-d1ca83b51ea2,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:09.663758-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2007
081a3dc7-45e1-457d-add0-c4686140a8d0,TCGA-AA-A00D,TCGA-COAD,70,-25689,--,747100df-4ef0-5906-95e6-dbcb6e9472fb,not reported,male,not reported,released,TCGA-AA-A00D_demographic,2019-07-31T18:41:21.213952-05:00,Alive,1937,--,25689,M0,N0,Stage I,T2,6th,not reported,578,73a32a00-6352-5d6f-a45f-a48bc9873287,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00D_diagnosis,No,Ascending colon,2019-04-28T11:25:04.498069-05:00,released,TCGA-AA-A00D_treatment_1,31d46572-4d8a-506b-808b-170564b5196c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:21.213952-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
081a3dc7-45e1-457d-add0-c4686140a8d0,TCGA-AA-A00D,TCGA-COAD,70,-25689,--,747100df-4ef0-5906-95e6-dbcb6e9472fb,not reported,male,not reported,released,TCGA-AA-A00D_demographic,2019-07-31T18:41:21.213952-05:00,Alive,1937,--,25689,M0,N0,Stage I,T2,6th,not reported,578,73a32a00-6352-5d6f-a45f-a48bc9873287,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00D_diagnosis,No,Ascending colon,--,released,TCGA-AA-A00D_treatment,e98a1acb-25a3-5ade-831c-9a75fb18be8e,no,"Radiation Therapy, NOS",2019-07-31T18:41:21.213952-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
13ae9d83-a22f-451f-88bb-686051725cf3,TCGA-AA-A01P,TCGA-COAD,80,-29554,1158,e4951595-51ea-5000-bc9a-98dd138c5e85,not reported,female,not reported,released,TCGA-AA-A01P_demographic,2019-07-31T18:24:41.665474-05:00,Dead,1923,--,29554,M0,N1,Stage III,T3,5th,not reported,--,4e76afdf-4d27-575c-9981-54cf863e9fe0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01P_diagnosis,No,Ascending colon,2019-04-28T11:11:11.142731-05:00,released,TCGA-AA-A01P_treatment_1,8cd64a52-fc82-5a5c-b2ba-fe71de58b0e9,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:41.665474-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2003
13ae9d83-a22f-451f-88bb-686051725cf3,TCGA-AA-A01P,TCGA-COAD,80,-29554,1158,e4951595-51ea-5000-bc9a-98dd138c5e85,not reported,female,not reported,released,TCGA-AA-A01P_demographic,2019-07-31T18:24:41.665474-05:00,Dead,1923,--,29554,M0,N1,Stage III,T3,5th,not reported,--,4e76afdf-4d27-575c-9981-54cf863e9fe0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01P_diagnosis,No,Ascending colon,--,released,TCGA-AA-A01P_treatment,ea77b7e7-dc5c-5624-bbc5-9a5717760048,no,"Radiation Therapy, NOS",2019-07-31T18:24:41.665474-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2003
d42bc7f0-cfb2-4ece-ae47-521308635633,TCGA-CM-6167,TCGA-COAD,57,-21031,--,ab963778-7fb6-560e-a665-85710781b69a,not hispanic or latino,female,black or african american,released,TCGA-CM-6167_demographic,2019-07-31T18:37:51.322708-05:00,Alive,1953,--,21031,M0,N2b,Stage IIIC,T3,7th,not reported,456,73e45c2a-67c3-5225-bdfc-d7ed8298dbc3,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6167_diagnosis,No,Cecum,2019-04-28T11:22:07.774623-05:00,released,TCGA-CM-6167_treatment_1,1bae18f5-099b-5c9b-8c6d-0f22856bf178,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:51.322708-05:00,not reported,stage iiic,2019-08-08T16:36:28.485406-05:00,2010
d42bc7f0-cfb2-4ece-ae47-521308635633,TCGA-CM-6167,TCGA-COAD,57,-21031,--,ab963778-7fb6-560e-a665-85710781b69a,not hispanic or latino,female,black or african american,released,TCGA-CM-6167_demographic,2019-07-31T18:37:51.322708-05:00,Alive,1953,--,21031,M0,N2b,Stage IIIC,T3,7th,not reported,456,73e45c2a-67c3-5225-bdfc-d7ed8298dbc3,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6167_diagnosis,No,Cecum,--,released,TCGA-CM-6167_treatment,bfc764f3-e1d1-5962-88c7-93600d050509,no,"Radiation Therapy, NOS",2019-07-31T18:37:51.322708-05:00,not reported,stage iiic,2019-08-08T16:36:28.485406-05:00,2010
c616f95f-4ea1-4019-8c17-041878085c88,TCGA-AA-3678,TCGA-COAD,60,-22219,--,3db68acf-2699-5cd4-91f1-504eea7d4991,not reported,female,not reported,released,TCGA-AA-3678_demographic,2019-07-31T18:36:31.769010-05:00,Alive,1946,--,22219,M0,N1,Stage III,T2,5th,not reported,1430,9e2afa49-fb82-58b9-9570-ddc5d4110507,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3678_diagnosis,No,Sigmoid colon,2019-04-28T11:21:01.608495-05:00,released,TCGA-AA-3678_treatment_1,74916ee0-9851-5916-946c-4ee26f334dec,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:31.769010-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2006
c616f95f-4ea1-4019-8c17-041878085c88,TCGA-AA-3678,TCGA-COAD,60,-22219,--,3db68acf-2699-5cd4-91f1-504eea7d4991,not reported,female,not reported,released,TCGA-AA-3678_demographic,2019-07-31T18:36:31.769010-05:00,Alive,1946,--,22219,M0,N1,Stage III,T2,5th,not reported,1430,9e2afa49-fb82-58b9-9570-ddc5d4110507,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3678_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3678_treatment,9de5934f-0568-5186-a1cd-413c638d3e29,no,"Radiation Therapy, NOS",2019-07-31T18:36:31.769010-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2006
abb0d53f-f74e-45dc-8fbb-40863016f3c6,TCGA-AA-3681,TCGA-COAD,77,-28399,--,0a43b7c1-b300-5c64-8f69-7f5a12807298,not reported,female,not reported,released,TCGA-AA-3681_demographic,2019-07-31T18:34:20.571682-05:00,Alive,1929,--,28399,M0,N1,Stage III,T3,5th,not reported,182,6d2ff619-391f-52dc-a114-0ce50422bc7b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3681_diagnosis,No,Cecum,--,released,TCGA-AA-3681_treatment,c8040220-ffb6-5b6b-9f35-60db5ac985a7,no,"Radiation Therapy, NOS",2019-07-31T18:34:20.571682-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2006
abb0d53f-f74e-45dc-8fbb-40863016f3c6,TCGA-AA-3681,TCGA-COAD,77,-28399,--,0a43b7c1-b300-5c64-8f69-7f5a12807298,not reported,female,not reported,released,TCGA-AA-3681_demographic,2019-07-31T18:34:20.571682-05:00,Alive,1929,--,28399,M0,N1,Stage III,T3,5th,not reported,182,6d2ff619-391f-52dc-a114-0ce50422bc7b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3681_diagnosis,No,Cecum,2019-04-28T11:19:12.165525-05:00,released,TCGA-AA-3681_treatment_1,f577f9fd-0203-5c86-a4ec-6bf56db9c0d7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:20.571682-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2006
fafd4576-0709-49e1-926f-ad1ee09907ec,TCGA-A6-2683,TCGA-COAD,57,-20871,504,5e81421e-03fe-56e3-928c-39715bd77570,not hispanic or latino,female,white,released,TCGA-A6-2683_demographic,2019-07-31T18:40:56.462989-05:00,Dead,1952,--,20871,M1,N0,Stage IV,T4,6th,not reported,472,ddb1d720-03f7-5d3f-b3b4-8dd94d3d1341,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-2683_diagnosis,No,Ascending colon,2019-04-28T11:24:44.471483-05:00,released,TCGA-A6-2683_treatment_1,8a9c5c85-56b3-50e9-b8ea-071903a4e78d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:56.462989-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
fafd4576-0709-49e1-926f-ad1ee09907ec,TCGA-A6-2683,TCGA-COAD,57,-20871,504,5e81421e-03fe-56e3-928c-39715bd77570,not hispanic or latino,female,white,released,TCGA-A6-2683_demographic,2019-07-31T18:40:56.462989-05:00,Dead,1952,--,20871,M1,N0,Stage IV,T4,6th,not reported,472,ddb1d720-03f7-5d3f-b3b4-8dd94d3d1341,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-2683_diagnosis,No,Ascending colon,--,released,TCGA-A6-2683_treatment,c2de6f20-10a7-537a-9915-eb0dabca66d9,no,"Radiation Therapy, NOS",2019-07-31T18:40:56.462989-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
8d0fa506-3f51-4108-8427-7dabf270bcd4,TCGA-SS-A7HO,TCGA-COAD,44,-16416,--,035adc94-bf62-5496-916b-c988dc532517,not hispanic or latino,female,black or african american,released,TCGA-SS-A7HO_demographic,2019-07-31T15:17:26.300299-05:00,Alive,1966,--,16416,M0,N0,Stage IIB,T4a,7th,not reported,1829,f9a59249-5f0b-5d2e-ae31-3e376510491b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-SS-A7HO_diagnosis,No,Cecum,--,released,TCGA-SS-A7HO_treatment,12d514ba-b232-530b-b140-a7137fcd6480,no,"Radiation Therapy, NOS",2019-07-31T15:17:26.300299-05:00,not reported,stage iib,2019-08-08T16:37:44.165377-05:00,2010
8d0fa506-3f51-4108-8427-7dabf270bcd4,TCGA-SS-A7HO,TCGA-COAD,44,-16416,--,035adc94-bf62-5496-916b-c988dc532517,not hispanic or latino,female,black or african american,released,TCGA-SS-A7HO_demographic,2019-07-31T15:17:26.300299-05:00,Alive,1966,--,16416,M0,N0,Stage IIB,T4a,7th,not reported,1829,f9a59249-5f0b-5d2e-ae31-3e376510491b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-SS-A7HO_diagnosis,No,Cecum,2019-04-28T08:37:59.754751-05:00,released,TCGA-SS-A7HO_treatment_1,25f7e529-07f2-5f18-baa3-7c9c9b35d44a,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:17:26.300299-05:00,not reported,stage iib,2019-08-08T16:37:44.165377-05:00,2010
39b6ae01-c97b-4234-8a28-208fdf170432,TCGA-A6-6649,TCGA-COAD,66,-24237,--,89ed96eb-fd47-5bad-aa32-831b887f9bdc,not hispanic or latino,male,white,released,TCGA-A6-6649_demographic,2019-07-31T18:26:58.238009-05:00,Alive,1944,--,24237,M0,N1b,Stage IIIB,T3,--,not reported,735,4ea167d1-f9ce-54e8-88f9-9ea418b34181,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-A6-6649_diagnosis,Not Reported,Ascending colon,2019-04-28T11:13:07.269578-05:00,released,TCGA-A6-6649_treatment_1,3640acf7-9e79-5950-9bf9-7e0fcb492044,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:58.238009-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
39b6ae01-c97b-4234-8a28-208fdf170432,TCGA-A6-6649,TCGA-COAD,66,-24237,--,89ed96eb-fd47-5bad-aa32-831b887f9bdc,not hispanic or latino,male,white,released,TCGA-A6-6649_demographic,2019-07-31T18:26:58.238009-05:00,Alive,1944,--,24237,M0,N1b,Stage IIIB,T3,--,not reported,735,4ea167d1-f9ce-54e8-88f9-9ea418b34181,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-A6-6649_diagnosis,Not Reported,Ascending colon,--,released,TCGA-A6-6649_treatment,3acb064a-90b9-5bd9-9631-b6c5cfbd233b,no,"Radiation Therapy, NOS",2019-07-31T18:26:58.238009-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
0a94eecf-4db2-4846-8383-c83ff02e4a9f,TCGA-D5-6922,TCGA-COAD,76,-27771,--,b25ea864-e3c5-598f-adec-bf4758562b23,not hispanic or latino,male,white,released,TCGA-D5-6922_demographic,2019-07-31T18:22:58.185643-05:00,Alive,1935,--,27771,M0,N1,Stage IIIA,T3,7th,not reported,308,176aca34-635f-53f4-bae2-f29a21c0dbb6,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6922_diagnosis,No,Sigmoid colon,2019-04-28T11:09:48.286176-05:00,released,TCGA-D5-6922_treatment_1,aca2db20-e231-5625-a68a-1491628b8b1c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:58.185643-05:00,not reported,stage iiia,2019-08-08T16:36:52.154454-05:00,2011
0a94eecf-4db2-4846-8383-c83ff02e4a9f,TCGA-D5-6922,TCGA-COAD,76,-27771,--,b25ea864-e3c5-598f-adec-bf4758562b23,not hispanic or latino,male,white,released,TCGA-D5-6922_demographic,2019-07-31T18:22:58.185643-05:00,Alive,1935,--,27771,M0,N1,Stage IIIA,T3,7th,not reported,308,176aca34-635f-53f4-bae2-f29a21c0dbb6,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6922_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6922_treatment,43bb17d9-a92f-5e0f-8fc1-125d689f2c51,no,"Radiation Therapy, NOS",2019-07-31T18:22:58.185643-05:00,not reported,stage iiia,2019-08-08T16:36:52.154454-05:00,2011
6454ff0c-26f8-4cc2-b77c-7e5abdc20acd,TCGA-NH-A8F7,TCGA-COAD,53,-19535,--,b3082edb-b74b-5118-85c1-bfac10d1cef0,not hispanic or latino,female,black or african american,released,TCGA-NH-A8F7_demographic,2019-07-31T15:19:43.861227-05:00,Alive,1960,--,19535,MX,N0,Stage IIA,T3,7th,not reported,543,4689c168-6a0b-5c0d-bdc8-73dfbc3315ad,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-NH-A8F7_diagnosis,Yes,Sigmoid colon,2019-04-28T08:39:59.417068-05:00,released,TCGA-NH-A8F7_treatment_1,9ecd6fbd-2362-5caa-a08d-bd869e82b5ba,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:19:43.861227-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2013
6454ff0c-26f8-4cc2-b77c-7e5abdc20acd,TCGA-NH-A8F7,TCGA-COAD,53,-19535,--,b3082edb-b74b-5118-85c1-bfac10d1cef0,not hispanic or latino,female,black or african american,released,TCGA-NH-A8F7_demographic,2019-07-31T15:19:43.861227-05:00,Alive,1960,--,19535,MX,N0,Stage IIA,T3,7th,not reported,543,4689c168-6a0b-5c0d-bdc8-73dfbc3315ad,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-NH-A8F7_diagnosis,Yes,Sigmoid colon,--,released,TCGA-NH-A8F7_treatment,dfd5ac97-f73d-513f-9c0a-c86d31e08d3b,yes,"Radiation Therapy, NOS",2019-07-31T15:19:43.861227-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2013
e6c8c5fc-158a-4de4-b3f6-3b645584bbc7,TCGA-AA-A03J,TCGA-COAD,65,-23986,--,e3d6910b-8cca-5e3c-8eda-63340feffcf7,not reported,female,not reported,released,TCGA-AA-A03J_demographic,2019-07-31T15:56:47.056863-05:00,Alive,1939,--,23986,M0,N0,Stage I,T2,5th,not reported,1246,53fa973b-8404-5207-9aa5-ce434cdeb97e,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A03J_diagnosis,No,Sigmoid colon,2019-04-28T09:11:22.473550-05:00,released,TCGA-AA-A03J_treatment_1,2b61e520-a9b9-5aa7-a62d-c0a6e9bdd6d0,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:56:47.056863-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2004
e6c8c5fc-158a-4de4-b3f6-3b645584bbc7,TCGA-AA-A03J,TCGA-COAD,65,-23986,--,e3d6910b-8cca-5e3c-8eda-63340feffcf7,not reported,female,not reported,released,TCGA-AA-A03J_demographic,2019-07-31T15:56:47.056863-05:00,Alive,1939,--,23986,M0,N0,Stage I,T2,5th,not reported,1246,53fa973b-8404-5207-9aa5-ce434cdeb97e,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A03J_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A03J_treatment,4d42b325-e0e9-58dc-bc81-4c1f52f2a0cf,no,"Radiation Therapy, NOS",2019-07-31T15:56:47.056863-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2004
d9d7f0d4-fa64-48f2-8037-52cbf0b34ad8,TCGA-AA-3516,TCGA-COAD,74,-27303,396,f7693363-b0a5-521e-8db4-dd7e0aee41c2,not reported,female,not reported,released,TCGA-AA-3516_demographic,2019-07-31T18:38:20.697226-05:00,Dead,1933,--,27303,M0,N2,Stage III,T3,5th,not reported,--,fdf60a53-e7e1-5c35-a5dc-5703b57650bc,C18.9,8480/3,Mucinous adenocarcinoma,yes,Yes,not reported,"Colon, NOS",released,TCGA-AA-3516_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3516_treatment,8e750655-a0b5-53ba-8e02-60a112cb0c59,no,"Radiation Therapy, NOS",2019-07-31T18:38:20.697226-05:00,not reported,stage iii,2019-08-08T16:34:13.342472-05:00,2007
d9d7f0d4-fa64-48f2-8037-52cbf0b34ad8,TCGA-AA-3516,TCGA-COAD,74,-27303,396,f7693363-b0a5-521e-8db4-dd7e0aee41c2,not reported,female,not reported,released,TCGA-AA-3516_demographic,2019-07-31T18:38:20.697226-05:00,Dead,1933,--,27303,M0,N2,Stage III,T3,5th,not reported,--,fdf60a53-e7e1-5c35-a5dc-5703b57650bc,C18.9,8480/3,Mucinous adenocarcinoma,yes,Yes,not reported,"Colon, NOS",released,TCGA-AA-3516_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:22:33.468818-05:00,released,TCGA-AA-3516_treatment_1,bdb2ae1f-1dbc-5ae6-a9d4-ecf5c0775654,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:20.697226-05:00,not reported,stage iii,2019-08-08T16:34:13.342472-05:00,2007
5eed7e8a-c219-4497-a99f-bfc48faca4d8,TCGA-G4-6625,TCGA-COAD,77,-28163,--,b485e92b-3300-5a1b-9b07-2d7ebd22b396,not hispanic or latino,female,white,released,TCGA-G4-6625_demographic,2019-07-31T18:29:21.993895-05:00,Alive,1927,--,28163,M0,N0,Stage IIA,T3,5th,not reported,2792,6bf0b827-b7ba-585a-a183-64a964ca7a9f,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-G4-6625_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-G4-6625_treatment,c9de9b2a-2852-51bd-b137-446c4d9fe1bd,no,"Radiation Therapy, NOS",2019-07-31T18:29:21.993895-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2004
5eed7e8a-c219-4497-a99f-bfc48faca4d8,TCGA-G4-6625,TCGA-COAD,77,-28163,--,b485e92b-3300-5a1b-9b07-2d7ebd22b396,not hispanic or latino,female,white,released,TCGA-G4-6625_demographic,2019-07-31T18:29:21.993895-05:00,Alive,1927,--,28163,M0,N0,Stage IIA,T3,5th,not reported,2792,6bf0b827-b7ba-585a-a183-64a964ca7a9f,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-G4-6625_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:15:06.891374-05:00,released,TCGA-G4-6625_treatment_1,e3aa925d-2d16-509c-9147-cc65300ff1b0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:21.993895-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2004
64dcf1a5-c78c-4d3f-852c-15865b3b6189,TCGA-AZ-6607,TCGA-COAD,69,-25448,97,5ef4356f-94e9-52ca-9db1-2905d8cfbe24,not hispanic or latino,male,white,released,TCGA-AZ-6607_demographic,2019-07-31T18:29:49.227597-05:00,Dead,1940,2009,25448,M1,N2,Stage IV,T4,6th,not reported,--,98bfc753-a803-5500-a6d5-7849ac00af42,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AZ-6607_diagnosis,No,Sigmoid colon,2019-04-28T11:15:29.140160-05:00,released,TCGA-AZ-6607_treatment_1,3321bc94-502e-5c60-9525-b2665af40c84,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:49.227597-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2009
64dcf1a5-c78c-4d3f-852c-15865b3b6189,TCGA-AZ-6607,TCGA-COAD,69,-25448,97,5ef4356f-94e9-52ca-9db1-2905d8cfbe24,not hispanic or latino,male,white,released,TCGA-AZ-6607_demographic,2019-07-31T18:29:49.227597-05:00,Dead,1940,2009,25448,M1,N2,Stage IV,T4,6th,not reported,--,98bfc753-a803-5500-a6d5-7849ac00af42,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AZ-6607_diagnosis,No,Sigmoid colon,--,released,TCGA-AZ-6607_treatment,360242c5-34cb-5a29-a87e-6c01f7565fa9,no,"Radiation Therapy, NOS",2019-07-31T18:29:49.227597-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2009
da21e143-dbf6-4ac7-8872-f1d9ae39512d,TCGA-G4-6320,TCGA-COAD,73,-26840,--,54a4dd14-0f05-58f1-9ed6-3c8c558377f1,not hispanic or latino,male,white,released,TCGA-G4-6320_demographic,2019-07-31T18:38:26.872409-05:00,Alive,1936,--,26840,MX,N1,Stage III,T3,6th,not reported,804,6409d6d5-6ed4-5f24-bbf5-293c5c2119f5,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-G4-6320_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-G4-6320_treatment,858d3247-b46f-5e66-a973-7865d156bd1b,no,"Radiation Therapy, NOS",2019-07-31T18:38:26.872409-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2009
da21e143-dbf6-4ac7-8872-f1d9ae39512d,TCGA-G4-6320,TCGA-COAD,73,-26840,--,54a4dd14-0f05-58f1-9ed6-3c8c558377f1,not hispanic or latino,male,white,released,TCGA-G4-6320_demographic,2019-07-31T18:38:26.872409-05:00,Alive,1936,--,26840,MX,N1,Stage III,T3,6th,not reported,804,6409d6d5-6ed4-5f24-bbf5-293c5c2119f5,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-G4-6320_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:22:38.239294-05:00,released,TCGA-G4-6320_treatment_1,a23b351b-9561-5c77-b2ae-f9eec652bd9a,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:26.872409-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2009
6a4031c6-ee88-48be-81a5-a522720edd02,TCGA-CM-6164,TCGA-COAD,46,-16802,--,ee5a5912-df43-59ba-8af8-ccc4e39e9c36,not hispanic or latino,female,white,released,TCGA-CM-6164_demographic,2019-07-31T18:30:13.081729-05:00,Alive,1963,--,16802,M0,N0,Stage IIA,T3,6th,not reported,883,e80e05ba-5267-5fee-bc18-fd16e1ef8fd5,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6164_diagnosis,No,Sigmoid colon,2019-04-28T11:15:49.099349-05:00,released,TCGA-CM-6164_treatment_1,7b180d8a-3dd0-5d96-a533-f56a3b8e4647,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:13.081729-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2009
6a4031c6-ee88-48be-81a5-a522720edd02,TCGA-CM-6164,TCGA-COAD,46,-16802,--,ee5a5912-df43-59ba-8af8-ccc4e39e9c36,not hispanic or latino,female,white,released,TCGA-CM-6164_demographic,2019-07-31T18:30:13.081729-05:00,Alive,1963,--,16802,M0,N0,Stage IIA,T3,6th,not reported,883,e80e05ba-5267-5fee-bc18-fd16e1ef8fd5,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6164_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6164_treatment,4a59bcc6-a2fc-5ebd-8801-016cdec0b0fa,no,"Radiation Therapy, NOS",2019-07-31T18:30:13.081729-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2009
cac80259-3a26-4a99-b0d3-13454068e6ed,TCGA-AZ-4684,TCGA-COAD,49,-18252,--,5a7e3e37-e164-5642-bab6-0d696393eaa3,not hispanic or latino,male,white,released,TCGA-AZ-4684_demographic,2019-07-31T18:37:13.482000-05:00,Alive,1957,--,18252,M1,N2,Stage IVA,T3,--,not reported,1977,0fcb44bf-bfbd-55e6-9975-2ab4512ec859,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-AZ-4684_diagnosis,No,Rectosigmoid junction,--,released,TCGA-AZ-4684_treatment,78d6b8e7-004c-5b7d-a144-6e6f1de8074a,no,"Radiation Therapy, NOS",2019-07-31T18:37:13.482000-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2006
cac80259-3a26-4a99-b0d3-13454068e6ed,TCGA-AZ-4684,TCGA-COAD,49,-18252,--,5a7e3e37-e164-5642-bab6-0d696393eaa3,not hispanic or latino,male,white,released,TCGA-AZ-4684_demographic,2019-07-31T18:37:13.482000-05:00,Alive,1957,--,18252,M1,N2,Stage IVA,T3,--,not reported,1977,0fcb44bf-bfbd-55e6-9975-2ab4512ec859,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-AZ-4684_diagnosis,No,Rectosigmoid junction,2019-04-28T11:21:34.521865-05:00,released,TCGA-AZ-4684_treatment_1,dd566a46-1a36-5fd2-917e-10e23a1334f9,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:13.482000-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2006
b54865b6-824e-4163-b759-21a6eacc98ce,TCGA-A6-6781,TCGA-COAD,43,-15842,--,cccd68c4-cb54-5bcd-9efd-6073599de319,not hispanic or latino,male,white,released,TCGA-A6-6781_demographic,2019-07-31T15:40:17.620662-05:00,Alive,1968,--,15842,MX,N1b,Stage IIIC,T4b,7th,not reported,598,66bbece6-f950-5d19-8a18-4ed49f8cbe55,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-A6-6781_diagnosis,No,"Colon, NOS",2019-04-28T08:57:42.793014-05:00,released,TCGA-A6-6781_treatment_1,8bc73d6d-53bd-55d4-a23a-06bee6ab8729,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:40:17.620662-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2011
b54865b6-824e-4163-b759-21a6eacc98ce,TCGA-A6-6781,TCGA-COAD,43,-15842,--,cccd68c4-cb54-5bcd-9efd-6073599de319,not hispanic or latino,male,white,released,TCGA-A6-6781_demographic,2019-07-31T15:40:17.620662-05:00,Alive,1968,--,15842,MX,N1b,Stage IIIC,T4b,7th,not reported,598,66bbece6-f950-5d19-8a18-4ed49f8cbe55,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-A6-6781_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-6781_treatment,e247fab9-117b-55c7-a288-b8ee530e48e9,no,"Radiation Therapy, NOS",2019-07-31T15:40:17.620662-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2011
7d8eab0a-e6c8-4449-9ebf-50c41db94a06,TCGA-A6-2681,TCGA-COAD,73,-26929,--,57f6c323-8f9e-55b2-b44a-2a54bb322d06,not hispanic or latino,female,white,released,TCGA-A6-2681_demographic,2019-07-31T18:42:02.992146-05:00,Alive,1936,--,26929,M0,N0,Stage IIA,T3,6th,not reported,1387,36ba4fb9-a407-5361-a1c1-6d00a62a867a,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-A6-2681_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:25:41.042900-05:00,released,TCGA-A6-2681_treatment_1,25613f32-f960-52e1-ace5-9c6bc5e33a8d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:02.992146-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
7d8eab0a-e6c8-4449-9ebf-50c41db94a06,TCGA-A6-2681,TCGA-COAD,73,-26929,--,57f6c323-8f9e-55b2-b44a-2a54bb322d06,not hispanic or latino,female,white,released,TCGA-A6-2681_demographic,2019-07-31T18:42:02.992146-05:00,Alive,1936,--,26929,M0,N0,Stage IIA,T3,6th,not reported,1387,36ba4fb9-a407-5361-a1c1-6d00a62a867a,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-A6-2681_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-A6-2681_treatment,3fda2555-04f3-5bc8-924e-359c19720345,no,"Radiation Therapy, NOS",2019-07-31T18:42:02.992146-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
64b0461f-038d-4712-948e-818dc2f10eef,TCGA-D5-6929,TCGA-COAD,49,-17919,--,cd486479-533e-5dca-bddf-f36118a648cb,not hispanic or latino,female,white,released,TCGA-D5-6929_demographic,2019-07-31T18:29:43.166615-05:00,Alive,1962,--,17919,M1,N1,Stage IV,T3,7th,not reported,408,393cbb77-5174-560d-b65f-c46b79ba95b9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6929_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6929_treatment,8d8d5e7b-6aee-59a1-9961-476835124f2e,no,"Radiation Therapy, NOS",2019-07-31T18:29:43.166615-05:00,not reported,stage iv,2019-08-08T16:36:52.154454-05:00,2011
64b0461f-038d-4712-948e-818dc2f10eef,TCGA-D5-6929,TCGA-COAD,49,-17919,--,cd486479-533e-5dca-bddf-f36118a648cb,not hispanic or latino,female,white,released,TCGA-D5-6929_demographic,2019-07-31T18:29:43.166615-05:00,Alive,1962,--,17919,M1,N1,Stage IV,T3,7th,not reported,408,393cbb77-5174-560d-b65f-c46b79ba95b9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6929_diagnosis,No,"Colon, NOS",2019-04-28T11:15:24.127866-05:00,released,TCGA-D5-6929_treatment_1,f6cf43b9-5b46-5b5d-a717-a2f399534803,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:43.166615-05:00,not reported,stage iv,2019-08-08T16:36:52.154454-05:00,2011
e394e9ec-7288-4ede-9ef8-41b631d100dd,TCGA-AA-3715,TCGA-COAD,77,-28428,579,cd5c31fe-5cf8-5281-95a0-9a34f951362b,not reported,male,not reported,released,TCGA-AA-3715_demographic,2019-07-31T18:38:59.564222-05:00,Dead,1929,--,28428,M0,N0,Stage II,T3,5th,not reported,30,72a17832-b07a-5d97-b70d-6c410f07cb9b,C18.2,8560/3,Adenosquamous carcinoma,yes,No,not reported,Ascending colon,released,TCGA-AA-3715_diagnosis,Not Reported,Ascending colon,2019-04-28T11:23:06.233204-05:00,released,TCGA-AA-3715_treatment_1,03712ca7-b887-5912-9453-29995d38d56b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:59.564222-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2006
e394e9ec-7288-4ede-9ef8-41b631d100dd,TCGA-AA-3715,TCGA-COAD,77,-28428,579,cd5c31fe-5cf8-5281-95a0-9a34f951362b,not reported,male,not reported,released,TCGA-AA-3715_demographic,2019-07-31T18:38:59.564222-05:00,Dead,1929,--,28428,M0,N0,Stage II,T3,5th,not reported,30,72a17832-b07a-5d97-b70d-6c410f07cb9b,C18.2,8560/3,Adenosquamous carcinoma,yes,No,not reported,Ascending colon,released,TCGA-AA-3715_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3715_treatment,e9642f97-50b1-58f8-b260-9ba9dcf6ee16,no,"Radiation Therapy, NOS",2019-07-31T18:38:59.564222-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2006
17633a60-e12b-4a7c-bd8a-c16341ddc606,TCGA-CA-5256,TCGA-COAD,54,-19785,--,d34d0a7c-fd0d-57aa-a1d5-0926105a00d0,not reported,female,asian,released,TCGA-CA-5256_demographic,2019-07-31T18:24:19.228828-05:00,Alive,1956,--,19785,M0,N0,Stage IIA,T3,--,not reported,379,d8ae5b86-0710-5358-a855-bfb4ad26a56d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5256_diagnosis,No,"Colon, NOS",--,released,TCGA-CA-5256_treatment,16fb0269-ca0e-570e-9b7d-f2c73aacdcb1,no,"Radiation Therapy, NOS",2019-07-31T18:24:19.228828-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
17633a60-e12b-4a7c-bd8a-c16341ddc606,TCGA-CA-5256,TCGA-COAD,54,-19785,--,d34d0a7c-fd0d-57aa-a1d5-0926105a00d0,not reported,female,asian,released,TCGA-CA-5256_demographic,2019-07-31T18:24:19.228828-05:00,Alive,1956,--,19785,M0,N0,Stage IIA,T3,--,not reported,379,d8ae5b86-0710-5358-a855-bfb4ad26a56d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5256_diagnosis,No,"Colon, NOS",2019-04-28T11:10:53.866620-05:00,released,TCGA-CA-5256_treatment_1,d8b5593a-473e-524e-812f-f2144a53e5f6,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:19.228828-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
0cbe9848-8eac-4ea8-a36b-fb74b4a33de7,TCGA-AA-A00K,TCGA-COAD,79,-29189,--,cf4a6e8a-674a-5a6e-95c8-40504419028c,not reported,male,not reported,released,TCGA-AA-A00K_demographic,2019-07-31T18:23:13.176989-05:00,Alive,1930,--,29189,M0,N0,Stage IIA,T3,6th,not reported,549,7166ec50-3689-5fa6-bbe7-0a04ebf9144e,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00K_diagnosis,No,Sigmoid colon,2019-04-28T11:10:00.759821-05:00,released,TCGA-AA-A00K_treatment_1,15b86a7a-41dc-58cb-95ea-4402f2208fa3,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:13.176989-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
0cbe9848-8eac-4ea8-a36b-fb74b4a33de7,TCGA-AA-A00K,TCGA-COAD,79,-29189,--,cf4a6e8a-674a-5a6e-95c8-40504419028c,not reported,male,not reported,released,TCGA-AA-A00K_demographic,2019-07-31T18:23:13.176989-05:00,Alive,1930,--,29189,M0,N0,Stage IIA,T3,6th,not reported,549,7166ec50-3689-5fa6-bbe7-0a04ebf9144e,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00K_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A00K_treatment,0b82dff1-f693-51d1-a58a-d1ae7e8f2a43,not reported,"Radiation Therapy, NOS",2019-07-31T18:23:13.176989-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
51dcbfac-6f04-4364-877d-0bf1bd566335,TCGA-NH-A6GA,TCGA-COAD,58,-21313,302,d902b9e4-6386-591d-9269-3b737710e2fb,not hispanic or latino,male,black or african american,released,TCGA-NH-A6GA_demographic,2019-07-31T15:55:59.137167-05:00,Dead,1955,--,21313,MX,N2a,Stage IIIC,T4a,7th,not reported,182,6a2b02be-3467-5b81-aabc-41644bb49652,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-NH-A6GA_diagnosis,No,Ascending colon,--,released,TCGA-NH-A6GA_treatment,f6879a65-0b05-5457-8c16-795d794228c6,no,"Radiation Therapy, NOS",2019-07-31T15:55:59.137167-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2013
51dcbfac-6f04-4364-877d-0bf1bd566335,TCGA-NH-A6GA,TCGA-COAD,58,-21313,302,d902b9e4-6386-591d-9269-3b737710e2fb,not hispanic or latino,male,black or african american,released,TCGA-NH-A6GA_demographic,2019-07-31T15:55:59.137167-05:00,Dead,1955,--,21313,MX,N2a,Stage IIIC,T4a,7th,not reported,182,6a2b02be-3467-5b81-aabc-41644bb49652,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-NH-A6GA_diagnosis,No,Ascending colon,2019-04-28T09:10:44.858442-05:00,released,TCGA-NH-A6GA_treatment_1,34d81ea8-9f6d-52e4-8f1f-d470a149ca11,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:55:59.137167-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2013
cab7bdbc-0a11-4901-97c3-26b884f79cb5,TCGA-AA-3968,TCGA-COAD,55,-20089,--,d99066a1-9155-5668-a699-ec17f0a7b6ee,not reported,female,not reported,released,TCGA-AA-3968_demographic,2019-07-31T18:37:10.479680-05:00,Alive,1953,--,20089,M0,N0,Stage I,T2,6th,not reported,669,102347b7-6298-5aed-a441-fe7d02f4ad61,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3968_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3968_treatment,10a66636-d17e-5f3e-8b13-327c1eeedbfa,no,"Radiation Therapy, NOS",2019-07-31T18:37:10.479680-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2008
cab7bdbc-0a11-4901-97c3-26b884f79cb5,TCGA-AA-3968,TCGA-COAD,55,-20089,--,d99066a1-9155-5668-a699-ec17f0a7b6ee,not reported,female,not reported,released,TCGA-AA-3968_demographic,2019-07-31T18:37:10.479680-05:00,Alive,1953,--,20089,M0,N0,Stage I,T2,6th,not reported,669,102347b7-6298-5aed-a441-fe7d02f4ad61,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3968_diagnosis,No,Sigmoid colon,2019-04-28T11:21:32.087737-05:00,released,TCGA-AA-3968_treatment_1,53c453d9-ba47-5e1f-a89d-04bb6078c8b0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:10.479680-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2008
ec3f3f11-75df-4fcc-ba03-f19aca907645,TCGA-CM-6162,TCGA-COAD,48,-17624,--,b93b0eda-c4f1-5349-808e-88360b6fe778,not hispanic or latino,female,white,released,TCGA-CM-6162_demographic,2019-07-31T18:39:58.787125-05:00,Alive,1962,--,17624,M0,N1a,Stage IIIB,T3,7th,not reported,365,0ab6867f-aa3b-5133-8fcc-dc0895bbeaa6,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CM-6162_diagnosis,No,Ascending colon,2019-04-28T11:23:56.936316-05:00,released,TCGA-CM-6162_treatment_1,831fd8f3-7f69-5a46-bbd4-86b4027b4d90,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:58.787125-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
ec3f3f11-75df-4fcc-ba03-f19aca907645,TCGA-CM-6162,TCGA-COAD,48,-17624,--,b93b0eda-c4f1-5349-808e-88360b6fe778,not hispanic or latino,female,white,released,TCGA-CM-6162_demographic,2019-07-31T18:39:58.787125-05:00,Alive,1962,--,17624,M0,N1a,Stage IIIB,T3,7th,not reported,365,0ab6867f-aa3b-5133-8fcc-dc0895bbeaa6,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CM-6162_diagnosis,No,Ascending colon,--,released,TCGA-CM-6162_treatment,b517832c-c386-5eda-86c5-4185f06ffed0,no,"Radiation Therapy, NOS",2019-07-31T18:39:58.787125-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
b3fea9bb-53f9-4ddb-922d-b570562d7a7d,TCGA-G4-6322,TCGA-COAD,65,-23825,--,34c664a3-2210-5ad8-97f4-081bdb0307ca,not hispanic or latino,male,white,released,TCGA-G4-6322_demographic,2019-07-31T18:35:05.399240-05:00,Alive,1944,--,23825,MX,N1,Stage IIIB,T3,6th,not reported,792,134bc369-19e4-5690-87c7-19bd79a87594,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-G4-6322_diagnosis,No,Descending colon,--,released,TCGA-G4-6322_treatment,ae117449-96a3-50bc-ae71-34e765bc47ce,no,"Radiation Therapy, NOS",2019-07-31T18:35:05.399240-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2009
b3fea9bb-53f9-4ddb-922d-b570562d7a7d,TCGA-G4-6322,TCGA-COAD,65,-23825,--,34c664a3-2210-5ad8-97f4-081bdb0307ca,not hispanic or latino,male,white,released,TCGA-G4-6322_demographic,2019-07-31T18:35:05.399240-05:00,Alive,1944,--,23825,MX,N1,Stage IIIB,T3,6th,not reported,792,134bc369-19e4-5690-87c7-19bd79a87594,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-G4-6322_diagnosis,No,Descending colon,2019-04-28T11:19:49.982689-05:00,released,TCGA-G4-6322_treatment_1,bf77108c-1cf2-58d6-8d2d-8f9774a09719,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:05.399240-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2009
0e87e5fd-d5bb-4c0d-952d-711a6abbf336,TCGA-AA-3821,TCGA-COAD,81,-29706,--,de6fe943-3d84-55ca-aaeb-e010bb853cc4,not reported,female,not reported,released,TCGA-AA-3821_demographic,2019-07-31T18:23:23.336454-05:00,Alive,1927,--,29706,M0,N0,Stage I,T2,6th,not reported,31,41287738-0c99-5c29-984e-35bd7d3bd38b,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-3821_diagnosis,No,Ascending colon,2019-04-28T11:10:07.990675-05:00,released,TCGA-AA-3821_treatment_1,077e75ef-3768-519d-a329-7dad5dc5b747,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:23.336454-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2008
0e87e5fd-d5bb-4c0d-952d-711a6abbf336,TCGA-AA-3821,TCGA-COAD,81,-29706,--,de6fe943-3d84-55ca-aaeb-e010bb853cc4,not reported,female,not reported,released,TCGA-AA-3821_demographic,2019-07-31T18:23:23.336454-05:00,Alive,1927,--,29706,M0,N0,Stage I,T2,6th,not reported,31,41287738-0c99-5c29-984e-35bd7d3bd38b,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-3821_diagnosis,No,Ascending colon,--,released,TCGA-AA-3821_treatment,9eb834d3-d9c0-5ecd-b16d-b719adbb902e,no,"Radiation Therapy, NOS",2019-07-31T18:23:23.336454-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2008
3a785e32-7960-4c72-84c4-fb42c4dd86f1,TCGA-A6-2678,TCGA-COAD,43,-16030,--,5fddc8ae-22bf-595b-9f53-e48cb6de77d3,not hispanic or latino,female,white,released,TCGA-A6-2678_demographic,2019-07-31T18:27:04.051557-05:00,Alive,1966,--,16030,M0,N1,Stage IIIB,T3,6th,not reported,1286,ccbdd2e1-7c04-5f88-a535-3883a1558658,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-A6-2678_diagnosis,No,Transverse colon,2019-04-28T11:13:12.528043-05:00,released,TCGA-A6-2678_treatment_1,886c4b6f-8404-5d08-b8f1-f45735168533,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:04.051557-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2009
3a785e32-7960-4c72-84c4-fb42c4dd86f1,TCGA-A6-2678,TCGA-COAD,43,-16030,--,5fddc8ae-22bf-595b-9f53-e48cb6de77d3,not hispanic or latino,female,white,released,TCGA-A6-2678_demographic,2019-07-31T18:27:04.051557-05:00,Alive,1966,--,16030,M0,N1,Stage IIIB,T3,6th,not reported,1286,ccbdd2e1-7c04-5f88-a535-3883a1558658,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-A6-2678_diagnosis,No,Transverse colon,--,released,TCGA-A6-2678_treatment,52d132c9-7e01-5882-93a4-8e36d3809ef0,no,"Radiation Therapy, NOS",2019-07-31T18:27:04.051557-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2009
d17a2ab0-faef-40de-a87d-1291868b200d,TCGA-AA-3679,TCGA-COAD,59,-21611,--,60825c73-4ab3-5a4e-a7f0-5ec39cee5ad5,not reported,male,not reported,released,TCGA-AA-3679_demographic,2019-07-31T18:37:39.712409-05:00,Alive,1947,--,21611,M1,N2,Stage IV,T3,6th,not reported,457,70eb2832-f00d-550a-900c-21a207b4a909,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3679_diagnosis,No,"Colon, NOS",2019-04-28T11:21:56.864726-05:00,released,TCGA-AA-3679_treatment_1,6f264b7a-0fcf-5f8e-afc6-af883def097c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:39.712409-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2006
d17a2ab0-faef-40de-a87d-1291868b200d,TCGA-AA-3679,TCGA-COAD,59,-21611,--,60825c73-4ab3-5a4e-a7f0-5ec39cee5ad5,not reported,male,not reported,released,TCGA-AA-3679_demographic,2019-07-31T18:37:39.712409-05:00,Alive,1947,--,21611,M1,N2,Stage IV,T3,6th,not reported,457,70eb2832-f00d-550a-900c-21a207b4a909,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3679_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3679_treatment,c7ace739-f023-59cb-a34e-d29abd001424,no,"Radiation Therapy, NOS",2019-07-31T18:37:39.712409-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2006
132229e5-947d-43e9-a54c-a97d4be7d604,TCGA-AA-A01F,TCGA-COAD,72,-26298,--,a3c73120-7dcc-5ac5-9c37-8c7f152cd4e1,not reported,male,not reported,released,TCGA-AA-A01F_demographic,2019-07-31T18:23:53.979466-05:00,Alive,1937,--,26298,M0,N1,Stage IIIB,T3,6th,not reported,974,3c7ef8dd-b767-5793-a46e-4b8954de6186,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01F_diagnosis,No,Sigmoid colon,2019-04-28T11:10:33.157007-05:00,released,TCGA-AA-A01F_treatment_1,0b548bf8-3126-5567-874d-21b258718e18,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:53.979466-05:00,not reported,stage iiib,2019-08-08T16:35:29.811838-05:00,2009
132229e5-947d-43e9-a54c-a97d4be7d604,TCGA-AA-A01F,TCGA-COAD,72,-26298,--,a3c73120-7dcc-5ac5-9c37-8c7f152cd4e1,not reported,male,not reported,released,TCGA-AA-A01F_demographic,2019-07-31T18:23:53.979466-05:00,Alive,1937,--,26298,M0,N1,Stage IIIB,T3,6th,not reported,974,3c7ef8dd-b767-5793-a46e-4b8954de6186,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01F_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A01F_treatment,9497099e-c646-5bdc-a81b-d051d5febd6a,no,"Radiation Therapy, NOS",2019-07-31T18:23:53.979466-05:00,not reported,stage iiib,2019-08-08T16:35:29.811838-05:00,2009
9cdca5d8-ea77-4df9-b2ba-0d5e8ec37bcd,TCGA-CA-6719,TCGA-COAD,77,-28343,--,a632206a-a584-567a-ae53-b1ac3053412a,not hispanic or latino,male,asian,released,TCGA-CA-6719_demographic,2019-07-31T18:33:22.977736-05:00,Alive,1934,--,28343,M0,N0,Stage IIA,T3,6th,not reported,435,97374a3c-5848-52fd-812a-06a41def4da6,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-CA-6719_diagnosis,No,Descending colon,2019-04-28T11:18:26.486883-05:00,released,TCGA-CA-6719_treatment_1,45fea666-89bb-59cf-9d6d-82ef5a2f18f8,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:22.977736-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2011
9cdca5d8-ea77-4df9-b2ba-0d5e8ec37bcd,TCGA-CA-6719,TCGA-COAD,77,-28343,--,a632206a-a584-567a-ae53-b1ac3053412a,not hispanic or latino,male,asian,released,TCGA-CA-6719_demographic,2019-07-31T18:33:22.977736-05:00,Alive,1934,--,28343,M0,N0,Stage IIA,T3,6th,not reported,435,97374a3c-5848-52fd-812a-06a41def4da6,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-CA-6719_diagnosis,No,Descending colon,--,released,TCGA-CA-6719_treatment,ef32fd62-f336-5932-8d5f-a79d6c7a325a,no,"Radiation Therapy, NOS",2019-07-31T18:33:22.977736-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2011
bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d,TCGA-AA-3692,TCGA-COAD,47,-17167,1095,a85ecfa6-9fb5-5187-a4e5-2b63523ecb48,not reported,female,not reported,released,TCGA-AA-3692_demographic,2019-07-31T18:35:41.616628-05:00,Dead,1961,--,17167,M1,N2,Stage IV,T3,6th,not reported,--,9e4cf95d-116c-5584-8fa3-2d02a576f7ab,C18.9,8480/3,Mucinous adenocarcinoma,yes,No,not reported,"Colon, NOS",released,TCGA-AA-3692_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3692_treatment,14a9506c-c78a-560d-a3e6-85cb31dd6456,yes,"Radiation Therapy, NOS",2019-07-31T18:35:41.616628-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2008
bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d,TCGA-AA-3692,TCGA-COAD,47,-17167,1095,a85ecfa6-9fb5-5187-a4e5-2b63523ecb48,not reported,female,not reported,released,TCGA-AA-3692_demographic,2019-07-31T18:35:41.616628-05:00,Dead,1961,--,17167,M1,N2,Stage IV,T3,6th,not reported,--,9e4cf95d-116c-5584-8fa3-2d02a576f7ab,C18.9,8480/3,Mucinous adenocarcinoma,yes,No,not reported,"Colon, NOS",released,TCGA-AA-3692_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:20:19.697162-05:00,released,TCGA-AA-3692_treatment_1,f2fe8f95-b882-5364-96a6-5b90a2d7f57f,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:41.616628-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2008
81555ac5-9cc2-49ae-9033-657f56243f20,TCGA-AA-3939,TCGA-COAD,83,-30439,--,a96c1391-bcf5-552e-87f4-1a8feff69315,not reported,male,not reported,released,TCGA-AA-3939_demographic,2019-07-31T18:42:08.489175-05:00,Alive,1926,--,30439,M0,N0,Stage IIA,T3,6th,not reported,395,9f5a70d8-c9b5-5f98-8afd-48c62e1fbd55,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3939_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:25:46.469864-05:00,released,TCGA-AA-3939_treatment_1,94c6f137-08e3-5c71-834e-8c58397344fb,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:08.489175-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
81555ac5-9cc2-49ae-9033-657f56243f20,TCGA-AA-3939,TCGA-COAD,83,-30439,--,a96c1391-bcf5-552e-87f4-1a8feff69315,not reported,male,not reported,released,TCGA-AA-3939_demographic,2019-07-31T18:42:08.489175-05:00,Alive,1926,--,30439,M0,N0,Stage IIA,T3,6th,not reported,395,9f5a70d8-c9b5-5f98-8afd-48c62e1fbd55,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3939_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3939_treatment,e5677b7b-de12-58c3-b7e3-8b07663ad6aa,no,"Radiation Therapy, NOS",2019-07-31T18:42:08.489175-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
6fbc2b46-6762-4778-aa7e-782162c5397c,TCGA-AZ-4681,TCGA-COAD,79,-28906,--,a9f00a86-33ea-5b90-9094-7cd252448513,not hispanic or latino,female,white,released,TCGA-AZ-4681_demographic,2019-07-31T18:41:56.760716-05:00,Alive,1925,--,28906,M0,N0,Stage IIA,T3,6th,not reported,3247,325a0411-a6ff-599c-9815-d0a630fe18f8,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-4681_diagnosis,No,Ascending colon,--,released,TCGA-AZ-4681_treatment,03aa2217-2248-57ff-ba02-4891fe6f4761,no,"Radiation Therapy, NOS",2019-07-31T18:41:56.760716-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2004
6fbc2b46-6762-4778-aa7e-782162c5397c,TCGA-AZ-4681,TCGA-COAD,79,-28906,--,a9f00a86-33ea-5b90-9094-7cd252448513,not hispanic or latino,female,white,released,TCGA-AZ-4681_demographic,2019-07-31T18:41:56.760716-05:00,Alive,1925,--,28906,M0,N0,Stage IIA,T3,6th,not reported,3247,325a0411-a6ff-599c-9815-d0a630fe18f8,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-4681_diagnosis,No,Ascending colon,2019-04-28T11:25:36.176647-05:00,released,TCGA-AZ-4681_treatment_1,fba7a852-b226-55da-87ee-5d5399775dcf,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:56.760716-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2004
b079a153-62f9-4026-a2f8-a1390168bbb9,TCGA-A6-4107,TCGA-COAD,57,-21064,--,25d325a5-206f-5001-b8f8-841ed97e71bb,not hispanic or latino,female,white,released,TCGA-A6-4107_demographic,2019-07-31T18:34:51.481651-05:00,Alive,1953,--,21064,M0,N1b,Stage IIIB,T3,7th,not reported,987,b1823162-a683-563f-ae54-d555f837203b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-4107_diagnosis,No,Ascending colon,--,released,TCGA-A6-4107_treatment,91d593b9-ac8c-5672-8bbf-2680e8124a02,no,"Radiation Therapy, NOS",2019-07-31T18:34:51.481651-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
b079a153-62f9-4026-a2f8-a1390168bbb9,TCGA-A6-4107,TCGA-COAD,57,-21064,--,25d325a5-206f-5001-b8f8-841ed97e71bb,not hispanic or latino,female,white,released,TCGA-A6-4107_demographic,2019-07-31T18:34:51.481651-05:00,Alive,1953,--,21064,M0,N1b,Stage IIIB,T3,7th,not reported,987,b1823162-a683-563f-ae54-d555f837203b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-4107_diagnosis,No,Ascending colon,2019-04-28T11:19:37.754398-05:00,released,TCGA-A6-4107_treatment_1,ef9938b5-3563-5cec-b067-5c6c0040373b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:51.481651-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
d259eeb2-d15e-436d-9d37-2d0b7658bc91,TCGA-D5-6534,TCGA-COAD,62,-22778,--,c091e693-7e51-5672-8125-6e5bc3ec1ed6,not hispanic or latino,female,white,released,TCGA-D5-6534_demographic,2019-07-31T18:42:49.628511-05:00,Alive,1948,--,22778,M0,N0,Stage IIA,T3,7th,not reported,1316,7db0b07f-421b-5ab7-8468-da685c95a0fc,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-D5-6534_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6534_treatment,aabd9f63-90cd-5f49-b74f-f45dc00b4d88,no,"Radiation Therapy, NOS",2019-07-31T18:42:49.628511-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2010
d259eeb2-d15e-436d-9d37-2d0b7658bc91,TCGA-D5-6534,TCGA-COAD,62,-22778,--,c091e693-7e51-5672-8125-6e5bc3ec1ed6,not hispanic or latino,female,white,released,TCGA-D5-6534_demographic,2019-07-31T18:42:49.628511-05:00,Alive,1948,--,22778,M0,N0,Stage IIA,T3,7th,not reported,1316,7db0b07f-421b-5ab7-8468-da685c95a0fc,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-D5-6534_diagnosis,No,"Colon, NOS",2019-04-28T11:26:21.791102-05:00,released,TCGA-D5-6534_treatment_1,16428f23-72a6-5fbd-882b-e5a90bab0eef,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:49.628511-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2010
ff1407c6-9174-4bae-a19b-d34ca71b898c,TCGA-A6-2680,TCGA-COAD,72,-26533,--,7eb4dece-b135-5dd1-8546-ff3efaf6e0a5,not hispanic or latino,female,black or african american,released,TCGA-A6-2680_demographic,2019-07-31T18:41:18.132336-05:00,Alive,1937,--,26533,M0,N0,Stage II,T3,6th,not reported,1068,8e46e12f-5b24-5c3a-83a3-08449a01971e,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-A6-2680_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:25:02.225830-05:00,released,TCGA-A6-2680_treatment_1,62d6934c-be96-5b08-bc40-7b5c7f853138,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:18.132336-05:00,not reported,stage ii,2019-08-08T16:33:45.855164-05:00,2009
ff1407c6-9174-4bae-a19b-d34ca71b898c,TCGA-A6-2680,TCGA-COAD,72,-26533,--,7eb4dece-b135-5dd1-8546-ff3efaf6e0a5,not hispanic or latino,female,black or african american,released,TCGA-A6-2680_demographic,2019-07-31T18:41:18.132336-05:00,Alive,1937,--,26533,M0,N0,Stage II,T3,6th,not reported,1068,8e46e12f-5b24-5c3a-83a3-08449a01971e,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-A6-2680_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-A6-2680_treatment,85aac433-4c23-58e4-a50b-05725f4c5c6d,no,"Radiation Therapy, NOS",2019-07-31T18:41:18.132336-05:00,not reported,stage ii,2019-08-08T16:33:45.855164-05:00,2009
28d03569-8717-40da-8989-70baf2b18f9f,TCGA-A6-5667,TCGA-COAD,40,-14756,--,92de1ac6-3cb7-5c0f-b59f-fca40319e098,not hispanic or latino,female,white,released,TCGA-A6-5667_demographic,2019-07-31T18:25:37.902004-05:00,Alive,1970,--,14756,MX,N1a,Stage IIIB,T3,7th,not reported,887,28c3a59f-43fb-5d70-b7ab-8618ef222721,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-5667_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-5667_treatment,ed02de2c-ffe0-51ba-87b2-aa0f16a187f0,no,"Radiation Therapy, NOS",2019-07-31T18:25:37.902004-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
28d03569-8717-40da-8989-70baf2b18f9f,TCGA-A6-5667,TCGA-COAD,40,-14756,--,92de1ac6-3cb7-5c0f-b59f-fca40319e098,not hispanic or latino,female,white,released,TCGA-A6-5667_demographic,2019-07-31T18:25:37.902004-05:00,Alive,1970,--,14756,MX,N1a,Stage IIIB,T3,7th,not reported,887,28c3a59f-43fb-5d70-b7ab-8618ef222721,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-5667_diagnosis,No,Sigmoid colon,2019-04-28T11:11:59.601226-05:00,released,TCGA-A6-5667_treatment_1,522559ba-f9ed-585a-804d-776bbdea37d6,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:37.902004-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
73448b56-a6c6-4c98-a153-ab704261e073,TCGA-AA-A02W,TCGA-COAD,73,-26693,--,751d51eb-bbb9-5a96-a1ac-ac81958600e2,not reported,female,not reported,released,TCGA-AA-A02W_demographic,2019-07-31T18:30:33.938759-05:00,Alive,1933,--,26693,M0,N0,Stage I,T2,5th,not reported,1247,61fae6d0-d54a-5720-aea8-1ebb9f8c868c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02W_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A02W_treatment,0a470a6c-9605-5e7e-8a33-6f31b14d728e,no,"Radiation Therapy, NOS",2019-07-31T18:30:33.938759-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2006
73448b56-a6c6-4c98-a153-ab704261e073,TCGA-AA-A02W,TCGA-COAD,73,-26693,--,751d51eb-bbb9-5a96-a1ac-ac81958600e2,not reported,female,not reported,released,TCGA-AA-A02W_demographic,2019-07-31T18:30:33.938759-05:00,Alive,1933,--,26693,M0,N0,Stage I,T2,5th,not reported,1247,61fae6d0-d54a-5720-aea8-1ebb9f8c868c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02W_diagnosis,No,Sigmoid colon,2019-04-28T11:16:06.200668-05:00,released,TCGA-AA-A02W_treatment_1,920161d9-7d4b-5353-ac75-7f0ec90bb8b2,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:33.938759-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2006
4be66108-e72a-406b-bb4b-f58ff2877336,TCGA-AA-A01Q,TCGA-COAD,48,-17715,--,8279c49a-45e6-5a6c-8be2-691381f27784,not reported,female,not reported,released,TCGA-AA-A01Q_demographic,2019-07-31T18:28:02.355155-05:00,Alive,1955,--,17715,M0,N0,Stage II,T3,5th,not reported,31,c9cf5037-2b85-51a3-8eae-ce4aa1747dcd,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01Q_diagnosis,No,Ascending colon,--,released,TCGA-AA-A01Q_treatment,4547dfd3-c008-5e9b-a8c9-77aceb60e85a,not reported,"Radiation Therapy, NOS",2019-07-31T18:28:02.355155-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2003
4be66108-e72a-406b-bb4b-f58ff2877336,TCGA-AA-A01Q,TCGA-COAD,48,-17715,--,8279c49a-45e6-5a6c-8be2-691381f27784,not reported,female,not reported,released,TCGA-AA-A01Q_demographic,2019-07-31T18:28:02.355155-05:00,Alive,1955,--,17715,M0,N0,Stage II,T3,5th,not reported,31,c9cf5037-2b85-51a3-8eae-ce4aa1747dcd,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01Q_diagnosis,No,Ascending colon,2019-04-28T11:13:59.399188-05:00,released,TCGA-AA-A01Q_treatment_1,90cde6ca-7dd9-5cb7-a471-a4e6c43f9bd4,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:02.355155-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2003
7a6c54f1-f4e4-426b-b306-2ca3c4de12ca,TCGA-AA-3854,TCGA-COAD,71,-26022,--,bba4d507-40b4-5e86-94d2-c6f475645e32,not reported,female,not reported,released,TCGA-AA-3854_demographic,2019-07-31T18:31:09.875019-05:00,Alive,1938,--,26022,M0,N0,Stage I,T2,6th,not reported,1096,8aabaacd-47cb-5be4-8835-07de88108f7e,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3854_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3854_treatment,054d6e13-1436-5649-a365-5f6462a1b8d4,no,"Radiation Therapy, NOS",2019-07-31T18:31:09.875019-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
7a6c54f1-f4e4-426b-b306-2ca3c4de12ca,TCGA-AA-3854,TCGA-COAD,71,-26022,--,bba4d507-40b4-5e86-94d2-c6f475645e32,not reported,female,not reported,released,TCGA-AA-3854_demographic,2019-07-31T18:31:09.875019-05:00,Alive,1938,--,26022,M0,N0,Stage I,T2,6th,not reported,1096,8aabaacd-47cb-5be4-8835-07de88108f7e,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3854_diagnosis,No,"Colon, NOS",2019-04-28T11:16:35.934959-05:00,released,TCGA-AA-3854_treatment_1,1e976188-4746-57a6-839a-8f0f8e1031e5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:09.875019-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
07dc5a1d-64b7-42ba-928e-9753bd533c1e,TCGA-A6-2675,TCGA-COAD,78,-28813,--,6295fa10-5e01-5173-b05c-e89c1d794787,not hispanic or latino,male,white,released,TCGA-A6-2675_demographic,2019-07-31T18:22:45.752269-05:00,Alive,1931,--,28813,MX,N0,Stage IIA,T3,6th,not reported,1321,730825f4-a364-56a2-878c-a19ec8b3b2ee,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-2675_diagnosis,No,Sigmoid colon,2019-04-28T11:09:37.885016-05:00,released,TCGA-A6-2675_treatment_1,95c46bfc-0f9f-53d5-846b-3fae9a1609ba,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:45.752269-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
07dc5a1d-64b7-42ba-928e-9753bd533c1e,TCGA-A6-2675,TCGA-COAD,78,-28813,--,6295fa10-5e01-5173-b05c-e89c1d794787,not hispanic or latino,male,white,released,TCGA-A6-2675_demographic,2019-07-31T18:22:45.752269-05:00,Alive,1931,--,28813,MX,N0,Stage IIA,T3,6th,not reported,1321,730825f4-a364-56a2-878c-a19ec8b3b2ee,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-2675_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-2675_treatment,b3be54c6-564e-5d3c-aa0e-1ad601b5bbc5,no,"Radiation Therapy, NOS",2019-07-31T18:22:45.752269-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
14c13b05-abfe-472e-83a9-b28f60e58ad8,TCGA-G4-6310,TCGA-COAD,69,-25243,--,e57a8984-eaae-56de-947c-6a86c67e90f4,not hispanic or latino,male,white,released,TCGA-G4-6310_demographic,2019-07-31T18:24:03.499723-05:00,Alive,1939,--,25243,M0,N1,Stage IIIB,T3,6th,not reported,1935,de98e152-ae68-58f9-96c5-56fce3abb87c,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-G4-6310_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:10:40.415601-05:00,released,TCGA-G4-6310_treatment_1,ba53ff43-7e4c-5e5f-97be-a565fec2b5ee,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:03.499723-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2008
14c13b05-abfe-472e-83a9-b28f60e58ad8,TCGA-G4-6310,TCGA-COAD,69,-25243,--,e57a8984-eaae-56de-947c-6a86c67e90f4,not hispanic or latino,male,white,released,TCGA-G4-6310_demographic,2019-07-31T18:24:03.499723-05:00,Alive,1939,--,25243,M0,N1,Stage IIIB,T3,6th,not reported,1935,de98e152-ae68-58f9-96c5-56fce3abb87c,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-G4-6310_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-G4-6310_treatment,6dc75294-117c-525e-85ca-f8e2ebc0fe95,yes,"Radiation Therapy, NOS",2019-07-31T18:24:03.499723-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2008
091e3084-04ee-4497-893c-d46226dec78f,TCGA-AA-A00U,TCGA-COAD,50,-18263,--,e587ebaa-fcdb-563c-8fc4-cd10cecd050a,not reported,male,not reported,released,TCGA-AA-A00U_demographic,2019-07-31T18:22:48.709240-05:00,Alive,1959,--,18263,M0,N1,Stage IIIB,T3,6th,not reported,518,faf63d6a-860f-5354-9088-7426f1aac751,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00U_diagnosis,No,Ascending colon,--,released,TCGA-AA-A00U_treatment,64ba0ac7-b43f-58fb-8215-21b7d9b4ffaf,no,"Radiation Therapy, NOS",2019-07-31T18:22:48.709240-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
091e3084-04ee-4497-893c-d46226dec78f,TCGA-AA-A00U,TCGA-COAD,50,-18263,--,e587ebaa-fcdb-563c-8fc4-cd10cecd050a,not reported,male,not reported,released,TCGA-AA-A00U_demographic,2019-07-31T18:22:48.709240-05:00,Alive,1959,--,18263,M0,N1,Stage IIIB,T3,6th,not reported,518,faf63d6a-860f-5354-9088-7426f1aac751,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00U_diagnosis,No,Ascending colon,2019-04-28T11:09:40.529280-05:00,released,TCGA-AA-A00U_treatment_1,c34189b3-e64d-57af-926b-3d7e6891a260,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:48.709240-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
bab21810-f51b-421e-a87f-1f1136cbc77a,TCGA-F4-6806,TCGA-COAD,59,-21625,--,65554987-3f5e-5c2c-9a46-8a4318499dd3,not hispanic or latino,female,white,released,TCGA-F4-6806_demographic,2019-07-31T18:35:32.407948-05:00,Alive,1952,--,21625,M0,N0,Stage I,T2,7th,not reported,1260,15b099e2-4b8d-58c4-a879-f113afd8b082,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6806_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6806_treatment,149c44dd-7a93-5e25-8c36-78ffb6968fba,no,"Radiation Therapy, NOS",2019-07-31T18:35:32.407948-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
bab21810-f51b-421e-a87f-1f1136cbc77a,TCGA-F4-6806,TCGA-COAD,59,-21625,--,65554987-3f5e-5c2c-9a46-8a4318499dd3,not hispanic or latino,female,white,released,TCGA-F4-6806_demographic,2019-07-31T18:35:32.407948-05:00,Alive,1952,--,21625,M0,N0,Stage I,T2,7th,not reported,1260,15b099e2-4b8d-58c4-a879-f113afd8b082,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6806_diagnosis,No,Sigmoid colon,2019-04-28T11:20:11.748369-05:00,released,TCGA-F4-6806_treatment_1,7db8981a-8526-5975-ac2b-63d2a5dbcc58,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:32.407948-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
80e677b1-5ebe-4069-a1a5-1538ffee6642,TCGA-AA-3509,TCGA-COAD,54,-19786,--,d7fa41e2-25f0-5ce5-b04e-9e913bd4c5f2,not reported,female,not reported,released,TCGA-AA-3509_demographic,2019-07-31T18:31:33.802067-05:00,Alive,1951,--,19786,M0,N0,Stage II,T3,5th,not reported,1915,234d2c11-c8e3-5ffa-908d-866aef718339,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3509_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3509_treatment,5d6c842e-da70-5cda-b402-1e4cef3c9a85,no,"Radiation Therapy, NOS",2019-07-31T18:31:33.802067-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2005
80e677b1-5ebe-4069-a1a5-1538ffee6642,TCGA-AA-3509,TCGA-COAD,54,-19786,--,d7fa41e2-25f0-5ce5-b04e-9e913bd4c5f2,not reported,female,not reported,released,TCGA-AA-3509_demographic,2019-07-31T18:31:33.802067-05:00,Alive,1951,--,19786,M0,N0,Stage II,T3,5th,not reported,1915,234d2c11-c8e3-5ffa-908d-866aef718339,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3509_diagnosis,No,Sigmoid colon,2019-04-28T11:16:55.805568-05:00,released,TCGA-AA-3509_treatment_1,bab3b131-bcf9-5130-9a0f-2bdc93c54d7a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:33.802067-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2005
6fc5e56a-1f5e-4ff1-948e-5ef636ebb48d,TCGA-AA-3852,TCGA-COAD,88,-32203,--,6b307a91-7f22-5189-942b-0ef85c625f55,not reported,male,not reported,released,TCGA-AA-3852_demographic,2019-07-31T18:30:25.108083-05:00,Dead,1921,2009,32203,M0,N0,Stage IIA,T3,6th,not reported,--,a411f0f1-167f-56ff-baf6-f8e45319a6cc,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3852_diagnosis,No,"Colon, NOS",2019-04-28T11:15:58.922167-05:00,released,TCGA-AA-3852_treatment_1,6f04f421-7945-5c41-8bac-1ffcca786ab4,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:25.108083-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
6fc5e56a-1f5e-4ff1-948e-5ef636ebb48d,TCGA-AA-3852,TCGA-COAD,88,-32203,--,6b307a91-7f22-5189-942b-0ef85c625f55,not reported,male,not reported,released,TCGA-AA-3852_demographic,2019-07-31T18:30:25.108083-05:00,Dead,1921,2009,32203,M0,N0,Stage IIA,T3,6th,not reported,--,a411f0f1-167f-56ff-baf6-f8e45319a6cc,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3852_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3852_treatment,cf640ec9-1113-5c55-864e-72b0edd81a35,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:25.108083-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
27e2438d-bd01-4c50-9102-563276ed9922,TCGA-D5-6898,TCGA-COAD,51,-18874,--,6bf21b44-689c-5d2f-9620-5f1f1ed6dca8,not hispanic or latino,female,white,released,TCGA-D5-6898_demographic,2019-07-31T18:25:29.412535-05:00,Alive,1960,--,18874,M0,N0,Stage I,T2,7th,not reported,229,c17555df-b5f9-5c6f-82c1-1462cf98d01d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6898_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6898_treatment,0d2f27be-1934-5219-a0ba-1793c64119d1,no,"Radiation Therapy, NOS",2019-07-31T18:25:29.412535-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2011
27e2438d-bd01-4c50-9102-563276ed9922,TCGA-D5-6898,TCGA-COAD,51,-18874,--,6bf21b44-689c-5d2f-9620-5f1f1ed6dca8,not hispanic or latino,female,white,released,TCGA-D5-6898_demographic,2019-07-31T18:25:29.412535-05:00,Alive,1960,--,18874,M0,N0,Stage I,T2,7th,not reported,229,c17555df-b5f9-5c6f-82c1-1462cf98d01d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6898_diagnosis,No,"Colon, NOS",2019-04-28T11:11:51.832398-05:00,released,TCGA-D5-6898_treatment_1,8e4142db-a0eb-5ab6-acc2-0b551a916618,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:29.412535-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2011
56c8b812-ca8e-4eb2-b0fe-f264316789bf,TCGA-DM-A1HA,TCGA-COAD,82,-30272,--,5af0991d-107f-590b-9e13-f93732c2ac3f,not hispanic or latino,male,white,released,TCGA-DM-A1HA_demographic,2019-07-31T18:28:44.110121-05:00,Alive,1918,--,30272,M0,N2,Stage IIIC,T3,--,not reported,2600,9068fce7-f3d2-5ea4-b4a4-d534d22238d0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A1HA_diagnosis,No,Ascending colon,--,released,TCGA-DM-A1HA_treatment,13886958-2f36-5d65-b643-1c5d09dbcc14,not reported,"Radiation Therapy, NOS",2019-07-31T18:28:44.110121-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2000
56c8b812-ca8e-4eb2-b0fe-f264316789bf,TCGA-DM-A1HA,TCGA-COAD,82,-30272,--,5af0991d-107f-590b-9e13-f93732c2ac3f,not hispanic or latino,male,white,released,TCGA-DM-A1HA_demographic,2019-07-31T18:28:44.110121-05:00,Alive,1918,--,30272,M0,N2,Stage IIIC,T3,--,not reported,2600,9068fce7-f3d2-5ea4-b4a4-d534d22238d0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A1HA_diagnosis,No,Ascending colon,2019-04-28T11:14:34.351410-05:00,released,TCGA-DM-A1HA_treatment_1,b66cf5c7-bf41-5e99-b857-45a575ab4352,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:44.110121-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2000
a782f174-241d-42c6-9bc4-61cc39f8b397,TCGA-D5-6927,TCGA-COAD,34,-12737,--,720717ae-e3a2-585f-a6fc-98aad79dd114,not hispanic or latino,male,white,released,TCGA-D5-6927_demographic,2019-07-31T18:42:31.904019-05:00,Alive,1977,--,12737,M0,N0,Stage IIA,T3,7th,not reported,287,028ebc82-2bba-504b-85db-a1e824225244,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6927_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6927_treatment,746625bf-ebe8-58ca-a1c9-552feda714d7,no,"Radiation Therapy, NOS",2019-07-31T18:42:31.904019-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
a782f174-241d-42c6-9bc4-61cc39f8b397,TCGA-D5-6927,TCGA-COAD,34,-12737,--,720717ae-e3a2-585f-a6fc-98aad79dd114,not hispanic or latino,male,white,released,TCGA-D5-6927_demographic,2019-07-31T18:42:31.904019-05:00,Alive,1977,--,12737,M0,N0,Stage IIA,T3,7th,not reported,287,028ebc82-2bba-504b-85db-a1e824225244,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6927_diagnosis,No,Sigmoid colon,2019-04-28T11:26:06.670180-05:00,released,TCGA-D5-6927_treatment_1,6f822511-9cb6-5249-ba0f-9c80ac0f531d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:31.904019-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
79d33c28-a7e2-4fca-8be1-a16fb6d68d49,TCGA-G4-6311,TCGA-COAD,80,-29297,--,ee10a0a5-1c22-56cf-97fd-19c84f229212,not hispanic or latino,male,white,released,TCGA-G4-6311_demographic,2019-07-31T18:31:06.786400-05:00,Alive,1928,--,29297,MX,N1,Stage III,T3,6th,not reported,1199,6313832d-c512-525d-9672-38a8d0a14339,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6311_diagnosis,No,Ascending colon,--,released,TCGA-G4-6311_treatment,b77d60da-9ab2-53a4-ad1c-a178d8ae7283,no,"Radiation Therapy, NOS",2019-07-31T18:31:06.786400-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2008
79d33c28-a7e2-4fca-8be1-a16fb6d68d49,TCGA-G4-6311,TCGA-COAD,80,-29297,--,ee10a0a5-1c22-56cf-97fd-19c84f229212,not hispanic or latino,male,white,released,TCGA-G4-6311_demographic,2019-07-31T18:31:06.786400-05:00,Alive,1928,--,29297,MX,N1,Stage III,T3,6th,not reported,1199,6313832d-c512-525d-9672-38a8d0a14339,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6311_diagnosis,No,Ascending colon,2019-04-28T11:16:33.371187-05:00,released,TCGA-G4-6311_treatment_1,cf0d2f7e-3f14-58d6-8163-092f9743ba4b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:06.786400-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2008
14cc6f5b-5692-471e-98b4-ae200b3d8fed,TCGA-AY-5543,TCGA-COAD,65,-23870,--,477428df-1c89-5345-9c06-99ed2b3f1342,not hispanic or latino,female,black or african american,released,TCGA-AY-5543_demographic,2019-07-31T18:24:06.073150-05:00,Alive,1945,--,23870,M1,N1a,Stage IVA,T3,7th,not reported,1004,8e9bb7ea-0ce3-5409-814e-74aee381480e,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AY-5543_diagnosis,No,Ascending colon,--,released,TCGA-AY-5543_treatment,f7b0d802-ae8a-50e6-8ec8-82a2a33e55ed,no,"Radiation Therapy, NOS",2019-07-31T18:24:06.073150-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2010
14cc6f5b-5692-471e-98b4-ae200b3d8fed,TCGA-AY-5543,TCGA-COAD,65,-23870,--,477428df-1c89-5345-9c06-99ed2b3f1342,not hispanic or latino,female,black or african american,released,TCGA-AY-5543_demographic,2019-07-31T18:24:06.073150-05:00,Alive,1945,--,23870,M1,N1a,Stage IVA,T3,7th,not reported,1004,8e9bb7ea-0ce3-5409-814e-74aee381480e,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AY-5543_diagnosis,No,Ascending colon,2019-04-28T11:10:42.956510-05:00,released,TCGA-AY-5543_treatment_1,f809ac4d-8b41-5da6-a191-1eb8d6965f75,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:06.073150-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2010
4138aca8-e085-45fb-b353-74852efe61bf,TCGA-CM-6676,TCGA-COAD,82,-30223,--,a213389b-efa9-58ec-bab9-60318c64ee62,not hispanic or latino,male,white,released,TCGA-CM-6676_demographic,2019-07-31T18:27:30.431652-05:00,Alive,1929,--,30223,M0,N0,Stage I,T2,7th,not reported,337,e1c49297-cf89-5da1-a906-cc6f64b3b611,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6676_diagnosis,No,Sigmoid colon,2019-04-28T11:13:34.524747-05:00,released,TCGA-CM-6676_treatment_1,aca10cf0-d962-5fda-8bbd-831af27bbdee,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:30.431652-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2011
4138aca8-e085-45fb-b353-74852efe61bf,TCGA-CM-6676,TCGA-COAD,82,-30223,--,a213389b-efa9-58ec-bab9-60318c64ee62,not hispanic or latino,male,white,released,TCGA-CM-6676_demographic,2019-07-31T18:27:30.431652-05:00,Alive,1929,--,30223,M0,N0,Stage I,T2,7th,not reported,337,e1c49297-cf89-5da1-a906-cc6f64b3b611,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6676_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6676_treatment,d089acde-c80c-5205-8011-0274e2e1212f,no,"Radiation Therapy, NOS",2019-07-31T18:27:30.431652-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2011
88832340-46ad-449c-8f81-6a8e5b495510,TCGA-A6-6780,TCGA-COAD,74,-27250,--,4c250774-5aea-5043-936c-3671b0636801,not hispanic or latino,male,white,released,TCGA-A6-6780_demographic,2019-07-31T15:16:30.948528-05:00,Alive,1937,--,27250,MX,N0,Stage IIA,T3,7th,not reported,612,ced60395-4b47-5c79-81d5-2660dda9b8d8,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-A6-6780_diagnosis,No,Ascending colon,2019-04-28T08:37:11.705532-05:00,released,TCGA-A6-6780_treatment_1,8451dd60-e25a-540a-bf9f-91bfed428d86,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:16:30.948528-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2011
88832340-46ad-449c-8f81-6a8e5b495510,TCGA-A6-6780,TCGA-COAD,74,-27250,--,4c250774-5aea-5043-936c-3671b0636801,not hispanic or latino,male,white,released,TCGA-A6-6780_demographic,2019-07-31T15:16:30.948528-05:00,Alive,1937,--,27250,MX,N0,Stage IIA,T3,7th,not reported,612,ced60395-4b47-5c79-81d5-2660dda9b8d8,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-A6-6780_diagnosis,No,Ascending colon,--,released,TCGA-A6-6780_treatment,ee40eb56-e74b-524a-ae65-63e6311705d1,no,"Radiation Therapy, NOS",2019-07-31T15:16:30.948528-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2011
58facedb-fcb8-4ecf-8338-2bfa4947acef,TCGA-A6-6141,TCGA-COAD,31,-11391,--,057119de-0312-5558-8ff2-ab431bd9dd5a,not hispanic or latino,male,black or african american,released,TCGA-A6-6141_demographic,2019-07-31T18:28:58.534318-05:00,Alive,1980,--,11391,M0,N0,Stage IIA,T3,7th,not reported,255,36a07e68-af21-58d7-9e21-79128cf04567,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6141_diagnosis,No,"Colon, NOS",2019-04-28T11:14:47.011915-05:00,released,TCGA-A6-6141_treatment_1,a0701d90-4700-5fd9-aa1e-a279a2e495fa,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:58.534318-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2011
58facedb-fcb8-4ecf-8338-2bfa4947acef,TCGA-A6-6141,TCGA-COAD,31,-11391,--,057119de-0312-5558-8ff2-ab431bd9dd5a,not hispanic or latino,male,black or african american,released,TCGA-A6-6141_demographic,2019-07-31T18:28:58.534318-05:00,Alive,1980,--,11391,M0,N0,Stage IIA,T3,7th,not reported,255,36a07e68-af21-58d7-9e21-79128cf04567,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6141_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-6141_treatment,a8d8a520-72be-5b61-8497-e2f6e30e6ec1,no,"Radiation Therapy, NOS",2019-07-31T18:28:58.534318-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2011
dca004bf-9c14-45a1-b186-ab3759f6c7fe,TCGA-AA-3685,TCGA-COAD,69,-25506,--,5f7ff1a0-f322-548d-8dd9-8f06d5a1f8a1,not reported,male,not reported,released,TCGA-AA-3685_demographic,2019-07-31T18:38:38.783979-05:00,Alive,1938,--,25506,M0,N0,Stage II,T3,5th,not reported,1127,8d5bb704-3dbc-5503-9d69-95de3313d6d9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3685_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3685_treatment,13bae645-6be0-559d-a11e-30cfa66337d9,no,"Radiation Therapy, NOS",2019-07-31T18:38:38.783979-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2007
dca004bf-9c14-45a1-b186-ab3759f6c7fe,TCGA-AA-3685,TCGA-COAD,69,-25506,--,5f7ff1a0-f322-548d-8dd9-8f06d5a1f8a1,not reported,male,not reported,released,TCGA-AA-3685_demographic,2019-07-31T18:38:38.783979-05:00,Alive,1938,--,25506,M0,N0,Stage II,T3,5th,not reported,1127,8d5bb704-3dbc-5503-9d69-95de3313d6d9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3685_diagnosis,No,"Colon, NOS",2019-04-28T11:22:48.391465-05:00,released,TCGA-AA-3685_treatment_1,3c4f33ab-45bb-55de-896d-c3c369a79e9a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:38.783979-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2007
a117ace8-ac5a-48d8-8aee-3024d6f0f873,TCGA-D5-6538,TCGA-COAD,79,-29194,--,895bb25b-4ace-5d8c-baae-a3b1e3bc1826,not hispanic or latino,female,white,released,TCGA-D5-6538_demographic,2019-07-31T18:33:38.226930-05:00,Alive,1931,--,29194,M0,N2,Stage IIIB,T3,--,not reported,521,a50224c5-748a-5811-af3e-920c10675178,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-D5-6538_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-D5-6538_treatment,1d2837c4-d04c-5842-8ff6-f32f3d885ef1,no,"Radiation Therapy, NOS",2019-07-31T18:33:38.226930-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2010
a117ace8-ac5a-48d8-8aee-3024d6f0f873,TCGA-D5-6538,TCGA-COAD,79,-29194,--,895bb25b-4ace-5d8c-baae-a3b1e3bc1826,not hispanic or latino,female,white,released,TCGA-D5-6538_demographic,2019-07-31T18:33:38.226930-05:00,Alive,1931,--,29194,M0,N2,Stage IIIB,T3,--,not reported,521,a50224c5-748a-5811-af3e-920c10675178,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-D5-6538_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:18:39.063629-05:00,released,TCGA-D5-6538_treatment_1,8b206ff3-39fc-541b-9641-1ad67ef0b300,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:38.226930-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2010
2dced66c-1f0d-4039-a5e5-54cca77c16e9,TCGA-AA-3548,TCGA-COAD,71,-26175,--,3a2d0137-148f-5d5c-b19c-acbc82c58c18,not reported,female,not reported,released,TCGA-AA-3548_demographic,2019-07-31T18:26:10.914803-05:00,Alive,1937,--,26175,M0,N2,Stage IIIC,T3,6th,not reported,1034,41f0e4ee-f424-507d-9864-bb2cdc80caee,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3548_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3548_treatment,5be25f37-18e4-5278-8a7d-e754c4670e19,no,"Radiation Therapy, NOS",2019-07-31T18:26:10.914803-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
2dced66c-1f0d-4039-a5e5-54cca77c16e9,TCGA-AA-3548,TCGA-COAD,71,-26175,--,3a2d0137-148f-5d5c-b19c-acbc82c58c18,not reported,female,not reported,released,TCGA-AA-3548_demographic,2019-07-31T18:26:10.914803-05:00,Alive,1937,--,26175,M0,N2,Stage IIIC,T3,6th,not reported,1034,41f0e4ee-f424-507d-9864-bb2cdc80caee,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3548_diagnosis,No,"Colon, NOS",2019-04-28T11:12:27.012148-05:00,released,TCGA-AA-3548_treatment_1,6297fabc-0716-53b0-a049-984025b82bec,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:10.914803-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
0c53b010-4243-4da3-a059-7f54c9a850ec,TCGA-F4-6703,TCGA-COAD,64,-23644,--,3f2a5106-5047-53ac-8a87-adc365124ef4,not hispanic or latino,male,white,released,TCGA-F4-6703_demographic,2019-07-31T18:23:07.149973-05:00,Alive,1947,--,23644,M0,N0,Stage IIA,T3,7th,not reported,1456,1aca2030-9e94-5d48-b5bf-aa12513a715f,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-F4-6703_diagnosis,No,Ascending colon,2019-04-28T11:09:56.015465-05:00,released,TCGA-F4-6703_treatment_1,ca9c566a-10ea-57dc-ab8b-e9f0fc7a9a00,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:07.149973-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
0c53b010-4243-4da3-a059-7f54c9a850ec,TCGA-F4-6703,TCGA-COAD,64,-23644,--,3f2a5106-5047-53ac-8a87-adc365124ef4,not hispanic or latino,male,white,released,TCGA-F4-6703_demographic,2019-07-31T18:23:07.149973-05:00,Alive,1947,--,23644,M0,N0,Stage IIA,T3,7th,not reported,1456,1aca2030-9e94-5d48-b5bf-aa12513a715f,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-F4-6703_diagnosis,No,Ascending colon,--,released,TCGA-F4-6703_treatment,91b3ffe4-f5eb-5382-aaf1-fa16c9e3837f,no,"Radiation Therapy, NOS",2019-07-31T18:23:07.149973-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
303286c2-bc58-4bbb-9171-74cdb1d7f62f,TCGA-G4-6306,TCGA-COAD,71,-26163,--,41396f24-e6d6-5c07-a29c-ab102203556c,not hispanic or latino,male,white,released,TCGA-G4-6306_demographic,2019-07-31T18:41:33.293540-05:00,Alive,1936,--,26163,M0,N0,--,T2,6th,not reported,1359,a42c1080-0386-5092-a10e-81f14ae7da15,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6306_diagnosis,No,Ascending colon,--,released,TCGA-G4-6306_treatment,0a009952-3873-542e-af38-bdbe6457d588,no,"Radiation Therapy, NOS",2019-07-31T18:41:33.293540-05:00,not reported,not reported,2019-08-08T16:37:18.448891-05:00,2007
303286c2-bc58-4bbb-9171-74cdb1d7f62f,TCGA-G4-6306,TCGA-COAD,71,-26163,--,41396f24-e6d6-5c07-a29c-ab102203556c,not hispanic or latino,male,white,released,TCGA-G4-6306_demographic,2019-07-31T18:41:33.293540-05:00,Alive,1936,--,26163,M0,N0,--,T2,6th,not reported,1359,a42c1080-0386-5092-a10e-81f14ae7da15,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6306_diagnosis,No,Ascending colon,2019-04-28T11:25:14.630003-05:00,released,TCGA-G4-6306_treatment_1,d05f24a3-f7a1-5e2b-8645-ecd576fd4fd0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:33.293540-05:00,not reported,not reported,2019-08-08T16:37:18.448891-05:00,2007
f83b909c-da90-41ed-b532-a2ef9371cff9,TCGA-DM-A28C,TCGA-COAD,74,-27073,2475,41ced1bb-9413-5ba2-b686-6ff53bd3cf11,not hispanic or latino,male,white,released,TCGA-DM-A28C_demographic,2019-07-31T18:40:35.758854-05:00,Dead,1927,2007,27073,M0,N0,Stage IIA,T3,6th,not reported,2475,7d775efb-6ce9-5c04-909c-06cf49d58c1a,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A28C_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A28C_treatment,da75c50f-2813-5894-9cf9-0671f83aedb1,not reported,"Radiation Therapy, NOS",2019-07-31T18:40:35.758854-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
f83b909c-da90-41ed-b532-a2ef9371cff9,TCGA-DM-A28C,TCGA-COAD,74,-27073,2475,41ced1bb-9413-5ba2-b686-6ff53bd3cf11,not hispanic or latino,male,white,released,TCGA-DM-A28C_demographic,2019-07-31T18:40:35.758854-05:00,Dead,1927,2007,27073,M0,N0,Stage IIA,T3,6th,not reported,2475,7d775efb-6ce9-5c04-909c-06cf49d58c1a,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A28C_diagnosis,No,Sigmoid colon,2019-04-28T11:24:26.413587-05:00,released,TCGA-DM-A28C_treatment_1,578af3d7-7b0c-52c9-bf7b-faae0f7208af,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:35.758854-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
131e0571-de86-415f-b3fb-dc9f971258d3,TCGA-D5-6932,TCGA-COAD,69,-25466,--,f0c1d6a4-006e-5318-ad7f-79c8cf867a8b,not hispanic or latino,male,white,released,TCGA-D5-6932_demographic,2019-07-31T18:23:51.069463-05:00,Alive,1942,--,25466,M0,N0,Stage IIA,T3,7th,not reported,346,dc47ad7a-9328-5797-9ac5-3254fc2bc4b9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6932_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6932_treatment,9ef83c71-a5e8-586b-b56b-f18aff8baabd,no,"Radiation Therapy, NOS",2019-07-31T18:23:51.069463-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
131e0571-de86-415f-b3fb-dc9f971258d3,TCGA-D5-6932,TCGA-COAD,69,-25466,--,f0c1d6a4-006e-5318-ad7f-79c8cf867a8b,not hispanic or latino,male,white,released,TCGA-D5-6932_demographic,2019-07-31T18:23:51.069463-05:00,Alive,1942,--,25466,M0,N0,Stage IIA,T3,7th,not reported,346,dc47ad7a-9328-5797-9ac5-3254fc2bc4b9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6932_diagnosis,No,"Colon, NOS",2019-04-28T11:10:30.728039-05:00,released,TCGA-D5-6932_treatment_1,dec078cd-03ff-505b-ac2c-a33c16565478,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:51.069463-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
d655bbf6-c710-411d-aff5-ceb0fb6e6680,TCGA-AA-3867,TCGA-COAD,74,-27028,--,2941aecc-4855-5a25-9813-6a17ea1e68c3,not reported,male,not reported,released,TCGA-AA-3867_demographic,2019-07-31T18:38:05.810166-05:00,Alive,1933,--,27028,M1,N2,Stage IV,T3,6th,not reported,731,60b256ac-8b86-5042-af26-744593617b67,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3867_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3867_treatment,5a7bc83c-19da-5e10-988b-ea98c3479731,no,"Radiation Therapy, NOS",2019-07-31T18:38:05.810166-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2007
d655bbf6-c710-411d-aff5-ceb0fb6e6680,TCGA-AA-3867,TCGA-COAD,74,-27028,--,2941aecc-4855-5a25-9813-6a17ea1e68c3,not reported,male,not reported,released,TCGA-AA-3867_demographic,2019-07-31T18:38:05.810166-05:00,Alive,1933,--,27028,M1,N2,Stage IV,T3,6th,not reported,731,60b256ac-8b86-5042-af26-744593617b67,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3867_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:22:20.138957-05:00,released,TCGA-AA-3867_treatment_1,2b34ecec-82e7-5274-a4b9-57f6a0c0b021,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:05.810166-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2007
c6ed47f4-358b-4f06-b5cd-cdf1d5c47b43,TCGA-F4-6704,TCGA-COAD,60,-21949,--,aa6c84e1-223e-5122-9451-3a919c8c4098,not hispanic or latino,male,american indian or alaska native,released,TCGA-F4-6704_demographic,2019-07-31T18:36:37.448631-05:00,Alive,1951,--,21949,MX,N2b,Stage IIIC,T3,7th,not reported,47,95fe5961-1169-5a88-8ea9-143da2b58902,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-F4-6704_diagnosis,No,Sigmoid colon,2019-04-28T11:21:06.381360-05:00,released,TCGA-F4-6704_treatment_1,e10090c1-94ec-5664-95cd-e300f47ddb5e,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:37.448631-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2011
c6ed47f4-358b-4f06-b5cd-cdf1d5c47b43,TCGA-F4-6704,TCGA-COAD,60,-21949,--,aa6c84e1-223e-5122-9451-3a919c8c4098,not hispanic or latino,male,american indian or alaska native,released,TCGA-F4-6704_demographic,2019-07-31T18:36:37.448631-05:00,Alive,1951,--,21949,MX,N2b,Stage IIIC,T3,7th,not reported,47,95fe5961-1169-5a88-8ea9-143da2b58902,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-F4-6704_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6704_treatment,b1a866e9-e659-5197-867e-237c7039d863,not reported,"Radiation Therapy, NOS",2019-07-31T18:36:37.448631-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2011
d2c99bed-3446-4d12-99e0-00611faa37dc,TCGA-AA-A004,TCGA-COAD,76,-27943,--,13a80f48-db5d-56e2-9093-65ed2c195fd6,not reported,male,not reported,released,TCGA-AA-A004_demographic,2019-07-31T18:37:45.574064-05:00,Alive,1933,--,27943,M0,N0,Stage IIA,T3,6th,not reported,424,ab8fea0d-211f-542c-ac65-acece7b79549,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A004_diagnosis,No,Sigmoid colon,2019-04-28T11:22:02.418827-05:00,released,TCGA-AA-A004_treatment_1,3d3cc9e6-c592-5beb-b417-af37b6b752e6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:45.574064-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
d2c99bed-3446-4d12-99e0-00611faa37dc,TCGA-AA-A004,TCGA-COAD,76,-27943,--,13a80f48-db5d-56e2-9093-65ed2c195fd6,not reported,male,not reported,released,TCGA-AA-A004_demographic,2019-07-31T18:37:45.574064-05:00,Alive,1933,--,27943,M0,N0,Stage IIA,T3,6th,not reported,424,ab8fea0d-211f-542c-ac65-acece7b79549,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A004_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A004_treatment,6f11fd84-7a76-5824-8fc5-fd0073bc7863,no,"Radiation Therapy, NOS",2019-07-31T18:37:45.574064-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
d181c72b-843c-4b2d-b014-2a6dd1c3c1ec,TCGA-AA-3553,TCGA-COAD,61,-22524,--,a4b0771d-0d31-5923-87e4-bf452561f38c,not reported,female,not reported,released,TCGA-AA-3553_demographic,2019-07-31T18:37:42.601159-05:00,Alive,1947,--,22524,M0,N0,Stage I,T2,6th,not reported,730,82bcc93b-4f76-58fb-b12a-027fb0b018a4,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3553_diagnosis,No,"Colon, NOS",2019-04-28T11:21:59.522372-05:00,released,TCGA-AA-3553_treatment_1,99c8a797-ec3d-5155-bfab-def806ec4f8f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:42.601159-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
d181c72b-843c-4b2d-b014-2a6dd1c3c1ec,TCGA-AA-3553,TCGA-COAD,61,-22524,--,a4b0771d-0d31-5923-87e4-bf452561f38c,not reported,female,not reported,released,TCGA-AA-3553_demographic,2019-07-31T18:37:42.601159-05:00,Alive,1947,--,22524,M0,N0,Stage I,T2,6th,not reported,730,82bcc93b-4f76-58fb-b12a-027fb0b018a4,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3553_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3553_treatment,a7e97754-cd30-50a6-8c98-dd013a99882d,no,"Radiation Therapy, NOS",2019-07-31T18:37:42.601159-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
c9e829d9-cd08-41a9-a5a4-34f2d7d619c7,TCGA-AA-A01Z,TCGA-COAD,68,-24990,--,15dbcc4f-af09-5513-964c-24c1b7e1ecd6,not reported,male,not reported,released,TCGA-AA-A01Z_demographic,2019-07-31T18:37:03.644247-05:00,Alive,1936,--,24990,M0,N0,Stage II,T3,5th,not reported,1126,76e1b134-dab1-5374-9de6-67c1ee3951d7,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01Z_diagnosis,No,Ascending colon,--,released,TCGA-AA-A01Z_treatment,4cb751c6-4787-5a24-a0f5-66ecd8278e62,no,"Radiation Therapy, NOS",2019-07-31T18:37:03.644247-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2004
c9e829d9-cd08-41a9-a5a4-34f2d7d619c7,TCGA-AA-A01Z,TCGA-COAD,68,-24990,--,15dbcc4f-af09-5513-964c-24c1b7e1ecd6,not reported,male,not reported,released,TCGA-AA-A01Z_demographic,2019-07-31T18:37:03.644247-05:00,Alive,1936,--,24990,M0,N0,Stage II,T3,5th,not reported,1126,76e1b134-dab1-5374-9de6-67c1ee3951d7,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01Z_diagnosis,No,Ascending colon,2019-04-28T11:21:27.101659-05:00,released,TCGA-AA-A01Z_treatment_1,8beabb1a-45f3-5430-83b2-043812193ce8,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:03.644247-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2004
b718134c-5231-4f29-a423-7bad17c93fc5,TCGA-AZ-5407,TCGA-COAD,51,-18820,--,8f9239f9-f1f4-59ec-945c-ca4cb9326c36,not hispanic or latino,female,white,released,TCGA-AZ-5407_demographic,2019-07-31T18:35:17.813588-05:00,Alive,1956,--,18820,M0,N0,Stage I,T1,6th,not reported,2683,8180f36e-bb8c-58dd-b1a9-853442e9a9da,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-5407_diagnosis,No,Cecum,2019-04-28T11:19:59.624100-05:00,released,TCGA-AZ-5407_treatment_1,cf6ad9a1-2fb7-5ed7-85a5-94425732ebd3,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:17.813588-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2007
b718134c-5231-4f29-a423-7bad17c93fc5,TCGA-AZ-5407,TCGA-COAD,51,-18820,--,8f9239f9-f1f4-59ec-945c-ca4cb9326c36,not hispanic or latino,female,white,released,TCGA-AZ-5407_demographic,2019-07-31T18:35:17.813588-05:00,Alive,1956,--,18820,M0,N0,Stage I,T1,6th,not reported,2683,8180f36e-bb8c-58dd-b1a9-853442e9a9da,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-5407_diagnosis,No,Cecum,--,released,TCGA-AZ-5407_treatment,1f33c4e0-4116-5c94-ae27-eada87d475ab,no,"Radiation Therapy, NOS",2019-07-31T18:35:17.813588-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2007
2e386e48-b99b-4806-a3e3-081d72a606e7,TCGA-AA-A01X,TCGA-COAD,80,-29281,--,d599a95a-49da-5ab8-adc8-9025b4269737,not reported,female,not reported,released,TCGA-AA-A01X_demographic,2019-07-31T15:55:29.238110-05:00,Alive,1924,--,29281,M0,N1,Stage III,T2,5th,not reported,791,c5b042a8-e7b0-5c31-86ad-f2cd4a7b3202,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01X_diagnosis,No,Sigmoid colon,2019-04-28T09:10:19.336261-05:00,released,TCGA-AA-A01X_treatment_1,d8b29d83-9b42-519d-a834-d5e656315ebb,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:55:29.238110-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
2e386e48-b99b-4806-a3e3-081d72a606e7,TCGA-AA-A01X,TCGA-COAD,80,-29281,--,d599a95a-49da-5ab8-adc8-9025b4269737,not reported,female,not reported,released,TCGA-AA-A01X_demographic,2019-07-31T15:55:29.238110-05:00,Alive,1924,--,29281,M0,N1,Stage III,T2,5th,not reported,791,c5b042a8-e7b0-5c31-86ad-f2cd4a7b3202,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01X_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A01X_treatment,3292e079-821f-5e57-92a7-5d062188dec4,no,"Radiation Therapy, NOS",2019-07-31T15:55:29.238110-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
af3a0634-4292-45bd-b948-6b6bd2d58090,TCGA-AA-A00Z,TCGA-COAD,70,-25872,--,0f6a7071-d3bb-5c1e-bb4e-86766f182e9b,not reported,male,not reported,released,TCGA-AA-A00Z_demographic,2019-07-31T18:42:37.368206-05:00,Alive,1938,--,25872,M0,N0,Stage IIA,T3,6th,not reported,669,ad169f28-2f31-5e2b-91ee-27c66ac7e804,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-A00Z_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-A00Z_treatment,98a25fa3-64e5-54eb-9dc4-f787857e9785,no,"Radiation Therapy, NOS",2019-07-31T18:42:37.368206-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2008
af3a0634-4292-45bd-b948-6b6bd2d58090,TCGA-AA-A00Z,TCGA-COAD,70,-25872,--,0f6a7071-d3bb-5c1e-bb4e-86766f182e9b,not reported,male,not reported,released,TCGA-AA-A00Z_demographic,2019-07-31T18:42:37.368206-05:00,Alive,1938,--,25872,M0,N0,Stage IIA,T3,6th,not reported,669,ad169f28-2f31-5e2b-91ee-27c66ac7e804,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-A00Z_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:26:12.164632-05:00,released,TCGA-AA-A00Z_treatment_1,caf43470-fe89-5cd5-9bb6-a4429469edc7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:37.368206-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2008
33522271-b2ca-4da4-a942-501ab9117c51,TCGA-AA-3693,TCGA-COAD,77,-28459,--,8c3cedd0-1d8d-506f-8bc2-36575eab3885,not reported,female,not reported,released,TCGA-AA-3693_demographic,2019-07-31T18:26:28.359620-05:00,Alive,1931,--,28459,M1,N1,Stage IV,T4,6th,not reported,--,74806ea0-7178-5698-90ad-2ccbc503c97c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3693_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3693_treatment,10499732-829a-558a-82cc-a309ee09d766,not reported,"Radiation Therapy, NOS",2019-07-31T18:26:28.359620-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2008
33522271-b2ca-4da4-a942-501ab9117c51,TCGA-AA-3693,TCGA-COAD,77,-28459,--,8c3cedd0-1d8d-506f-8bc2-36575eab3885,not reported,female,not reported,released,TCGA-AA-3693_demographic,2019-07-31T18:26:28.359620-05:00,Alive,1931,--,28459,M1,N1,Stage IV,T4,6th,not reported,--,74806ea0-7178-5698-90ad-2ccbc503c97c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3693_diagnosis,No,Sigmoid colon,2019-04-28T11:12:41.820002-05:00,released,TCGA-AA-3693_treatment_1,75cb9175-ccae-5a12-96eb-9b06dc74a58d,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:28.359620-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2008
eecaa5cd-0b69-4af2-a782-035025f207b6,TCGA-D5-6928,TCGA-COAD,80,-29411,--,31c756ee-c3bd-5354-9f5b-be84f78f6890,not hispanic or latino,male,white,released,TCGA-D5-6928_demographic,2019-07-31T18:40:04.364622-05:00,Alive,1931,--,29411,M0,N0,Stage IIA,T3,7th,not reported,354,50208049-0c46-5c6c-9173-f75b3a6a424d,C18.3,8480/3,Mucinous adenocarcinoma,no,No,not reported,Hepatic flexure of colon,released,TCGA-D5-6928_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-D5-6928_treatment,13c21504-d801-5664-a4d3-e888fd6bd5dd,no,"Radiation Therapy, NOS",2019-07-31T18:40:04.364622-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
eecaa5cd-0b69-4af2-a782-035025f207b6,TCGA-D5-6928,TCGA-COAD,80,-29411,--,31c756ee-c3bd-5354-9f5b-be84f78f6890,not hispanic or latino,male,white,released,TCGA-D5-6928_demographic,2019-07-31T18:40:04.364622-05:00,Alive,1931,--,29411,M0,N0,Stage IIA,T3,7th,not reported,354,50208049-0c46-5c6c-9173-f75b3a6a424d,C18.3,8480/3,Mucinous adenocarcinoma,no,No,not reported,Hepatic flexure of colon,released,TCGA-D5-6928_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:24:01.697952-05:00,released,TCGA-D5-6928_treatment_1,7d7cca62-2414-51e7-9e9f-1e18a8fc07d0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:04.364622-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
af06cde0-c69a-4bb1-a234-8023b95e4835,TCGA-AA-A017,TCGA-COAD,57,-21032,--,2b639c53-6686-5c8a-ae87-87bbe741dc69,not reported,female,not reported,released,TCGA-AA-A017_demographic,2019-07-31T18:34:45.765961-05:00,Alive,1952,--,21032,M0,N0,Stage IIA,T3,6th,not reported,457,1518d884-6bf0-53f8-8775-41f5cb143f84,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A017_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A017_treatment,ac029135-8b68-5042-b912-df700297cffe,no,"Radiation Therapy, NOS",2019-07-31T18:34:45.765961-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2009
af06cde0-c69a-4bb1-a234-8023b95e4835,TCGA-AA-A017,TCGA-COAD,57,-21032,--,2b639c53-6686-5c8a-ae87-87bbe741dc69,not reported,female,not reported,released,TCGA-AA-A017_demographic,2019-07-31T18:34:45.765961-05:00,Alive,1952,--,21032,M0,N0,Stage IIA,T3,6th,not reported,457,1518d884-6bf0-53f8-8775-41f5cb143f84,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A017_diagnosis,No,Sigmoid colon,2019-04-28T11:19:32.729852-05:00,released,TCGA-AA-A017_treatment_1,d283af14-0eb8-5f84-afd2-59ed6fa6d884,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:45.765961-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2009
97f6c8d3-09a0-4128-8f10-41e736648a5f,TCGA-AA-A01R,TCGA-COAD,47,-17289,--,2cbe9da5-2735-5957-a87e-79e2dca023f5,not reported,male,not reported,released,TCGA-AA-A01R_demographic,2019-07-31T15:14:27.571753-05:00,Alive,1957,--,17289,M0,N2,Stage III,T3,5th,not reported,1065,1e2bbe44-f276-58dc-a71a-965c0d535f44,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-A01R_diagnosis,No,Ascending colon,2019-04-28T08:35:31.314379-05:00,released,TCGA-AA-A01R_treatment_1,210f9f04-c18f-5366-9014-5f60c07a4828,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:14:27.571753-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
97f6c8d3-09a0-4128-8f10-41e736648a5f,TCGA-AA-A01R,TCGA-COAD,47,-17289,--,2cbe9da5-2735-5957-a87e-79e2dca023f5,not reported,male,not reported,released,TCGA-AA-A01R_demographic,2019-07-31T15:14:27.571753-05:00,Alive,1957,--,17289,M0,N2,Stage III,T3,5th,not reported,1065,1e2bbe44-f276-58dc-a71a-965c0d535f44,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-A01R_diagnosis,No,Ascending colon,--,released,TCGA-AA-A01R_treatment,eabd4faa-1f5b-5524-910e-be97f075c066,yes,"Radiation Therapy, NOS",2019-07-31T15:14:27.571753-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
265d7b06-65fe-42c5-ad21-e6b160e94718,TCGA-AA-3552,TCGA-COAD,85,-31290,396,2cc9277f-d15a-5411-a6ff-5436a004fdb8,not reported,male,not reported,released,TCGA-AA-3552_demographic,2019-07-31T18:25:11.881454-05:00,Dead,1923,--,31290,M0,N2,Stage IIIC,T3,6th,not reported,--,0fd47f76-6705-5d95-a27c-03824413de88,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AA-3552_diagnosis,Not Reported,Cecum,--,released,TCGA-AA-3552_treatment,627e6ffb-3166-5dc5-a163-01577417e3e8,no,"Radiation Therapy, NOS",2019-07-31T18:25:11.881454-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
265d7b06-65fe-42c5-ad21-e6b160e94718,TCGA-AA-3552,TCGA-COAD,85,-31290,396,2cc9277f-d15a-5411-a6ff-5436a004fdb8,not reported,male,not reported,released,TCGA-AA-3552_demographic,2019-07-31T18:25:11.881454-05:00,Dead,1923,--,31290,M0,N2,Stage IIIC,T3,6th,not reported,--,0fd47f76-6705-5d95-a27c-03824413de88,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AA-3552_diagnosis,Not Reported,Cecum,2019-04-28T11:11:36.677382-05:00,released,TCGA-AA-3552_treatment_1,852c86ba-6d2a-503f-8f5f-2a80ce8a1b22,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:11.881454-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
c6f6c032-5d4e-4028-aed0-24a587620354,TCGA-AY-A8YK,TCGA-COAD,44,-16140,--,bcdfc1c9-9c33-5f4f-bd9f-05a21f088f51,not hispanic or latino,male,black or african american,released,TCGA-AY-A8YK_demographic,2019-07-31T15:23:05.133316-05:00,Alive,1969,--,16140,M1,N2a,Stage IVA,T3,7th,not reported,573,176ddfa0-7423-514e-84e9-7b626b4fe654,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AY-A8YK_diagnosis,No,Sigmoid colon,2019-04-28T08:42:51.339958-05:00,released,TCGA-AY-A8YK_treatment_1,e468b2fd-24d5-5f5c-beec-f91f08247cac,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:23:05.133316-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2013
c6f6c032-5d4e-4028-aed0-24a587620354,TCGA-AY-A8YK,TCGA-COAD,44,-16140,--,bcdfc1c9-9c33-5f4f-bd9f-05a21f088f51,not hispanic or latino,male,black or african american,released,TCGA-AY-A8YK_demographic,2019-07-31T15:23:05.133316-05:00,Alive,1969,--,16140,M1,N2a,Stage IVA,T3,7th,not reported,573,176ddfa0-7423-514e-84e9-7b626b4fe654,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AY-A8YK_diagnosis,No,Sigmoid colon,--,released,TCGA-AY-A8YK_treatment,90f524bb-2c93-5b70-843f-223b3ba30dd8,no,"Radiation Therapy, NOS",2019-07-31T15:23:05.133316-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2013
9f45a227-1fd5-478c-a194-4a5c61b68cc3,TCGA-QG-A5YW,TCGA-COAD,55,-20391,--,ee32dde0-02b5-50d2-959d-c3df2a4880d1,not hispanic or latino,female,black or african american,released,TCGA-QG-A5YW_demographic,2019-07-31T18:42:20.143759-05:00,Alive,1956,--,20391,MX,N2b,Stage IIIC,T3,7th,not reported,896,bb8b7de9-849b-58c4-acac-313925a234ff,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-QG-A5YW_diagnosis,No,Cecum,2019-04-28T11:25:56.833415-05:00,released,TCGA-QG-A5YW_treatment_1,3b730be3-edf2-596a-87d3-87151770823c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:20.143759-05:00,not reported,stage iiic,2019-08-08T16:37:44.165377-05:00,2011
9f45a227-1fd5-478c-a194-4a5c61b68cc3,TCGA-QG-A5YW,TCGA-COAD,55,-20391,--,ee32dde0-02b5-50d2-959d-c3df2a4880d1,not hispanic or latino,female,black or african american,released,TCGA-QG-A5YW_demographic,2019-07-31T18:42:20.143759-05:00,Alive,1956,--,20391,MX,N2b,Stage IIIC,T3,7th,not reported,896,bb8b7de9-849b-58c4-acac-313925a234ff,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-QG-A5YW_diagnosis,No,Cecum,--,released,TCGA-QG-A5YW_treatment,40a6fe0d-66f6-528e-81b6-b954d7e933ab,no,"Radiation Therapy, NOS",2019-07-31T18:42:20.143759-05:00,not reported,stage iiic,2019-08-08T16:37:44.165377-05:00,2011
d7ba64d7-b4e5-488d-9f28-bcb7bf3c0f35,TCGA-AA-3522,TCGA-COAD,67,-24653,--,2f67d8f1-1e33-5af7-b756-333371f796eb,not reported,male,not reported,released,TCGA-AA-3522_demographic,2019-07-31T18:38:14.744288-05:00,Alive,1940,--,24653,M0,N0,Stage IIA,T3,6th,not reported,1127,d18fc9ab-3aef-57ac-97d8-3db794c2fc10,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3522_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3522_treatment,2c99bb28-6a7e-5f5f-acaa-32edbd6ddb39,no,"Radiation Therapy, NOS",2019-07-31T18:38:14.744288-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
d7ba64d7-b4e5-488d-9f28-bcb7bf3c0f35,TCGA-AA-3522,TCGA-COAD,67,-24653,--,2f67d8f1-1e33-5af7-b756-333371f796eb,not reported,male,not reported,released,TCGA-AA-3522_demographic,2019-07-31T18:38:14.744288-05:00,Alive,1940,--,24653,M0,N0,Stage IIA,T3,6th,not reported,1127,d18fc9ab-3aef-57ac-97d8-3db794c2fc10,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3522_diagnosis,Not Reported,Ascending colon,2019-04-28T11:22:28.185137-05:00,released,TCGA-AA-3522_treatment_1,3598dd59-cccb-53ca-9074-cfb788673192,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:14.744288-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
56e612e8-2c29-4782-be79-2813cc8dd2e6,TCGA-AA-A00J,TCGA-COAD,80,-29371,--,c6399881-f3d3-5d46-b5fd-5235d0228725,not reported,male,not reported,released,TCGA-AA-A00J_demographic,2019-07-31T15:53:34.727339-05:00,Alive,1929,--,29371,M0,N1,Stage IIIB,T4,6th,not reported,549,53cf1c88-4c17-55ce-9215-0cacf97aba53,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-A00J_diagnosis,No,Ascending colon,--,released,TCGA-AA-A00J_treatment,bf260065-f720-5558-8c6c-c48164a477d1,no,"Radiation Therapy, NOS",2019-07-31T15:53:34.727339-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
56e612e8-2c29-4782-be79-2813cc8dd2e6,TCGA-AA-A00J,TCGA-COAD,80,-29371,--,c6399881-f3d3-5d46-b5fd-5235d0228725,not reported,male,not reported,released,TCGA-AA-A00J_demographic,2019-07-31T15:53:34.727339-05:00,Alive,1929,--,29371,M0,N1,Stage IIIB,T4,6th,not reported,549,53cf1c88-4c17-55ce-9215-0cacf97aba53,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-A00J_diagnosis,No,Ascending colon,2019-04-28T09:08:44.836797-05:00,released,TCGA-AA-A00J_treatment_1,fd6d4bfa-5763-5289-b92d-019937fa87d0,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:53:34.727339-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
dbbee8f5-d83d-4195-85cf-f89d327da0a9,TCGA-A6-5657,TCGA-COAD,65,-23920,--,e1aa7cf4-318a-541b-83c4-aea4cdfb586b,not hispanic or latino,male,black or african american,released,TCGA-A6-5657_demographic,2019-07-31T18:38:32.901134-05:00,Alive,1945,--,23920,M0,N1,Stage IIIB,T3,--,not reported,962,e664e65a-7980-53f1-a4ab-82c1296b41ab,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-5657_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-5657_treatment,552163af-3733-5e62-a88e-7784a4531d48,no,"Radiation Therapy, NOS",2019-07-31T18:38:32.901134-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
dbbee8f5-d83d-4195-85cf-f89d327da0a9,TCGA-A6-5657,TCGA-COAD,65,-23920,--,e1aa7cf4-318a-541b-83c4-aea4cdfb586b,not hispanic or latino,male,black or african american,released,TCGA-A6-5657_demographic,2019-07-31T18:38:32.901134-05:00,Alive,1945,--,23920,M0,N1,Stage IIIB,T3,--,not reported,962,e664e65a-7980-53f1-a4ab-82c1296b41ab,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-5657_diagnosis,No,"Colon, NOS",2019-04-28T11:22:43.155216-05:00,released,TCGA-A6-5657_treatment_1,852c7cdc-8900-54a0-ac79-613444c00a7b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:32.901134-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
26a41625-4680-47b2-afa9-6a72b148e1c0,TCGA-CA-5254,TCGA-COAD,42,-15415,--,16e204ca-354a-530f-b9ae-70540a980401,not hispanic or latino,female,asian,released,TCGA-CA-5254_demographic,2019-07-31T18:25:23.751819-05:00,Alive,1968,--,15415,M0,N0,Stage IIA,T3,6th,not reported,386,4dc6ee72-f99b-50f6-aaa6-3b43649762ae,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5254_diagnosis,No,"Colon, NOS",--,released,TCGA-CA-5254_treatment,8f0b882b-623d-569c-b6ad-456b01356526,no,"Radiation Therapy, NOS",2019-07-31T18:25:23.751819-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
26a41625-4680-47b2-afa9-6a72b148e1c0,TCGA-CA-5254,TCGA-COAD,42,-15415,--,16e204ca-354a-530f-b9ae-70540a980401,not hispanic or latino,female,asian,released,TCGA-CA-5254_demographic,2019-07-31T18:25:23.751819-05:00,Alive,1968,--,15415,M0,N0,Stage IIA,T3,6th,not reported,386,4dc6ee72-f99b-50f6-aaa6-3b43649762ae,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5254_diagnosis,No,"Colon, NOS",2019-04-28T11:11:46.883422-05:00,released,TCGA-CA-5254_treatment_1,ac271767-e6c6-51cf-aaf0-1660f1bc432e,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:23.751819-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
10881458-55b2-41d1-8358-4ee6ccb8ec85,TCGA-AA-A02K,TCGA-COAD,50,-18506,426,18caaaf1-0fc5-53e0-b98a-d604c514e129,not reported,male,not reported,released,TCGA-AA-A02K_demographic,2019-07-31T18:23:38.577860-05:00,Dead,1959,--,18506,M1,N2,Stage IV,T4,6th,not reported,--,61150f8f-fec8-5c85-8f04-0c15cfabbc4f,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A02K_diagnosis,No,Ascending colon,2019-04-28T11:10:20.182300-05:00,released,TCGA-AA-A02K_treatment_1,31320661-b623-5ce8-9ba2-d9c4ce06f8c1,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:38.577860-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2009
10881458-55b2-41d1-8358-4ee6ccb8ec85,TCGA-AA-A02K,TCGA-COAD,50,-18506,426,18caaaf1-0fc5-53e0-b98a-d604c514e129,not reported,male,not reported,released,TCGA-AA-A02K_demographic,2019-07-31T18:23:38.577860-05:00,Dead,1959,--,18506,M1,N2,Stage IV,T4,6th,not reported,--,61150f8f-fec8-5c85-8f04-0c15cfabbc4f,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A02K_diagnosis,No,Ascending colon,--,released,TCGA-AA-A02K_treatment,382f2cd4-ead6-5c4f-afde-401c15253866,no,"Radiation Therapy, NOS",2019-07-31T18:23:38.577860-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2009
e3b6018c-ab2c-47c5-b183-a295d0110835,TCGA-DM-A1D9,TCGA-COAD,67,-24514,--,63294017-f52b-592f-9328-b7d23eb4d49c,not hispanic or latino,female,white,released,TCGA-DM-A1D9_demographic,2019-07-31T18:39:05.127570-05:00,Alive,1933,--,24514,M0,N0,Stage IIA,T3,--,not reported,4270,44f385ec-91a3-5739-954e-3236040455f1,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A1D9_diagnosis,No,Cecum,--,released,TCGA-DM-A1D9_treatment,246d1898-0b38-59c6-8682-c9946f8702a4,not reported,"Radiation Therapy, NOS",2019-07-31T18:39:05.127570-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
e3b6018c-ab2c-47c5-b183-a295d0110835,TCGA-DM-A1D9,TCGA-COAD,67,-24514,--,63294017-f52b-592f-9328-b7d23eb4d49c,not hispanic or latino,female,white,released,TCGA-DM-A1D9_demographic,2019-07-31T18:39:05.127570-05:00,Alive,1933,--,24514,M0,N0,Stage IIA,T3,--,not reported,4270,44f385ec-91a3-5739-954e-3236040455f1,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A1D9_diagnosis,No,Cecum,2019-04-28T11:23:11.408388-05:00,released,TCGA-DM-A1D9_treatment_1,a3db8b07-5b94-5ffd-8fdc-01e38a095cea,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:05.127570-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
2d3ce817-b269-4662-a92d-392bd3662399,TCGA-CM-5341,TCGA-COAD,82,-30163,--,7d9537d3-8a2c-5575-b273-0c47ac7223d3,not hispanic or latino,female,white,released,TCGA-CM-5341_demographic,2019-07-31T18:26:04.836829-05:00,Alive,1928,--,30163,M0,N1a,Stage IIIA,T2,--,not reported,884,7722d2df-9bfe-5453-95e4-32882e64486a,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-5341_diagnosis,No,Sigmoid colon,2019-04-28T11:12:22.000777-05:00,released,TCGA-CM-5341_treatment_1,08a16a6f-e883-5d3e-90bb-cb26fdd0256d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:04.836829-05:00,not reported,stage iiia,2019-08-08T16:36:28.485406-05:00,2010
2d3ce817-b269-4662-a92d-392bd3662399,TCGA-CM-5341,TCGA-COAD,82,-30163,--,7d9537d3-8a2c-5575-b273-0c47ac7223d3,not hispanic or latino,female,white,released,TCGA-CM-5341_demographic,2019-07-31T18:26:04.836829-05:00,Alive,1928,--,30163,M0,N1a,Stage IIIA,T2,--,not reported,884,7722d2df-9bfe-5453-95e4-32882e64486a,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-5341_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-5341_treatment,3e4739f3-7830-54b7-a820-2864d25dc5ec,no,"Radiation Therapy, NOS",2019-07-31T18:26:04.836829-05:00,not reported,stage iiia,2019-08-08T16:36:28.485406-05:00,2010
60ad2c8a-6bbf-43fc-ae73-cc1f6d6c163c,TCGA-AA-A00F,TCGA-COAD,66,-24379,--,82bc2dac-2130-5a30-8783-d3748376a907,not reported,male,not reported,released,TCGA-AA-A00F_demographic,2019-07-31T18:29:31.282611-05:00,Alive,1941,--,24379,M0,N2,Stage IIIC,T3,6th,not reported,1035,cf087410-19be-5f49-9fd4-9a6e93f8bc49,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00F_diagnosis,No,Sigmoid colon,2019-04-28T11:15:14.276124-05:00,released,TCGA-AA-A00F_treatment_1,7772deae-fb9c-5221-8d47-4cd564a94179,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:31.282611-05:00,not reported,stage iiic,2019-08-08T16:35:04.140343-05:00,2007
60ad2c8a-6bbf-43fc-ae73-cc1f6d6c163c,TCGA-AA-A00F,TCGA-COAD,66,-24379,--,82bc2dac-2130-5a30-8783-d3748376a907,not reported,male,not reported,released,TCGA-AA-A00F_demographic,2019-07-31T18:29:31.282611-05:00,Alive,1941,--,24379,M0,N2,Stage IIIC,T3,6th,not reported,1035,cf087410-19be-5f49-9fd4-9a6e93f8bc49,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00F_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A00F_treatment,bf8676e4-8420-596e-abbf-414bd07b1460,no,"Radiation Therapy, NOS",2019-07-31T18:29:31.282611-05:00,not reported,stage iiic,2019-08-08T16:35:04.140343-05:00,2007
ae6b315f-3f78-4695-adfa-48b0bbab2c89,TCGA-D5-5537,TCGA-COAD,83,-30505,1381,15a326a0-2b9a-54f2-a720-51d5532c1bdc,not hispanic or latino,male,white,released,TCGA-D5-5537_demographic,2019-07-31T18:34:35.998425-05:00,Dead,1927,--,30505,MX,N2,--,T3,7th,not reported,456,352aa0c9-9e80-52d7-812f-6ad601b45629,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-5537_diagnosis,No,"Colon, NOS",2019-04-28T11:19:25.152520-05:00,released,TCGA-D5-5537_treatment_1,12842c73-d51f-5a68-b63e-b082fc951abf,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:35.998425-05:00,not reported,not reported,2019-08-08T16:36:28.485406-05:00,2010
ae6b315f-3f78-4695-adfa-48b0bbab2c89,TCGA-D5-5537,TCGA-COAD,83,-30505,1381,15a326a0-2b9a-54f2-a720-51d5532c1bdc,not hispanic or latino,male,white,released,TCGA-D5-5537_demographic,2019-07-31T18:34:35.998425-05:00,Dead,1927,--,30505,MX,N2,--,T3,7th,not reported,456,352aa0c9-9e80-52d7-812f-6ad601b45629,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-5537_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-5537_treatment,2656e17c-431e-5e87-a469-d4886d0488fe,no,"Radiation Therapy, NOS",2019-07-31T18:34:35.998425-05:00,not reported,not reported,2019-08-08T16:36:28.485406-05:00,2010
77a44132-af22-4115-9fa2-78f2f74bf687,TCGA-A6-2682,TCGA-COAD,70,-25683,424,2f8f5b9f-bad1-5635-89c9-71b352132c9e,not hispanic or latino,male,white,released,TCGA-A6-2682_demographic,2019-07-31T18:30:57.986699-05:00,Dead,1939,2010,25683,M1,N1,Stage IV,T4b,6th,not reported,--,6d721115-f251-55c5-a46e-098461255a58,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-A6-2682_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:16:25.991910-05:00,released,TCGA-A6-2682_treatment_1,4a318ee5-fa3e-5fa7-bc0d-37d2372f97a6,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:57.986699-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
77a44132-af22-4115-9fa2-78f2f74bf687,TCGA-A6-2682,TCGA-COAD,70,-25683,424,2f8f5b9f-bad1-5635-89c9-71b352132c9e,not hispanic or latino,male,white,released,TCGA-A6-2682_demographic,2019-07-31T18:30:57.986699-05:00,Dead,1939,2010,25683,M1,N1,Stage IV,T4b,6th,not reported,--,6d721115-f251-55c5-a46e-098461255a58,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-A6-2682_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-A6-2682_treatment,cdd15d7c-e705-57fd-a8b6-c7105dc1d012,no,"Radiation Therapy, NOS",2019-07-31T18:30:57.986699-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
9d68516e-7e5c-403e-8aca-ea1abe0d6014,TCGA-NH-A50U,TCGA-COAD,42,-15450,334,d673f1a9-77ba-5f57-ba20-6fe5a6c2ea16,not hispanic or latino,male,black or african american,released,TCGA-NH-A50U_demographic,2019-07-31T15:14:01.678414-05:00,Dead,1970,2012,15450,M1a,N0,Stage IVA,T4a,7th,not reported,--,5b8b4f4e-06c3-5338-a459-efb975b8274e,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-NH-A50U_diagnosis,No,Cecum,--,released,TCGA-NH-A50U_treatment,1246afb1-5282-5ad3-a6ca-84b544bd4903,no,"Radiation Therapy, NOS",2019-07-31T15:14:01.678414-05:00,not reported,stage iva,2019-08-08T16:37:18.448891-05:00,2012
9d68516e-7e5c-403e-8aca-ea1abe0d6014,TCGA-NH-A50U,TCGA-COAD,42,-15450,334,d673f1a9-77ba-5f57-ba20-6fe5a6c2ea16,not hispanic or latino,male,black or african american,released,TCGA-NH-A50U_demographic,2019-07-31T15:14:01.678414-05:00,Dead,1970,2012,15450,M1a,N0,Stage IVA,T4a,7th,not reported,--,5b8b4f4e-06c3-5338-a459-efb975b8274e,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-NH-A50U_diagnosis,No,Cecum,2019-04-28T08:35:07.706055-05:00,released,TCGA-NH-A50U_treatment_1,9a0de30f-578f-54ee-b41b-9681dabb8be9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:14:01.678414-05:00,not reported,stage iva,2019-08-08T16:37:18.448891-05:00,2012
d761bc06-dee8-478a-be99-8af9c504e49c,TCGA-AA-3684,TCGA-COAD,65,-23741,--,d610c462-f062-5c40-8982-7975d4469b5e,not reported,female,not reported,released,TCGA-AA-3684_demographic,2019-07-31T18:38:11.818234-05:00,Alive,1942,--,23741,M1,N2,Stage IV,T4,5th,not reported,--,0282bb0f-aab6-504c-ab3d-ad5501c29619,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-3684_diagnosis,No,Cecum,2019-04-28T11:22:25.699344-05:00,released,TCGA-AA-3684_treatment_1,65cc1bf2-3bcb-5ac3-aeb1-ac9e230a395a,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:11.818234-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2007
d761bc06-dee8-478a-be99-8af9c504e49c,TCGA-AA-3684,TCGA-COAD,65,-23741,--,d610c462-f062-5c40-8982-7975d4469b5e,not reported,female,not reported,released,TCGA-AA-3684_demographic,2019-07-31T18:38:11.818234-05:00,Alive,1942,--,23741,M1,N2,Stage IV,T4,5th,not reported,--,0282bb0f-aab6-504c-ab3d-ad5501c29619,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-3684_diagnosis,No,Cecum,--,released,TCGA-AA-3684_treatment,e6c4bdb6-6c54-5d61-8219-4b2b2eeabf99,not reported,"Radiation Therapy, NOS",2019-07-31T18:38:11.818234-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2007
af17788e-a562-43aa-bd36-fd3e031f483c,TCGA-AA-3979,TCGA-COAD,84,-30742,--,075e80f5-8f2a-58e1-a77c-6fde4a88ec43,not reported,male,not reported,released,TCGA-AA-3979_demographic,2019-07-31T18:34:48.562443-05:00,Alive,1926,--,30742,M0,N0,Stage IIA,T3,6th,not reported,730,3fa87b5c-f47a-5560-93fe-b72d717da436,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3979_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:19:35.363816-05:00,released,TCGA-AA-3979_treatment_1,a4cfb9dd-79fb-5ffb-8783-2397fd72108c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:48.562443-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2010
af17788e-a562-43aa-bd36-fd3e031f483c,TCGA-AA-3979,TCGA-COAD,84,-30742,--,075e80f5-8f2a-58e1-a77c-6fde4a88ec43,not reported,male,not reported,released,TCGA-AA-3979_demographic,2019-07-31T18:34:48.562443-05:00,Alive,1926,--,30742,M0,N0,Stage IIA,T3,6th,not reported,730,3fa87b5c-f47a-5560-93fe-b72d717da436,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3979_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3979_treatment,e55018ca-adcf-5ee0-96d3-fe5992b65398,no,"Radiation Therapy, NOS",2019-07-31T18:34:48.562443-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2010
10994156-7c2f-420e-aeb8-11d566b3d5e4,TCGA-AA-3971,TCGA-COAD,58,-21518,--,4ce6b4b0-2291-51c6-b8af-70cb89990b83,not reported,male,not reported,released,TCGA-AA-3971_demographic,2019-07-31T18:23:41.844984-05:00,Alive,1949,--,21518,M0,N1,Stage III,T3,5th,not reported,489,1711fb18-e219-5644-ab0f-5e673b4c7b6f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3971_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3971_treatment,0a059c5f-f996-52d5-8c76-f0c150692cda,no,"Radiation Therapy, NOS",2019-07-31T18:23:41.844984-05:00,not reported,stage iii,2019-08-08T16:35:04.140343-05:00,2007
10994156-7c2f-420e-aeb8-11d566b3d5e4,TCGA-AA-3971,TCGA-COAD,58,-21518,--,4ce6b4b0-2291-51c6-b8af-70cb89990b83,not reported,male,not reported,released,TCGA-AA-3971_demographic,2019-07-31T18:23:41.844984-05:00,Alive,1949,--,21518,M0,N1,Stage III,T3,5th,not reported,489,1711fb18-e219-5644-ab0f-5e673b4c7b6f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3971_diagnosis,No,"Colon, NOS",2019-04-28T11:10:22.781772-05:00,released,TCGA-AA-3971_treatment_1,ed6c3ce3-dd06-58ac-90ac-728a81cd92cd,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:41.844984-05:00,not reported,stage iii,2019-08-08T16:35:04.140343-05:00,2007
3e1886a8-2ed2-41ee-8b58-10f5321ade6f,TCGA-DM-A28K,TCGA-COAD,75,-27428,--,0ae9bba9-25e0-5813-91ba-6efa814406cf,not hispanic or latino,male,white,released,TCGA-DM-A28K_demographic,2019-07-31T18:27:18.512339-05:00,Alive,1928,--,27428,M0,N0,Stage IIA,T3,6th,not reported,2988,d3ef577e-6214-5657-a8a3-15a47610914f,C18.3,8480/3,Mucinous adenocarcinoma,no,No,not reported,Hepatic flexure of colon,released,TCGA-DM-A28K_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-DM-A28K_treatment,db67bf55-fa5c-5650-8db8-ede3215135a9,not reported,"Radiation Therapy, NOS",2019-07-31T18:27:18.512339-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2003
3e1886a8-2ed2-41ee-8b58-10f5321ade6f,TCGA-DM-A28K,TCGA-COAD,75,-27428,--,0ae9bba9-25e0-5813-91ba-6efa814406cf,not hispanic or latino,male,white,released,TCGA-DM-A28K_demographic,2019-07-31T18:27:18.512339-05:00,Alive,1928,--,27428,M0,N0,Stage IIA,T3,6th,not reported,2988,d3ef577e-6214-5657-a8a3-15a47610914f,C18.3,8480/3,Mucinous adenocarcinoma,no,No,not reported,Hepatic flexure of colon,released,TCGA-DM-A28K_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:13:24.808435-05:00,released,TCGA-DM-A28K_treatment_1,7fca931c-1faa-54fb-b572-4926bed58bdd,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:18.512339-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2003
cc22913d-2dda-48bb-82aa-9960b73f3e44,TCGA-NH-A5IV,TCGA-COAD,90,-32872,--,43bc16bf-588a-5f3c-98c0-87666f50e5f9,not hispanic or latino,female,black or african american,released,TCGA-NH-A5IV_demographic,2019-07-31T18:36:51.195826-05:00,Alive,1922,--,32872,MX,N0,Stage IIA,T3,7th,not reported,--,9ad56fce-723f-566a-bcab-512921b1e38f,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-NH-A5IV_diagnosis,No,Transverse colon,2019-04-28T11:21:16.594783-05:00,released,TCGA-NH-A5IV_treatment_1,239863ba-594e-5012-b438-5dd62e85d72e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:51.195826-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2012
cc22913d-2dda-48bb-82aa-9960b73f3e44,TCGA-NH-A5IV,TCGA-COAD,90,-32872,--,43bc16bf-588a-5f3c-98c0-87666f50e5f9,not hispanic or latino,female,black or african american,released,TCGA-NH-A5IV_demographic,2019-07-31T18:36:51.195826-05:00,Alive,1922,--,32872,MX,N0,Stage IIA,T3,7th,not reported,--,9ad56fce-723f-566a-bcab-512921b1e38f,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-NH-A5IV_diagnosis,No,Transverse colon,--,released,TCGA-NH-A5IV_treatment,2ea5dafb-1283-5542-a189-a352812feaac,no,"Radiation Therapy, NOS",2019-07-31T18:36:51.195826-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2012
2db3c23d-c591-4ea0-b0a8-ed9c4343c80e,TCGA-CK-4951,TCGA-COAD,79,-28982,2134,5f6a9f22-d705-5303-9231-5a7c539201ed,not hispanic or latino,female,white,released,TCGA-CK-4951_demographic,2019-07-31T18:26:07.709477-05:00,Dead,1928,--,28982,M0,N0,Stage IIA,T3,6th,not reported,2134,fe3d8d09-badd-562f-a5a0-39a5d1f2eaea,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CK-4951_diagnosis,No,Cecum,--,released,TCGA-CK-4951_treatment,ad52bb6b-58f7-5e30-9cc0-85afb1d902fb,no,"Radiation Therapy, NOS",2019-07-31T18:26:07.709477-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2007
2db3c23d-c591-4ea0-b0a8-ed9c4343c80e,TCGA-CK-4951,TCGA-COAD,79,-28982,2134,5f6a9f22-d705-5303-9231-5a7c539201ed,not hispanic or latino,female,white,released,TCGA-CK-4951_demographic,2019-07-31T18:26:07.709477-05:00,Dead,1928,--,28982,M0,N0,Stage IIA,T3,6th,not reported,2134,fe3d8d09-badd-562f-a5a0-39a5d1f2eaea,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CK-4951_diagnosis,No,Cecum,2019-04-28T11:12:24.554481-05:00,released,TCGA-CK-4951_treatment_1,ea58547e-1ae4-5a5e-ae92-dae18cde71c8,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:07.709477-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2007
dde411b2-5d2b-4638-8149-89bc1eb3c7ad,TCGA-AA-3697,TCGA-COAD,77,-28367,--,4e3b2806-119c-5734-bcea-2f53fc98a487,not reported,male,not reported,released,TCGA-AA-3697_demographic,2019-07-31T18:38:41.885490-05:00,Alive,1926,--,28367,M0,N0,Stage II,T3,5th,not reported,2587,426cdd16-1c95-59db-9faf-c5c6b8391ddf,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3697_diagnosis,No,"Colon, NOS",2019-04-28T11:22:50.830144-05:00,released,TCGA-AA-3697_treatment_1,5b8dce59-d58c-552c-a30d-3478d23ed43c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:41.885490-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2003
dde411b2-5d2b-4638-8149-89bc1eb3c7ad,TCGA-AA-3697,TCGA-COAD,77,-28367,--,4e3b2806-119c-5734-bcea-2f53fc98a487,not reported,male,not reported,released,TCGA-AA-3697_demographic,2019-07-31T18:38:41.885490-05:00,Alive,1926,--,28367,M0,N0,Stage II,T3,5th,not reported,2587,426cdd16-1c95-59db-9faf-c5c6b8391ddf,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3697_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3697_treatment,ca6a7524-4c65-5806-8e2b-5b2ea2abe952,no,"Radiation Therapy, NOS",2019-07-31T18:38:41.885490-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2003
6baf61b6-ae5b-42f0-adc9-0d26fda231f7,TCGA-AY-4070,TCGA-COAD,50,-18621,496,5d0d5433-6e21-597f-9df5-bbc6285de646,not hispanic or latino,female,black or african american,released,TCGA-AY-4070_demographic,2019-07-31T18:30:16.029059-05:00,Dead,1957,2008,18621,M0,N2,Stage IIIC,T3,6th,not reported,--,a23ab279-17fb-520f-b50d-b025038634e5,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-4070_diagnosis,No,Cecum,--,released,TCGA-AY-4070_treatment,14cab3a8-feb9-55a4-8730-3ea84fa263fe,no,"Radiation Therapy, NOS",2019-07-31T18:30:16.029059-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2007
6baf61b6-ae5b-42f0-adc9-0d26fda231f7,TCGA-AY-4070,TCGA-COAD,50,-18621,496,5d0d5433-6e21-597f-9df5-bbc6285de646,not hispanic or latino,female,black or african american,released,TCGA-AY-4070_demographic,2019-07-31T18:30:16.029059-05:00,Dead,1957,2008,18621,M0,N2,Stage IIIC,T3,6th,not reported,--,a23ab279-17fb-520f-b50d-b025038634e5,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-4070_diagnosis,No,Cecum,2019-04-28T11:15:51.648413-05:00,released,TCGA-AY-4070_treatment_1,abbc4583-c214-572c-a82f-b7d05832c895,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:16.029059-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2007
e83e5700-f968-4978-bb78-56a83936ce8c,TCGA-D5-6536,TCGA-COAD,73,-26890,--,df44ec8b-94a9-5380-8ceb-f626bbc07fb2,not hispanic or latino,male,white,released,TCGA-D5-6536_demographic,2019-07-31T18:39:43.755018-05:00,Alive,1937,--,26890,M0,N0,Stage IIA,T3,7th,not reported,543,81065b87-a6cc-5582-b165-717cfec835b8,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6536_diagnosis,No,"Colon, NOS",2019-04-28T11:23:44.235867-05:00,released,TCGA-D5-6536_treatment_1,36e1f9c8-c75e-5a59-ac91-7c287a6d3a00,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:43.755018-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2010
e83e5700-f968-4978-bb78-56a83936ce8c,TCGA-D5-6536,TCGA-COAD,73,-26890,--,df44ec8b-94a9-5380-8ceb-f626bbc07fb2,not hispanic or latino,male,white,released,TCGA-D5-6536_demographic,2019-07-31T18:39:43.755018-05:00,Alive,1937,--,26890,M0,N0,Stage IIA,T3,7th,not reported,543,81065b87-a6cc-5582-b165-717cfec835b8,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6536_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6536_treatment,f8d19b08-71c1-51f4-912b-bae9bbb8432e,no,"Radiation Therapy, NOS",2019-07-31T18:39:43.755018-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2010
05ff79c5-1127-4cac-8f4c-84089a3f2cde,TCGA-AA-3862,TCGA-COAD,82,-30163,--,2f6eb888-2add-50bc-91ee-0c1530fadabf,not reported,male,not reported,released,TCGA-AA-3862_demographic,2019-07-31T18:22:40.027972-05:00,Alive,1927,--,30163,M0,N0,Stage IIA,T3,6th,not reported,914,eac426b6-824a-5ce0-8183-721ffb082625,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3862_diagnosis,Not Reported,Ascending colon,2019-04-28T11:09:32.961671-05:00,released,TCGA-AA-3862_treatment_1,8b9b6487-a08e-5c89-8704-bf1f33b361c8,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:40.027972-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
05ff79c5-1127-4cac-8f4c-84089a3f2cde,TCGA-AA-3862,TCGA-COAD,82,-30163,--,2f6eb888-2add-50bc-91ee-0c1530fadabf,not reported,male,not reported,released,TCGA-AA-3862_demographic,2019-07-31T18:22:40.027972-05:00,Alive,1927,--,30163,M0,N0,Stage IIA,T3,6th,not reported,914,eac426b6-824a-5ce0-8183-721ffb082625,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3862_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3862_treatment,f72551b2-f940-5ecb-b0b1-0b9f5532414a,no,"Radiation Therapy, NOS",2019-07-31T18:22:40.027972-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
67ba29e7-f294-4dcd-9630-ad768c22c588,TCGA-AA-3494,TCGA-COAD,55,-20089,--,9b9aec68-5ded-5f26-ae35-c9e87f80f573,not reported,male,not reported,released,TCGA-AA-3494_demographic,2019-07-31T18:30:04.027219-05:00,Alive,1947,--,20089,M1,N0,Stage IV,T3,5th,not reported,31,842f46a5-c93c-5aaf-bf61-b776c834bd82,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3494_diagnosis,No,"Colon, NOS",2019-04-28T11:15:41.724701-05:00,released,TCGA-AA-3494_treatment_1,e0604fdc-38a9-5439-9896-282c8dbd6521,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:04.027219-05:00,not reported,stage iv,2019-08-08T16:34:13.342472-05:00,2002
67ba29e7-f294-4dcd-9630-ad768c22c588,TCGA-AA-3494,TCGA-COAD,55,-20089,--,9b9aec68-5ded-5f26-ae35-c9e87f80f573,not reported,male,not reported,released,TCGA-AA-3494_demographic,2019-07-31T18:30:04.027219-05:00,Alive,1947,--,20089,M1,N0,Stage IV,T3,5th,not reported,31,842f46a5-c93c-5aaf-bf61-b776c834bd82,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3494_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3494_treatment,2a7f7f1f-024e-5776-bec1-143d53754a3f,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:04.027219-05:00,not reported,stage iv,2019-08-08T16:34:13.342472-05:00,2002
fa96d094-0165-401c-8fd5-6d1ee4ef3994,TCGA-AA-A00W,TCGA-COAD,80,-29311,--,c6d42a06-2470-57c5-a69e-4a85b5126648,not reported,male,not reported,released,TCGA-AA-A00W_demographic,2019-07-31T15:13:58.430021-05:00,Alive,1928,--,29311,M0,N0,Stage I,T1,6th,not reported,456,e97e2807-cbb0-5d33-ab4d-cc15f92ad909,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00W_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A00W_treatment,a74a042c-c3aa-58b0-b583-7860a1e0deb8,no,"Radiation Therapy, NOS",2019-07-31T15:13:58.430021-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2008
fa96d094-0165-401c-8fd5-6d1ee4ef3994,TCGA-AA-A00W,TCGA-COAD,80,-29311,--,c6d42a06-2470-57c5-a69e-4a85b5126648,not reported,male,not reported,released,TCGA-AA-A00W_demographic,2019-07-31T15:13:58.430021-05:00,Alive,1928,--,29311,M0,N0,Stage I,T1,6th,not reported,456,e97e2807-cbb0-5d33-ab4d-cc15f92ad909,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00W_diagnosis,No,Sigmoid colon,2019-04-28T08:35:05.244993-05:00,released,TCGA-AA-A00W_treatment_1,d54b51ac-58a9-5e02-8c65-c8abfc302f8c,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:13:58.430021-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2008
563d67a1-f1ba-4722-aa2d-9b35b1689468,TCGA-CA-5255,TCGA-COAD,45,-16743,--,c5721314-291b-59a1-bcaf-98c51b45b14d,not hispanic or latino,male,asian,released,TCGA-CA-5255_demographic,2019-07-31T18:28:32.060169-05:00,Alive,1965,--,16743,M0,N0,Stage IIA,T3,6th,not reported,376,59ebd28c-ef4a-5cda-8429-042492c3f55d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5255_diagnosis,No,"Colon, NOS",2019-04-28T11:14:24.345156-05:00,released,TCGA-CA-5255_treatment_1,9e883af1-0bb2-5847-bf71-d5c66fad8b45,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:32.060169-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
563d67a1-f1ba-4722-aa2d-9b35b1689468,TCGA-CA-5255,TCGA-COAD,45,-16743,--,c5721314-291b-59a1-bcaf-98c51b45b14d,not hispanic or latino,male,asian,released,TCGA-CA-5255_demographic,2019-07-31T18:28:32.060169-05:00,Alive,1965,--,16743,M0,N0,Stage IIA,T3,6th,not reported,376,59ebd28c-ef4a-5cda-8429-042492c3f55d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5255_diagnosis,No,"Colon, NOS",--,released,TCGA-CA-5255_treatment,a04a14c7-e511-5396-86cc-8a6aec89e049,yes,"Radiation Therapy, NOS",2019-07-31T18:28:32.060169-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
622cc1c4-d721-4b5c-a88b-216d6368660b,TCGA-G4-6297,TCGA-COAD,55,-20103,--,a5c2b8a3-7d6d-5ada-a374-64cb80ee62a6,not hispanic or latino,female,white,released,TCGA-G4-6297_demographic,2019-07-31T18:29:34.317618-05:00,Alive,1950,--,20103,M1,N2,Stage IV,T3,6th,not reported,2506,89e6b80e-a799-518c-b79f-a0514a8346bd,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-G4-6297_diagnosis,No,Cecum,2019-04-28T11:15:16.836486-05:00,released,TCGA-G4-6297_treatment_1,28802f96-9bc1-532f-8b2b-b6699ddd11df,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:34.317618-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2005
622cc1c4-d721-4b5c-a88b-216d6368660b,TCGA-G4-6297,TCGA-COAD,55,-20103,--,a5c2b8a3-7d6d-5ada-a374-64cb80ee62a6,not hispanic or latino,female,white,released,TCGA-G4-6297_demographic,2019-07-31T18:29:34.317618-05:00,Alive,1950,--,20103,M1,N2,Stage IV,T3,6th,not reported,2506,89e6b80e-a799-518c-b79f-a0514a8346bd,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-G4-6297_diagnosis,No,Cecum,--,released,TCGA-G4-6297_treatment,5b0b567f-9b2a-5ea7-8575-99ff5953b74c,no,"Radiation Therapy, NOS",2019-07-31T18:29:34.317618-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2005
4beee9d4-ee52-4fed-bcc4-d300f5ddd4d0,TCGA-A6-5661,TCGA-COAD,80,-29446,--,a5f4b3c0-6fc7-596a-87b2-adec9d4459eb,not hispanic or latino,female,black or african american,released,TCGA-A6-5661_demographic,2019-07-31T18:41:41.769044-05:00,Alive,1930,--,29446,M0,N0,Stage IIA,T3,--,not reported,1020,43747f68-3f64-5169-8744-6950c6bd54e0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-5661_diagnosis,No,Ascending colon,--,released,TCGA-A6-5661_treatment,0b79782b-0945-5abc-8fb3-e2d0b2f04708,no,"Radiation Therapy, NOS",2019-07-31T18:41:41.769044-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
4beee9d4-ee52-4fed-bcc4-d300f5ddd4d0,TCGA-A6-5661,TCGA-COAD,80,-29446,--,a5f4b3c0-6fc7-596a-87b2-adec9d4459eb,not hispanic or latino,female,black or african american,released,TCGA-A6-5661_demographic,2019-07-31T18:41:41.769044-05:00,Alive,1930,--,29446,M0,N0,Stage IIA,T3,--,not reported,1020,43747f68-3f64-5169-8744-6950c6bd54e0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-5661_diagnosis,No,Ascending colon,2019-04-28T11:25:22.911767-05:00,released,TCGA-A6-5661_treatment_1,0811c4f6-f44e-50fa-8f05-b480aa2a98e7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:41.769044-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1,TCGA-AA-3972,TCGA-COAD,72,-26360,--,a9242d51-f8f8-5887-b02c-34cd1964927f,not reported,male,not reported,released,TCGA-AA-3972_demographic,2019-07-31T18:32:43.740385-05:00,Alive,1936,--,26360,M1,N1,Stage IV,T3,6th,not reported,1551,cc2734a6-c268-5ea0-8269-4d987520c821,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3972_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3972_treatment,a2065dde-e777-554a-8134-21ff499a0a4b,no,"Radiation Therapy, NOS",2019-07-31T18:32:43.740385-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2008
93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1,TCGA-AA-3972,TCGA-COAD,72,-26360,--,a9242d51-f8f8-5887-b02c-34cd1964927f,not reported,male,not reported,released,TCGA-AA-3972_demographic,2019-07-31T18:32:43.740385-05:00,Alive,1936,--,26360,M1,N1,Stage IV,T3,6th,not reported,1551,cc2734a6-c268-5ea0-8269-4d987520c821,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3972_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:17:54.234600-05:00,released,TCGA-AA-3972_treatment_1,ca1f2968-7621-5da4-ae3a-a36baefb238a,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:43.740385-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2008
02f9668c-71e6-485f-88b1-b37dc8bdd2ab,TCGA-AA-3866,TCGA-COAD,78,-28672,--,0d68cd8c-1859-51f9-a998-b66a10c86b22,not reported,female,not reported,released,TCGA-AA-3866_demographic,2019-07-31T18:22:28.241053-05:00,Alive,1928,--,28672,M0,N0,Stage I,T2,5th,not reported,518,9118e109-4742-5920-8c95-a81fd4a04f8a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3866_diagnosis,No,"Colon, NOS",2019-04-28T11:09:23.001630-05:00,released,TCGA-AA-3866_treatment_1,5017c37d-b470-5ac4-9bd6-5a8c51e15d6d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:28.241053-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2006
02f9668c-71e6-485f-88b1-b37dc8bdd2ab,TCGA-AA-3866,TCGA-COAD,78,-28672,--,0d68cd8c-1859-51f9-a998-b66a10c86b22,not reported,female,not reported,released,TCGA-AA-3866_demographic,2019-07-31T18:22:28.241053-05:00,Alive,1928,--,28672,M0,N0,Stage I,T2,5th,not reported,518,9118e109-4742-5920-8c95-a81fd4a04f8a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3866_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3866_treatment,a7f054cc-cc54-5bc1-be35-6006214dcf17,no,"Radiation Therapy, NOS",2019-07-31T18:22:28.241053-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2006
acd51808-870c-4684-a2de-aa0b058729e1,TCGA-AY-A69D,TCGA-COAD,55,-20299,--,d7bcc82e-0b7f-5c4b-b382-817b2ee88bd7,not hispanic or latino,female,black or african american,released,TCGA-AY-A69D_demographic,2019-07-31T15:22:45.817415-05:00,Alive,1957,--,20299,M0,N0,Stage IIA,T3,7th,not reported,543,131820a3-20aa-5dee-8902-f4ccc4fbdc48,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AY-A69D_diagnosis,No,Transverse colon,2019-04-28T08:42:33.574091-05:00,released,TCGA-AY-A69D_treatment_1,336c6dcd-1c67-5f33-bcd4-552bff5171d9,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:22:45.817415-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2012
acd51808-870c-4684-a2de-aa0b058729e1,TCGA-AY-A69D,TCGA-COAD,55,-20299,--,d7bcc82e-0b7f-5c4b-b382-817b2ee88bd7,not hispanic or latino,female,black or african american,released,TCGA-AY-A69D_demographic,2019-07-31T15:22:45.817415-05:00,Alive,1957,--,20299,M0,N0,Stage IIA,T3,7th,not reported,543,131820a3-20aa-5dee-8902-f4ccc4fbdc48,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AY-A69D_diagnosis,No,Transverse colon,--,released,TCGA-AY-A69D_treatment,d36d3c39-bad9-527f-a634-e658d0179e5e,no,"Radiation Therapy, NOS",2019-07-31T15:22:45.817415-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2012
95a54459-3fac-42d5-8ec1-ed66d971d64d,TCGA-CA-6716,TCGA-COAD,65,-23943,--,835878dd-88ec-5f31-87aa-903f194902a0,not hispanic or latino,male,asian,released,TCGA-CA-6716_demographic,2019-07-31T18:32:52.754728-05:00,Alive,1945,--,23943,M0,N0,Stage IIA,T3,6th,not reported,371,5ffa3638-b473-55b3-94af-39ec5d771c57,C18.2,8260/3,"Papillary adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CA-6716_diagnosis,No,Ascending colon,2019-04-28T11:18:01.951961-05:00,released,TCGA-CA-6716_treatment_1,24c11f60-b5e9-5321-8bd4-be6964a329a9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:52.754728-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
95a54459-3fac-42d5-8ec1-ed66d971d64d,TCGA-CA-6716,TCGA-COAD,65,-23943,--,835878dd-88ec-5f31-87aa-903f194902a0,not hispanic or latino,male,asian,released,TCGA-CA-6716_demographic,2019-07-31T18:32:52.754728-05:00,Alive,1945,--,23943,M0,N0,Stage IIA,T3,6th,not reported,371,5ffa3638-b473-55b3-94af-39ec5d771c57,C18.2,8260/3,"Papillary adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CA-6716_diagnosis,No,Ascending colon,--,released,TCGA-CA-6716_treatment,e94101f6-ed5b-526c-b175-9a0399fdcd97,no,"Radiation Therapy, NOS",2019-07-31T18:32:52.754728-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
cc15469c-7bad-4e86-9da3-ae0c72e9d380,TCGA-CM-4744,TCGA-COAD,69,-25506,--,8ed81db0-bac1-5350-9ce4-cc5d13acdbfd,not hispanic or latino,male,white,released,TCGA-CM-4744_demographic,2019-07-31T18:37:22.401888-05:00,Alive,1941,--,25506,M0,N0,Stage I,T2,--,not reported,609,268f0995-b3ad-5915-99a9-0fbb28923454,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-4744_diagnosis,No,Cecum,--,released,TCGA-CM-4744_treatment,7030e1c7-ef02-5a84-8040-005b8390346a,no,"Radiation Therapy, NOS",2019-07-31T18:37:22.401888-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
cc15469c-7bad-4e86-9da3-ae0c72e9d380,TCGA-CM-4744,TCGA-COAD,69,-25506,--,8ed81db0-bac1-5350-9ce4-cc5d13acdbfd,not hispanic or latino,male,white,released,TCGA-CM-4744_demographic,2019-07-31T18:37:22.401888-05:00,Alive,1941,--,25506,M0,N0,Stage I,T2,--,not reported,609,268f0995-b3ad-5915-99a9-0fbb28923454,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-4744_diagnosis,No,Cecum,2019-04-28T11:21:41.805421-05:00,released,TCGA-CM-4744_treatment_1,c657c585-b91c-5bd8-b3c4-ad31ac8d7945,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:22.401888-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
31d960d7-8f5b-4d22-bf5e-fae0849c4efd,TCGA-D5-5540,TCGA-COAD,73,-26972,--,814a6741-4e21-59bc-8a46-a1cc18fdcea5,not hispanic or latino,male,white,released,TCGA-D5-5540_demographic,2019-07-31T18:41:36.058829-05:00,Alive,1937,--,26972,M0,N0,Stage IIA,T3,--,not reported,1706,691c0cb7-1028-5010-bd33-addf71df36bf,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-D5-5540_diagnosis,No,Cecum,--,released,TCGA-D5-5540_treatment,fb524c97-7103-52c0-ba19-e256bd49d105,no,"Radiation Therapy, NOS",2019-07-31T18:41:36.058829-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
31d960d7-8f5b-4d22-bf5e-fae0849c4efd,TCGA-D5-5540,TCGA-COAD,73,-26972,--,814a6741-4e21-59bc-8a46-a1cc18fdcea5,not hispanic or latino,male,white,released,TCGA-D5-5540_demographic,2019-07-31T18:41:36.058829-05:00,Alive,1937,--,26972,M0,N0,Stage IIA,T3,--,not reported,1706,691c0cb7-1028-5010-bd33-addf71df36bf,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-D5-5540_diagnosis,No,Cecum,2019-04-28T11:25:17.093076-05:00,released,TCGA-D5-5540_treatment_1,136bf2f0-86f1-58cd-a0bb-0995b9a583f8,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:36.058829-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
96e013d9-8e89-46a7-8d07-bae95af36708,TCGA-CM-5860,TCGA-COAD,44,-16344,--,944bea9b-d8c7-595c-a620-94ebce973d52,not hispanic or latino,male,white,released,TCGA-CM-5860_demographic,2019-07-31T18:33:05.194724-05:00,Alive,1966,--,16344,M0,N0,Stage IIA,T3,7th,not reported,974,7642a5b2-69ce-552e-a009-1802356e97fe,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-5860_diagnosis,No,Ascending colon,--,released,TCGA-CM-5860_treatment,0425142e-b357-52d0-ab90-48fd75434539,no,"Radiation Therapy, NOS",2019-07-31T18:33:05.194724-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
96e013d9-8e89-46a7-8d07-bae95af36708,TCGA-CM-5860,TCGA-COAD,44,-16344,--,944bea9b-d8c7-595c-a620-94ebce973d52,not hispanic or latino,male,white,released,TCGA-CM-5860_demographic,2019-07-31T18:33:05.194724-05:00,Alive,1966,--,16344,M0,N0,Stage IIA,T3,7th,not reported,974,7642a5b2-69ce-552e-a009-1802356e97fe,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-5860_diagnosis,No,Ascending colon,2019-04-28T11:18:11.522352-05:00,released,TCGA-CM-5860_treatment_1,1fd98d46-2322-54d1-965a-0900c9613865,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:05.194724-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
cd845618-4cc4-49c2-9055-c171d4c24ee1,TCGA-CM-4748,TCGA-COAD,53,-19509,--,97bcee21-efcf-5bf1-8503-c09c549f40e2,not hispanic or latino,male,white,released,TCGA-CM-4748_demographic,2019-07-31T18:37:31.327736-05:00,Alive,1957,--,19509,M0,N1a,Stage IIIB,T4a,--,not reported,792,140198d2-bc2e-5ece-b811-ad48845d6874,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-CM-4748_diagnosis,No,Transverse colon,--,released,TCGA-CM-4748_treatment,53f458de-d636-56c4-900f-8ded6c5ca557,no,"Radiation Therapy, NOS",2019-07-31T18:37:31.327736-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
cd845618-4cc4-49c2-9055-c171d4c24ee1,TCGA-CM-4748,TCGA-COAD,53,-19509,--,97bcee21-efcf-5bf1-8503-c09c549f40e2,not hispanic or latino,male,white,released,TCGA-CM-4748_demographic,2019-07-31T18:37:31.327736-05:00,Alive,1957,--,19509,M0,N1a,Stage IIIB,T4a,--,not reported,792,140198d2-bc2e-5ece-b811-ad48845d6874,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-CM-4748_diagnosis,No,Transverse colon,2019-04-28T11:21:49.306107-05:00,released,TCGA-CM-4748_treatment_1,fee2b8ca-e129-53e9-b646-e3e2a45d4032,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:31.327736-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
8c0894fb-5e78-40ae-be0b-329ca30f758a,TCGA-DM-A1HB,TCGA-COAD,75,-27708,--,3c887632-e3f7-5d97-a304-5ab310e522af,not hispanic or latino,male,white,released,TCGA-DM-A1HB_demographic,2019-07-31T18:32:21.914136-05:00,Alive,1925,--,27708,M0,N1,Stage IIIB,T3,--,not reported,4126,f17a5510-d76a-51e6-b625-3a6580727093,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-DM-A1HB_diagnosis,No,Transverse colon,--,released,TCGA-DM-A1HB_treatment,2c0609ed-6294-580f-9078-a4e5667ddd71,not reported,"Radiation Therapy, NOS",2019-07-31T18:32:21.914136-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2000
8c0894fb-5e78-40ae-be0b-329ca30f758a,TCGA-DM-A1HB,TCGA-COAD,75,-27708,--,3c887632-e3f7-5d97-a304-5ab310e522af,not hispanic or latino,male,white,released,TCGA-DM-A1HB_demographic,2019-07-31T18:32:21.914136-05:00,Alive,1925,--,27708,M0,N1,Stage IIIB,T3,--,not reported,4126,f17a5510-d76a-51e6-b625-3a6580727093,C18.4,8480/3,Mucinous adenocarcinoma,no,No,not reported,Transverse colon,released,TCGA-DM-A1HB_diagnosis,No,Transverse colon,2019-04-28T11:17:36.386331-05:00,released,TCGA-DM-A1HB_treatment_1,4b3e195f-5ad5-527e-bb36-2965d4eb0dff,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:21.914136-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2000
01f493d4-229d-47a6-baa8-32a342c65d01,TCGA-AA-A00O,TCGA-COAD,83,-30316,--,9fa619a1-6ccf-554c-aaac-4b8ea61319df,not reported,female,not reported,released,TCGA-AA-A00O_demographic,2019-07-31T18:22:22.240264-05:00,Alive,1925,--,30316,M0,N2,Stage IIIC,T3,6th,not reported,822,5294556a-13c8-5e63-9b3b-6ac0b429aa77,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00O_diagnosis,No,Sigmoid colon,2019-04-28T11:09:17.563368-05:00,released,TCGA-AA-A00O_treatment_1,68c4580c-a12d-59c7-969c-46fccf381769,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:22.240264-05:00,not reported,stage iiic,2019-08-08T16:35:04.140343-05:00,2008
01f493d4-229d-47a6-baa8-32a342c65d01,TCGA-AA-A00O,TCGA-COAD,83,-30316,--,9fa619a1-6ccf-554c-aaac-4b8ea61319df,not reported,female,not reported,released,TCGA-AA-A00O_demographic,2019-07-31T18:22:22.240264-05:00,Alive,1925,--,30316,M0,N2,Stage IIIC,T3,6th,not reported,822,5294556a-13c8-5e63-9b3b-6ac0b429aa77,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A00O_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A00O_treatment,d04b2b03-119d-5e18-bf1e-9bfcb97efa06,no,"Radiation Therapy, NOS",2019-07-31T18:22:22.240264-05:00,not reported,stage iiic,2019-08-08T16:35:04.140343-05:00,2008
4a785dc7-f5f6-4607-a19d-e6354b2fb5a9,TCGA-F4-6808,TCGA-COAD,54,-19803,--,789fb9cf-a7a3-5013-89a7-bdb822a8fd97,not hispanic or latino,female,white,released,TCGA-F4-6808_demographic,2019-07-31T18:27:53.410244-05:00,Alive,1957,--,19803,M0,N0,Stage I,T1,7th,not reported,1024,515b3765-b1b0-56e3-b4e0-61f94527d133,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6808_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6808_treatment,dedb9c30-4f2e-55dc-8090-3cab4cc59d50,no,"Radiation Therapy, NOS",2019-07-31T18:27:53.410244-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
4a785dc7-f5f6-4607-a19d-e6354b2fb5a9,TCGA-F4-6808,TCGA-COAD,54,-19803,--,789fb9cf-a7a3-5013-89a7-bdb822a8fd97,not hispanic or latino,female,white,released,TCGA-F4-6808_demographic,2019-07-31T18:27:53.410244-05:00,Alive,1957,--,19803,M0,N0,Stage I,T1,7th,not reported,1024,515b3765-b1b0-56e3-b4e0-61f94527d133,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6808_diagnosis,No,Sigmoid colon,2019-04-28T11:13:51.930153-05:00,released,TCGA-F4-6808_treatment_1,aa1bbde9-ac02-56d2-80ad-f0f07c72fa47,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:53.410244-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
6fa41234-9077-4d05-a295-6820f3bedf5b,TCGA-AA-A02O,TCGA-COAD,82,-30288,--,79a94353-960a-5a6a-863a-35fc4b296cf1,not reported,male,not reported,released,TCGA-AA-A02O_demographic,2019-07-31T18:30:22.188331-05:00,Alive,1923,--,30288,M0,N0,Stage II,T3,6th,not reported,28,5e9dd2aa-c52d-5099-b9ef-6160de373ecc,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-A02O_diagnosis,No,Transverse colon,2019-04-28T11:15:56.468832-05:00,released,TCGA-AA-A02O_treatment_1,7ee4cf40-96ed-5fca-b32c-7af30b9c75dd,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:22.188331-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2005
6fa41234-9077-4d05-a295-6820f3bedf5b,TCGA-AA-A02O,TCGA-COAD,82,-30288,--,79a94353-960a-5a6a-863a-35fc4b296cf1,not reported,male,not reported,released,TCGA-AA-A02O_demographic,2019-07-31T18:30:22.188331-05:00,Alive,1923,--,30288,M0,N0,Stage II,T3,6th,not reported,28,5e9dd2aa-c52d-5099-b9ef-6160de373ecc,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-A02O_diagnosis,No,Transverse colon,--,released,TCGA-AA-A02O_treatment,a3cbd390-7eb5-51b3-9e43-da648f7078e3,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:22.188331-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2005
d7048098-09b3-4763-ad54-9c5c6fe14bc0,TCGA-CM-6678,TCGA-COAD,63,-23070,--,7ba0029e-82a4-51e6-86a4-a64d780a8381,not hispanic or latino,female,white,released,TCGA-CM-6678_demographic,2019-07-31T18:42:55.657264-05:00,Alive,1948,--,23070,M1a,N1c,Stage IVA,T4a,7th,not reported,335,b44c595d-245a-5b2c-baab-ee22c6c63cdf,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6678_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6678_treatment,3861350f-14e5-57d8-93d0-fefb9830d264,no,"Radiation Therapy, NOS",2019-07-31T18:42:55.657264-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2011
d7048098-09b3-4763-ad54-9c5c6fe14bc0,TCGA-CM-6678,TCGA-COAD,63,-23070,--,7ba0029e-82a4-51e6-86a4-a64d780a8381,not hispanic or latino,female,white,released,TCGA-CM-6678_demographic,2019-07-31T18:42:55.657264-05:00,Alive,1948,--,23070,M1a,N1c,Stage IVA,T4a,7th,not reported,335,b44c595d-245a-5b2c-baab-ee22c6c63cdf,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6678_diagnosis,No,Sigmoid colon,2019-04-28T11:26:26.979875-05:00,released,TCGA-CM-6678_treatment_1,2fb9b54c-cb55-58f2-bc4e-f838a4385815,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:55.657264-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2011
73f9681a-f9ef-4880-bd16-93624fd117c6,TCGA-CK-4947,TCGA-COAD,46,-16980,--,68498a5f-f5be-5c30-9a05-98213190cb4e,not hispanic or latino,female,white,released,TCGA-CK-4947_demographic,2019-07-31T18:30:39.997882-05:00,Alive,1957,--,16980,M0,N1,Stage IIIB,T4,6th,not reported,534,712fbcfb-670c-5aeb-8996-7b58d3e88ff8,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-4947_diagnosis,No,Sigmoid colon,--,released,TCGA-CK-4947_treatment,22e90399-92fa-5467-bf62-e1b2c7638416,no,"Radiation Therapy, NOS",2019-07-31T18:30:39.997882-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2003
73f9681a-f9ef-4880-bd16-93624fd117c6,TCGA-CK-4947,TCGA-COAD,46,-16980,--,68498a5f-f5be-5c30-9a05-98213190cb4e,not hispanic or latino,female,white,released,TCGA-CK-4947_demographic,2019-07-31T18:30:39.997882-05:00,Alive,1957,--,16980,M0,N1,Stage IIIB,T4,6th,not reported,534,712fbcfb-670c-5aeb-8996-7b58d3e88ff8,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-4947_diagnosis,No,Sigmoid colon,2019-04-28T11:16:11.144205-05:00,released,TCGA-CK-4947_treatment_1,d0e1886b-a422-5e91-b5cd-a238fe84e8c4,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:39.997882-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2003
143f2dd6-a280-41c5-9242-442ef91b73ec,TCGA-DM-A288,TCGA-COAD,68,-25084,427,699ff82a-ac64-5a73-80e5-095427c61b9c,not hispanic or latino,male,white,released,TCGA-DM-A288_demographic,2019-07-31T18:24:00.473294-05:00,Dead,1933,2002,25084,M0,N2,Stage IIIC,T3,6th,not reported,427,2b982cbb-fec5-5422-9975-4897eb665b79,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-DM-A288_diagnosis,No,Cecum,--,released,TCGA-DM-A288_treatment,914c1f9b-2918-5508-80d7-81ee648284a4,not reported,"Radiation Therapy, NOS",2019-07-31T18:24:00.473294-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2001
143f2dd6-a280-41c5-9242-442ef91b73ec,TCGA-DM-A288,TCGA-COAD,68,-25084,427,699ff82a-ac64-5a73-80e5-095427c61b9c,not hispanic or latino,male,white,released,TCGA-DM-A288_demographic,2019-07-31T18:24:00.473294-05:00,Dead,1933,2002,25084,M0,N2,Stage IIIC,T3,6th,not reported,427,2b982cbb-fec5-5422-9975-4897eb665b79,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-DM-A288_diagnosis,No,Cecum,2019-04-28T11:10:38.071819-05:00,released,TCGA-DM-A288_treatment_1,b1f76d43-7656-512f-ac11-fd3f0314c474,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:00.473294-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2001
d976782c-90c1-421d-b83c-7fc2617e2709,TCGA-A6-2677,TCGA-COAD,68,-25143,740,0fa0b722-54aa-589a-ba12-11afe5060707,not hispanic or latino,female,white,released,TCGA-A6-2677_demographic,2019-07-31T15:50:45.465340-05:00,Dead,1941,--,25143,M0,N2,Stage IIIC,T3,6th,not reported,541,1b22285c-890a-5cb1-8a8b-5434ef479f18,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-A6-2677_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-A6-2677_treatment,9e66ff79-cb78-5cf6-866f-3f1111b9ec7a,no,"Radiation Therapy, NOS",2019-07-31T15:50:45.465340-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2009
d976782c-90c1-421d-b83c-7fc2617e2709,TCGA-A6-2677,TCGA-COAD,68,-25143,740,0fa0b722-54aa-589a-ba12-11afe5060707,not hispanic or latino,female,white,released,TCGA-A6-2677_demographic,2019-07-31T15:50:45.465340-05:00,Dead,1941,--,25143,M0,N2,Stage IIIC,T3,6th,not reported,541,1b22285c-890a-5cb1-8a8b-5434ef479f18,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-A6-2677_diagnosis,Not Reported,"Colon, NOS",2019-04-28T09:06:25.063101-05:00,released,TCGA-A6-2677_treatment_1,081e273b-c2f6-5f1e-9266-5ae7296323f9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:50:45.465340-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2009
0f940ec0-eb0b-422a-a764-a26c8e5c216d,TCGA-AA-3837,TCGA-COAD,67,-24655,--,6bd95c53-2879-5adb-ba50-35e284a667a4,not reported,male,not reported,released,TCGA-AA-3837_demographic,2019-07-31T18:23:35.593809-05:00,Alive,1941,--,24655,M0,N0,Stage IIA,T3,6th,not reported,1186,6bfb588f-58df-5cb6-ad0c-c1193cdda0fd,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3837_diagnosis,No,"Colon, NOS",2019-04-28T11:10:17.615384-05:00,released,TCGA-AA-3837_treatment_1,7893a993-e465-5cd6-a1d4-a2206e1a19f5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:35.593809-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
0f940ec0-eb0b-422a-a764-a26c8e5c216d,TCGA-AA-3837,TCGA-COAD,67,-24655,--,6bd95c53-2879-5adb-ba50-35e284a667a4,not reported,male,not reported,released,TCGA-AA-3837_demographic,2019-07-31T18:23:35.593809-05:00,Alive,1941,--,24655,M0,N0,Stage IIA,T3,6th,not reported,1186,6bfb588f-58df-5cb6-ad0c-c1193cdda0fd,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3837_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3837_treatment,de941c56-e85c-5d4e-a332-026300b27140,no,"Radiation Therapy, NOS",2019-07-31T18:23:35.593809-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
a8b4284d-cbbb-43e3-897b-d04af4bfba74,TCGA-AZ-6598,TCGA-COAD,77,-28182,1503,72daa562-b946-50e4-9180-0b86762bf4b7,not hispanic or latino,female,white,released,TCGA-AZ-6598_demographic,2019-07-31T18:34:05.456227-05:00,Dead,1923,2004,28182,MX,N0,Stage II,T3,5th,not reported,--,9296de96-7ae4-51eb-a98f-e1f19b60abe0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-6598_diagnosis,No,Ascending colon,--,released,TCGA-AZ-6598_treatment,36e9647c-3a5d-5bb7-9ae9-fa5fde2ce4fe,no,"Radiation Therapy, NOS",2019-07-31T18:34:05.456227-05:00,not reported,stage ii,2019-08-08T16:35:57.350058-05:00,2000
a8b4284d-cbbb-43e3-897b-d04af4bfba74,TCGA-AZ-6598,TCGA-COAD,77,-28182,1503,72daa562-b946-50e4-9180-0b86762bf4b7,not hispanic or latino,female,white,released,TCGA-AZ-6598_demographic,2019-07-31T18:34:05.456227-05:00,Dead,1923,2004,28182,MX,N0,Stage II,T3,5th,not reported,--,9296de96-7ae4-51eb-a98f-e1f19b60abe0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-6598_diagnosis,No,Ascending colon,2019-04-28T11:19:00.557735-05:00,released,TCGA-AZ-6598_treatment_1,a39db71d-2e72-5d84-b60c-792d6d5a2ebe,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:05.456227-05:00,not reported,stage ii,2019-08-08T16:35:57.350058-05:00,2000
56d5b0b9-9093-4286-a2c6-7faa9a1680f5,TCGA-AZ-6603,TCGA-COAD,77,-28424,899,47002c0b-7aac-513a-b3f3-1162c207f568,not hispanic or latino,female,white,released,TCGA-AZ-6603_demographic,2019-07-31T18:28:46.919389-05:00,Dead,1925,2004,28424,MX,N1,--,T2,5th,not reported,--,868f5395-7661-5049-b831-fd03c273451b,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AZ-6603_diagnosis,No,Sigmoid colon,--,released,TCGA-AZ-6603_treatment,2231d0c0-3523-5c46-bb00-3f76ae0ed452,no,"Radiation Therapy, NOS",2019-07-31T18:28:46.919389-05:00,not reported,not reported,2019-08-08T16:35:57.350058-05:00,2002
56d5b0b9-9093-4286-a2c6-7faa9a1680f5,TCGA-AZ-6603,TCGA-COAD,77,-28424,899,47002c0b-7aac-513a-b3f3-1162c207f568,not hispanic or latino,female,white,released,TCGA-AZ-6603_demographic,2019-07-31T18:28:46.919389-05:00,Dead,1925,2004,28424,MX,N1,--,T2,5th,not reported,--,868f5395-7661-5049-b831-fd03c273451b,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AZ-6603_diagnosis,No,Sigmoid colon,2019-04-28T11:14:36.777372-05:00,released,TCGA-AZ-6603_treatment_1,8248c85b-802c-52f4-aced-2a8ef1f17fb0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:46.919389-05:00,not reported,not reported,2019-08-08T16:35:57.350058-05:00,2002
d71ae66e-2c8a-4fd8-8b4b-a5a2d456a21d,TCGA-DM-A1DB,TCGA-COAD,68,-24888,1348,485d561a-80f8-5192-8ead-e41f95716e58,not hispanic or latino,male,white,released,TCGA-DM-A1DB_demographic,2019-07-31T18:38:08.934690-05:00,Dead,1932,2003,24888,M0,N0,Stage IIA,T3,--,not reported,1348,a9df2c29-a077-5482-9a87-68c39090c44c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A1DB_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A1DB_treatment,bf46e469-d18f-5e38-b3f6-b3b486a63f9e,not reported,"Radiation Therapy, NOS",2019-07-31T18:38:08.934690-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
d71ae66e-2c8a-4fd8-8b4b-a5a2d456a21d,TCGA-DM-A1DB,TCGA-COAD,68,-24888,1348,485d561a-80f8-5192-8ead-e41f95716e58,not hispanic or latino,male,white,released,TCGA-DM-A1DB_demographic,2019-07-31T18:38:08.934690-05:00,Dead,1932,2003,24888,M0,N0,Stage IIA,T3,--,not reported,1348,a9df2c29-a077-5482-9a87-68c39090c44c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A1DB_diagnosis,No,Sigmoid colon,2019-04-28T11:22:23.094198-05:00,released,TCGA-DM-A1DB_treatment_1,db4ef4fc-c345-545c-9cc9-62060aa0d286,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:08.934690-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
d3062aac-4c42-41b4-a9f3-90aa72e6fb1e,TCGA-F4-6569,TCGA-COAD,60,-22203,--,497f348a-a489-53b1-adf6-046db39d520a,not hispanic or latino,male,white,released,TCGA-F4-6569_demographic,2019-07-31T18:37:48.496806-05:00,Alive,1951,--,22203,M0,N0,Stage I,T2,7th,not reported,1087,ec17048e-f3d3-5384-a493-04b209c0f89c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6569_diagnosis,No,"Colon, NOS",--,released,TCGA-F4-6569_treatment,94626453-b9b2-5f14-8003-9ee7ed8f4792,no,"Radiation Therapy, NOS",2019-07-31T18:37:48.496806-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
d3062aac-4c42-41b4-a9f3-90aa72e6fb1e,TCGA-F4-6569,TCGA-COAD,60,-22203,--,497f348a-a489-53b1-adf6-046db39d520a,not hispanic or latino,male,white,released,TCGA-F4-6569_demographic,2019-07-31T18:37:48.496806-05:00,Alive,1951,--,22203,M0,N0,Stage I,T2,7th,not reported,1087,ec17048e-f3d3-5384-a493-04b209c0f89c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6569_diagnosis,No,"Colon, NOS",2019-04-28T11:22:05.158540-05:00,released,TCGA-F4-6569_treatment_1,a341ead7-4900-5b72-8f13-f88b9d8f6769,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:48.496806-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
384400c1-98d6-4cc3-8724-de6711f6208b,TCGA-AA-3980,TCGA-COAD,89,-32630,--,a3ccf839-9d7f-50c3-91c0-bd0e4441823d,not reported,female,not reported,released,TCGA-AA-3980_demographic,2019-07-31T18:26:49.581278-05:00,Alive,1920,--,32630,M0,N0,Stage I,T2,6th,not reported,242,459930e0-5f0f-5abe-8d68-f0fa595f29b6,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3980_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3980_treatment,697d562a-0c5f-5861-9409-fde97fc4003a,no,"Radiation Therapy, NOS",2019-07-31T18:26:49.581278-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2009
384400c1-98d6-4cc3-8724-de6711f6208b,TCGA-AA-3980,TCGA-COAD,89,-32630,--,a3ccf839-9d7f-50c3-91c0-bd0e4441823d,not reported,female,not reported,released,TCGA-AA-3980_demographic,2019-07-31T18:26:49.581278-05:00,Alive,1920,--,32630,M0,N0,Stage I,T2,6th,not reported,242,459930e0-5f0f-5abe-8d68-f0fa595f29b6,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3980_diagnosis,No,"Colon, NOS",2019-04-28T11:12:59.732393-05:00,released,TCGA-AA-3980_treatment_1,dc074e22-6183-5d20-b83a-919ff63c5729,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:49.581278-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2009
84959e50-17f5-4f2b-8e0c-5ebb139d2c3a,TCGA-QG-A5Z2,TCGA-COAD,61,-22367,--,3938ad7a-df4b-57b4-9cee-86551686edbe,not hispanic or latino,male,black or african american,released,TCGA-QG-A5Z2_demographic,2019-07-31T18:42:14.274407-05:00,Alive,1951,--,22367,M0,N0,Stage I,T2,7th,not reported,952,b7ab64e0-5e21-5cdc-9b4b-be1c0f97e5fd,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-QG-A5Z2_diagnosis,No,Cecum,2019-04-28T11:25:51.839622-05:00,released,TCGA-QG-A5Z2_treatment_1,b13e4a23-8cec-5aeb-803b-b9b92dfd9928,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:14.274407-05:00,not reported,stage i,2019-08-08T16:37:44.165377-05:00,2012
84959e50-17f5-4f2b-8e0c-5ebb139d2c3a,TCGA-QG-A5Z2,TCGA-COAD,61,-22367,--,3938ad7a-df4b-57b4-9cee-86551686edbe,not hispanic or latino,male,black or african american,released,TCGA-QG-A5Z2_demographic,2019-07-31T18:42:14.274407-05:00,Alive,1951,--,22367,M0,N0,Stage I,T2,7th,not reported,952,b7ab64e0-5e21-5cdc-9b4b-be1c0f97e5fd,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-QG-A5Z2_diagnosis,No,Cecum,--,released,TCGA-QG-A5Z2_treatment,fa64d202-7ce9-54ee-a895-56707450eb4e,no,"Radiation Therapy, NOS",2019-07-31T18:42:14.274407-05:00,not reported,stage i,2019-08-08T16:37:44.165377-05:00,2012
8e87ddca-f43e-4c6f-9d5b-430b666a7f6c,TCGA-CM-6169,TCGA-COAD,67,-24564,--,3b5f798e-d726-5655-96d7-6f1d69ed3c56,not hispanic or latino,male,black or african american,released,TCGA-CM-6169_demographic,2019-07-31T18:32:24.762331-05:00,Alive,1943,--,24564,M0,N0,Stage IIA,T3,7th,not reported,396,df7cf2b4-45d8-5d59-b398-5732ca66ff0c,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6169_diagnosis,No,Cecum,--,released,TCGA-CM-6169_treatment,2041500f-414f-503b-9124-1aabafa9b457,no,"Radiation Therapy, NOS",2019-07-31T18:32:24.762331-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
8e87ddca-f43e-4c6f-9d5b-430b666a7f6c,TCGA-CM-6169,TCGA-COAD,67,-24564,--,3b5f798e-d726-5655-96d7-6f1d69ed3c56,not hispanic or latino,male,black or african american,released,TCGA-CM-6169_demographic,2019-07-31T18:32:24.762331-05:00,Alive,1943,--,24564,M0,N0,Stage IIA,T3,7th,not reported,396,df7cf2b4-45d8-5d59-b398-5732ca66ff0c,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6169_diagnosis,No,Cecum,2019-04-28T11:17:38.934584-05:00,released,TCGA-CM-6169_treatment_1,e9ef24ad-5a60-5180-ac44-666707c7a485,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:24.762331-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
e703af88-c05f-4d7b-b225-d640e4d1a2a5,TCGA-AZ-4616,TCGA-COAD,82,-30043,156,e8a6ce8b-960a-5fc0-ab98-c5d13c6248de,not hispanic or latino,female,white,released,TCGA-AZ-4616_demographic,2019-07-31T18:39:28.024694-05:00,Dead,1927,2009,30043,M1,N2,Stage IV,T3,6th,not reported,--,34f404e6-5b64-52ca-a259-6880878b6045,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4616_diagnosis,No,Cecum,2019-04-28T11:23:31.698947-05:00,released,TCGA-AZ-4616_treatment_1,8bde95a5-f07c-5e1c-8541-1bf5c4aaa0ec,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:28.024694-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2009
e703af88-c05f-4d7b-b225-d640e4d1a2a5,TCGA-AZ-4616,TCGA-COAD,82,-30043,156,e8a6ce8b-960a-5fc0-ab98-c5d13c6248de,not hispanic or latino,female,white,released,TCGA-AZ-4616_demographic,2019-07-31T18:39:28.024694-05:00,Dead,1927,2009,30043,M1,N2,Stage IV,T3,6th,not reported,--,34f404e6-5b64-52ca-a259-6880878b6045,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4616_diagnosis,No,Cecum,--,released,TCGA-AZ-4616_treatment,d8837b8c-c45c-5e85-98a7-9ad98aa99872,no,"Radiation Therapy, NOS",2019-07-31T18:39:28.024694-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2009
98d45099-feae-4dad-aa38-ec03fed6d999,TCGA-A6-5659,TCGA-COAD,82,-30028,--,efa76b30-7409-59de-89bf-87210fa0ef3e,not hispanic or latino,male,white,released,TCGA-A6-5659_demographic,2019-07-31T18:33:11.158741-05:00,Alive,1928,--,30028,M0,N0,Stage I,T2,--,not reported,926,98c4bea5-1f9c-5c13-adc8-21ed84b5f07b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-5659_diagnosis,No,"Colon, NOS",2019-04-28T11:18:16.435795-05:00,released,TCGA-A6-5659_treatment_1,e4c2ac8c-3e2c-5b97-bd59-9f3f0237a25a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:11.158741-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2010
98d45099-feae-4dad-aa38-ec03fed6d999,TCGA-A6-5659,TCGA-COAD,82,-30028,--,efa76b30-7409-59de-89bf-87210fa0ef3e,not hispanic or latino,male,white,released,TCGA-A6-5659_demographic,2019-07-31T18:33:11.158741-05:00,Alive,1928,--,30028,M0,N0,Stage I,T2,--,not reported,926,98c4bea5-1f9c-5c13-adc8-21ed84b5f07b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-5659_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-5659_treatment,34ca33a1-59da-55ed-a02b-c174f961f1ef,no,"Radiation Therapy, NOS",2019-07-31T18:33:11.158741-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2010
1c111912-c664-42f5-9802-065b1994a2f4,TCGA-F4-6855,TCGA-COAD,70,-25890,--,69607e74-32b2-536e-91b2-abd5dba74149,not hispanic or latino,female,white,released,TCGA-F4-6855_demographic,2019-07-31T18:41:30.033341-05:00,Alive,1941,--,25890,M0,N0,Stage IIA,T3,7th,not reported,1442,cbebb7f5-b576-56ce-843e-05cd3cfe8414,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6855_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6855_treatment,e906adc9-19fc-5b63-b0aa-b676708850cc,no,"Radiation Therapy, NOS",2019-07-31T18:41:30.033341-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
1c111912-c664-42f5-9802-065b1994a2f4,TCGA-F4-6855,TCGA-COAD,70,-25890,--,69607e74-32b2-536e-91b2-abd5dba74149,not hispanic or latino,female,white,released,TCGA-F4-6855_demographic,2019-07-31T18:41:30.033341-05:00,Alive,1941,--,25890,M0,N0,Stage IIA,T3,7th,not reported,1442,cbebb7f5-b576-56ce-843e-05cd3cfe8414,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6855_diagnosis,No,Sigmoid colon,2019-04-28T11:25:11.819017-05:00,released,TCGA-F4-6855_treatment_1,aec209d0-dd94-5ad0-9743-e97e35577e55,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:30.033341-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
b3c267aa-345d-40d8-a8da-f9f08c64f9c7,TCGA-D5-6923,TCGA-COAD,57,-21118,--,54f01104-5f2c-5643-9ff9-aa2fa0da8a8b,not hispanic or latino,male,white,released,TCGA-D5-6923_demographic,2019-07-31T18:35:02.788966-05:00,Alive,1954,--,21118,M0,N0,Stage I,T2,7th,not reported,378,c89b3bc7-35a1-5a24-8d9f-383ff624c55d,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6923_diagnosis,No,Sigmoid colon,2019-04-28T11:19:47.583570-05:00,released,TCGA-D5-6923_treatment_1,63dcdf27-3164-5c43-897c-85098fc28d6c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:02.788966-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2011
b3c267aa-345d-40d8-a8da-f9f08c64f9c7,TCGA-D5-6923,TCGA-COAD,57,-21118,--,54f01104-5f2c-5643-9ff9-aa2fa0da8a8b,not hispanic or latino,male,white,released,TCGA-D5-6923_demographic,2019-07-31T18:35:02.788966-05:00,Alive,1954,--,21118,M0,N0,Stage I,T2,7th,not reported,378,c89b3bc7-35a1-5a24-8d9f-383ff624c55d,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6923_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6923_treatment,f021cae6-194d-5f6d-b7db-00175a2d2833,no,"Radiation Therapy, NOS",2019-07-31T18:35:02.788966-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2011
e8841edf-e070-425b-b4d4-bbb2115f9dbd,TCGA-AA-3973,TCGA-COAD,69,-25536,--,445c9ff3-7e42-59ce-bfe4-8143a169bc72,not reported,male,not reported,released,TCGA-AA-3973_demographic,2019-07-31T18:39:47.064327-05:00,Alive,1938,--,25536,M1,N1,Stage IV,T4,5th,not reported,397,2893b098-4b2e-5401-8bac-2e4888f4e30f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3973_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3973_treatment,f994da7a-798f-5399-945a-c12a0593bc8c,no,"Radiation Therapy, NOS",2019-07-31T18:39:47.064327-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2007
e8841edf-e070-425b-b4d4-bbb2115f9dbd,TCGA-AA-3973,TCGA-COAD,69,-25536,--,445c9ff3-7e42-59ce-bfe4-8143a169bc72,not reported,male,not reported,released,TCGA-AA-3973_demographic,2019-07-31T18:39:47.064327-05:00,Alive,1938,--,25536,M1,N1,Stage IV,T4,5th,not reported,397,2893b098-4b2e-5401-8bac-2e4888f4e30f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3973_diagnosis,No,"Colon, NOS",2019-04-28T11:23:46.473337-05:00,released,TCGA-AA-3973_treatment_1,44bd85c5-df8c-509e-ae88-79e0f035614b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:47.064327-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2007
e8ec26bd-c88d-42b9-ac8a-ab121b8140f8,TCGA-AD-A5EK,TCGA-COAD,51,-18731,--,a77c1606-ec4c-54ff-bcb3-30129b8cbb5e,not hispanic or latino,male,black or african american,released,TCGA-AD-A5EK_demographic,2019-07-31T18:43:01.784429-05:00,Alive,1961,--,18731,MX,N0,Stage I,T2,7th,not reported,500,f167d1bb-13df-55ae-8ca8-ae1c57cd0fba,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-A5EK_diagnosis,No,Ascending colon,--,released,TCGA-AD-A5EK_treatment,330c90aa-ac8b-5e21-9e65-98219a173eb3,no,"Radiation Therapy, NOS",2019-07-31T18:43:01.784429-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2012
e8ec26bd-c88d-42b9-ac8a-ab121b8140f8,TCGA-AD-A5EK,TCGA-COAD,51,-18731,--,a77c1606-ec4c-54ff-bcb3-30129b8cbb5e,not hispanic or latino,male,black or african american,released,TCGA-AD-A5EK_demographic,2019-07-31T18:43:01.784429-05:00,Alive,1961,--,18731,MX,N0,Stage I,T2,7th,not reported,500,f167d1bb-13df-55ae-8ca8-ae1c57cd0fba,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-A5EK_diagnosis,No,Ascending colon,2019-04-28T11:26:32.279477-05:00,released,TCGA-AD-A5EK_treatment_1,9ad6b0a2-d180-51ee-8739-e46166c09b37,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:43:01.784429-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2012
92c043b6-8d53-4c1c-808a-c4be5e2926e6,TCGA-DM-A1D8,TCGA-COAD,50,-18311,383,fdcc9b92-8eb9-5351-b84f-a161ca315dbd,not hispanic or latino,female,white,released,TCGA-DM-A1D8_demographic,2019-07-31T18:32:31.709354-05:00,Dead,1950,2001,18311,--,N1,--,T3,--,not reported,383,5836d9ce-200b-594e-8a4f-1614e251b714,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A1D8_diagnosis,No,Ascending colon,2019-04-28T11:17:44.053729-05:00,released,TCGA-DM-A1D8_treatment_1,52bdd7ac-9c6d-5f76-a78a-b53da10c94b0,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:31.709354-05:00,not reported,not reported,2019-08-08T16:36:52.154454-05:00,2000
92c043b6-8d53-4c1c-808a-c4be5e2926e6,TCGA-DM-A1D8,TCGA-COAD,50,-18311,383,fdcc9b92-8eb9-5351-b84f-a161ca315dbd,not hispanic or latino,female,white,released,TCGA-DM-A1D8_demographic,2019-07-31T18:32:31.709354-05:00,Dead,1950,2001,18311,--,N1,--,T3,--,not reported,383,5836d9ce-200b-594e-8a4f-1614e251b714,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A1D8_diagnosis,No,Ascending colon,--,released,TCGA-DM-A1D8_treatment,9c5d82e4-e1dd-5935-95e7-9577b97e7027,not reported,"Radiation Therapy, NOS",2019-07-31T18:32:31.709354-05:00,not reported,not reported,2019-08-08T16:36:52.154454-05:00,2000
47a8e514-904c-4867-8f43-7eb573be835b,TCGA-AD-6963,TCGA-COAD,58,-21294,--,264d88d1-8960-5386-9285-f11b198da527,not reported,male,white,released,TCGA-AD-6963_demographic,2019-07-31T18:27:46.936278-05:00,Alive,1953,--,21294,MX,N0,--,T3,7th,not reported,834,a73cc9d4-8bbf-5acb-a5a1-298ddf744b3c,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-6963_diagnosis,No,Ascending colon,--,released,TCGA-AD-6963_treatment,1bd49920-cccc-53f3-843e-3ff7465d6571,no,"Radiation Therapy, NOS",2019-07-31T18:27:46.936278-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2011
47a8e514-904c-4867-8f43-7eb573be835b,TCGA-AD-6963,TCGA-COAD,58,-21294,--,264d88d1-8960-5386-9285-f11b198da527,not reported,male,white,released,TCGA-AD-6963_demographic,2019-07-31T18:27:46.936278-05:00,Alive,1953,--,21294,MX,N0,--,T3,7th,not reported,834,a73cc9d4-8bbf-5acb-a5a1-298ddf744b3c,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-6963_diagnosis,No,Ascending colon,2019-04-28T11:13:47.149028-05:00,released,TCGA-AD-6963_treatment_1,7838ae38-8303-50d3-bfca-4c005523778a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:46.936278-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2011
0712566e-3371-4715-95f1-5b792e72d758,TCGA-AA-A010,TCGA-COAD,46,-16922,--,26c192f6-5570-5a2d-b565-aee0bf5be5fc,not reported,female,not reported,released,TCGA-AA-A010_demographic,2019-07-31T15:45:12.526241-05:00,Alive,1962,--,16922,M0,N0,Stage IIB,T4,6th,not reported,1064,63966309-fae4-54a9-8724-918ae2f797fd,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-A010_diagnosis,No,Transverse colon,2019-04-28T09:01:56.625182-05:00,released,TCGA-AA-A010_treatment_1,7029f67e-6718-557d-bd73-01fea28b1b74,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:45:12.526241-05:00,not reported,stage iib,2019-08-08T16:35:29.811838-05:00,2008
0712566e-3371-4715-95f1-5b792e72d758,TCGA-AA-A010,TCGA-COAD,46,-16922,--,26c192f6-5570-5a2d-b565-aee0bf5be5fc,not reported,female,not reported,released,TCGA-AA-A010_demographic,2019-07-31T15:45:12.526241-05:00,Alive,1962,--,16922,M0,N0,Stage IIB,T4,6th,not reported,1064,63966309-fae4-54a9-8724-918ae2f797fd,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-A010_diagnosis,No,Transverse colon,--,released,TCGA-AA-A010_treatment,e5382d3b-c964-5d52-b5be-f9c97da0587e,no,"Radiation Therapy, NOS",2019-07-31T15:45:12.526241-05:00,not reported,stage iib,2019-08-08T16:35:29.811838-05:00,2008
bc42fe2d-1a33-428d-a601-b1871f4c8d9b,TCGA-AA-3966,TCGA-COAD,89,-32537,--,2bb51496-8d0f-54da-8f69-4ffc8d649e4e,not reported,female,not reported,released,TCGA-AA-3966_demographic,2019-07-31T18:35:38.693607-05:00,Alive,1920,--,32537,M0,N0,Stage IIA,T3,6th,not reported,61,d180dffc-341f-5349-ada4-75a90c0b70a9,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3966_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3966_treatment,8be4a587-9af2-586a-8e20-b88666a620af,not reported,"Radiation Therapy, NOS",2019-07-31T18:35:38.693607-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
bc42fe2d-1a33-428d-a601-b1871f4c8d9b,TCGA-AA-3966,TCGA-COAD,89,-32537,--,2bb51496-8d0f-54da-8f69-4ffc8d649e4e,not reported,female,not reported,released,TCGA-AA-3966_demographic,2019-07-31T18:35:38.693607-05:00,Alive,1920,--,32537,M0,N0,Stage IIA,T3,6th,not reported,61,d180dffc-341f-5349-ada4-75a90c0b70a9,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3966_diagnosis,No,"Colon, NOS",2019-04-28T11:20:16.965606-05:00,released,TCGA-AA-3966_treatment_1,77e0c69a-9f89-5bd5-b36e-a3121f1307f6,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:38.693607-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
628408ce-0691-4e0b-b4c7-aca9a0d73bb0,TCGA-AA-3673,TCGA-COAD,53,-19509,--,e3b8dce5-6dd9-5a7b-9a95-8fd99b88ad58,not reported,female,not reported,released,TCGA-AA-3673_demographic,2019-07-31T18:29:37.514182-05:00,Alive,1953,--,19509,M0,N0,Stage II,T3,5th,not reported,1522,9aa00f9a-c92a-52a6-a67a-d21d2ee470a7,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-3673_diagnosis,No,Transverse colon,--,released,TCGA-AA-3673_treatment,1c617fd6-8de5-538e-b29a-97d4d6f43743,no,"Radiation Therapy, NOS",2019-07-31T18:29:37.514182-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2006
628408ce-0691-4e0b-b4c7-aca9a0d73bb0,TCGA-AA-3673,TCGA-COAD,53,-19509,--,e3b8dce5-6dd9-5a7b-9a95-8fd99b88ad58,not reported,female,not reported,released,TCGA-AA-3673_demographic,2019-07-31T18:29:37.514182-05:00,Alive,1953,--,19509,M0,N0,Stage II,T3,5th,not reported,1522,9aa00f9a-c92a-52a6-a67a-d21d2ee470a7,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-3673_diagnosis,No,Transverse colon,2019-04-28T11:15:19.307909-05:00,released,TCGA-AA-3673_treatment_1,f6af04f7-6b81-559c-9771-f636745b70e6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:37.514182-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2006
e3b0ee77-c419-4b2b-833f-90a221415489,TCGA-NH-A6GB,TCGA-COAD,71,-26100,--,d390cdb9-2962-5a8c-9467-b566a0994993,not hispanic or latino,female,black or african american,released,TCGA-NH-A6GB_demographic,2019-07-31T15:17:23.114741-05:00,Alive,1942,--,26100,MX,N2b,Stage IIIC,T3,7th,not reported,476,0f68ad1d-46cc-51a2-99bc-7d11cb21f7f4,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-NH-A6GB_diagnosis,No,Transverse colon,2019-04-28T08:37:57.123368-05:00,released,TCGA-NH-A6GB_treatment_1,471bf91d-6f82-593e-8208-07916c1958ab,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:17:23.114741-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2013
e3b0ee77-c419-4b2b-833f-90a221415489,TCGA-NH-A6GB,TCGA-COAD,71,-26100,--,d390cdb9-2962-5a8c-9467-b566a0994993,not hispanic or latino,female,black or african american,released,TCGA-NH-A6GB_demographic,2019-07-31T15:17:23.114741-05:00,Alive,1942,--,26100,MX,N2b,Stage IIIC,T3,7th,not reported,476,0f68ad1d-46cc-51a2-99bc-7d11cb21f7f4,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-NH-A6GB_diagnosis,No,Transverse colon,--,released,TCGA-NH-A6GB_treatment,7d197c62-029e-57d5-a1e4-1202a2b62779,no,"Radiation Therapy, NOS",2019-07-31T15:17:23.114741-05:00,not reported,stage iiic,2019-08-08T16:37:18.448891-05:00,2013
f89bbd17-c732-4847-b71c-a8627a702747,TCGA-D5-6530,TCGA-COAD,53,-19591,--,c1f81395-9d1b-5485-b875-abdd8ce17b21,not hispanic or latino,male,white,released,TCGA-D5-6530_demographic,2019-07-31T18:40:44.676093-05:00,Alive,1957,--,19591,M0,N0,Stage I,T2,7th,not reported,621,0971e0f4-22cd-550e-bc80-012515dcf658,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-D5-6530_diagnosis,No,Cecum,--,released,TCGA-D5-6530_treatment,87a6f2d1-5555-5ee6-9c2f-0f7a8cfcb7c2,no,"Radiation Therapy, NOS",2019-07-31T18:40:44.676093-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
f89bbd17-c732-4847-b71c-a8627a702747,TCGA-D5-6530,TCGA-COAD,53,-19591,--,c1f81395-9d1b-5485-b875-abdd8ce17b21,not hispanic or latino,male,white,released,TCGA-D5-6530_demographic,2019-07-31T18:40:44.676093-05:00,Alive,1957,--,19591,M0,N0,Stage I,T2,7th,not reported,621,0971e0f4-22cd-550e-bc80-012515dcf658,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-D5-6530_diagnosis,No,Cecum,2019-04-28T11:24:34.368003-05:00,released,TCGA-D5-6530_treatment_1,e14c084f-328b-59ad-bad6-8bd920d8a9cc,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:44.676093-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
605baa86-79e3-484d-82d2-4de27d405ba1,TCGA-AM-5821,TCGA-COAD,68,-24903,--,5e0a63ae-49d0-5431-acb1-c9b75431ed78,not hispanic or latino,female,white,released,TCGA-AM-5821_demographic,2019-07-31T18:29:28.270545-05:00,Alive,1942,--,24903,M0,N0,Stage IIA,T3,7th,not reported,28,58b7c032-e7e1-5a6c-a73f-1898ea0db3d1,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AM-5821_diagnosis,No,Sigmoid colon,--,released,TCGA-AM-5821_treatment,e58c1e84-77d7-5534-a9c5-af1e91b228a1,not reported,"Radiation Therapy, NOS",2019-07-31T18:29:28.270545-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2010
605baa86-79e3-484d-82d2-4de27d405ba1,TCGA-AM-5821,TCGA-COAD,68,-24903,--,5e0a63ae-49d0-5431-acb1-c9b75431ed78,not hispanic or latino,female,white,released,TCGA-AM-5821_demographic,2019-07-31T18:29:28.270545-05:00,Alive,1942,--,24903,M0,N0,Stage IIA,T3,7th,not reported,28,58b7c032-e7e1-5a6c-a73f-1898ea0db3d1,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AM-5821_diagnosis,No,Sigmoid colon,2019-04-28T11:15:11.874842-05:00,released,TCGA-AM-5821_treatment_1,def18efd-836d-5fc0-8dd6-59d90f781440,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:28.270545-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2010
9c45eaec-d854-4f51-80a3-2d80d6b4aebc,TCGA-QG-A5Z1,TCGA-COAD,71,-26220,256,76805563-a81a-586d-ae73-4e2f9cb0a168,not hispanic or latino,male,black or african american,released,TCGA-QG-A5Z1_demographic,2019-07-31T18:42:17.146012-05:00,Dead,1940,--,26220,MX,N1b,Stage IIIB,T3,7th,not reported,202,f34a7fe5-294f-51f9-9340-9813a2b67492,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-QG-A5Z1_diagnosis,No,Rectosigmoid junction,2019-04-28T11:25:54.297980-05:00,released,TCGA-QG-A5Z1_treatment_1,210dda41-6be6-5ec4-9748-56fc6a2a7d6e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:17.146012-05:00,not reported,stage iiib,2019-08-08T16:37:44.165377-05:00,2011
9c45eaec-d854-4f51-80a3-2d80d6b4aebc,TCGA-QG-A5Z1,TCGA-COAD,71,-26220,256,76805563-a81a-586d-ae73-4e2f9cb0a168,not hispanic or latino,male,black or african american,released,TCGA-QG-A5Z1_demographic,2019-07-31T18:42:17.146012-05:00,Dead,1940,--,26220,MX,N1b,Stage IIIB,T3,7th,not reported,202,f34a7fe5-294f-51f9-9340-9813a2b67492,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-QG-A5Z1_diagnosis,No,Rectosigmoid junction,--,released,TCGA-QG-A5Z1_treatment,c3f040e4-9b82-5dce-8863-658f3543dc03,no,"Radiation Therapy, NOS",2019-07-31T18:42:17.146012-05:00,not reported,stage iiib,2019-08-08T16:37:44.165377-05:00,2011
955464c8-9c62-430c-87b8-107db5c980a8,TCGA-AD-6889,TCGA-COAD,76,--,2532,598c5165-520c-52b2-a804-cdb32f7b467d,not reported,male,asian,released,TCGA-AD-6889_demographic,2019-07-31T15:18:02.111000-05:00,Dead,1929,--,--,M0,N0,Stage IIA,T3,6th,not reported,2056,ee5a8954-e59b-5faf-b117-a1bb2fc6eb4b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-6889_diagnosis,No,Ascending colon,2019-04-28T08:38:32.252157-05:00,released,TCGA-AD-6889_treatment_1,422ef266-43ac-511a-9c66-0b91c2e194ab,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:18:02.111000-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2005
955464c8-9c62-430c-87b8-107db5c980a8,TCGA-AD-6889,TCGA-COAD,76,--,2532,598c5165-520c-52b2-a804-cdb32f7b467d,not reported,male,asian,released,TCGA-AD-6889_demographic,2019-07-31T15:18:02.111000-05:00,Dead,1929,--,--,M0,N0,Stage IIA,T3,6th,not reported,2056,ee5a8954-e59b-5faf-b117-a1bb2fc6eb4b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-6889_diagnosis,No,Ascending colon,--,released,TCGA-AD-6889_treatment,889e96bf-050a-583a-95f7-6bfe5f9a2fc9,no,"Radiation Therapy, NOS",2019-07-31T15:18:02.111000-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2005
0dacc5ce-498f-4c60-9f78-7a013ffaa9ce,TCGA-D5-5538,TCGA-COAD,60,-21974,1661,52491011-8d8e-598b-a242-efe4df7726ed,not hispanic or latino,female,white,released,TCGA-D5-5538_demographic,2019-07-31T18:23:16.130831-05:00,Dead,1950,--,21974,M0,N1b,Stage IIIB,T3,--,not reported,373,5ffdc3f3-ff68-5df8-8138-7c4a90c82635,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-D5-5538_diagnosis,No,Cecum,--,released,TCGA-D5-5538_treatment,0cf3294e-61db-52cf-ab4d-78c7a5652298,no,"Radiation Therapy, NOS",2019-07-31T18:23:16.130831-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
0dacc5ce-498f-4c60-9f78-7a013ffaa9ce,TCGA-D5-5538,TCGA-COAD,60,-21974,1661,52491011-8d8e-598b-a242-efe4df7726ed,not hispanic or latino,female,white,released,TCGA-D5-5538_demographic,2019-07-31T18:23:16.130831-05:00,Dead,1950,--,21974,M0,N1b,Stage IIIB,T3,--,not reported,373,5ffdc3f3-ff68-5df8-8138-7c4a90c82635,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-D5-5538_diagnosis,No,Cecum,2019-04-28T11:10:03.222827-05:00,released,TCGA-D5-5538_treatment_1,25075779-953d-5b9d-bb70-679ddc03ec89,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:16.130831-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
75ea63a9-357b-4566-bd78-eaa67809decd,TCGA-DM-A0X9,TCGA-COAD,71,-26217,--,cc33ada5-289b-599b-b91e-88a43ba929ad,not hispanic or latino,female,white,released,TCGA-DM-A0X9_demographic,2019-07-31T18:30:52.194720-05:00,Alive,1930,--,26217,M0,N0,Stage IIA,T3,--,not reported,3641,89cf4bb6-e3c2-5a3d-954a-b7fc6fc5128d,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A0X9_diagnosis,No,Ascending colon,--,released,TCGA-DM-A0X9_treatment,8abe456e-66d1-52d9-9fa4-6ab2bd5435ac,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:52.194720-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
75ea63a9-357b-4566-bd78-eaa67809decd,TCGA-DM-A0X9,TCGA-COAD,71,-26217,--,cc33ada5-289b-599b-b91e-88a43ba929ad,not hispanic or latino,female,white,released,TCGA-DM-A0X9_demographic,2019-07-31T18:30:52.194720-05:00,Alive,1930,--,26217,M0,N0,Stage IIA,T3,--,not reported,3641,89cf4bb6-e3c2-5a3d-954a-b7fc6fc5128d,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A0X9_diagnosis,No,Ascending colon,2019-04-28T11:16:20.922120-05:00,released,TCGA-DM-A0X9_treatment_1,b2fcca28-87c5-5a95-8836-029ec4e68f42,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:52.194720-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
75c3004d-1ef4-49f9-86e0-1bb7b9553a3d,TCGA-CM-6168,TCGA-COAD,84,-30834,--,cc6a690a-6f45-5b5a-9140-0831b3e2defa,not hispanic or latino,female,black or african american,released,TCGA-CM-6168_demographic,2019-07-31T18:30:48.804935-05:00,Alive,1926,--,30834,M0,N0,Stage IIA,T3,7th,not reported,395,4d675235-6e2b-572c-8588-2aee9c15dde6,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-6168_diagnosis,No,Ascending colon,2019-04-28T11:16:18.539203-05:00,released,TCGA-CM-6168_treatment_1,8d85d1ad-86b5-5d7b-832a-371ef0adafba,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:48.804935-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
75c3004d-1ef4-49f9-86e0-1bb7b9553a3d,TCGA-CM-6168,TCGA-COAD,84,-30834,--,cc6a690a-6f45-5b5a-9140-0831b3e2defa,not hispanic or latino,female,black or african american,released,TCGA-CM-6168_demographic,2019-07-31T18:30:48.804935-05:00,Alive,1926,--,30834,M0,N0,Stage IIA,T3,7th,not reported,395,4d675235-6e2b-572c-8588-2aee9c15dde6,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-6168_diagnosis,No,Ascending colon,--,released,TCGA-CM-6168_treatment,fe9ccd63-4e63-52c3-b59c-dc5d1a351397,no,"Radiation Therapy, NOS",2019-07-31T18:30:48.804935-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
6775ce57-b4cf-425c-a898-061bb9a8a1a8,TCGA-DM-A280,TCGA-COAD,70,-25649,236,ce4b0ee3-4cc0-50b7-8889-41e4eaa98854,not hispanic or latino,female,white,released,TCGA-DM-A280_demographic,2019-07-31T18:30:01.167502-05:00,Dead,1928,1998,25649,M0,N0,Stage IIA,T3,6th,not reported,236,c790cea4-9f04-5243-a617-c58c5dfb319f,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-DM-A280_diagnosis,No,Ascending colon,--,released,TCGA-DM-A280_treatment,ae58d843-5aa1-511c-bcb7-1f3ef012a2dc,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:01.167502-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,1998
6775ce57-b4cf-425c-a898-061bb9a8a1a8,TCGA-DM-A280,TCGA-COAD,70,-25649,236,ce4b0ee3-4cc0-50b7-8889-41e4eaa98854,not hispanic or latino,female,white,released,TCGA-DM-A280_demographic,2019-07-31T18:30:01.167502-05:00,Dead,1928,1998,25649,M0,N0,Stage IIA,T3,6th,not reported,236,c790cea4-9f04-5243-a617-c58c5dfb319f,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-DM-A280_diagnosis,No,Ascending colon,2019-04-28T11:15:39.189384-05:00,released,TCGA-DM-A280_treatment_1,1d7779ec-32c7-5087-8124-2dd10966c663,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:01.167502-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,1998
a56d528b-238a-4556-92c8-7645304a2da0,TCGA-AA-3558,TCGA-COAD,70,-25752,--,55aa4a11-3c11-5fce-b7f9-5e7887d4e419,not reported,male,not reported,released,TCGA-AA-3558_demographic,2019-07-31T18:33:50.400422-05:00,Alive,1938,--,25752,M0,N0,Stage I,T2,6th,not reported,638,96e3aaaa-7898-5776-be4f-02920ae54683,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3558_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3558_treatment,752732e0-a46a-5c56-af27-081947a66c6e,no,"Radiation Therapy, NOS",2019-07-31T18:33:50.400422-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
a56d528b-238a-4556-92c8-7645304a2da0,TCGA-AA-3558,TCGA-COAD,70,-25752,--,55aa4a11-3c11-5fce-b7f9-5e7887d4e419,not reported,male,not reported,released,TCGA-AA-3558_demographic,2019-07-31T18:33:50.400422-05:00,Alive,1938,--,25752,M0,N0,Stage I,T2,6th,not reported,638,96e3aaaa-7898-5776-be4f-02920ae54683,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3558_diagnosis,No,Sigmoid colon,2019-04-28T11:18:48.566677-05:00,released,TCGA-AA-3558_treatment_1,4a7825b4-54e5-5dcc-917c-08ec21318c2e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:50.400422-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
3470b1af-689f-467a-9f9e-de74088f9b94,TCGA-CM-6161,TCGA-COAD,36,-13363,--,d98de8d4-ed85-5548-aefb-1375de8d69f5,not hispanic or latino,female,white,released,TCGA-CM-6161_demographic,2019-07-31T18:26:34.111560-05:00,Alive,1974,--,13363,M0,N0,Stage I,T2,7th,not reported,457,0b3b197f-8275-5314-92cd-929913784f4c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6161_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6161_treatment,8f56d396-0ce5-58d4-b0fd-4561c3ced322,no,"Radiation Therapy, NOS",2019-07-31T18:26:34.111560-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
3470b1af-689f-467a-9f9e-de74088f9b94,TCGA-CM-6161,TCGA-COAD,36,-13363,--,d98de8d4-ed85-5548-aefb-1375de8d69f5,not hispanic or latino,female,white,released,TCGA-CM-6161_demographic,2019-07-31T18:26:34.111560-05:00,Alive,1974,--,13363,M0,N0,Stage I,T2,7th,not reported,457,0b3b197f-8275-5314-92cd-929913784f4c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6161_diagnosis,No,Sigmoid colon,2019-04-28T11:12:47.027598-05:00,released,TCGA-CM-6161_treatment_1,4c3b7dbf-54ff-5e0a-b6fb-793634af28c4,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:34.111560-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
7ea546ce-f48a-4d9c-96b4-a0124c692870,TCGA-CM-4752,TCGA-COAD,58,-21519,--,dadadc53-46cb-54fb-a3b3-90f98a9e35ff,not hispanic or latino,male,black or african american,released,TCGA-CM-4752_demographic,2019-07-31T18:31:22.074292-05:00,Alive,1952,--,21519,M0,N0,Stage IIA,T3,--,not reported,396,ebbf6f30-948e-5b00-a24d-408d89366428,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-4752_diagnosis,No,Ascending colon,2019-04-28T11:16:46.032202-05:00,released,TCGA-CM-4752_treatment_1,12991c19-a44d-506c-847c-5870c53681bd,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:22.074292-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
7ea546ce-f48a-4d9c-96b4-a0124c692870,TCGA-CM-4752,TCGA-COAD,58,-21519,--,dadadc53-46cb-54fb-a3b3-90f98a9e35ff,not hispanic or latino,male,black or african american,released,TCGA-CM-4752_demographic,2019-07-31T18:31:22.074292-05:00,Alive,1952,--,21519,M0,N0,Stage IIA,T3,--,not reported,396,ebbf6f30-948e-5b00-a24d-408d89366428,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-4752_diagnosis,No,Ascending colon,--,released,TCGA-CM-4752_treatment,532534f6-e6c1-53bd-9d6d-6de7758d6803,no,"Radiation Therapy, NOS",2019-07-31T18:31:22.074292-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
2900eadd-7e27-4371-94e5-7d58cdff0138,TCGA-F4-6461,TCGA-COAD,41,-15151,338,aea73888-9d46-524e-85fb-8a550ecd225a,not hispanic or latino,female,white,released,TCGA-F4-6461_demographic,2019-07-31T18:25:40.677636-05:00,Dead,1970,--,15151,M0,N2,Stage IIIC,T4b,7th,not reported,--,523d8470-1368-5f8b-97eb-5455a11d7047,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6461_diagnosis,No,"Colon, NOS",2019-04-28T11:12:02.043976-05:00,released,TCGA-F4-6461_treatment_1,a2bba4f1-d6bf-5627-8596-ce1fbff81850,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:40.677636-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2011
2900eadd-7e27-4371-94e5-7d58cdff0138,TCGA-F4-6461,TCGA-COAD,41,-15151,338,aea73888-9d46-524e-85fb-8a550ecd225a,not hispanic or latino,female,white,released,TCGA-F4-6461_demographic,2019-07-31T18:25:40.677636-05:00,Dead,1970,--,15151,M0,N2,Stage IIIC,T4b,7th,not reported,--,523d8470-1368-5f8b-97eb-5455a11d7047,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6461_diagnosis,No,"Colon, NOS",--,released,TCGA-F4-6461_treatment,90daebd6-a63b-55b7-8f2f-5ca13ec48ce4,no,"Radiation Therapy, NOS",2019-07-31T18:25:40.677636-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2011
c1e141af-bdd1-4176-8c0e-cf1ab0c1d9d3,TCGA-AA-3952,TCGA-COAD,68,-24868,61,3da5eec1-f9a6-5344-803b-82465b9265ad,not reported,male,not reported,released,TCGA-AA-3952_demographic,2019-07-31T18:36:07.406746-05:00,Dead,1940,2008,24868,M0,N2,Stage IIIC,T3,6th,not reported,--,5bbd7063-8caf-5ee2-8f3f-8aee22dc150b,C18.6,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Descending colon,released,TCGA-AA-3952_diagnosis,Not Reported,Descending colon,2019-04-28T11:20:41.755415-05:00,released,TCGA-AA-3952_treatment_1,4e6b03d9-fdc0-5543-8071-bfc736e3422a,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:07.406746-05:00,not reported,stage iiic,2019-08-08T16:35:04.140343-05:00,2008
c1e141af-bdd1-4176-8c0e-cf1ab0c1d9d3,TCGA-AA-3952,TCGA-COAD,68,-24868,61,3da5eec1-f9a6-5344-803b-82465b9265ad,not reported,male,not reported,released,TCGA-AA-3952_demographic,2019-07-31T18:36:07.406746-05:00,Dead,1940,2008,24868,M0,N2,Stage IIIC,T3,6th,not reported,--,5bbd7063-8caf-5ee2-8f3f-8aee22dc150b,C18.6,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Descending colon,released,TCGA-AA-3952_diagnosis,Not Reported,Descending colon,--,released,TCGA-AA-3952_treatment,abc65800-c317-54ac-b189-1669a89b3a6d,not reported,"Radiation Therapy, NOS",2019-07-31T18:36:07.406746-05:00,not reported,stage iiic,2019-08-08T16:35:04.140343-05:00,2008
86a9e44f-728e-48e4-9e1b-682b023f7c0a,TCGA-AA-3967,TCGA-COAD,77,-28216,--,e3142f27-970d-5b63-8dd4-988e924f9226,not reported,male,not reported,released,TCGA-AA-3967_demographic,2019-07-31T18:32:03.907932-05:00,Alive,1931,--,28216,M0,N1,Stage IIIB,T3,6th,not reported,943,7a38d688-1e81-5fd9-9f09-5206af934e57,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3967_diagnosis,No,"Colon, NOS",2019-04-28T11:17:21.451470-05:00,released,TCGA-AA-3967_treatment_1,0a40516d-5564-52dc-b7d6-126848b1b24f,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:03.907932-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2008
86a9e44f-728e-48e4-9e1b-682b023f7c0a,TCGA-AA-3967,TCGA-COAD,77,-28216,--,e3142f27-970d-5b63-8dd4-988e924f9226,not reported,male,not reported,released,TCGA-AA-3967_demographic,2019-07-31T18:32:03.907932-05:00,Alive,1931,--,28216,M0,N1,Stage IIIB,T3,6th,not reported,943,7a38d688-1e81-5fd9-9f09-5206af934e57,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3967_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3967_treatment,e5ebbf84-e8b9-5bfa-83ad-eba7f790e1fe,no,"Radiation Therapy, NOS",2019-07-31T18:32:03.907932-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2008
35c295c2-37d1-44b2-87a3-1039645e5bae,TCGA-AA-3510,TCGA-COAD,70,-25902,--,9b985e80-252c-5994-b06a-242af22a6ff7,not reported,male,not reported,released,TCGA-AA-3510_demographic,2019-07-31T18:26:39.827708-05:00,Alive,1935,--,25902,M0,N0,Stage II,T3,5th,not reported,1946,399e6de9-aaff-503e-b3bd-d6514cc82375,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3510_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3510_treatment,3391d1fe-afbb-5179-a97c-2f09edd9676c,no,"Radiation Therapy, NOS",2019-07-31T18:26:39.827708-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2005
35c295c2-37d1-44b2-87a3-1039645e5bae,TCGA-AA-3510,TCGA-COAD,70,-25902,--,9b985e80-252c-5994-b06a-242af22a6ff7,not reported,male,not reported,released,TCGA-AA-3510_demographic,2019-07-31T18:26:39.827708-05:00,Alive,1935,--,25902,M0,N0,Stage II,T3,5th,not reported,1946,399e6de9-aaff-503e-b3bd-d6514cc82375,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3510_diagnosis,No,"Colon, NOS",2019-04-28T11:12:52.385198-05:00,released,TCGA-AA-3510_treatment_1,a7825dd2-104a-54e0-a016-448d903dd99d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:39.827708-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2005
b89267a4-0e6b-401e-85b0-e66775858aa6,TCGA-CM-5348,TCGA-COAD,72,-26543,--,a1f63f56-d110-5eab-85c2-29ceb08b05b6,not hispanic or latino,male,white,released,TCGA-CM-5348_demographic,2019-07-31T18:35:26.297757-05:00,Alive,1938,--,26543,M0,N1a,Stage IIIB,T3,7th,not reported,699,9a44cd1d-d56d-5525-bee2-254188b9f2c4,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5348_diagnosis,No,Cecum,--,released,TCGA-CM-5348_treatment,001ecf97-455e-53b5-a9e9-e644c0d84a3a,no,"Radiation Therapy, NOS",2019-07-31T18:35:26.297757-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
b89267a4-0e6b-401e-85b0-e66775858aa6,TCGA-CM-5348,TCGA-COAD,72,-26543,--,a1f63f56-d110-5eab-85c2-29ceb08b05b6,not hispanic or latino,male,white,released,TCGA-CM-5348_demographic,2019-07-31T18:35:26.297757-05:00,Alive,1938,--,26543,M0,N1a,Stage IIIB,T3,7th,not reported,699,9a44cd1d-d56d-5525-bee2-254188b9f2c4,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5348_diagnosis,No,Cecum,2019-04-28T11:20:06.699093-05:00,released,TCGA-CM-5348_treatment_1,9dcd41e8-9dec-5155-ac76-fcc5c3f94508,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:26.297757-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
eeb42912-0c7a-46bb-bd95-369b2b425727,TCGA-F4-6570,TCGA-COAD,78,-28772,188,ecfd61d9-9340-55c8-a7bc-97bfab69c984,not hispanic or latino,female,white,released,TCGA-F4-6570_demographic,2019-07-31T18:40:01.608242-05:00,Dead,1933,--,28772,M0,N0,Stage IIA,T3,7th,not reported,--,153a8ff7-0401-556e-b598-af8cd120f18f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6570_diagnosis,No,"Colon, NOS",2019-04-28T11:23:59.256741-05:00,released,TCGA-F4-6570_treatment_1,0616a60d-80e6-51a1-9069-6fb149b1223d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:01.608242-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
eeb42912-0c7a-46bb-bd95-369b2b425727,TCGA-F4-6570,TCGA-COAD,78,-28772,188,ecfd61d9-9340-55c8-a7bc-97bfab69c984,not hispanic or latino,female,white,released,TCGA-F4-6570_demographic,2019-07-31T18:40:01.608242-05:00,Dead,1933,--,28772,M0,N0,Stage IIA,T3,7th,not reported,--,153a8ff7-0401-556e-b598-af8cd120f18f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6570_diagnosis,No,"Colon, NOS",--,released,TCGA-F4-6570_treatment,97e2e8e8-5895-5fa8-9484-0c000dc98f1a,no,"Radiation Therapy, NOS",2019-07-31T18:40:01.608242-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
124b6856-f581-46da-9068-b0a49b999785,TCGA-AA-A00E,TCGA-COAD,65,-23741,--,116dc500-7949-5cf2-8305-9977c72f7a65,not reported,male,not reported,released,TCGA-AA-A00E_demographic,2019-07-31T15:20:36.232246-05:00,Alive,1942,--,23741,M0,N0,Stage IIA,T3,6th,not reported,913,d0ad61da-8e28-515f-a724-c21a256dd18c,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00E_diagnosis,No,Ascending colon,2019-04-28T08:40:42.843616-05:00,released,TCGA-AA-A00E_treatment_1,6fd7dfe6-dbe0-5c99-8dde-609f1a43400d,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:20:36.232246-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2007
124b6856-f581-46da-9068-b0a49b999785,TCGA-AA-A00E,TCGA-COAD,65,-23741,--,116dc500-7949-5cf2-8305-9977c72f7a65,not reported,male,not reported,released,TCGA-AA-A00E_demographic,2019-07-31T15:20:36.232246-05:00,Alive,1942,--,23741,M0,N0,Stage IIA,T3,6th,not reported,913,d0ad61da-8e28-515f-a724-c21a256dd18c,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00E_diagnosis,No,Ascending colon,--,released,TCGA-AA-A00E_treatment,8b636ab6-9f98-57b9-8512-e0d078122de0,no,"Radiation Therapy, NOS",2019-07-31T15:20:36.232246-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2007
56eb96a4-d2c2-42fb-b26c-1a80012bcb8e,TCGA-CM-4747,TCGA-COAD,47,-17198,--,8cb58cf9-cb5d-5878-be79-205b0a150465,not hispanic or latino,male,white,released,TCGA-CM-4747_demographic,2019-07-31T18:28:50.102004-05:00,Alive,1963,--,17198,M1a,N1b,Stage IVA,T4a,--,not reported,761,097e4ef7-102e-5d81-bca5-5223be36d9a8,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-4747_diagnosis,No,Cecum,--,released,TCGA-CM-4747_treatment,1af9b586-cea5-5109-9673-60c264b16701,no,"Radiation Therapy, NOS",2019-07-31T18:28:50.102004-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2010
56eb96a4-d2c2-42fb-b26c-1a80012bcb8e,TCGA-CM-4747,TCGA-COAD,47,-17198,--,8cb58cf9-cb5d-5878-be79-205b0a150465,not hispanic or latino,male,white,released,TCGA-CM-4747_demographic,2019-07-31T18:28:50.102004-05:00,Alive,1963,--,17198,M1a,N1b,Stage IVA,T4a,--,not reported,761,097e4ef7-102e-5d81-bca5-5223be36d9a8,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-4747_diagnosis,No,Cecum,2019-04-28T11:14:39.284937-05:00,released,TCGA-CM-4747_treatment_1,fcccb843-5797-5c9a-a287-c483d661b093,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:50.102004-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2010
0a815133-0edd-4422-89f2-2f067b6f2156,TCGA-AA-3848,TCGA-COAD,82,-30194,306,61c342e7-1da9-5998-a948-4eb0bd936ff8,not reported,female,not reported,released,TCGA-AA-3848_demographic,2019-07-31T18:22:55.320431-05:00,Dead,1927,--,30194,M0,N2,Stage IIIC,T3,6th,not reported,30,011296e6-c072-587c-833f-9343d05b00d2,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3848_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3848_treatment,ff2fb4ad-62cd-5812-9f46-cef6eaf8043f,no,"Radiation Therapy, NOS",2019-07-31T18:22:55.320431-05:00,not reported,stage iiic,2019-08-08T16:34:38.138144-05:00,2009
0a815133-0edd-4422-89f2-2f067b6f2156,TCGA-AA-3848,TCGA-COAD,82,-30194,306,61c342e7-1da9-5998-a948-4eb0bd936ff8,not reported,female,not reported,released,TCGA-AA-3848_demographic,2019-07-31T18:22:55.320431-05:00,Dead,1927,--,30194,M0,N2,Stage IIIC,T3,6th,not reported,30,011296e6-c072-587c-833f-9343d05b00d2,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3848_diagnosis,No,Sigmoid colon,2019-04-28T11:09:45.609820-05:00,released,TCGA-AA-3848_treatment_1,3f3d711b-dc6e-5b91-9e65-830aa137c8e4,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:55.320431-05:00,not reported,stage iiic,2019-08-08T16:34:38.138144-05:00,2009
e5921d6b-51cf-44be-b295-610cf7c3a69a,TCGA-A6-2685,TCGA-COAD,48,-17757,--,50b66dbc-1154-51f0-bbd6-6be25828da49,not hispanic or latino,female,black or african american,released,TCGA-A6-2685_demographic,2019-07-31T18:39:22.135471-05:00,Alive,1961,--,17757,M0,N0,Stage IIA,T3,6th,not reported,1133,5282aefe-aaaf-5d5a-9073-890938f1b777,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2685_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-2685_treatment,d8b36390-a3b4-525a-85a7-6add9ca4f63b,no,"Radiation Therapy, NOS",2019-07-31T18:39:22.135471-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
e5921d6b-51cf-44be-b295-610cf7c3a69a,TCGA-A6-2685,TCGA-COAD,48,-17757,--,50b66dbc-1154-51f0-bbd6-6be25828da49,not hispanic or latino,female,black or african american,released,TCGA-A6-2685_demographic,2019-07-31T18:39:22.135471-05:00,Alive,1961,--,17757,M0,N0,Stage IIA,T3,6th,not reported,1133,5282aefe-aaaf-5d5a-9073-890938f1b777,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2685_diagnosis,No,"Colon, NOS",2019-04-28T11:23:26.723808-05:00,released,TCGA-A6-2685_treatment_1,e93ad888-d928-5f75-a663-117851c91ad9,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:22.135471-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
c8d7eb0f-2502-4277-a8ef-435b08f3c863,TCGA-CM-4743,TCGA-COAD,69,-25291,--,19ba703e-aaa2-5a13-8161-dcc3fc1e1ee0,not hispanic or latino,male,white,released,TCGA-CM-4743_demographic,2019-07-31T18:36:57.429223-05:00,Alive,1941,--,25291,M0,N0,Stage IIA,T3,--,not reported,701,1eb8d123-4bf7-5b98-b1d3-f3ae783dd970,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-4743_diagnosis,No,Ascending colon,2019-04-28T11:21:21.688182-05:00,released,TCGA-CM-4743_treatment_1,3cd0a287-12a7-51de-91a7-e74d15a235eb,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:57.429223-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
c8d7eb0f-2502-4277-a8ef-435b08f3c863,TCGA-CM-4743,TCGA-COAD,69,-25291,--,19ba703e-aaa2-5a13-8161-dcc3fc1e1ee0,not hispanic or latino,male,white,released,TCGA-CM-4743_demographic,2019-07-31T18:36:57.429223-05:00,Alive,1941,--,25291,M0,N0,Stage IIA,T3,--,not reported,701,1eb8d123-4bf7-5b98-b1d3-f3ae783dd970,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-4743_diagnosis,No,Ascending colon,--,released,TCGA-CM-4743_treatment,8b5a6045-98cf-5eb6-bfac-7ae5a342a997,no,"Radiation Therapy, NOS",2019-07-31T18:36:57.429223-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
bce5579c-08c6-48e9-853e-fac85ba8cbea,TCGA-AA-3831,TCGA-COAD,66,-24411,--,0b5ea4b5-8aa8-5c6e-9f59-a87763cd9809,not reported,male,not reported,released,TCGA-AA-3831_demographic,2019-07-31T18:35:44.392443-05:00,Alive,1942,--,24411,M0,N0,Stage IIA,T3,6th,not reported,547,c68c9ced-ede7-557f-a2a8-cd7321196b1a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3831_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3831_treatment,d7894d1c-2d92-57fb-83df-3aa546924521,no,"Radiation Therapy, NOS",2019-07-31T18:35:44.392443-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
bce5579c-08c6-48e9-853e-fac85ba8cbea,TCGA-AA-3831,TCGA-COAD,66,-24411,--,0b5ea4b5-8aa8-5c6e-9f59-a87763cd9809,not reported,male,not reported,released,TCGA-AA-3831_demographic,2019-07-31T18:35:44.392443-05:00,Alive,1942,--,24411,M0,N0,Stage IIA,T3,6th,not reported,547,c68c9ced-ede7-557f-a2a8-cd7321196b1a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3831_diagnosis,No,"Colon, NOS",2019-04-28T11:20:22.188597-05:00,released,TCGA-AA-3831_treatment_1,e3cabd23-3606-5dfd-82e1-ace4c54382dd,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:44.392443-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
25c3201a-3dd5-4edf-ad09-104e5c10663e,TCGA-A6-5666,TCGA-COAD,78,-28514,--,f6c21c44-fb58-5e15-9481-6ac1081950d1,not hispanic or latino,male,white,released,TCGA-A6-5666_demographic,2019-07-31T18:25:05.494747-05:00,Alive,1932,--,28514,M0,N0,Stage IIC,T4b,--,not reported,995,cf1a7629-300d-543e-91eb-c63ef4d55991,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-5666_diagnosis,No,"Colon, NOS",2019-04-28T11:11:31.854764-05:00,released,TCGA-A6-5666_treatment_1,40fbe4d2-8c17-5dc1-8c5d-0098962e73fb,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:05.494747-05:00,not reported,stage iic,2019-08-08T16:33:45.855164-05:00,2010
25c3201a-3dd5-4edf-ad09-104e5c10663e,TCGA-A6-5666,TCGA-COAD,78,-28514,--,f6c21c44-fb58-5e15-9481-6ac1081950d1,not hispanic or latino,male,white,released,TCGA-A6-5666_demographic,2019-07-31T18:25:05.494747-05:00,Alive,1932,--,28514,M0,N0,Stage IIC,T4b,--,not reported,995,cf1a7629-300d-543e-91eb-c63ef4d55991,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-5666_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-5666_treatment,e6a5b94d-ce86-5d3e-83e8-b212d56027cf,no,"Radiation Therapy, NOS",2019-07-31T18:25:05.494747-05:00,not reported,stage iic,2019-08-08T16:33:45.855164-05:00,2010
4563e4e0-a661-46de-ad25-9c86a621e147,TCGA-AA-3812,TCGA-COAD,82,-29980,--,c0c402b8-1f08-5eff-86d0-f695a0d8d839,not reported,female,not reported,released,TCGA-AA-3812_demographic,2019-07-31T18:27:43.749797-05:00,Alive,1925,--,29980,M0,N0,Stage IIA,T3,6th,not reported,1066,168d0332-9b37-53f6-a3c8-bb9e0c3a22aa,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3812_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3812_treatment,28cb17e6-4585-53d0-b734-25ad60387de4,no,"Radiation Therapy, NOS",2019-07-31T18:27:43.749797-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
4563e4e0-a661-46de-ad25-9c86a621e147,TCGA-AA-3812,TCGA-COAD,82,-29980,--,c0c402b8-1f08-5eff-86d0-f695a0d8d839,not reported,female,not reported,released,TCGA-AA-3812_demographic,2019-07-31T18:27:43.749797-05:00,Alive,1925,--,29980,M0,N0,Stage IIA,T3,6th,not reported,1066,168d0332-9b37-53f6-a3c8-bb9e0c3a22aa,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3812_diagnosis,No,Sigmoid colon,2019-04-28T11:13:44.615692-05:00,released,TCGA-AA-3812_treatment_1,38dd3b70-0487-56b4-a2dc-78b42685c682,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:43.749797-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
a19cd9f8-482b-4b70-b7d7-06d6bb1b0260,TCGA-CM-5862,TCGA-COAD,80,-29493,153,1e849995-e3aa-5bfd-a926-b1e5f9184677,not hispanic or latino,male,white,released,TCGA-CM-5862_demographic,2019-07-31T18:42:23.122622-05:00,Dead,1930,2010,29493,M1a,N1a,Stage IVA,T3,7th,not reported,--,24bad2de-65c7-5d7e-9e37-d66e42c6081b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-5862_diagnosis,No,Ascending colon,--,released,TCGA-CM-5862_treatment,3ce23852-519f-57a3-9374-6eedcf61c552,no,"Radiation Therapy, NOS",2019-07-31T18:42:23.122622-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2010
a19cd9f8-482b-4b70-b7d7-06d6bb1b0260,TCGA-CM-5862,TCGA-COAD,80,-29493,153,1e849995-e3aa-5bfd-a926-b1e5f9184677,not hispanic or latino,male,white,released,TCGA-CM-5862_demographic,2019-07-31T18:42:23.122622-05:00,Dead,1930,2010,29493,M1a,N1a,Stage IVA,T3,7th,not reported,--,24bad2de-65c7-5d7e-9e37-d66e42c6081b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-5862_diagnosis,No,Ascending colon,2019-04-28T11:25:59.245623-05:00,released,TCGA-CM-5862_treatment_1,ac755304-fe50-5d8e-b377-09327cbeb88b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:23.122622-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2010
5c24435e-8e50-42c2-80c7-919b1cad0133,TCGA-AA-3955,TCGA-COAD,38,-14186,--,32c8861f-6d58-5709-b4e6-47949cbc0756,not reported,male,not reported,released,TCGA-AA-3955_demographic,2019-07-31T18:29:07.444906-05:00,Alive,1972,--,14186,M0,N2a,Stage IIIB,T2,7th,not reported,638,7eb98bf4-2628-5c83-9296-87f2080d4666,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3955_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3955_treatment,ad713610-d5ab-58b2-87d4-de20ece4524b,no,"Radiation Therapy, NOS",2019-07-31T18:29:07.444906-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2010
5c24435e-8e50-42c2-80c7-919b1cad0133,TCGA-AA-3955,TCGA-COAD,38,-14186,--,32c8861f-6d58-5709-b4e6-47949cbc0756,not reported,male,not reported,released,TCGA-AA-3955_demographic,2019-07-31T18:29:07.444906-05:00,Alive,1972,--,14186,M0,N2a,Stage IIIB,T2,7th,not reported,638,7eb98bf4-2628-5c83-9296-87f2080d4666,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3955_diagnosis,No,"Colon, NOS",2019-04-28T11:14:54.436471-05:00,released,TCGA-AA-3955_treatment_1,00f7fe95-19ae-5f68-a2d7-02472f554f5e,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:07.444906-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2010
15d1b0fb-5c5f-4689-94f5-b33120a2bfae,TCGA-D5-5539,TCGA-COAD,60,-22097,--,ce84d1f4-ee6d-5b85-ba93-3457107c3ec0,not hispanic or latino,male,white,released,TCGA-D5-5539_demographic,2019-07-31T18:24:16.038347-05:00,Alive,1950,--,22097,M0,N1,Stage IIIA,T3,--,not reported,596,b0cf33e0-db3f-59e0-a094-fe220669e16e,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-D5-5539_diagnosis,No,Ascending colon,2019-04-28T11:10:51.394231-05:00,released,TCGA-D5-5539_treatment_1,02bf4b33-3358-5abe-a41f-f89fa7d1bde2,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:16.038347-05:00,not reported,stage iiia,2019-08-08T16:36:28.485406-05:00,2010
15d1b0fb-5c5f-4689-94f5-b33120a2bfae,TCGA-D5-5539,TCGA-COAD,60,-22097,--,ce84d1f4-ee6d-5b85-ba93-3457107c3ec0,not hispanic or latino,male,white,released,TCGA-D5-5539_demographic,2019-07-31T18:24:16.038347-05:00,Alive,1950,--,22097,M0,N1,Stage IIIA,T3,--,not reported,596,b0cf33e0-db3f-59e0-a094-fe220669e16e,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-D5-5539_diagnosis,No,Ascending colon,--,released,TCGA-D5-5539_treatment,61cd9821-ddc0-587f-b57e-2bb8d8fb5fdc,no,"Radiation Therapy, NOS",2019-07-31T18:24:16.038347-05:00,not reported,stage iiia,2019-08-08T16:36:28.485406-05:00,2010
cbdabbcd-d8f1-4d7c-9e18-ebd83d888c51,TCGA-AA-3949,TCGA-COAD,87,-32081,--,23a11678-b2ca-5590-bff6-60a6cb0266db,not reported,female,not reported,released,TCGA-AA-3949_demographic,2019-07-31T18:37:16.500308-05:00,Alive,1922,--,32081,M0,N1,Stage IIIB,T3,6th,not reported,791,21646236-9cf4-5310-97dd-7622cddcd25c,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-3949_diagnosis,No,Ascending colon,2019-04-28T11:21:36.996054-05:00,released,TCGA-AA-3949_treatment_1,0a46731b-a930-59b8-828f-9d54e95bb468,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:16.500308-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
cbdabbcd-d8f1-4d7c-9e18-ebd83d888c51,TCGA-AA-3949,TCGA-COAD,87,-32081,--,23a11678-b2ca-5590-bff6-60a6cb0266db,not reported,female,not reported,released,TCGA-AA-3949_demographic,2019-07-31T18:37:16.500308-05:00,Alive,1922,--,32081,M0,N1,Stage IIIB,T3,6th,not reported,791,21646236-9cf4-5310-97dd-7622cddcd25c,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AA-3949_diagnosis,No,Ascending colon,--,released,TCGA-AA-3949_treatment,7315135f-faba-5b11-889b-13861c357d9f,no,"Radiation Therapy, NOS",2019-07-31T18:37:16.500308-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
aedde4a5-6520-40b9-9721-c9b826490b7a,TCGA-CM-6166,TCGA-COAD,48,-17807,--,2e1fb0ff-bc7d-5621-985e-2ccfabf99ab1,not hispanic or latino,female,white,released,TCGA-CM-6166_demographic,2019-07-31T18:34:42.592211-05:00,Alive,1962,--,17807,M0,N0,Stage I,T2,7th,not reported,669,6d96df8d-ad80-51c8-b8c1-0946514e26b7,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-6166_diagnosis,No,Ascending colon,2019-04-28T11:19:30.181575-05:00,released,TCGA-CM-6166_treatment_1,64823e88-e259-5d2b-9c9a-bfe54b7912ca,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:42.592211-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
aedde4a5-6520-40b9-9721-c9b826490b7a,TCGA-CM-6166,TCGA-COAD,48,-17807,--,2e1fb0ff-bc7d-5621-985e-2ccfabf99ab1,not hispanic or latino,female,white,released,TCGA-CM-6166_demographic,2019-07-31T18:34:42.592211-05:00,Alive,1962,--,17807,M0,N0,Stage I,T2,7th,not reported,669,6d96df8d-ad80-51c8-b8c1-0946514e26b7,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-6166_diagnosis,No,Ascending colon,--,released,TCGA-CM-6166_treatment,531d7cdf-24ae-5257-8f6f-0ed8569b54fc,no,"Radiation Therapy, NOS",2019-07-31T18:34:42.592211-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
ce00896a-f7d2-4123-bb95-24cb6e53fc32,TCGA-5M-AAT6,TCGA-COAD,40,-14852,290,2eb0db81-6eba-5f19-95c1-cfabd25a509f,hispanic or latino,female,black or african american,released,TCGA-5M-AAT6_demographic,2019-07-31T18:37:34.287456-05:00,Dead,1969,2009,14852,M1a,N2b,Stage IV,T4a,6th,not reported,--,f3c29c8b-1c74-53b0-badf-e374629ff3bf,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-5M-AAT6_diagnosis,No,Ascending colon,2019-04-28T11:21:51.877345-05:00,released,TCGA-5M-AAT6_treatment_1,1eb5a97b-f373-55a9-86a3-623541ee0943,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:34.287456-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
ce00896a-f7d2-4123-bb95-24cb6e53fc32,TCGA-5M-AAT6,TCGA-COAD,40,-14852,290,2eb0db81-6eba-5f19-95c1-cfabd25a509f,hispanic or latino,female,black or african american,released,TCGA-5M-AAT6_demographic,2019-07-31T18:37:34.287456-05:00,Dead,1969,2009,14852,M1a,N2b,Stage IV,T4a,6th,not reported,--,f3c29c8b-1c74-53b0-badf-e374629ff3bf,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-5M-AAT6_diagnosis,No,Ascending colon,--,released,TCGA-5M-AAT6_treatment,f5fc0794-6888-55ca-a73e-3452a587baa4,no,"Radiation Therapy, NOS",2019-07-31T18:37:34.287456-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
eed7405f-f8f3-41a4-a0e7-242f23087f59,TCGA-CM-6171,TCGA-COAD,77,-28307,--,5807287b-a6cc-5b35-b86a-bb6aeedd2b60,not hispanic or latino,female,white,released,TCGA-CM-6171_demographic,2019-07-31T18:40:07.152399-05:00,Alive,1933,--,28307,M0,N0,Stage I,T2,7th,not reported,427,731bfe8e-3661-5c00-b871-5e3af5c80143,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-6171_diagnosis,No,Ascending colon,2019-04-28T11:24:04.234713-05:00,released,TCGA-CM-6171_treatment_1,b4ce1c0c-32eb-55b1-935b-f108adc1324b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:07.152399-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
eed7405f-f8f3-41a4-a0e7-242f23087f59,TCGA-CM-6171,TCGA-COAD,77,-28307,--,5807287b-a6cc-5b35-b86a-bb6aeedd2b60,not hispanic or latino,female,white,released,TCGA-CM-6171_demographic,2019-07-31T18:40:07.152399-05:00,Alive,1933,--,28307,M0,N0,Stage I,T2,7th,not reported,427,731bfe8e-3661-5c00-b871-5e3af5c80143,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CM-6171_diagnosis,No,Ascending colon,--,released,TCGA-CM-6171_treatment,d265c7f8-7b5b-55d6-9562-d56008f8d4b6,no,"Radiation Therapy, NOS",2019-07-31T18:40:07.152399-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
5116e3b4-2bac-40f5-8046-b9c1783faaa5,TCGA-A6-3807,TCGA-COAD,53,-19624,--,b49caaf7-9d9e-5b7d-9840-5dcd4d9cd549,not hispanic or latino,female,white,released,TCGA-A6-3807_demographic,2019-07-31T18:28:17.141935-05:00,Alive,1956,--,19624,M0,N2,Stage IIIC,T3,--,not reported,1054,99cb6c71-bd5a-5fa1-9727-52a5949fa87e,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-3807_diagnosis,No,Sigmoid colon,2019-04-28T11:14:11.607389-05:00,released,TCGA-A6-3807_treatment_1,2195d4e0-9b52-52a6-a10c-6547940c9136,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:17.141935-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2009
5116e3b4-2bac-40f5-8046-b9c1783faaa5,TCGA-A6-3807,TCGA-COAD,53,-19624,--,b49caaf7-9d9e-5b7d-9840-5dcd4d9cd549,not hispanic or latino,female,white,released,TCGA-A6-3807_demographic,2019-07-31T18:28:17.141935-05:00,Alive,1956,--,19624,M0,N2,Stage IIIC,T3,--,not reported,1054,99cb6c71-bd5a-5fa1-9727-52a5949fa87e,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-3807_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-3807_treatment,274647a5-d0dc-5125-90c8-e5783b2ff4d1,no,"Radiation Therapy, NOS",2019-07-31T18:28:17.141935-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2009
d7ebd11a-1339-4b28-be90-a788d2cfa706,TCGA-AA-3811,TCGA-COAD,84,-30893,306,0c8e6d4f-ad9a-5c63-8bd6-f4d77fa7bbe4,not reported,female,not reported,released,TCGA-AA-3811_demographic,2019-07-31T18:38:17.823056-05:00,Dead,1923,--,30893,M0,N2,Stage III,T3,5th,not reported,30,29178fea-dd19-5f95-b09f-5c9106582c9f,C18.9,8574/3,Adenocarcinoma with neuroendocrine differentiation,no,No,not reported,"Colon, NOS",released,TCGA-AA-3811_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3811_treatment,bc0e611c-1deb-5b35-860c-a5a01e0f52d9,no,"Radiation Therapy, NOS",2019-07-31T18:38:17.823056-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2007
d7ebd11a-1339-4b28-be90-a788d2cfa706,TCGA-AA-3811,TCGA-COAD,84,-30893,306,0c8e6d4f-ad9a-5c63-8bd6-f4d77fa7bbe4,not reported,female,not reported,released,TCGA-AA-3811_demographic,2019-07-31T18:38:17.823056-05:00,Dead,1923,--,30893,M0,N2,Stage III,T3,5th,not reported,30,29178fea-dd19-5f95-b09f-5c9106582c9f,C18.9,8574/3,Adenocarcinoma with neuroendocrine differentiation,no,No,not reported,"Colon, NOS",released,TCGA-AA-3811_diagnosis,No,"Colon, NOS",2019-04-28T11:22:30.888225-05:00,released,TCGA-AA-3811_treatment_1,c9dcd578-9078-5afb-9d54-4b3dcdf0769d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:17.823056-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2007
1136dd50-242a-4659-aad4-c53f9e759bb3,TCGA-5M-AAT4,TCGA-COAD,74,-27095,49,5b750c50-ce20-5725-876f-87eaea5d0db6,hispanic or latino,male,black or african american,released,TCGA-5M-AAT4_demographic,2019-07-31T18:23:44.907638-05:00,Dead,1935,2009,27095,M1b,N0,Stage IV,T3,6th,not reported,--,166d8efb-b84a-583d-9a95-fbd3a6151feb,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-5M-AAT4_diagnosis,No,Ascending colon,2019-04-28T11:10:25.901738-05:00,released,TCGA-5M-AAT4_treatment_1,68488849-f72d-51a5-953b-65be3915cb9f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:44.907638-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
1136dd50-242a-4659-aad4-c53f9e759bb3,TCGA-5M-AAT4,TCGA-COAD,74,-27095,49,5b750c50-ce20-5725-876f-87eaea5d0db6,hispanic or latino,male,black or african american,released,TCGA-5M-AAT4_demographic,2019-07-31T18:23:44.907638-05:00,Dead,1935,2009,27095,M1b,N0,Stage IV,T3,6th,not reported,--,166d8efb-b84a-583d-9a95-fbd3a6151feb,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-5M-AAT4_diagnosis,No,Ascending colon,--,released,TCGA-5M-AAT4_treatment,88de00a5-45b9-5174-b453-869217d73ef2,no,"Radiation Therapy, NOS",2019-07-31T18:23:44.907638-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
21ddbfaa-1b21-4a2b-be2c-237dd69b20ff,TCGA-A6-6140,TCGA-COAD,62,-22835,--,24eca2c1-ea38-541c-afb3-4763d18df5ff,not hispanic or latino,male,white,released,TCGA-A6-6140_demographic,2019-07-31T18:24:53.644034-05:00,Alive,1949,--,22835,M0,N0,Stage IIA,T3,--,not reported,734,fea2d32f-850b-529c-a57a-93ef7dd28027,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-A6-6140_diagnosis,No,Descending colon,2019-04-28T11:11:21.568233-05:00,released,TCGA-A6-6140_treatment_1,138b1464-3de4-5360-a9ef-d7b41eae2044,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:53.644034-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2011
21ddbfaa-1b21-4a2b-be2c-237dd69b20ff,TCGA-A6-6140,TCGA-COAD,62,-22835,--,24eca2c1-ea38-541c-afb3-4763d18df5ff,not hispanic or latino,male,white,released,TCGA-A6-6140_demographic,2019-07-31T18:24:53.644034-05:00,Alive,1949,--,22835,M0,N0,Stage IIA,T3,--,not reported,734,fea2d32f-850b-529c-a57a-93ef7dd28027,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-A6-6140_diagnosis,No,Descending colon,--,released,TCGA-A6-6140_treatment,18d6ad45-58cf-5c34-ae8e-dfb84e5475dd,no,"Radiation Therapy, NOS",2019-07-31T18:24:53.644034-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2011
b6202d8d-dd3c-4fa2-9242-6e55759846af,TCGA-CM-5344,TCGA-COAD,39,-14426,--,c7b57a53-bab3-5377-be63-6263997f9eea,hispanic or latino,female,white,released,TCGA-CM-5344_demographic,2019-07-31T18:35:14.517094-05:00,Alive,1971,--,14426,M0,N1b,Stage IIIB,T3,7th,not reported,670,6f2490b3-9010-5d8c-9e89-5fe50560ee78,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-5344_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-5344_treatment,c2b5266b-24cd-53e4-a91f-78f230a0756d,no,"Radiation Therapy, NOS",2019-07-31T18:35:14.517094-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
b6202d8d-dd3c-4fa2-9242-6e55759846af,TCGA-CM-5344,TCGA-COAD,39,-14426,--,c7b57a53-bab3-5377-be63-6263997f9eea,hispanic or latino,female,white,released,TCGA-CM-5344_demographic,2019-07-31T18:35:14.517094-05:00,Alive,1971,--,14426,M0,N1b,Stage IIIB,T3,7th,not reported,670,6f2490b3-9010-5d8c-9e89-5fe50560ee78,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-5344_diagnosis,No,Sigmoid colon,2019-04-28T11:19:57.213547-05:00,released,TCGA-CM-5344_treatment_1,4a6fd852-3198-55c6-94fa-4b3c0efb5ae8,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:14.517094-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
6cd8d2dd-5545-43b0-b796-ae0506d62eb8,TCGA-A6-6650,TCGA-COAD,69,-25516,--,e97aa7ba-4b50-59fa-b603-f7a9657229ac,not hispanic or latino,female,black or african american,released,TCGA-A6-6650_demographic,2019-07-31T15:21:13.921799-05:00,Alive,1941,--,25516,M0,N0,Stage IIA,T3,7th,not reported,627,4a27df98-2f99-51e4-a0d8-f324ed8ea8bc,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-6650_diagnosis,No,Ascending colon,--,released,TCGA-A6-6650_treatment,590200f9-4fc4-57a6-af2f-64d321a9e1c5,no,"Radiation Therapy, NOS",2019-07-31T15:21:13.921799-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
6cd8d2dd-5545-43b0-b796-ae0506d62eb8,TCGA-A6-6650,TCGA-COAD,69,-25516,--,e97aa7ba-4b50-59fa-b603-f7a9657229ac,not hispanic or latino,female,black or african american,released,TCGA-A6-6650_demographic,2019-07-31T15:21:13.921799-05:00,Alive,1941,--,25516,M0,N0,Stage IIA,T3,7th,not reported,627,4a27df98-2f99-51e4-a0d8-f324ed8ea8bc,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-6650_diagnosis,No,Ascending colon,2019-04-28T08:41:14.478387-05:00,released,TCGA-A6-6650_treatment_1,e8044245-1521-5b8b-8a39-6ef9e12ee1b8,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:21:13.921799-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2010
a56f6562-d2af-47b9-bf81-94b3b4893173,TCGA-DM-A0XD,TCGA-COAD,65,-23966,743,d175e6af-3d84-5eb7-8139-34051936fc73,not hispanic or latino,male,white,released,TCGA-DM-A0XD_demographic,2019-07-31T18:33:53.433527-05:00,Dead,1935,2002,23966,M0,N0,Stage IIA,T3,--,not reported,--,b9767a71-83d3-5d8b-95ae-632cda2027c2,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A0XD_diagnosis,No,Cecum,2019-04-28T11:18:50.886099-05:00,released,TCGA-DM-A0XD_treatment_1,7df8c055-e4c6-56f6-b540-d8ce9a04c614,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:53.433527-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
a56f6562-d2af-47b9-bf81-94b3b4893173,TCGA-DM-A0XD,TCGA-COAD,65,-23966,743,d175e6af-3d84-5eb7-8139-34051936fc73,not hispanic or latino,male,white,released,TCGA-DM-A0XD_demographic,2019-07-31T18:33:53.433527-05:00,Dead,1935,2002,23966,M0,N0,Stage IIA,T3,--,not reported,--,b9767a71-83d3-5d8b-95ae-632cda2027c2,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A0XD_diagnosis,No,Cecum,--,released,TCGA-DM-A0XD_treatment,90d25b73-c7b4-592c-82a1-a0ee9bb298e2,no,"Radiation Therapy, NOS",2019-07-31T18:33:53.433527-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2000
ea923671-3903-4a79-830d-e7e4b1eabab0,TCGA-AD-6899,TCGA-COAD,84,-30693,176,f4f7c95d-d171-5ee5-96dc-3757fbbde3da,not reported,male,white,released,TCGA-AD-6899_demographic,2019-07-31T18:39:53.127160-05:00,Dead,1927,--,30693,MX,N2b,Stage IIIC,T4a,7th,not reported,48,7ff5fb0e-c1ae-5b73-8a82-95b11c32689c,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AD-6899_diagnosis,No,"Colon, NOS",--,released,TCGA-AD-6899_treatment,bb7b024c-9ed6-5de7-8b71-3fdc2b4a525b,no,"Radiation Therapy, NOS",2019-07-31T18:39:53.127160-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2011
ea923671-3903-4a79-830d-e7e4b1eabab0,TCGA-AD-6899,TCGA-COAD,84,-30693,176,f4f7c95d-d171-5ee5-96dc-3757fbbde3da,not reported,male,white,released,TCGA-AD-6899_demographic,2019-07-31T18:39:53.127160-05:00,Dead,1927,--,30693,MX,N2b,Stage IIIC,T4a,7th,not reported,48,7ff5fb0e-c1ae-5b73-8a82-95b11c32689c,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AD-6899_diagnosis,No,"Colon, NOS",2019-04-28T11:23:51.939456-05:00,released,TCGA-AD-6899_treatment_1,c59a2d09-b2c6-544b-b070-d262d7ea4fde,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:53.127160-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2011
44c2854e-3f8c-48e1-b4d5-1b5778d4fce4,TCGA-AA-3858,TCGA-COAD,67,-24806,--,9ca11ea4-19f8-51d7-afa3-1657eb351c10,not reported,male,not reported,released,TCGA-AA-3858_demographic,2019-07-31T18:27:40.409648-05:00,Alive,1942,--,24806,M0,N0,Stage I,T2,6th,not reported,945,a6cbe109-9796-5c9b-a740-60fa88c2ccc5,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3858_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3858_treatment,9d3c8eb0-b971-5485-b026-148febc921f9,no,"Radiation Therapy, NOS",2019-07-31T18:27:40.409648-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
44c2854e-3f8c-48e1-b4d5-1b5778d4fce4,TCGA-AA-3858,TCGA-COAD,67,-24806,--,9ca11ea4-19f8-51d7-afa3-1657eb351c10,not reported,male,not reported,released,TCGA-AA-3858_demographic,2019-07-31T18:27:40.409648-05:00,Alive,1942,--,24806,M0,N0,Stage I,T2,6th,not reported,945,a6cbe109-9796-5c9b-a740-60fa88c2ccc5,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3858_diagnosis,No,"Colon, NOS",2019-04-28T11:13:42.221954-05:00,released,TCGA-AA-3858_treatment_1,579b0c5e-fad9-526e-b574-b5b51a55d147,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:40.409648-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
b612d491-7442-4119-a53c-5ebcc35c31f4,TCGA-A6-2672,TCGA-COAD,82,-30237,--,918caa67-eaae-5180-80ef-f391346af883,not hispanic or latino,female,white,released,TCGA-A6-2672_demographic,2019-07-31T18:35:11.530956-05:00,Alive,1927,--,30237,M0,N1,Stage IIIB,T3,--,not reported,1419,e44a132f-749a-5557-bf02-ed71326b0393,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-2672_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-2672_treatment,f78e7d8d-64f7-5c68-a701-517e6b271774,no,"Radiation Therapy, NOS",2019-07-31T18:35:11.530956-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2009
b612d491-7442-4119-a53c-5ebcc35c31f4,TCGA-A6-2672,TCGA-COAD,82,-30237,--,918caa67-eaae-5180-80ef-f391346af883,not hispanic or latino,female,white,released,TCGA-A6-2672_demographic,2019-07-31T18:35:11.530956-05:00,Alive,1927,--,30237,M0,N1,Stage IIIB,T3,--,not reported,1419,e44a132f-749a-5557-bf02-ed71326b0393,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-2672_diagnosis,No,"Colon, NOS",2019-04-28T11:19:54.848416-05:00,released,TCGA-A6-2672_treatment_1,c58cffd6-9c82-50e2-8bbd-eceb4d57e940,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:11.530956-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2009
89a6384e-1cea-440b-9f17-d57cb0805174,TCGA-A6-2676,TCGA-COAD,75,-27403,1305,199efa66-f51f-5f7e-941e-b84a49eb4142,not hispanic or latino,female,white,released,TCGA-A6-2676_demographic,2019-07-31T18:32:12.741234-05:00,Dead,1934,--,27403,M0,N0,Stage IIB,T4,6th,not reported,711,73a2dbc2-0e39-517c-869e-d1274662476c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2676_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-2676_treatment,a41f87d6-398a-5073-96ac-babf4f6a087a,no,"Radiation Therapy, NOS",2019-07-31T18:32:12.741234-05:00,not reported,stage iib,2019-08-08T16:33:45.855164-05:00,2009
89a6384e-1cea-440b-9f17-d57cb0805174,TCGA-A6-2676,TCGA-COAD,75,-27403,1305,199efa66-f51f-5f7e-941e-b84a49eb4142,not hispanic or latino,female,white,released,TCGA-A6-2676_demographic,2019-07-31T18:32:12.741234-05:00,Dead,1934,--,27403,M0,N0,Stage IIB,T4,6th,not reported,711,73a2dbc2-0e39-517c-869e-d1274662476c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2676_diagnosis,No,"Colon, NOS",2019-04-28T11:17:28.758085-05:00,released,TCGA-A6-2676_treatment_1,7a211057-8c82-55d9-b802-85954a723606,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:12.741234-05:00,not reported,stage iib,2019-08-08T16:33:45.855164-05:00,2009
6e9e0c2f-2ddb-40f1-8e8c-618119e62ec1,TCGA-AA-3488,TCGA-COAD,58,-21519,153,22372700-c2f3-5b29-936a-aa0f0de0639c,not reported,male,not reported,released,TCGA-AA-3488_demographic,2019-07-31T18:41:50.703011-05:00,Dead,1944,2002,21519,M1,N2,Stage IV,T3,5th,not reported,--,b52160a1-a328-520a-bfb1-a783a09927e5,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-AA-3488_diagnosis,No,Rectosigmoid junction,--,released,TCGA-AA-3488_treatment,6669c9f1-f66e-5faf-9939-908ea277de95,not reported,"Radiation Therapy, NOS",2019-07-31T18:41:50.703011-05:00,not reported,stage iv,2019-08-08T16:34:13.342472-05:00,2002
6e9e0c2f-2ddb-40f1-8e8c-618119e62ec1,TCGA-AA-3488,TCGA-COAD,58,-21519,153,22372700-c2f3-5b29-936a-aa0f0de0639c,not reported,male,not reported,released,TCGA-AA-3488_demographic,2019-07-31T18:41:50.703011-05:00,Dead,1944,2002,21519,M1,N2,Stage IV,T3,5th,not reported,--,b52160a1-a328-520a-bfb1-a783a09927e5,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-AA-3488_diagnosis,No,Rectosigmoid junction,2019-04-28T11:25:30.651299-05:00,released,TCGA-AA-3488_treatment_1,5cdd6351-e09f-5160-adc5-5397d908c980,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:50.703011-05:00,not reported,stage iv,2019-08-08T16:34:13.342472-05:00,2002
7144a65f-a63f-4b79-8fe2-cfe48696de03,TCGA-G4-6302,TCGA-COAD,90,-32872,--,0fb8220a-e834-51f9-bf42-968596293789,not hispanic or latino,female,white,released,TCGA-G4-6302_demographic,2019-07-31T18:30:27.889946-05:00,Dead,1916,--,32872,M0,N0,Stage IIA,T3,6th,not reported,--,4d824623-649b-532f-bee5-d404b1aa2289,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-G4-6302_diagnosis,No,Cecum,--,released,TCGA-G4-6302_treatment,9a80f8e7-3060-5c23-922e-d2a039397bb3,no,"Radiation Therapy, NOS",2019-07-31T18:30:27.889946-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2006
7144a65f-a63f-4b79-8fe2-cfe48696de03,TCGA-G4-6302,TCGA-COAD,90,-32872,--,0fb8220a-e834-51f9-bf42-968596293789,not hispanic or latino,female,white,released,TCGA-G4-6302_demographic,2019-07-31T18:30:27.889946-05:00,Dead,1916,--,32872,M0,N0,Stage IIA,T3,6th,not reported,--,4d824623-649b-532f-bee5-d404b1aa2289,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-G4-6302_diagnosis,No,Cecum,2019-04-28T11:16:01.567696-05:00,released,TCGA-G4-6302_treatment_1,d8d9a70f-657f-57d9-8f65-076cd055476f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:27.889946-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2006
abe658e0-33f9-4f57-849b-dec4d20964d6,TCGA-G4-6314,TCGA-COAD,76,-27958,--,2d92831f-7ef0-5e37-8002-1159276605a2,not hispanic or latino,female,white,released,TCGA-G4-6314_demographic,2019-07-31T18:34:23.715531-05:00,Alive,1932,--,27958,M1,N2,Stage IV,T3,6th,not reported,1093,3091e2ae-a6f2-5cb9-8fc5-4ceeeef0f864,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6314_diagnosis,Not Reported,Cecum,2019-04-28T11:19:14.630320-05:00,released,TCGA-G4-6314_treatment_1,3b0fcd87-0f2b-58ab-878a-52404320287c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:23.715531-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2008
abe658e0-33f9-4f57-849b-dec4d20964d6,TCGA-G4-6314,TCGA-COAD,76,-27958,--,2d92831f-7ef0-5e37-8002-1159276605a2,not hispanic or latino,female,white,released,TCGA-G4-6314_demographic,2019-07-31T18:34:23.715531-05:00,Alive,1932,--,27958,M1,N2,Stage IV,T3,6th,not reported,1093,3091e2ae-a6f2-5cb9-8fc5-4ceeeef0f864,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6314_diagnosis,Not Reported,Cecum,--,released,TCGA-G4-6314_treatment,e4a6d7b6-9352-5b12-8bbf-9a32a4ac027b,no,"Radiation Therapy, NOS",2019-07-31T18:34:23.715531-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2008
d8e9ea52-ff28-4626-baa3-71350fd53ddf,TCGA-AY-A54L,TCGA-COAD,74,-27074,--,31b56f9b-7ea9-5261-9f2a-b02b75387f67,not reported,female,black or african american,released,TCGA-AY-A54L_demographic,2019-07-31T15:55:09.971667-05:00,Alive,1938,--,27074,M0,N0,Stage I,T2,7th,not reported,525,af0fee33-b63d-574d-ae4e-70506f32a99f,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AY-A54L_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-AY-A54L_treatment,18bb45ae-5a87-5894-bfb3-4fb185139d78,no,"Radiation Therapy, NOS",2019-07-31T15:55:09.971667-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2012
d8e9ea52-ff28-4626-baa3-71350fd53ddf,TCGA-AY-A54L,TCGA-COAD,74,-27074,--,31b56f9b-7ea9-5261-9f2a-b02b75387f67,not reported,female,black or african american,released,TCGA-AY-A54L_demographic,2019-07-31T15:55:09.971667-05:00,Alive,1938,--,27074,M0,N0,Stage I,T2,7th,not reported,525,af0fee33-b63d-574d-ae4e-70506f32a99f,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AY-A54L_diagnosis,No,Hepatic flexure of colon,2019-04-28T09:10:03.916812-05:00,released,TCGA-AY-A54L_treatment_1,ac68e81f-1afc-50f3-b2d6-126c7bc398d8,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:55:09.971667-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2012
39d3b5b3-d51e-4d77-a8aa-2977fa734fab,TCGA-AA-3869,TCGA-COAD,76,-28062,822,c5a52726-4f01-5772-b2d3-0bfae555512e,not reported,male,not reported,released,TCGA-AA-3869_demographic,2019-07-31T18:27:00.999740-05:00,Dead,1933,--,28062,M1,N2,Stage IV,T4,6th,not reported,--,59781278-ba80-557b-8bbb-8ce666fbdb2b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3869_diagnosis,No,Cecum,2019-04-28T11:13:09.790382-05:00,released,TCGA-AA-3869_treatment_1,2401c58e-2b35-5448-a4c7-5db762832338,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:00.999740-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
39d3b5b3-d51e-4d77-a8aa-2977fa734fab,TCGA-AA-3869,TCGA-COAD,76,-28062,822,c5a52726-4f01-5772-b2d3-0bfae555512e,not reported,male,not reported,released,TCGA-AA-3869_demographic,2019-07-31T18:27:00.999740-05:00,Dead,1933,--,28062,M1,N2,Stage IV,T4,6th,not reported,--,59781278-ba80-557b-8bbb-8ce666fbdb2b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3869_diagnosis,No,Cecum,--,released,TCGA-AA-3869_treatment,649145da-5a62-5476-abaf-02a83e577d57,no,"Radiation Therapy, NOS",2019-07-31T18:27:00.999740-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
ac13d568-f79e-4ba7-b7bf-18e4354e0920,TCGA-D5-6532,TCGA-COAD,61,-22344,--,7091e4c0-7d46-5e13-90fe-2b0332d271e4,not hispanic or latino,male,white,released,TCGA-D5-6532_demographic,2019-07-31T18:34:26.833135-05:00,Alive,1949,--,22344,M0,N0,Stage IIA,T3,--,not reported,555,2014341e-cff1-50ff-a76e-cd349ed64fb5,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6532_diagnosis,No,Sigmoid colon,2019-04-28T11:19:17.313194-05:00,released,TCGA-D5-6532_treatment_1,e7b55592-9ec6-56a0-84f8-b215aedeef7c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:26.833135-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
ac13d568-f79e-4ba7-b7bf-18e4354e0920,TCGA-D5-6532,TCGA-COAD,61,-22344,--,7091e4c0-7d46-5e13-90fe-2b0332d271e4,not hispanic or latino,male,white,released,TCGA-D5-6532_demographic,2019-07-31T18:34:26.833135-05:00,Alive,1949,--,22344,M0,N0,Stage IIA,T3,--,not reported,555,2014341e-cff1-50ff-a76e-cd349ed64fb5,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6532_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6532_treatment,f9c3599c-93ca-5d7a-9170-beb99c720bb6,no,"Radiation Therapy, NOS",2019-07-31T18:34:26.833135-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
cc1d6ad3-b60d-482e-8fa4-0af26823007d,TCGA-CM-5863,TCGA-COAD,60,-22127,--,e0b1d021-4b78-541b-b63a-1030fb3b9a24,not hispanic or latino,female,white,released,TCGA-CM-5863_demographic,2019-07-31T18:37:25.394451-05:00,Alive,1950,--,22127,M0,N1b,Stage IIIB,T3,7th,not reported,457,fdd1b003-3414-5cc1-80b0-f0d44f82bf3e,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CM-5863_diagnosis,No,Ascending colon,--,released,TCGA-CM-5863_treatment,b42b53bc-441c-5382-aad5-ee7f0b5fe456,no,"Radiation Therapy, NOS",2019-07-31T18:37:25.394451-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
cc1d6ad3-b60d-482e-8fa4-0af26823007d,TCGA-CM-5863,TCGA-COAD,60,-22127,--,e0b1d021-4b78-541b-b63a-1030fb3b9a24,not hispanic or latino,female,white,released,TCGA-CM-5863_demographic,2019-07-31T18:37:25.394451-05:00,Alive,1950,--,22127,M0,N1b,Stage IIIB,T3,7th,not reported,457,fdd1b003-3414-5cc1-80b0-f0d44f82bf3e,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CM-5863_diagnosis,No,Ascending colon,2019-04-28T11:21:44.257739-05:00,released,TCGA-CM-5863_treatment_1,b437f4b5-7f84-5911-b29b-9ce89ce947d6,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:25.394451-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
b16bb717-d1cf-4237-a554-43f3995b82f2,TCGA-AA-3815,TCGA-COAD,65,-23922,--,8960346c-1041-5498-9029-a21db0d95b7e,not reported,female,not reported,released,TCGA-AA-3815_demographic,2019-07-31T18:34:59.839783-05:00,Alive,1942,--,23922,M0,N0,Stage IIA,T3,6th,not reported,1005,ff509225-8cad-5d5d-8cc2-7c8c57c523a4,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3815_diagnosis,No,Cecum,--,released,TCGA-AA-3815_treatment,3285e3ab-1be3-58c7-8c02-75e01dcbe8f9,no,"Radiation Therapy, NOS",2019-07-31T18:34:59.839783-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
b16bb717-d1cf-4237-a554-43f3995b82f2,TCGA-AA-3815,TCGA-COAD,65,-23922,--,8960346c-1041-5498-9029-a21db0d95b7e,not reported,female,not reported,released,TCGA-AA-3815_demographic,2019-07-31T18:34:59.839783-05:00,Alive,1942,--,23922,M0,N0,Stage IIA,T3,6th,not reported,1005,ff509225-8cad-5d5d-8cc2-7c8c57c523a4,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3815_diagnosis,No,Cecum,2019-04-28T11:19:45.262005-05:00,released,TCGA-AA-3815_treatment_1,4ebfe82e-51ec-5bb3-af03-57f89410a78a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:59.839783-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
d5a296ae-c165-413c-adcc-33c9e99ff873,TCGA-D5-7000,TCGA-COAD,79,-28913,--,cac9309f-9c47-50f4-8ebe-1e09efefba1e,not hispanic or latino,female,white,released,TCGA-D5-7000_demographic,2019-07-31T18:42:52.417357-05:00,Alive,1932,--,28913,M0,N0,Stage I,T2,7th,not reported,312,a8b868c3-91a6-54f5-9887-7609a489a8e6,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-D5-7000_diagnosis,No,Cecum,--,released,TCGA-D5-7000_treatment,8e6bb396-5e96-52e4-b4a1-01cd97040441,no,"Radiation Therapy, NOS",2019-07-31T18:42:52.417357-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2011
d5a296ae-c165-413c-adcc-33c9e99ff873,TCGA-D5-7000,TCGA-COAD,79,-28913,--,cac9309f-9c47-50f4-8ebe-1e09efefba1e,not hispanic or latino,female,white,released,TCGA-D5-7000_demographic,2019-07-31T18:42:52.417357-05:00,Alive,1932,--,28913,M0,N0,Stage I,T2,7th,not reported,312,a8b868c3-91a6-54f5-9887-7609a489a8e6,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-D5-7000_diagnosis,No,Cecum,2019-04-28T11:26:24.505010-05:00,released,TCGA-D5-7000_treatment_1,8ef60676-7b99-51ec-93c0-6eb5c3e27f51,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:52.417357-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2011
85bdc1ac-a1a4-46c2-bc2d-e5fabf5c89e9,TCGA-DM-A28E,TCGA-COAD,72,-26602,--,191a26f7-6218-55b1-803d-8aa5ad8a2db6,not hispanic or latino,female,white,released,TCGA-DM-A28E_demographic,2019-07-31T18:31:57.851279-05:00,Alive,1929,--,26602,M0,N0,Stage IIA,T3,6th,not reported,3648,ae2c9a12-1c86-51ee-b51f-cb56cb5e9b82,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A28E_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A28E_treatment,b110ab71-f0a4-5def-a627-1893d474d1c7,not reported,"Radiation Therapy, NOS",2019-07-31T18:31:57.851279-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
85bdc1ac-a1a4-46c2-bc2d-e5fabf5c89e9,TCGA-DM-A28E,TCGA-COAD,72,-26602,--,191a26f7-6218-55b1-803d-8aa5ad8a2db6,not hispanic or latino,female,white,released,TCGA-DM-A28E_demographic,2019-07-31T18:31:57.851279-05:00,Alive,1929,--,26602,M0,N0,Stage IIA,T3,6th,not reported,3648,ae2c9a12-1c86-51ee-b51f-cb56cb5e9b82,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A28E_diagnosis,No,Sigmoid colon,2019-04-28T11:17:16.568065-05:00,released,TCGA-DM-A28E_treatment_1,d120ec36-388f-502d-912c-8f47ff3d89f0,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:57.851279-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
76e96b5a-b565-42c7-a651-34d5132e6dde,TCGA-CM-6679,TCGA-COAD,58,-21519,--,00fbda86-7554-568e-839c-baf98379d0b8,not hispanic or latino,male,white,released,TCGA-CM-6679_demographic,2019-07-31T18:30:55.059254-05:00,Alive,1953,--,21519,M0,N0,Stage IIA,T3,7th,not reported,306,5dd13842-d923-5e9a-9968-30299c7bb39c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6679_diagnosis,No,Sigmoid colon,2019-04-28T11:16:23.295173-05:00,released,TCGA-CM-6679_treatment_1,65cf8832-8973-590d-8c9a-8561142464d1,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:55.059254-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2011
76e96b5a-b565-42c7-a651-34d5132e6dde,TCGA-CM-6679,TCGA-COAD,58,-21519,--,00fbda86-7554-568e-839c-baf98379d0b8,not hispanic or latino,male,white,released,TCGA-CM-6679_demographic,2019-07-31T18:30:55.059254-05:00,Alive,1953,--,21519,M0,N0,Stage IIA,T3,7th,not reported,306,5dd13842-d923-5e9a-9968-30299c7bb39c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6679_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6679_treatment,a5ca5e8f-9ea3-5545-95f9-aa8a2a04e523,no,"Radiation Therapy, NOS",2019-07-31T18:30:55.059254-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2011
490eabca-4575-4bd6-9604-6b6e23d069ce,TCGA-NH-A50T,TCGA-COAD,68,-25089,--,b0dcda03-2548-5498-b4ce-2afa432c89d3,not hispanic or latino,female,black or african american,released,TCGA-NH-A50T_demographic,2019-07-31T15:52:05.805483-05:00,Alive,1944,--,25089,MX,N0,Stage IIA,T3,7th,not reported,553,becb2a7c-39c6-5aec-a7fa-b394063a3600,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-NH-A50T_diagnosis,No,Splenic flexure of colon,2019-04-28T09:07:32.492970-05:00,released,TCGA-NH-A50T_treatment_1,fbf9bccb-37f5-5010-9895-4cc08199d487,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:52:05.805483-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2012
490eabca-4575-4bd6-9604-6b6e23d069ce,TCGA-NH-A50T,TCGA-COAD,68,-25089,--,b0dcda03-2548-5498-b4ce-2afa432c89d3,not hispanic or latino,female,black or african american,released,TCGA-NH-A50T_demographic,2019-07-31T15:52:05.805483-05:00,Alive,1944,--,25089,MX,N0,Stage IIA,T3,7th,not reported,553,becb2a7c-39c6-5aec-a7fa-b394063a3600,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-NH-A50T_diagnosis,No,Splenic flexure of colon,--,released,TCGA-NH-A50T_treatment,4a9bd90e-2954-5e19-bcb0-afd37f0f837d,no,"Radiation Therapy, NOS",2019-07-31T15:52:05.805483-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2012
0f74d992-00da-4728-9564-086ca1b95921,TCGA-A6-2679,TCGA-COAD,73,-26820,--,02d1eacf-3d26-5d2f-8850-09b27c585787,not hispanic or latino,female,white,released,TCGA-A6-2679_demographic,2019-07-31T18:23:32.264546-05:00,Alive,1936,--,26820,--,N0,Stage IIB,T3,6th,not reported,1366,9fb756f6-d611-5c22-bebc-e14dc407b293,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-2679_diagnosis,No,Ascending colon,2019-04-28T11:10:15.151367-05:00,released,TCGA-A6-2679_treatment_1,ce0e6b06-afbc-5865-91cc-1e60c2ba243f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:32.264546-05:00,not reported,stage iib,2019-08-08T16:33:45.855164-05:00,2009
0f74d992-00da-4728-9564-086ca1b95921,TCGA-A6-2679,TCGA-COAD,73,-26820,--,02d1eacf-3d26-5d2f-8850-09b27c585787,not hispanic or latino,female,white,released,TCGA-A6-2679_demographic,2019-07-31T18:23:32.264546-05:00,Alive,1936,--,26820,--,N0,Stage IIB,T3,6th,not reported,1366,9fb756f6-d611-5c22-bebc-e14dc407b293,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-2679_diagnosis,No,Ascending colon,--,released,TCGA-A6-2679_treatment,12e9ea4e-defd-5518-a6f1-25795e3374a6,no,"Radiation Therapy, NOS",2019-07-31T18:23:32.264546-05:00,not reported,stage iib,2019-08-08T16:33:45.855164-05:00,2009
e2edbf3f-25d8-49aa-b656-2a59c3b99aeb,TCGA-AA-A01D,TCGA-COAD,47,-17318,334,e8c679ff-8a2e-5865-bae0-595d0c0e9b9e,not reported,female,not reported,released,TCGA-AA-A01D_demographic,2019-07-31T18:39:02.262114-05:00,Dead,1962,--,17318,M0,N2,Stage IIIC,T3,6th,not reported,30,733d7252-78bf-5188-becb-e3a8e830a948,C19,8480/3,Mucinous adenocarcinoma,no,No,not reported,Rectosigmoid junction,released,TCGA-AA-A01D_diagnosis,No,Rectosigmoid junction,2019-04-28T11:23:08.847511-05:00,released,TCGA-AA-A01D_treatment_1,b93df8ed-ee94-5a63-9815-d5db0f680b3d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:02.262114-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2009
e2edbf3f-25d8-49aa-b656-2a59c3b99aeb,TCGA-AA-A01D,TCGA-COAD,47,-17318,334,e8c679ff-8a2e-5865-bae0-595d0c0e9b9e,not reported,female,not reported,released,TCGA-AA-A01D_demographic,2019-07-31T18:39:02.262114-05:00,Dead,1962,--,17318,M0,N2,Stage IIIC,T3,6th,not reported,30,733d7252-78bf-5188-becb-e3a8e830a948,C19,8480/3,Mucinous adenocarcinoma,no,No,not reported,Rectosigmoid junction,released,TCGA-AA-A01D_diagnosis,No,Rectosigmoid junction,--,released,TCGA-AA-A01D_treatment,be85d18f-9596-5b38-86d5-b2b68b7be3fd,no,"Radiation Therapy, NOS",2019-07-31T18:39:02.262114-05:00,not reported,stage iiic,2019-08-08T16:35:29.811838-05:00,2009
f4e047a5-bdb2-4bc2-aff0-e0f45bcc9062,TCGA-CM-6165,TCGA-COAD,74,-27302,--,e9a0fed5-aa17-54fa-9582-a0c96c661eb9,not hispanic or latino,male,white,released,TCGA-CM-6165_demographic,2019-07-31T18:40:26.830700-05:00,Alive,1936,--,27302,M0,N0,Stage IIA,T3,7th,not reported,488,1ed95394-78fd-5ce8-943c-2444c934e5fa,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6165_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6165_treatment,5783d78a-5733-5c85-aa15-9399262eda20,no,"Radiation Therapy, NOS",2019-07-31T18:40:26.830700-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
f4e047a5-bdb2-4bc2-aff0-e0f45bcc9062,TCGA-CM-6165,TCGA-COAD,74,-27302,--,e9a0fed5-aa17-54fa-9582-a0c96c661eb9,not hispanic or latino,male,white,released,TCGA-CM-6165_demographic,2019-07-31T18:40:26.830700-05:00,Alive,1936,--,27302,M0,N0,Stage IIA,T3,7th,not reported,488,1ed95394-78fd-5ce8-943c-2444c934e5fa,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6165_diagnosis,No,Sigmoid colon,2019-04-28T11:24:19.163953-05:00,released,TCGA-CM-6165_treatment_1,9706e62f-bc9d-51cc-b507-79c4f5666c58,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:26.830700-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
f6c674bf-396d-4bfe-8d08-e7266c314be3,TCGA-AY-6197,TCGA-COAD,60,-21957,--,8144d3ff-3b1c-58de-bc55-0087da104ab1,not hispanic or latino,male,white,released,TCGA-AY-6197_demographic,2019-07-31T18:40:32.882821-05:00,Alive,1950,--,21957,--,N0,Stage IIA,T3,7th,not reported,652,fe4ed6b2-940d-5717-925a-98b87ad70188,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-6197_diagnosis,No,Ascending colon,--,released,TCGA-AY-6197_treatment,69cc9d13-2606-5442-ab06-7e2ef23d9e02,no,"Radiation Therapy, NOS",2019-07-31T18:40:32.882821-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
f6c674bf-396d-4bfe-8d08-e7266c314be3,TCGA-AY-6197,TCGA-COAD,60,-21957,--,8144d3ff-3b1c-58de-bc55-0087da104ab1,not hispanic or latino,male,white,released,TCGA-AY-6197_demographic,2019-07-31T18:40:32.882821-05:00,Alive,1950,--,21957,--,N0,Stage IIA,T3,7th,not reported,652,fe4ed6b2-940d-5717-925a-98b87ad70188,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-6197_diagnosis,No,Ascending colon,2019-04-28T11:24:24.049125-05:00,released,TCGA-AY-6197_treatment_1,99242146-c31a-5c81-a81b-cf3d0287c84c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:32.882821-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
1e0789d6-7efb-4807-8d36-cd9224675a0c,TCGA-NH-A8F8,TCGA-COAD,79,-29185,511,e0c3e476-04e4-5f50-937c-349d2475c93c,not hispanic or latino,male,black or african american,released,TCGA-NH-A8F8_demographic,2019-07-31T15:52:52.168716-05:00,Dead,1934,--,29185,M1,N2b,Stage IV,T4a,7th,not reported,167,ed18144d-6234-56bc-be7e-8db632076627,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-NH-A8F8_diagnosis,No,Ascending colon,2019-04-28T09:08:09.420116-05:00,released,TCGA-NH-A8F8_treatment_1,2d06febf-2316-5d5b-b0d3-30cebd159da3,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:52:52.168716-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2013
1e0789d6-7efb-4807-8d36-cd9224675a0c,TCGA-NH-A8F8,TCGA-COAD,79,-29185,511,e0c3e476-04e4-5f50-937c-349d2475c93c,not hispanic or latino,male,black or african american,released,TCGA-NH-A8F8_demographic,2019-07-31T15:52:52.168716-05:00,Dead,1934,--,29185,M1,N2b,Stage IV,T4a,7th,not reported,167,ed18144d-6234-56bc-be7e-8db632076627,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-NH-A8F8_diagnosis,No,Ascending colon,--,released,TCGA-NH-A8F8_treatment,5baed5d3-9a90-59c6-8a45-15140bc619ca,no,"Radiation Therapy, NOS",2019-07-31T15:52:52.168716-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2013
ca22edd4-eb7c-4677-84aa-6f0354459a19,TCGA-AA-A00R,TCGA-COAD,64,-23528,--,577f05bb-c883-5b9b-b2bc-5a30a907ca94,not reported,female,not reported,released,TCGA-AA-A00R_demographic,2019-07-31T18:42:46.423729-05:00,Alive,1944,--,23528,M0,N0,Stage I,T2,6th,not reported,30,216f1d6a-6cb6-56cf-a370-e889b9fa096b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A00R_diagnosis,No,Cecum,--,released,TCGA-AA-A00R_treatment,b75f7997-d7cd-5bbb-832c-0b30ea9d6f06,not reported,"Radiation Therapy, NOS",2019-07-31T18:42:46.423729-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2008
ca22edd4-eb7c-4677-84aa-6f0354459a19,TCGA-AA-A00R,TCGA-COAD,64,-23528,--,577f05bb-c883-5b9b-b2bc-5a30a907ca94,not reported,female,not reported,released,TCGA-AA-A00R_demographic,2019-07-31T18:42:46.423729-05:00,Alive,1944,--,23528,M0,N0,Stage I,T2,6th,not reported,30,216f1d6a-6cb6-56cf-a370-e889b9fa096b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A00R_diagnosis,No,Cecum,2019-04-28T11:26:19.341569-05:00,released,TCGA-AA-A00R_treatment_1,14ef31b0-d5bb-57c7-a428-019c6a743a76,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:46.423729-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2008
ef4bb5bf-4535-4bd1-8a74-aba920123ee2,TCGA-D5-6539,TCGA-COAD,45,-16703,--,e2d72bcf-e2c7-56d6-b0ca-970431415b5f,not hispanic or latino,female,white,released,TCGA-D5-6539_demographic,2019-07-31T18:40:09.841472-05:00,Alive,1965,--,16703,M0,N0,--,T3,7th,not reported,380,4bfb1c19-97af-53f6-af54-e9f0eee857b4,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-D5-6539_diagnosis,No,Transverse colon,--,released,TCGA-D5-6539_treatment,3224c810-d63e-5da4-86c6-4e8b05f917ce,no,"Radiation Therapy, NOS",2019-07-31T18:40:09.841472-05:00,not reported,not reported,2019-08-08T16:36:52.154454-05:00,2010
ef4bb5bf-4535-4bd1-8a74-aba920123ee2,TCGA-D5-6539,TCGA-COAD,45,-16703,--,e2d72bcf-e2c7-56d6-b0ca-970431415b5f,not hispanic or latino,female,white,released,TCGA-D5-6539_demographic,2019-07-31T18:40:09.841472-05:00,Alive,1965,--,16703,M0,N0,--,T3,7th,not reported,380,4bfb1c19-97af-53f6-af54-e9f0eee857b4,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-D5-6539_diagnosis,No,Transverse colon,2019-04-28T11:24:06.659185-05:00,released,TCGA-D5-6539_treatment_1,761f84d5-afdc-5ad9-9ae1-957e2cd3e061,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:09.841472-05:00,not reported,not reported,2019-08-08T16:36:52.154454-05:00,2010
c59d90a6-9cda-426d-b8ea-41f0a87033d5,TCGA-AZ-4323,TCGA-COAD,37,-13755,43,8a7cdb16-d76e-5885-ad90-074d98f4d0b8,not hispanic or latino,male,white,released,TCGA-AZ-4323_demographic,2019-07-31T18:36:25.899595-05:00,Dead,1965,2002,13755,M1,N2,Stage IV,T4,--,not reported,--,77454d92-f720-56ea-8268-ca4ae9ddb755,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4323_diagnosis,No,Cecum,2019-04-28T11:20:56.386357-05:00,released,TCGA-AZ-4323_treatment_1,fa82469a-bf07-5d90-9cbd-5cafb10588be,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:25.899595-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2002
c59d90a6-9cda-426d-b8ea-41f0a87033d5,TCGA-AZ-4323,TCGA-COAD,37,-13755,43,8a7cdb16-d76e-5885-ad90-074d98f4d0b8,not hispanic or latino,male,white,released,TCGA-AZ-4323_demographic,2019-07-31T18:36:25.899595-05:00,Dead,1965,2002,13755,M1,N2,Stage IV,T4,--,not reported,--,77454d92-f720-56ea-8268-ca4ae9ddb755,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4323_diagnosis,No,Cecum,--,released,TCGA-AZ-4323_treatment,5218bf03-6acb-5789-9dd4-ab2fea75a17d,no,"Radiation Therapy, NOS",2019-07-31T18:36:25.899595-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2002
ebc5a6f8-34fd-48c1-a2b9-7f60f45fbf27,TCGA-D5-6537,TCGA-COAD,64,-23381,146,5d921ba9-005f-527b-8487-c1c9933d7fa7,not hispanic or latino,male,white,released,TCGA-D5-6537_demographic,2019-07-31T18:39:55.867777-05:00,Dead,1946,--,23381,MX,N1a,Stage IIIB,T3,7th,not reported,137,ea332b9d-93f4-55fa-8a52-4387a0e55de3,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-D5-6537_diagnosis,No,Transverse colon,2019-04-28T11:23:54.305008-05:00,released,TCGA-D5-6537_treatment_1,76692a06-1098-54b3-b974-79583416230f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:55.867777-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2010
ebc5a6f8-34fd-48c1-a2b9-7f60f45fbf27,TCGA-D5-6537,TCGA-COAD,64,-23381,146,5d921ba9-005f-527b-8487-c1c9933d7fa7,not hispanic or latino,male,white,released,TCGA-D5-6537_demographic,2019-07-31T18:39:55.867777-05:00,Dead,1946,--,23381,MX,N1a,Stage IIIB,T3,7th,not reported,137,ea332b9d-93f4-55fa-8a52-4387a0e55de3,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-D5-6537_diagnosis,No,Transverse colon,--,released,TCGA-D5-6537_treatment,d07ccad2-180e-5520-979a-b702d0b35ced,no,"Radiation Therapy, NOS",2019-07-31T18:39:55.867777-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2010
a435fdf4-a89a-499e-9006-cbb5693eab26,TCGA-AA-A02Y,TCGA-COAD,73,-26724,--,5db310cb-5c9c-5d21-bdd7-28e935a38ec1,not reported,male,not reported,released,TCGA-AA-A02Y_demographic,2019-07-31T18:33:44.432650-05:00,Alive,1934,--,26724,M0,N0,Stage I,T2,6th,not reported,1216,fdcd8dda-1d70-5ccb-b84f-b54428d94a44,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A02Y_diagnosis,No,Cecum,2019-04-28T11:18:43.927696-05:00,released,TCGA-AA-A02Y_treatment_1,559f0db8-7756-5add-8a7f-b1a0738a2616,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:44.432650-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2007
a435fdf4-a89a-499e-9006-cbb5693eab26,TCGA-AA-A02Y,TCGA-COAD,73,-26724,--,5db310cb-5c9c-5d21-bdd7-28e935a38ec1,not reported,male,not reported,released,TCGA-AA-A02Y_demographic,2019-07-31T18:33:44.432650-05:00,Alive,1934,--,26724,M0,N0,Stage I,T2,6th,not reported,1216,fdcd8dda-1d70-5ccb-b84f-b54428d94a44,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A02Y_diagnosis,No,Cecum,--,released,TCGA-AA-A02Y_treatment,24206bfd-6b95-521c-a4f4-c379d48fa149,no,"Radiation Therapy, NOS",2019-07-31T18:33:44.432650-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2007
db246424-3979-4f23-b316-8d30c449ee15,TCGA-AA-3984,TCGA-COAD,61,-22585,--,e3e37e37-4885-5ae2-ac09-a24b9bccaf98,not reported,female,not reported,released,TCGA-AA-3984_demographic,2019-07-31T18:38:29.903545-05:00,Alive,1948,--,22585,M0,N0,Stage IIA,T3,6th,not reported,--,8ca947bf-1e8b-559c-859c-bf9e24a736e0,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3984_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3984_treatment,b17eedc0-dd91-5d99-abd8-42c5a1e9acb0,not reported,"Radiation Therapy, NOS",2019-07-31T18:38:29.903545-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
db246424-3979-4f23-b316-8d30c449ee15,TCGA-AA-3984,TCGA-COAD,61,-22585,--,e3e37e37-4885-5ae2-ac09-a24b9bccaf98,not reported,female,not reported,released,TCGA-AA-3984_demographic,2019-07-31T18:38:29.903545-05:00,Alive,1948,--,22585,M0,N0,Stage IIA,T3,6th,not reported,--,8ca947bf-1e8b-559c-859c-bf9e24a736e0,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3984_diagnosis,No,Sigmoid colon,2019-04-28T11:22:40.696981-05:00,released,TCGA-AA-3984_treatment_1,a2325983-d0fd-5843-aa77-81580958f622,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:29.903545-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
c7c5348f-5708-45bf-b40e-1bf7c9348f60,TCGA-A6-6142,TCGA-COAD,56,-20485,--,1657bd60-dd18-5467-aa4d-a9e304dbc9c3,not hispanic or latino,female,white,released,TCGA-A6-6142_demographic,2019-07-31T18:36:43.822686-05:00,Alive,1955,--,20485,M1a,N1a,Stage IVA,T3,7th,not reported,763,978c97a1-d97b-5dba-a6ff-5708b6bf4526,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-6142_diagnosis,No,Sigmoid colon,2019-04-28T11:21:11.570637-05:00,released,TCGA-A6-6142_treatment_1,b2f629c6-fba0-5a65-8920-be9f0f3716f3,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:43.822686-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2011
c7c5348f-5708-45bf-b40e-1bf7c9348f60,TCGA-A6-6142,TCGA-COAD,56,-20485,--,1657bd60-dd18-5467-aa4d-a9e304dbc9c3,not hispanic or latino,female,white,released,TCGA-A6-6142_demographic,2019-07-31T18:36:43.822686-05:00,Alive,1955,--,20485,M1a,N1a,Stage IVA,T3,7th,not reported,763,978c97a1-d97b-5dba-a6ff-5708b6bf4526,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-6142_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-6142_treatment,f5d98677-62d3-5a2b-a347-83b888f5c316,no,"Radiation Therapy, NOS",2019-07-31T18:36:43.822686-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2011
849442d3-eb82-416e-9d36-2fc15dfac67a,TCGA-DM-A1D4,TCGA-COAD,80,-29403,2821,1bc292f5-e894-5a4b-8611-fe8d9c0fc7f1,not hispanic or latino,male,white,released,TCGA-DM-A1D4_demographic,2019-07-31T18:31:51.832057-05:00,Dead,1919,2006,29403,M0,N0,Stage IIA,T3,--,not reported,2821,fead98ec-33e6-50e1-b99a-7545e6325300,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A1D4_diagnosis,No,Cecum,2019-04-28T11:17:10.556683-05:00,released,TCGA-DM-A1D4_treatment_1,0a45232f-9acc-5973-a6f4-9a523ea042f2,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:51.832057-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,1999
849442d3-eb82-416e-9d36-2fc15dfac67a,TCGA-DM-A1D4,TCGA-COAD,80,-29403,2821,1bc292f5-e894-5a4b-8611-fe8d9c0fc7f1,not hispanic or latino,male,white,released,TCGA-DM-A1D4_demographic,2019-07-31T18:31:51.832057-05:00,Dead,1919,2006,29403,M0,N0,Stage IIA,T3,--,not reported,2821,fead98ec-33e6-50e1-b99a-7545e6325300,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A1D4_diagnosis,No,Cecum,--,released,TCGA-DM-A1D4_treatment,2b788434-fef4-5391-be08-4494d81121f8,not reported,"Radiation Therapy, NOS",2019-07-31T18:31:51.832057-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,1999
2b94070a-21ec-457b-88af-3d2a89b97ac6,TCGA-AA-3712,TCGA-COAD,65,-23831,--,9c60413d-7219-52ee-9d5e-cc5f15c2f7ce,not reported,male,not reported,released,TCGA-AA-3712_demographic,2019-07-31T18:25:49.559834-05:00,Alive,1939,--,23831,M0,N2,Stage III,T3,5th,not reported,--,8ac722ac-b6c7-5aa3-aa6b-4f9c8eb87500,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-AA-3712_diagnosis,No,Descending colon,--,released,TCGA-AA-3712_treatment,453ad2a5-3155-596d-a9cc-61e35db83ce8,not reported,"Radiation Therapy, NOS",2019-07-31T18:25:49.559834-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2004
2b94070a-21ec-457b-88af-3d2a89b97ac6,TCGA-AA-3712,TCGA-COAD,65,-23831,--,9c60413d-7219-52ee-9d5e-cc5f15c2f7ce,not reported,male,not reported,released,TCGA-AA-3712_demographic,2019-07-31T18:25:49.559834-05:00,Alive,1939,--,23831,M0,N2,Stage III,T3,5th,not reported,--,8ac722ac-b6c7-5aa3-aa6b-4f9c8eb87500,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-AA-3712_diagnosis,No,Descending colon,2019-04-28T11:12:09.924440-05:00,released,TCGA-AA-3712_treatment_1,d236d810-9de5-59f7-8846-31610a0dfe03,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:49.559834-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2004
286cbae3-8324-43b7-9b20-0f40dda1588e,TCGA-D5-6930,TCGA-COAD,67,-24764,--,c1b22be9-1cf4-5a59-b394-72e89713de30,not hispanic or latino,male,white,released,TCGA-D5-6930_demographic,2019-07-31T18:25:35.087220-05:00,Alive,1944,--,24764,M0,N0,Stage IIA,T3,7th,not reported,406,af57e04f-922e-5a31-b1f0-4a2ae169f575,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-D5-6930_diagnosis,No,Cecum,2019-04-28T11:11:57.122338-05:00,released,TCGA-D5-6930_treatment_1,83d1e1d0-0e77-53a6-9dd8-846282e42452,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:35.087220-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
286cbae3-8324-43b7-9b20-0f40dda1588e,TCGA-D5-6930,TCGA-COAD,67,-24764,--,c1b22be9-1cf4-5a59-b394-72e89713de30,not hispanic or latino,male,white,released,TCGA-D5-6930_demographic,2019-07-31T18:25:35.087220-05:00,Alive,1944,--,24764,M0,N0,Stage IIA,T3,7th,not reported,406,af57e04f-922e-5a31-b1f0-4a2ae169f575,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-D5-6930_diagnosis,No,Cecum,--,released,TCGA-D5-6930_treatment,fa798d2f-bdf0-587f-9356-3b0ec2c30173,no,"Radiation Therapy, NOS",2019-07-31T18:25:35.087220-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
be85f845-b281-467c-8b97-bed7b7fdff64,TCGA-D5-6924,TCGA-COAD,68,-24964,--,c8d9fd52-6e3a-51dc-9079-18d7a326654c,not hispanic or latino,male,white,released,TCGA-D5-6924_demographic,2019-07-31T18:35:47.126331-05:00,Alive,1943,--,24964,M0,N0,Stage IIA,T3,7th,not reported,435,a93300be-6f11-5e17-96e9-d09fbd1e5bbf,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6924_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6924_treatment,68f2bb47-5dde-5ca7-8da7-9d2f0a7c5fc3,no,"Radiation Therapy, NOS",2019-07-31T18:35:47.126331-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
be85f845-b281-467c-8b97-bed7b7fdff64,TCGA-D5-6924,TCGA-COAD,68,-24964,--,c8d9fd52-6e3a-51dc-9079-18d7a326654c,not hispanic or latino,male,white,released,TCGA-D5-6924_demographic,2019-07-31T18:35:47.126331-05:00,Alive,1943,--,24964,M0,N0,Stage IIA,T3,7th,not reported,435,a93300be-6f11-5e17-96e9-d09fbd1e5bbf,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6924_diagnosis,No,Sigmoid colon,2019-04-28T11:20:24.501022-05:00,released,TCGA-D5-6924_treatment_1,854f1ae1-73d0-5375-926d-24836391e701,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:47.126331-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2011
6f2b5a14-569c-4084-8c67-b1a44d787897,TCGA-AA-A01G,TCGA-COAD,63,-23133,--,2b6d02fb-f076-59e4-ac66-c970ede21ce0,not reported,male,not reported,released,TCGA-AA-A01G_demographic,2019-07-31T18:41:53.905234-05:00,Alive,1946,--,23133,M0,N0,Stage IIA,T3,6th,not reported,365,b1200905-f7bb-5810-adad-bc0a6f859aae,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-A01G_diagnosis,No,Cecum,2019-04-28T11:25:33.522993-05:00,released,TCGA-AA-A01G_treatment_1,94ccf463-6785-5db4-870f-a4ff191bc482,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:53.905234-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2009
6f2b5a14-569c-4084-8c67-b1a44d787897,TCGA-AA-A01G,TCGA-COAD,63,-23133,--,2b6d02fb-f076-59e4-ac66-c970ede21ce0,not reported,male,not reported,released,TCGA-AA-A01G_demographic,2019-07-31T18:41:53.905234-05:00,Alive,1946,--,23133,M0,N0,Stage IIA,T3,6th,not reported,365,b1200905-f7bb-5810-adad-bc0a6f859aae,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-A01G_diagnosis,No,Cecum,--,released,TCGA-AA-A01G_treatment,01ad1c36-4288-5480-8ccc-462365f6d303,no,"Radiation Therapy, NOS",2019-07-31T18:41:53.905234-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2009
c594196e-49ef-4195-a6b6-4ef4a1d9ec15,TCGA-AA-3538,TCGA-COAD,54,-19752,--,52fd0e75-a7b2-55c9-a298-2ea7f54ab8e8,not reported,female,not reported,released,TCGA-AA-3538_demographic,2019-07-31T18:36:22.652410-05:00,Alive,1954,--,19752,M0,N0,Stage I,T2,6th,not reported,791,1f283489-a15c-5177-9d42-551a578dd6ae,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3538_diagnosis,No,Sigmoid colon,2019-04-28T11:20:53.787018-05:00,released,TCGA-AA-3538_treatment_1,273f2518-6b11-5b4f-b64a-a2b53862e4b7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:22.652410-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
c594196e-49ef-4195-a6b6-4ef4a1d9ec15,TCGA-AA-3538,TCGA-COAD,54,-19752,--,52fd0e75-a7b2-55c9-a298-2ea7f54ab8e8,not reported,female,not reported,released,TCGA-AA-3538_demographic,2019-07-31T18:36:22.652410-05:00,Alive,1954,--,19752,M0,N0,Stage I,T2,6th,not reported,791,1f283489-a15c-5177-9d42-551a578dd6ae,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3538_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3538_treatment,f8f535ab-c153-5298-9911-44085d46490b,no,"Radiation Therapy, NOS",2019-07-31T18:36:22.652410-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
aee20b98-df51-4ead-86cc-0d5f60a74b90,TCGA-AZ-6600,TCGA-COAD,64,-23581,368,b6889148-140a-5a54-9f51-94f386ba49a0,not hispanic or latino,male,black or african american,released,TCGA-AZ-6600_demographic,2019-07-31T18:42:34.741708-05:00,Dead,1937,2002,23581,M1,N1,Stage IV,T4,5th,not reported,--,1e80f65b-6805-5579-b995-78644a73fac4,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-6600_diagnosis,No,Ascending colon,2019-04-28T11:26:09.381297-05:00,released,TCGA-AZ-6600_treatment_1,d10547cf-fec1-5b9f-8830-f9bd9e561bfc,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:34.741708-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2001
aee20b98-df51-4ead-86cc-0d5f60a74b90,TCGA-AZ-6600,TCGA-COAD,64,-23581,368,b6889148-140a-5a54-9f51-94f386ba49a0,not hispanic or latino,male,black or african american,released,TCGA-AZ-6600_demographic,2019-07-31T18:42:34.741708-05:00,Dead,1937,2002,23581,M1,N1,Stage IV,T4,5th,not reported,--,1e80f65b-6805-5579-b995-78644a73fac4,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AZ-6600_diagnosis,No,Ascending colon,--,released,TCGA-AZ-6600_treatment,e92da8e7-b8b1-50cc-9436-afd25958f9d0,no,"Radiation Therapy, NOS",2019-07-31T18:42:34.741708-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2001
3758f4f7-ac2f-4f9d-bee2-526196f8129a,TCGA-CK-5913,TCGA-COAD,58,-21399,--,ce8da64a-23fa-5424-83d5-2250c08362a4,not hispanic or latino,female,white,released,TCGA-CK-5913_demographic,2019-07-31T18:41:38.821950-05:00,Alive,1950,--,21399,MX,N0,Stage IIA,T3,6th,not reported,1561,6a26adb2-f82c-5dcf-a119-ad71b3f88342,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CK-5913_diagnosis,No,Ascending colon,2019-04-28T11:25:19.530526-05:00,released,TCGA-CK-5913_treatment_1,2c36f82a-1112-5023-ad9e-e4f09c37288a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:38.821950-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2008
3758f4f7-ac2f-4f9d-bee2-526196f8129a,TCGA-CK-5913,TCGA-COAD,58,-21399,--,ce8da64a-23fa-5424-83d5-2250c08362a4,not hispanic or latino,female,white,released,TCGA-CK-5913_demographic,2019-07-31T18:41:38.821950-05:00,Alive,1950,--,21399,MX,N0,Stage IIA,T3,6th,not reported,1561,6a26adb2-f82c-5dcf-a119-ad71b3f88342,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-CK-5913_diagnosis,No,Ascending colon,--,released,TCGA-CK-5913_treatment,8db97912-39b0-5e4c-a928-df9be71110d1,no,"Radiation Therapy, NOS",2019-07-31T18:41:38.821950-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2008
e588714a-7753-4c3c-abb6-eaf1aab53ab3,TCGA-AZ-4682,TCGA-COAD,61,-22409,680,b766f760-d247-5ab9-bc83-3afe21f23b02,not hispanic or latino,male,white,released,TCGA-AZ-4682_demographic,2019-07-31T18:39:19.217257-05:00,Dead,1945,2007,22409,M1,N0,Stage IVA,T3,--,not reported,--,e1318e65-ca4c-5fa3-a912-3054974b2f1b,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-AZ-4682_diagnosis,No,Rectosigmoid junction,2019-04-28T11:23:23.971563-05:00,released,TCGA-AZ-4682_treatment_1,4eb4639b-b1e1-5d84-a4e2-d0ec856e6110,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:19.217257-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2006
e588714a-7753-4c3c-abb6-eaf1aab53ab3,TCGA-AZ-4682,TCGA-COAD,61,-22409,680,b766f760-d247-5ab9-bc83-3afe21f23b02,not hispanic or latino,male,white,released,TCGA-AZ-4682_demographic,2019-07-31T18:39:19.217257-05:00,Dead,1945,2007,22409,M1,N0,Stage IVA,T3,--,not reported,--,e1318e65-ca4c-5fa3-a912-3054974b2f1b,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-AZ-4682_diagnosis,No,Rectosigmoid junction,--,released,TCGA-AZ-4682_treatment,7ab30617-ddf1-5713-97d7-1a0cffaf42a0,no,"Radiation Therapy, NOS",2019-07-31T18:39:19.217257-05:00,not reported,stage iva,2019-08-08T16:35:57.350058-05:00,2006
31a3877d-3e82-450e-811f-3448b06f3950,TCGA-AA-3655,TCGA-COAD,68,-24896,--,91f94292-9f7b-50dc-a973-26648a291537,not reported,male,not reported,released,TCGA-AA-3655_demographic,2019-07-31T18:26:16.731182-05:00,Alive,1937,--,24896,M0,N0,Stage II,T3,5th,not reported,1856,2be5eb4c-da5b-5987-adf9-6f89e1dc97de,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3655_diagnosis,No,Sigmoid colon,2019-04-28T11:12:31.765999-05:00,released,TCGA-AA-3655_treatment_1,4e0ee602-6620-50e2-8c2c-ed461d3efc4c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:16.731182-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
31a3877d-3e82-450e-811f-3448b06f3950,TCGA-AA-3655,TCGA-COAD,68,-24896,--,91f94292-9f7b-50dc-a973-26648a291537,not reported,male,not reported,released,TCGA-AA-3655_demographic,2019-07-31T18:26:16.731182-05:00,Alive,1937,--,24896,M0,N0,Stage II,T3,5th,not reported,1856,2be5eb4c-da5b-5987-adf9-6f89e1dc97de,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3655_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3655_treatment,d444cf54-85de-5723-823f-2d43c8043ef9,no,"Radiation Therapy, NOS",2019-07-31T18:26:16.731182-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
7dfbc0ed-e684-4966-8b59-fb6b9e80c129,TCGA-AA-3841,TCGA-COAD,66,-24230,--,925535be-0272-57b9-87f6-e52730ef6e37,not reported,male,not reported,released,TCGA-AA-3841_demographic,2019-07-31T18:42:05.899429-05:00,Alive,1943,--,24230,M0,N0,Stage IIA,T3,6th,not reported,1124,6d856e29-c95d-5e94-a37b-a0358f4f7c4c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3841_diagnosis,No,"Colon, NOS",2019-04-28T11:25:43.915237-05:00,released,TCGA-AA-3841_treatment_1,ee4e9d94-6592-56d1-abb4-bf81901b0935,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:05.899429-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
7dfbc0ed-e684-4966-8b59-fb6b9e80c129,TCGA-AA-3841,TCGA-COAD,66,-24230,--,925535be-0272-57b9-87f6-e52730ef6e37,not reported,male,not reported,released,TCGA-AA-3841_demographic,2019-07-31T18:42:05.899429-05:00,Alive,1943,--,24230,M0,N0,Stage IIA,T3,6th,not reported,1124,6d856e29-c95d-5e94-a37b-a0358f4f7c4c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3841_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3841_treatment,60caf72c-45af-5347-9bc1-287c63ba7a34,no,"Radiation Therapy, NOS",2019-07-31T18:42:05.899429-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
de287a25-981d-49f8-81af-fe0300e4cd31,TCGA-AZ-4315,TCGA-COAD,61,-22340,--,95cccfe1-6693-56f2-a5c2-a1adec17da7c,not hispanic or latino,male,white,released,TCGA-AZ-4315_demographic,2019-07-31T18:38:47.442783-05:00,Alive,1945,--,22340,M0,N0,Stage IIA,T3,--,not reported,1776,3535d001-bb4e-5051-a9e5-a0c01e21137e,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4315_diagnosis,No,Cecum,--,released,TCGA-AZ-4315_treatment,59a62fc2-4a1a-5297-b277-c793eb76b549,no,"Radiation Therapy, NOS",2019-07-31T18:38:47.442783-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2006
de287a25-981d-49f8-81af-fe0300e4cd31,TCGA-AZ-4315,TCGA-COAD,61,-22340,--,95cccfe1-6693-56f2-a5c2-a1adec17da7c,not hispanic or latino,male,white,released,TCGA-AZ-4315_demographic,2019-07-31T18:38:47.442783-05:00,Alive,1945,--,22340,M0,N0,Stage IIA,T3,--,not reported,1776,3535d001-bb4e-5051-a9e5-a0c01e21137e,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-4315_diagnosis,No,Cecum,2019-04-28T11:22:56.122275-05:00,released,TCGA-AZ-4315_treatment_1,dd8ccb8e-60ff-53fb-afae-32ef79e5d9a8,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:47.442783-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2006
ca5b878f-8bff-410a-8e6e-b1c133018c8d,TCGA-G4-6315,TCGA-COAD,66,-24174,--,95e4766b-dc27-57b5-9e2e-ca25bfa6dc79,not hispanic or latino,male,white,released,TCGA-G4-6315_demographic,2019-07-31T18:37:06.518994-05:00,Alive,1942,--,24174,M1,N1,Stage IV,T3,6th,not reported,1883,91d21a44-bb9b-5352-ba3a-2b1982d827b4,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-G4-6315_diagnosis,No,Descending colon,--,released,TCGA-G4-6315_treatment,1be8681d-df18-510a-b8a8-8d9280df8efc,no,"Radiation Therapy, NOS",2019-07-31T18:37:06.518994-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2008
ca5b878f-8bff-410a-8e6e-b1c133018c8d,TCGA-G4-6315,TCGA-COAD,66,-24174,--,95e4766b-dc27-57b5-9e2e-ca25bfa6dc79,not hispanic or latino,male,white,released,TCGA-G4-6315_demographic,2019-07-31T18:37:06.518994-05:00,Alive,1942,--,24174,M1,N1,Stage IV,T3,6th,not reported,1883,91d21a44-bb9b-5352-ba3a-2b1982d827b4,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-G4-6315_diagnosis,No,Descending colon,2019-04-28T11:21:29.588606-05:00,released,TCGA-G4-6315_treatment_1,c489c9eb-bd72-573d-9a83-8f96a7857c82,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:06.518994-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2008
2a971e32-b0e7-4a3f-8c40-62d69c0307d8,TCGA-AA-A03F,TCGA-COAD,90,-32872,--,9cfa7019-c6d6-57c9-b3d8-b6f4d41952ef,not reported,female,not reported,released,TCGA-AA-A03F_demographic,2019-07-31T18:25:46.701345-05:00,Dead,1914,--,32872,M0,N2,Stage III,T3,5th,not reported,--,f7927902-da63-5206-9c6e-1389e4977a3c,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-A03F_diagnosis,No,Cecum,--,released,TCGA-AA-A03F_treatment,6b0f5bc9-b025-53d5-b232-31c2eff5f4a8,no,"Radiation Therapy, NOS",2019-07-31T18:25:46.701345-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
2a971e32-b0e7-4a3f-8c40-62d69c0307d8,TCGA-AA-A03F,TCGA-COAD,90,-32872,--,9cfa7019-c6d6-57c9-b3d8-b6f4d41952ef,not reported,female,not reported,released,TCGA-AA-A03F_demographic,2019-07-31T18:25:46.701345-05:00,Dead,1914,--,32872,M0,N2,Stage III,T3,5th,not reported,--,f7927902-da63-5206-9c6e-1389e4977a3c,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-AA-A03F_diagnosis,No,Cecum,2019-04-30T16:18:08.907355-05:00,released,TCGA-AA-A03F_treatment_1,fa6e866d-019e-5e41-bd56-9c5a3eda01d2,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:46.701345-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
19d1a5fc-3ce9-4e43-a364-a4150bcf911b,TCGA-A6-2686,TCGA-COAD,81,-29623,1126,bb0ddbdc-2db2-51d3-a31b-03a88b60cea8,not hispanic or latino,female,white,released,TCGA-A6-2686_demographic,2019-07-31T18:24:25.530554-05:00,Dead,1928,--,29623,M0,N0,Stage IIA,T3,6th,not reported,488,b2a175d4-c7ee-5a11-99d2-fbc2d42047db,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2686_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-2686_treatment,b9c10f28-450f-582c-82a6-a2de77d10dec,no,"Radiation Therapy, NOS",2019-07-31T18:24:25.530554-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
19d1a5fc-3ce9-4e43-a364-a4150bcf911b,TCGA-A6-2686,TCGA-COAD,81,-29623,1126,bb0ddbdc-2db2-51d3-a31b-03a88b60cea8,not hispanic or latino,female,white,released,TCGA-A6-2686_demographic,2019-07-31T18:24:25.530554-05:00,Dead,1928,--,29623,M0,N0,Stage IIA,T3,6th,not reported,488,b2a175d4-c7ee-5a11-99d2-fbc2d42047db,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2686_diagnosis,No,"Colon, NOS",2019-04-28T11:10:58.936617-05:00,released,TCGA-A6-2686_treatment_1,c75b2c45-1dd6-54b8-8678-1df96d938b58,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:25.530554-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
4aadf2a2-ce1e-4f94-b146-59292e83e7fd,TCGA-CM-5868,TCGA-COAD,59,-21672,--,3c25352f-f9b7-5658-b7bd-1963fee6ac55,not hispanic or latino,female,white,released,TCGA-CM-5868_demographic,2019-07-31T18:27:56.334448-05:00,Alive,1951,--,21672,M1a,N1a,Stage IVA,T4a,7th,not reported,518,f8558795-eee3-52a5-9269-6ab3c053b18f,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-5868_diagnosis,No,Sigmoid colon,2019-04-28T11:13:54.294960-05:00,released,TCGA-CM-5868_treatment_1,98034aff-650a-58fc-96eb-cf8b9b67e6dd,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:56.334448-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2010
4aadf2a2-ce1e-4f94-b146-59292e83e7fd,TCGA-CM-5868,TCGA-COAD,59,-21672,--,3c25352f-f9b7-5658-b7bd-1963fee6ac55,not hispanic or latino,female,white,released,TCGA-CM-5868_demographic,2019-07-31T18:27:56.334448-05:00,Alive,1951,--,21672,M1a,N1a,Stage IVA,T4a,7th,not reported,518,f8558795-eee3-52a5-9269-6ab3c053b18f,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-5868_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-5868_treatment,070743c9-ebd9-5a37-8c54-cc49eea32be3,no,"Radiation Therapy, NOS",2019-07-31T18:27:56.334448-05:00,not reported,stage iva,2019-08-08T16:36:28.485406-05:00,2010
3e0c34cb-fca5-4bcf-a5c1-5a7d286dd072,TCGA-CA-5797,TCGA-COAD,56,-20662,--,74e1217b-fb3f-5011-a6c1-dcb2cba47f09,not hispanic or latino,male,asian,released,TCGA-CA-5797_demographic,2019-07-31T18:27:15.598131-05:00,Alive,1954,--,20662,M0,N0,Stage IIA,T3,--,not reported,383,50279fb7-7420-5702-8326-b0ddbb10235c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5797_diagnosis,No,"Colon, NOS",--,released,TCGA-CA-5797_treatment,1ea6a8b1-4f1a-5cde-9473-6f62337c2805,no,"Radiation Therapy, NOS",2019-07-31T18:27:15.598131-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
3e0c34cb-fca5-4bcf-a5c1-5a7d286dd072,TCGA-CA-5797,TCGA-COAD,56,-20662,--,74e1217b-fb3f-5011-a6c1-dcb2cba47f09,not hispanic or latino,male,asian,released,TCGA-CA-5797_demographic,2019-07-31T18:27:15.598131-05:00,Alive,1954,--,20662,M0,N0,Stage IIA,T3,--,not reported,383,50279fb7-7420-5702-8326-b0ddbb10235c,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-CA-5797_diagnosis,No,"Colon, NOS",2019-04-28T11:13:22.289242-05:00,released,TCGA-CA-5797_treatment_1,257d936d-7bac-5143-9fdb-bb5e2d3072f4,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:15.598131-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
80311cf5-7e18-4545-92ad-c4b7dd5c9677,TCGA-AA-3842,TCGA-COAD,51,-18842,--,9f3201bf-d3aa-50bc-9b9e-d54ca09c2e9e,not reported,male,not reported,released,TCGA-AA-3842_demographic,2019-07-31T18:31:27.627489-05:00,Alive,1958,--,18842,M0,N1,Stage IIIA,T2,6th,not reported,1126,d4340b2b-6950-5e12-b1b3-313b868150d9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3842_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3842_treatment,98e7cd13-d717-5200-a52f-2aca81dbfe2d,no,"Radiation Therapy, NOS",2019-07-31T18:31:27.627489-05:00,not reported,stage iiia,2019-08-08T16:34:38.138144-05:00,2009
80311cf5-7e18-4545-92ad-c4b7dd5c9677,TCGA-AA-3842,TCGA-COAD,51,-18842,--,9f3201bf-d3aa-50bc-9b9e-d54ca09c2e9e,not reported,male,not reported,released,TCGA-AA-3842_demographic,2019-07-31T18:31:27.627489-05:00,Alive,1958,--,18842,M0,N1,Stage IIIA,T2,6th,not reported,1126,d4340b2b-6950-5e12-b1b3-313b868150d9,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3842_diagnosis,No,"Colon, NOS",2019-04-28T11:16:50.879229-05:00,released,TCGA-AA-3842_treatment_1,ade47b8b-cd34-576a-83cb-8ad71f7f163d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:27.627489-05:00,not reported,stage iiia,2019-08-08T16:34:38.138144-05:00,2009
b728e6e8-a0e4-496b-904c-6f07c12e901f,TCGA-A6-3810,TCGA-COAD,62,-22999,--,e408c820-4c59-58da-8824-49e61badf2af,not hispanic or latino,male,white,released,TCGA-A6-3810_demographic,2019-07-31T15:15:04.148193-05:00,Alive,1947,--,22999,M0,N0,Stage IIA,T3,--,not reported,1111,6686205a-ba93-5e31-b2d6-4be973d595ee,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-3810_diagnosis,No,"Colon, NOS",2019-04-28T08:36:00.651831-05:00,released,TCGA-A6-3810_treatment_1,c433e194-a1ce-5ef9-a4d5-1ef334d23435,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:15:04.148193-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
b728e6e8-a0e4-496b-904c-6f07c12e901f,TCGA-A6-3810,TCGA-COAD,62,-22999,--,e408c820-4c59-58da-8824-49e61badf2af,not hispanic or latino,male,white,released,TCGA-A6-3810_demographic,2019-07-31T15:15:04.148193-05:00,Alive,1947,--,22999,M0,N0,Stage IIA,T3,--,not reported,1111,6686205a-ba93-5e31-b2d6-4be973d595ee,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-3810_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-3810_treatment,8e1c3e76-7ca5-5e10-a8ac-9d9f7b165d61,no,"Radiation Therapy, NOS",2019-07-31T15:15:04.148193-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
8632579e-d318-4dab-9994-d3945afc42ab,TCGA-A6-3809,TCGA-COAD,71,-26274,--,782e2ba4-94e0-5cfa-bcd7-78a68590c5ce,not hispanic or latino,female,white,released,TCGA-A6-3809_demographic,2019-07-31T15:16:33.683794-05:00,Alive,1938,--,26274,M0,N0,Stage IIB,T4,6th,not reported,996,120822c3-8829-56ac-a714-8c78f092698c,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-A6-3809_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-3809_treatment,da596f20-aed9-5dbb-80d3-4b9aa0ae7528,no,"Radiation Therapy, NOS",2019-07-31T15:16:33.683794-05:00,not reported,stage iib,2019-08-08T16:33:45.855164-05:00,2009
8632579e-d318-4dab-9994-d3945afc42ab,TCGA-A6-3809,TCGA-COAD,71,-26274,--,782e2ba4-94e0-5cfa-bcd7-78a68590c5ce,not hispanic or latino,female,white,released,TCGA-A6-3809_demographic,2019-07-31T15:16:33.683794-05:00,Alive,1938,--,26274,M0,N0,Stage IIB,T4,6th,not reported,996,120822c3-8829-56ac-a714-8c78f092698c,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-A6-3809_diagnosis,No,"Colon, NOS",2019-04-28T08:37:14.180345-05:00,released,TCGA-A6-3809_treatment_1,ed1ff32a-fd9a-542a-857a-1aa8573bd1d2,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:16:33.683794-05:00,not reported,stage iib,2019-08-08T16:33:45.855164-05:00,2009
f2ef5afa-6191-43a1-a023-d53c0d985139,TCGA-AA-3846,TCGA-COAD,74,-27057,--,7e42c8da-8aab-52fc-9ebb-a6109ef0370f,not reported,female,not reported,released,TCGA-AA-3846_demographic,2019-07-31T18:40:16.258229-05:00,Alive,1935,--,27057,M0,N0,Stage IIA,T3,6th,not reported,518,3ea5cd3a-d86e-581a-9441-bce00029e406,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3846_diagnosis,No,Sigmoid colon,2019-04-28T11:24:11.706021-05:00,released,TCGA-AA-3846_treatment_1,c194707a-c268-5998-a049-b9c1d4f8bfdf,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:16.258229-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
f2ef5afa-6191-43a1-a023-d53c0d985139,TCGA-AA-3846,TCGA-COAD,74,-27057,--,7e42c8da-8aab-52fc-9ebb-a6109ef0370f,not reported,female,not reported,released,TCGA-AA-3846_demographic,2019-07-31T18:40:16.258229-05:00,Alive,1935,--,27057,M0,N0,Stage IIA,T3,6th,not reported,518,3ea5cd3a-d86e-581a-9441-bce00029e406,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3846_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3846_treatment,46d83e31-476e-5ab5-8955-413610d1de33,no,"Radiation Therapy, NOS",2019-07-31T18:40:16.258229-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
9c34830b-4d7f-4b41-9659-fbfc36c145c9,TCGA-D5-6529,TCGA-COAD,69,-25394,--,809bcb4f-ced3-5029-be8c-2ae8e2891dc9,not hispanic or latino,male,white,released,TCGA-D5-6529_demographic,2019-07-31T18:33:20.024029-05:00,Alive,1941,--,25394,M0,N0,Stage IIA,T3,7th,not reported,614,9fbc2a6b-5c5a-5841-9901-87f8b5927ec5,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6529_diagnosis,No,"Colon, NOS",2019-04-28T11:18:23.950442-05:00,released,TCGA-D5-6529_treatment_1,6f4dba94-960a-509d-b411-23dcc9d9cbfc,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:20.024029-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
9c34830b-4d7f-4b41-9659-fbfc36c145c9,TCGA-D5-6529,TCGA-COAD,69,-25394,--,809bcb4f-ced3-5029-be8c-2ae8e2891dc9,not hispanic or latino,male,white,released,TCGA-D5-6529_demographic,2019-07-31T18:33:20.024029-05:00,Alive,1941,--,25394,M0,N0,Stage IIA,T3,7th,not reported,614,9fbc2a6b-5c5a-5841-9901-87f8b5927ec5,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6529_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6529_treatment,fcfe5bfd-1219-5af6-a749-28c8c510cf15,no,"Radiation Therapy, NOS",2019-07-31T18:33:20.024029-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
d3b7ada6-5395-4212-a921-8e97c92b605d,TCGA-NH-A50V,TCGA-COAD,69,-25467,--,2cd3534b-ec54-5bba-9568-defc8632bdd0,not hispanic or latino,male,black or african american,released,TCGA-NH-A50V_demographic,2019-07-31T18:37:54.053558-05:00,Alive,1943,--,25467,M0,N2a,Stage IIIB,T3,7th,not reported,588,4326b129-c829-5fb3-9cbc-30bca6aaccac,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-NH-A50V_diagnosis,No,Cecum,--,released,TCGA-NH-A50V_treatment,3730e4aa-bfcb-5708-84de-ede6d1f5cc79,no,"Radiation Therapy, NOS",2019-07-31T18:37:54.053558-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2012
d3b7ada6-5395-4212-a921-8e97c92b605d,TCGA-NH-A50V,TCGA-COAD,69,-25467,--,2cd3534b-ec54-5bba-9568-defc8632bdd0,not hispanic or latino,male,black or african american,released,TCGA-NH-A50V_demographic,2019-07-31T18:37:54.053558-05:00,Alive,1943,--,25467,M0,N2a,Stage IIIB,T3,7th,not reported,588,4326b129-c829-5fb3-9cbc-30bca6aaccac,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-NH-A50V_diagnosis,No,Cecum,2019-04-28T11:22:10.136000-05:00,released,TCGA-NH-A50V_treatment_1,1d630841-4912-5ae0-9cef-a1a5dd9bc204,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:54.053558-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2012
c658f35d-ceeb-4189-8e3d-03e3b9706667,TCGA-CK-5915,TCGA-COAD,63,-23040,--,8729646f-ec82-57a1-b1df-d0363b4acd80,not hispanic or latino,male,white,released,TCGA-CK-5915_demographic,2019-07-31T18:36:34.668876-05:00,Alive,1944,--,23040,MX,N0,Stage I,T2,6th,not reported,--,2c028632-1922-56fe-8752-cfad3a87a6c9,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-5915_diagnosis,No,Sigmoid colon,2019-04-28T11:21:03.943382-05:00,released,TCGA-CK-5915_treatment_1,5ee91552-9a1a-510f-8705-edc7099883cf,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:34.668876-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2007
c658f35d-ceeb-4189-8e3d-03e3b9706667,TCGA-CK-5915,TCGA-COAD,63,-23040,--,8729646f-ec82-57a1-b1df-d0363b4acd80,not hispanic or latino,male,white,released,TCGA-CK-5915_demographic,2019-07-31T18:36:34.668876-05:00,Alive,1944,--,23040,MX,N0,Stage I,T2,6th,not reported,--,2c028632-1922-56fe-8752-cfad3a87a6c9,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-5915_diagnosis,No,Sigmoid colon,--,released,TCGA-CK-5915_treatment,a95d6130-e77e-52fa-885f-513915962fad,not reported,"Radiation Therapy, NOS",2019-07-31T18:36:34.668876-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2007
fdffda5f-72b2-4153-b7f1-d7043b7ca898,TCGA-AA-3818,TCGA-COAD,78,-28763,30,eff05748-edd2-5f7d-8111-daf6918bb923,not reported,female,not reported,released,TCGA-AA-3818_demographic,2019-07-31T18:41:15.434480-05:00,Dead,1929,2007,28763,M0,N0,Stage IIA,T3,6th,not reported,--,2767af06-0453-5d4a-b4b2-4d36ff1abddb,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3818_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3818_treatment,4f68bba4-5739-5a87-aa87-b631d5e76281,not reported,"Radiation Therapy, NOS",2019-07-31T18:41:15.434480-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
fdffda5f-72b2-4153-b7f1-d7043b7ca898,TCGA-AA-3818,TCGA-COAD,78,-28763,30,eff05748-edd2-5f7d-8111-daf6918bb923,not reported,female,not reported,released,TCGA-AA-3818_demographic,2019-07-31T18:41:15.434480-05:00,Dead,1929,2007,28763,M0,N0,Stage IIA,T3,6th,not reported,--,2767af06-0453-5d4a-b4b2-4d36ff1abddb,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3818_diagnosis,No,"Colon, NOS",2019-04-28T11:24:59.674336-05:00,released,TCGA-AA-3818_treatment_1,a86c8a25-f07f-5d7b-801f-4fec2d9aff84,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:15.434480-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2007
c21d2c68-920f-4526-b754-286579c049f3,TCGA-AA-3663,TCGA-COAD,42,-15675,--,6350ff32-a2c0-543d-bf5f-ec458385869a,not reported,male,not reported,released,TCGA-AA-3663_demographic,2019-07-31T18:36:10.375142-05:00,Alive,1963,--,15675,M0,N0,Stage II,T3,5th,not reported,212,adc29aad-bc6c-5ec7-8192-69c7c0515e3f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3663_diagnosis,No,Cecum,2019-04-28T11:20:44.164398-05:00,released,TCGA-AA-3663_treatment_1,7b2ec202-26fb-5de1-9f02-e464decbbde3,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:10.375142-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
c21d2c68-920f-4526-b754-286579c049f3,TCGA-AA-3663,TCGA-COAD,42,-15675,--,6350ff32-a2c0-543d-bf5f-ec458385869a,not reported,male,not reported,released,TCGA-AA-3663_demographic,2019-07-31T18:36:10.375142-05:00,Alive,1963,--,15675,M0,N0,Stage II,T3,5th,not reported,212,adc29aad-bc6c-5ec7-8192-69c7c0515e3f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3663_diagnosis,No,Cecum,--,released,TCGA-AA-3663_treatment,97d3fc0b-f536-525c-be4d-ed52ec41587e,no,"Radiation Therapy, NOS",2019-07-31T18:36:10.375142-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
127f738d-afa1-42f6-a9a0-f33806667b84,TCGA-AA-3562,TCGA-COAD,82,-30254,--,882c4f50-45a6-5dcc-9581-3bf72ee0ca45,not reported,male,not reported,released,TCGA-AA-3562_demographic,2019-07-31T18:23:47.994488-05:00,Alive,1926,--,30254,M0,N2,Stage IIIC,T3,6th,not reported,608,5aca5776-21f4-56bf-ab98-7e0efff8a000,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3562_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3562_treatment,b26c2197-ebf4-572f-8000-596599776ffc,no,"Radiation Therapy, NOS",2019-07-31T18:23:47.994488-05:00,not reported,stage iiic,2019-08-08T16:34:38.138144-05:00,2008
127f738d-afa1-42f6-a9a0-f33806667b84,TCGA-AA-3562,TCGA-COAD,82,-30254,--,882c4f50-45a6-5dcc-9581-3bf72ee0ca45,not reported,male,not reported,released,TCGA-AA-3562_demographic,2019-07-31T18:23:47.994488-05:00,Alive,1926,--,30254,M0,N2,Stage IIIC,T3,6th,not reported,608,5aca5776-21f4-56bf-ab98-7e0efff8a000,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3562_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:10:28.328504-05:00,released,TCGA-AA-3562_treatment_1,bbdc0709-f004-5945-83ed-c55683f6d5c8,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:47.994488-05:00,not reported,stage iiic,2019-08-08T16:34:38.138144-05:00,2008
49929108-023e-4d35-b26d-50ab4d3ae581,TCGA-A6-2684,TCGA-COAD,75,-27708,--,68f16cb0-25c5-511d-abac-4b57eec5754a,not hispanic or latino,female,white,released,TCGA-A6-2684_demographic,2019-07-31T18:28:19.797349-05:00,Alive,1934,--,27708,M0,N0,Stage I,T2,--,not reported,1127,808ef8fb-23c4-5b7f-9546-90aba7a19854,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2684_diagnosis,No,"Colon, NOS",2019-04-28T11:14:14.145411-05:00,released,TCGA-A6-2684_treatment_1,9f3d6bda-e58b-5e9e-b68b-ff65cd96dd36,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:19.797349-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2009
49929108-023e-4d35-b26d-50ab4d3ae581,TCGA-A6-2684,TCGA-COAD,75,-27708,--,68f16cb0-25c5-511d-abac-4b57eec5754a,not hispanic or latino,female,white,released,TCGA-A6-2684_demographic,2019-07-31T18:28:19.797349-05:00,Alive,1934,--,27708,M0,N0,Stage I,T2,--,not reported,1127,808ef8fb-23c4-5b7f-9546-90aba7a19854,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-2684_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-2684_treatment,1de044b2-fb47-5404-8f34-c51eabe91136,yes,"Radiation Therapy, NOS",2019-07-31T18:28:19.797349-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2009
790266bc-c252-43f4-85d1-1b06ee529cf8,TCGA-A6-A566,TCGA-COAD,55,-20181,758,9fba374d-a4e5-5141-8ecc-674c5b3bbd1d,not hispanic or latino,female,black or african american,released,TCGA-A6-A566_demographic,2019-07-31T15:13:31.650064-05:00,Dead,1952,2009,20181,M0,N1,Stage IIIB,T4,6th,not reported,--,df472421-61b7-5f90-84af-163805514b04,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-A6-A566_diagnosis,No,Descending colon,2019-04-28T08:34:41.324652-05:00,released,TCGA-A6-A566_treatment_1,9b48d275-85e1-5c21-ba3a-94e310ecc787,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:13:31.650064-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2007
790266bc-c252-43f4-85d1-1b06ee529cf8,TCGA-A6-A566,TCGA-COAD,55,-20181,758,9fba374d-a4e5-5141-8ecc-674c5b3bbd1d,not hispanic or latino,female,black or african american,released,TCGA-A6-A566_demographic,2019-07-31T15:13:31.650064-05:00,Dead,1952,2009,20181,M0,N1,Stage IIIB,T4,6th,not reported,--,df472421-61b7-5f90-84af-163805514b04,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-A6-A566_diagnosis,No,Descending colon,--,released,TCGA-A6-A566_treatment,d2cdb34c-1b08-5449-af5a-e92ca6358fc7,no,"Radiation Therapy, NOS",2019-07-31T15:13:31.650064-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2007
81f6b141-2195-4091-9cd3-dfb022663949,TCGA-AA-3930,TCGA-COAD,66,-24321,61,fdbd38b9-eb2d-53d4-8d40-24cc7d97f462,not reported,male,not reported,released,TCGA-AA-3930_demographic,2019-07-31T18:31:39.954893-05:00,Dead,1942,--,24321,M1,N2,Stage IV,T3,6th,not reported,--,ae26a8ce-62c0-58b9-b5e3-ab09e552cb15,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3930_diagnosis,No,Ascending colon,2019-04-28T11:17:00.869019-05:00,released,TCGA-AA-3930_treatment_1,24ac957b-9f73-5f07-92a4-11686648c852,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:39.954893-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2008
81f6b141-2195-4091-9cd3-dfb022663949,TCGA-AA-3930,TCGA-COAD,66,-24321,61,fdbd38b9-eb2d-53d4-8d40-24cc7d97f462,not reported,male,not reported,released,TCGA-AA-3930_demographic,2019-07-31T18:31:39.954893-05:00,Dead,1942,--,24321,M1,N2,Stage IV,T3,6th,not reported,--,ae26a8ce-62c0-58b9-b5e3-ab09e552cb15,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3930_diagnosis,No,Ascending colon,--,released,TCGA-AA-3930_treatment,a114c85f-fad9-5e71-8a49-6163d5b4a222,no,"Radiation Therapy, NOS",2019-07-31T18:31:39.954893-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2008
5d73b382-3da3-4220-890e-2095228bbe6c,TCGA-CK-4948,TCGA-COAD,45,-16736,--,a057b6db-e155-517d-8598-8217538bb2ec,not hispanic or latino,female,white,released,TCGA-CK-4948_demographic,2019-07-31T18:29:13.060468-05:00,Alive,1957,--,16736,M0,N1,Stage III,T3,5th,not reported,4502,36c85ac7-0c3a-549d-90f8-474cf6f47ec8,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-4948_diagnosis,No,Sigmoid colon,2019-04-28T11:14:59.585956-05:00,released,TCGA-CK-4948_treatment_1,a72cd344-9dd3-5634-b13e-d38660000bff,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:13.060468-05:00,not reported,stage iii,2019-08-08T16:35:57.350058-05:00,2002
5d73b382-3da3-4220-890e-2095228bbe6c,TCGA-CK-4948,TCGA-COAD,45,-16736,--,a057b6db-e155-517d-8598-8217538bb2ec,not hispanic or latino,female,white,released,TCGA-CK-4948_demographic,2019-07-31T18:29:13.060468-05:00,Alive,1957,--,16736,M0,N1,Stage III,T3,5th,not reported,4502,36c85ac7-0c3a-549d-90f8-474cf6f47ec8,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-4948_diagnosis,No,Sigmoid colon,--,released,TCGA-CK-4948_treatment,c98b3214-adca-5722-bfdb-fd6dea8a8a0d,no,"Radiation Therapy, NOS",2019-07-31T18:29:13.060468-05:00,not reported,stage iii,2019-08-08T16:35:57.350058-05:00,2002
8c043ecd-2265-411f-bc3b-dc341cf56ac2,TCGA-CM-6163,TCGA-COAD,74,-27150,--,6dc3279b-5a0e-57f8-a201-21fbef181217,not hispanic or latino,male,white,released,TCGA-CM-6163_demographic,2019-07-31T18:32:18.949476-05:00,Alive,1936,--,27150,M0,N0,Stage I,T1,7th,not reported,427,6d20d61d-0f6a-5b57-8aef-ac7d014ea389,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6163_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6163_treatment,3f9d9817-3e47-5fa4-94b7-2666f6bf84eb,no,"Radiation Therapy, NOS",2019-07-31T18:32:18.949476-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
8c043ecd-2265-411f-bc3b-dc341cf56ac2,TCGA-CM-6163,TCGA-COAD,74,-27150,--,6dc3279b-5a0e-57f8-a201-21fbef181217,not hispanic or latino,male,white,released,TCGA-CM-6163_demographic,2019-07-31T18:32:18.949476-05:00,Alive,1936,--,27150,M0,N0,Stage I,T1,7th,not reported,427,6d20d61d-0f6a-5b57-8aef-ac7d014ea389,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6163_diagnosis,No,Sigmoid colon,2019-04-28T11:17:33.734713-05:00,released,TCGA-CM-6163_treatment_1,7aa36edb-43c8-52cc-9d43-8e213d6fc8fb,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:18.949476-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
0c463362-7925-4d9a-9d63-098b50af2fb9,TCGA-G4-6323,TCGA-COAD,50,-18334,--,6e1feef1-8128-51b2-b72d-95a3898dcc81,not hispanic or latino,male,black or african american,released,TCGA-G4-6323_demographic,2019-07-31T18:23:04.516140-05:00,Alive,1960,--,18334,MX,N0,Stage IA,Tis,7th,not reported,419,59a932d0-c0c0-5567-ad46-79db02c10df2,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-G4-6323_diagnosis,No,Cecum,--,released,TCGA-G4-6323_treatment,5ad2dfa2-1fe8-5c6c-9c01-2627723d7284,no,"Radiation Therapy, NOS",2019-07-31T18:23:04.516140-05:00,not reported,stage ia,2019-08-08T16:37:18.448891-05:00,2010
0c463362-7925-4d9a-9d63-098b50af2fb9,TCGA-G4-6323,TCGA-COAD,50,-18334,--,6e1feef1-8128-51b2-b72d-95a3898dcc81,not hispanic or latino,male,black or african american,released,TCGA-G4-6323_demographic,2019-07-31T18:23:04.516140-05:00,Alive,1960,--,18334,MX,N0,Stage IA,Tis,7th,not reported,419,59a932d0-c0c0-5567-ad46-79db02c10df2,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-G4-6323_diagnosis,No,Cecum,2019-04-28T11:09:53.337906-05:00,released,TCGA-G4-6323_treatment_1,c086ec3c-be56-5b3f-9f34-7a85e452cef7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:04.516140-05:00,not reported,stage ia,2019-08-08T16:37:18.448891-05:00,2010
fd16b634-2e04-44a3-862d-fb03cd73c057,TCGA-AA-3556,TCGA-COAD,78,-28704,--,db88a4d4-0436-5e30-a155-f2736c303c1c,not reported,male,not reported,released,TCGA-AA-3556_demographic,2019-07-31T18:41:12.243393-05:00,Alive,1930,--,28704,M0,N0,Stage I,T2,6th,not reported,700,edf50138-dc58-51a3-a0c6-b7b878e850a0,C18.7,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Sigmoid colon,released,TCGA-AA-3556_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:24:57.181692-05:00,released,TCGA-AA-3556_treatment_1,1b22b353-4a28-5640-8969-56ee8c4213d0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:12.243393-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
fd16b634-2e04-44a3-862d-fb03cd73c057,TCGA-AA-3556,TCGA-COAD,78,-28704,--,db88a4d4-0436-5e30-a155-f2736c303c1c,not reported,male,not reported,released,TCGA-AA-3556_demographic,2019-07-31T18:41:12.243393-05:00,Alive,1930,--,28704,M0,N0,Stage I,T2,6th,not reported,700,edf50138-dc58-51a3-a0c6-b7b878e850a0,C18.7,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Sigmoid colon,released,TCGA-AA-3556_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3556_treatment,cf9c33ad-a8bc-588f-b058-6ca313d6d4a1,no,"Radiation Therapy, NOS",2019-07-31T18:41:12.243393-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
c82bbe23-0264-45a7-b1a6-82b4654108c8,TCGA-AA-3864,TCGA-COAD,71,-26237,--,70360ab2-ff10-5791-946c-9e3f4a5112b8,not reported,male,not reported,released,TCGA-AA-3864_demographic,2019-07-31T18:36:47.084648-05:00,Alive,1934,--,26237,M0,N0,Stage II,T3,5th,not reported,1612,218db2e3-1145-533b-b152-77995d10272f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3864_diagnosis,No,Cecum,2019-04-28T11:21:14.178752-05:00,released,TCGA-AA-3864_treatment_1,0a0908c0-91c9-5202-8d29-ded0b02d7614,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:47.084648-05:00,not reported,stage ii,2019-08-08T16:35:04.140343-05:00,2005
c82bbe23-0264-45a7-b1a6-82b4654108c8,TCGA-AA-3864,TCGA-COAD,71,-26237,--,70360ab2-ff10-5791-946c-9e3f4a5112b8,not reported,male,not reported,released,TCGA-AA-3864_demographic,2019-07-31T18:36:47.084648-05:00,Alive,1934,--,26237,M0,N0,Stage II,T3,5th,not reported,1612,218db2e3-1145-533b-b152-77995d10272f,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3864_diagnosis,No,Cecum,--,released,TCGA-AA-3864_treatment,0157dfc3-9e6c-5424-b83e-bc4d4ad99a75,no,"Radiation Therapy, NOS",2019-07-31T18:36:47.084648-05:00,not reported,stage ii,2019-08-08T16:35:04.140343-05:00,2005
96ac1f4b-79b0-4517-8caf-fc05abcaaf4f,TCGA-A6-6652,TCGA-COAD,59,-21638,--,fe777ace-c641-5f4f-9ad1-67875b7739ee,not hispanic or latino,male,black or african american,released,TCGA-A6-6652_demographic,2019-07-31T18:33:02.766877-05:00,Alive,1952,--,21638,M1,N0,Stage IVA,T3,--,not reported,751,efdb8332-fe81-59a8-b4ed-41c084cc2af9,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-6652_diagnosis,No,Sigmoid colon,2019-04-28T11:18:09.011286-05:00,released,TCGA-A6-6652_treatment_1,0c685a01-42ad-57cf-8d8b-ffc91c2e7573,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:02.766877-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2011
96ac1f4b-79b0-4517-8caf-fc05abcaaf4f,TCGA-A6-6652,TCGA-COAD,59,-21638,--,fe777ace-c641-5f4f-9ad1-67875b7739ee,not hispanic or latino,male,black or african american,released,TCGA-A6-6652_demographic,2019-07-31T18:33:02.766877-05:00,Alive,1952,--,21638,M1,N0,Stage IVA,T3,--,not reported,751,efdb8332-fe81-59a8-b4ed-41c084cc2af9,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-6652_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-6652_treatment,5539b094-39d1-5a00-8add-6e5cc276ef16,no,"Radiation Therapy, NOS",2019-07-31T18:33:02.766877-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2011
93690a96-421c-4c59-85ba-fa6dd538c721,TCGA-G4-6588,TCGA-COAD,58,-21532,--,4557b4bc-67f3-5327-9a67-d4158310ecf6,not hispanic or latino,female,white,released,TCGA-G4-6588_demographic,2019-07-31T18:32:34.722042-05:00,Alive,1951,--,21532,M0,N0,Stage IIA,T3,6th,not reported,796,cd2f01ad-f9c1-5dac-92ad-1eb40ee46126,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6588_diagnosis,Not Reported,Cecum,2019-04-28T11:17:46.661721-05:00,released,TCGA-G4-6588_treatment_1,d13287d5-95ea-5c86-aa13-22acec54e5ea,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:34.722042-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2009
93690a96-421c-4c59-85ba-fa6dd538c721,TCGA-G4-6588,TCGA-COAD,58,-21532,--,4557b4bc-67f3-5327-9a67-d4158310ecf6,not hispanic or latino,female,white,released,TCGA-G4-6588_demographic,2019-07-31T18:32:34.722042-05:00,Alive,1951,--,21532,M0,N0,Stage IIA,T3,6th,not reported,796,cd2f01ad-f9c1-5dac-92ad-1eb40ee46126,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6588_diagnosis,Not Reported,Cecum,--,released,TCGA-G4-6588_treatment,4380a27e-fb8c-54a9-8952-2968cf7c8598,no,"Radiation Therapy, NOS",2019-07-31T18:32:34.722042-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2009
b76d1de7-6447-474d-bf67-77e0bb2da73a,TCGA-AD-6901,TCGA-COAD,78,-28579,682,476c0dea-a497-5229-bf1d-6d324ac5e54e,not reported,male,white,released,TCGA-AD-6901_demographic,2019-07-31T18:35:20.988785-05:00,Dead,1933,--,28579,MX,N0,--,T3,7th,not reported,31,b82a29e8-d609-5639-9edf-3a1a9070c416,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AD-6901_diagnosis,No,Cecum,2019-04-28T11:20:02.039624-05:00,released,TCGA-AD-6901_treatment_1,b6eae999-313c-5197-8d1b-a9e7c29d7b29,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:20.988785-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2011
b76d1de7-6447-474d-bf67-77e0bb2da73a,TCGA-AD-6901,TCGA-COAD,78,-28579,682,476c0dea-a497-5229-bf1d-6d324ac5e54e,not reported,male,white,released,TCGA-AD-6901_demographic,2019-07-31T18:35:20.988785-05:00,Dead,1933,--,28579,MX,N0,--,T3,7th,not reported,31,b82a29e8-d609-5639-9edf-3a1a9070c416,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AD-6901_diagnosis,No,Cecum,--,released,TCGA-AD-6901_treatment,c44176df-a585-526c-b93f-22c91e2768a5,yes,"Radiation Therapy, NOS",2019-07-31T18:35:20.988785-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2011
ffa7e03a-4a3c-41f0-937a-4fb862fd2194,TCGA-DM-A28G,TCGA-COAD,75,-27641,1849,48dc6d87-d1bb-5f7e-a2c7-8634698f54cd,not hispanic or latino,male,white,released,TCGA-DM-A28G_demographic,2019-07-31T15:17:59.324160-05:00,Dead,1926,2006,27641,M0,N0,Stage IIA,T3,6th,not reported,1849,ebbe9a5e-3680-56fb-80b5-1ab2873bff97,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A28G_diagnosis,No,Ascending colon,--,released,TCGA-DM-A28G_treatment,a0530d23-9778-5329-b70b-39275fcb19d5,not reported,"Radiation Therapy, NOS",2019-07-31T15:17:59.324160-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
ffa7e03a-4a3c-41f0-937a-4fb862fd2194,TCGA-DM-A28G,TCGA-COAD,75,-27641,1849,48dc6d87-d1bb-5f7e-a2c7-8634698f54cd,not hispanic or latino,male,white,released,TCGA-DM-A28G_demographic,2019-07-31T15:17:59.324160-05:00,Dead,1926,2006,27641,M0,N0,Stage IIA,T3,6th,not reported,1849,ebbe9a5e-3680-56fb-80b5-1ab2873bff97,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-DM-A28G_diagnosis,No,Ascending colon,2019-04-28T08:38:29.636176-05:00,released,TCGA-DM-A28G_treatment_1,470cd724-84ed-5856-9491-061f8b5d462e,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T15:17:59.324160-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2001
e8e80df9-e3ba-4dec-b8fc-a5e80d8c6798,TCGA-AD-6890,TCGA-COAD,65,-23769,--,f003e20f-205d-5e05-bf80-adfb12953d50,not reported,male,white,released,TCGA-AD-6890_demographic,2019-07-31T18:39:49.978075-05:00,Alive,1945,--,23769,MX,N0,--,T1,7th,not reported,746,4ed53357-9b74-5c57-bf07-8350d58db404,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-6890_diagnosis,No,Ascending colon,2019-04-28T11:23:49.163039-05:00,released,TCGA-AD-6890_treatment_1,98858d13-5fd2-5ef0-a54a-d1016651f20a,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:49.978075-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2010
e8e80df9-e3ba-4dec-b8fc-a5e80d8c6798,TCGA-AD-6890,TCGA-COAD,65,-23769,--,f003e20f-205d-5e05-bf80-adfb12953d50,not reported,male,white,released,TCGA-AD-6890_demographic,2019-07-31T18:39:49.978075-05:00,Alive,1945,--,23769,MX,N0,--,T1,7th,not reported,746,4ed53357-9b74-5c57-bf07-8350d58db404,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AD-6890_diagnosis,No,Ascending colon,--,released,TCGA-AD-6890_treatment,f8934200-8f59-508e-954c-e456006f7a04,no,"Radiation Therapy, NOS",2019-07-31T18:39:49.978075-05:00,not reported,not reported,2019-08-08T16:35:29.811838-05:00,2010
a512701f-88bb-4b05-8c94-fd285b9dd13e,TCGA-AA-3666,TCGA-COAD,68,-25020,61,4ee04c24-f5cc-5868-9736-c907ccc2d622,not reported,male,not reported,released,TCGA-AA-3666_demographic,2019-07-31T18:33:47.460705-05:00,Dead,1937,2005,25020,M0,N1,Stage III,T3,5th,not reported,--,b715b278-9765-55c9-bd18-682cd16bfd28,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3666_diagnosis,No,"Colon, NOS",2019-04-28T11:18:46.331038-05:00,released,TCGA-AA-3666_treatment_1,3c4e0051-d59e-5f98-a168-61d3f434e85b,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:47.460705-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2005
a512701f-88bb-4b05-8c94-fd285b9dd13e,TCGA-AA-3666,TCGA-COAD,68,-25020,61,4ee04c24-f5cc-5868-9736-c907ccc2d622,not reported,male,not reported,released,TCGA-AA-3666_demographic,2019-07-31T18:33:47.460705-05:00,Dead,1937,2005,25020,M0,N1,Stage III,T3,5th,not reported,--,b715b278-9765-55c9-bd18-682cd16bfd28,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3666_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3666_treatment,7a6fc1ba-6a17-5a59-822c-4d1961731575,not reported,"Radiation Therapy, NOS",2019-07-31T18:33:47.460705-05:00,not reported,stage iii,2019-08-08T16:34:38.138144-05:00,2005
268c01b3-d2ce-44c0-a2fe-ea846a1253cc,TCGA-CA-6717,TCGA-COAD,57,-20984,--,884c13a0-9d17-53a4-bfaa-a01e5ab299b2,not hispanic or latino,male,asian,released,TCGA-CA-6717_demographic,2019-07-31T18:25:15.075322-05:00,Alive,1953,--,20984,M0,N0,Stage IIA,T3,6th,not reported,388,de6eb804-6c2b-5cbb-8781-e940d79e7fc0,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CA-6717_diagnosis,No,Ascending colon,--,released,TCGA-CA-6717_treatment,b8d19e49-4343-5650-8c18-b9f789029466,no,"Radiation Therapy, NOS",2019-07-31T18:25:15.075322-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
268c01b3-d2ce-44c0-a2fe-ea846a1253cc,TCGA-CA-6717,TCGA-COAD,57,-20984,--,884c13a0-9d17-53a4-bfaa-a01e5ab299b2,not hispanic or latino,male,asian,released,TCGA-CA-6717_demographic,2019-07-31T18:25:15.075322-05:00,Alive,1953,--,20984,M0,N0,Stage IIA,T3,6th,not reported,388,de6eb804-6c2b-5cbb-8781-e940d79e7fc0,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CA-6717_diagnosis,No,Ascending colon,2019-04-28T11:11:39.128137-05:00,released,TCGA-CA-6717_treatment_1,6b02d7c6-a5d8-5b28-ae2b-c37654c8e214,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:15.075322-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
84e34cf2-b3bb-4a1a-8fb7-6c2c604c4008,TCGA-AA-A01S,TCGA-COAD,47,-17257,--,88d0b310-0f50-5bfb-8e17-aeb1ce3cb2d6,not reported,female,not reported,released,TCGA-AA-A01S_demographic,2019-07-31T15:20:24.323194-05:00,Alive,1957,--,17257,M0,N1,Stage III,T3,5th,not reported,31,ad341620-4e22-5379-a522-c2bf92543836,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01S_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A01S_treatment,0d6a161c-8e10-5588-b3f6-29302048ce5f,not reported,"Radiation Therapy, NOS",2019-07-31T15:20:24.323194-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
84e34cf2-b3bb-4a1a-8fb7-6c2c604c4008,TCGA-AA-A01S,TCGA-COAD,47,-17257,--,88d0b310-0f50-5bfb-8e17-aeb1ce3cb2d6,not reported,female,not reported,released,TCGA-AA-A01S_demographic,2019-07-31T15:20:24.323194-05:00,Alive,1957,--,17257,M0,N1,Stage III,T3,5th,not reported,31,ad341620-4e22-5379-a522-c2bf92543836,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01S_diagnosis,No,Sigmoid colon,2019-04-28T08:40:32.791301-05:00,released,TCGA-AA-A01S_treatment_1,a0677cbf-f43c-5198-a0d7-bce30b93d99a,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T15:20:24.323194-05:00,not reported,stage iii,2019-08-08T16:35:29.811838-05:00,2004
5d66191d-da49-4d7e-89a4-a382db338340,TCGA-D5-6931,TCGA-COAD,77,-28292,--,fce05e82-6d67-52b8-931d-0cfcf1788ca9,not hispanic or latino,male,white,released,TCGA-D5-6931_demographic,2019-07-31T18:29:10.380795-05:00,Alive,1934,--,28292,M0,N2,Stage IIIC,T4b,7th,not reported,365,483ec054-023d-5d7f-9737-48e4fd9d713d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6931_diagnosis,No,"Colon, NOS",2019-04-28T11:14:57.080475-05:00,released,TCGA-D5-6931_treatment_1,21ee8add-76d7-5bd6-8723-43d01d96a4a2,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:10.380795-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2011
5d66191d-da49-4d7e-89a4-a382db338340,TCGA-D5-6931,TCGA-COAD,77,-28292,--,fce05e82-6d67-52b8-931d-0cfcf1788ca9,not hispanic or latino,male,white,released,TCGA-D5-6931_demographic,2019-07-31T18:29:10.380795-05:00,Alive,1934,--,28292,M0,N2,Stage IIIC,T4b,7th,not reported,365,483ec054-023d-5d7f-9737-48e4fd9d713d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-D5-6931_diagnosis,No,"Colon, NOS",--,released,TCGA-D5-6931_treatment,91a4fb94-c9b3-5056-8d0f-ce03aa3188b1,no,"Radiation Therapy, NOS",2019-07-31T18:29:10.380795-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2011
b08b5f49-9434-4653-9772-097ec29b2ca3,TCGA-D5-6540,TCGA-COAD,66,-24282,--,5247e763-eef4-529e-a4c1-821a285251be,not hispanic or latino,male,white,released,TCGA-D5-6540_demographic,2019-07-31T18:34:54.160488-05:00,Alive,1944,--,24282,M0,N0,Stage I,T2,--,not reported,491,72fac932-4563-5f25-b1ca-4cb49c11fd2d,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-D5-6540_diagnosis,No,Cecum,2019-04-28T11:19:40.201331-05:00,released,TCGA-D5-6540_treatment_1,8716487a-acf0-5d7c-a498-d9843f6fba22,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:54.160488-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2010
b08b5f49-9434-4653-9772-097ec29b2ca3,TCGA-D5-6540,TCGA-COAD,66,-24282,--,5247e763-eef4-529e-a4c1-821a285251be,not hispanic or latino,male,white,released,TCGA-D5-6540_demographic,2019-07-31T18:34:54.160488-05:00,Alive,1944,--,24282,M0,N0,Stage I,T2,--,not reported,491,72fac932-4563-5f25-b1ca-4cb49c11fd2d,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-D5-6540_diagnosis,No,Cecum,--,released,TCGA-D5-6540_treatment,cc37f1e9-3a5b-5adf-a475-ac3f7170adbb,no,"Radiation Therapy, NOS",2019-07-31T18:34:54.160488-05:00,not reported,stage i,2019-08-08T16:36:52.154454-05:00,2010
aec0c661-afac-4f7a-8c31-154d743f2499,TCGA-DM-A28H,TCGA-COAD,50,-18325,--,eb8cdd62-7df0-5e7f-bd54-7e765a090809,not hispanic or latino,male,white,released,TCGA-DM-A28H_demographic,2019-07-31T18:34:39.319684-05:00,Alive,1952,--,18325,M0,N2,Stage IIIC,T3,6th,not reported,3561,28aa3ee1-6072-5863-953e-27c7f5c2606a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A28H_diagnosis,No,Cecum,--,released,TCGA-DM-A28H_treatment,c9b43bb8-9a4a-52e7-8d18-9ccbdcbe064e,yes,"Radiation Therapy, NOS",2019-07-31T18:34:39.319684-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2002
aec0c661-afac-4f7a-8c31-154d743f2499,TCGA-DM-A28H,TCGA-COAD,50,-18325,--,eb8cdd62-7df0-5e7f-bd54-7e765a090809,not hispanic or latino,male,white,released,TCGA-DM-A28H_demographic,2019-07-31T18:34:39.319684-05:00,Alive,1952,--,18325,M0,N2,Stage IIIC,T3,6th,not reported,3561,28aa3ee1-6072-5863-953e-27c7f5c2606a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A28H_diagnosis,No,Cecum,2019-04-28T11:19:27.581199-05:00,released,TCGA-DM-A28H_treatment_1,60cb678a-fe88-5480-bed6-6e3de405bf9a,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:39.319684-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2002
5342e2e8-1465-4f7b-9450-ef27280f80c7,TCGA-CK-4952,TCGA-COAD,48,-17826,--,16e92c56-21ea-53be-9bc2-68f0516ecaf2,not hispanic or latino,female,white,released,TCGA-CK-4952_demographic,2019-07-31T18:28:22.656208-05:00,Alive,1959,--,17826,M0,N2,Stage IIIC,T4,6th,not reported,475,158b2d77-e651-5c89-9842-7ead7df77e0b,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CK-4952_diagnosis,No,Ascending colon,2019-04-28T11:14:16.829313-05:00,released,TCGA-CK-4952_treatment_1,498db4c7-6688-5b58-9535-1a8abea59431,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:22.656208-05:00,not reported,stage iiic,2019-08-08T16:35:57.350058-05:00,2007
5342e2e8-1465-4f7b-9450-ef27280f80c7,TCGA-CK-4952,TCGA-COAD,48,-17826,--,16e92c56-21ea-53be-9bc2-68f0516ecaf2,not hispanic or latino,female,white,released,TCGA-CK-4952_demographic,2019-07-31T18:28:22.656208-05:00,Alive,1959,--,17826,M0,N2,Stage IIIC,T4,6th,not reported,475,158b2d77-e651-5c89-9842-7ead7df77e0b,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CK-4952_diagnosis,No,Ascending colon,--,released,TCGA-CK-4952_treatment,4b7d56e5-9568-5504-88a7-030789866643,not reported,"Radiation Therapy, NOS",2019-07-31T18:28:22.656208-05:00,not reported,stage iiic,2019-08-08T16:35:57.350058-05:00,2007
1fd75c4d-e74c-410c-a150-814722c6c1cc,TCGA-AZ-4313,TCGA-COAD,51,-18765,--,c27185fd-85dd-5e36-ade2-51ba17e546a4,not hispanic or latino,female,white,released,TCGA-AZ-4313_demographic,2019-07-31T18:24:44.963025-05:00,Alive,1956,--,18765,M0,N0,Stage I,T1,6th,not reported,2310,e5739d9c-d8ff-5def-9c89-930949fa64cf,C18.6,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Descending colon,released,TCGA-AZ-4313_diagnosis,Not Reported,Descending colon,--,released,TCGA-AZ-4313_treatment,19b1dcf5-3259-5a3e-995e-633334a69012,no,"Radiation Therapy, NOS",2019-07-31T18:24:44.963025-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2007
1fd75c4d-e74c-410c-a150-814722c6c1cc,TCGA-AZ-4313,TCGA-COAD,51,-18765,--,c27185fd-85dd-5e36-ade2-51ba17e546a4,not hispanic or latino,female,white,released,TCGA-AZ-4313_demographic,2019-07-31T18:24:44.963025-05:00,Alive,1956,--,18765,M0,N0,Stage I,T1,6th,not reported,2310,e5739d9c-d8ff-5def-9c89-930949fa64cf,C18.6,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Descending colon,released,TCGA-AZ-4313_diagnosis,Not Reported,Descending colon,2019-04-28T11:11:13.616951-05:00,released,TCGA-AZ-4313_treatment_1,7626b0bc-c50d-55c1-bdcd-82d99af15ba5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:44.963025-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2007
35620be9-3ba5-4be7-9e00-83103e6a92e6,TCGA-AA-A02E,TCGA-COAD,82,-30256,90,264fc370-1d4d-5ad1-a9b2-1596d24b64f7,not reported,female,not reported,released,TCGA-AA-A02E_demographic,2019-07-31T15:23:31.286814-05:00,Dead,1925,2007,30256,M1,N1,Stage IV,T3,6th,not reported,--,b24593bb-d02e-56be-8b72-c3da726a1d0b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A02E_diagnosis,No,Cecum,2019-04-28T08:43:14.035988-05:00,released,TCGA-AA-A02E_treatment_1,7a2aa98a-dc4f-54f7-9411-a44bf0be2132,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T15:23:31.286814-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2007
35620be9-3ba5-4be7-9e00-83103e6a92e6,TCGA-AA-A02E,TCGA-COAD,82,-30256,90,264fc370-1d4d-5ad1-a9b2-1596d24b64f7,not reported,female,not reported,released,TCGA-AA-A02E_demographic,2019-07-31T15:23:31.286814-05:00,Dead,1925,2007,30256,M1,N1,Stage IV,T3,6th,not reported,--,b24593bb-d02e-56be-8b72-c3da726a1d0b,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A02E_diagnosis,No,Cecum,--,released,TCGA-AA-A02E_treatment,0771db3a-6477-5672-bfa6-87f2238ee087,not reported,"Radiation Therapy, NOS",2019-07-31T15:23:31.286814-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2007
567ddc8e-2b00-417d-a326-479cb02e08dd,TCGA-G4-6304,TCGA-COAD,66,-24172,--,ffffa817-e120-5d64-83cb-898b0562f023,not hispanic or latino,female,white,released,TCGA-G4-6304_demographic,2019-07-31T18:28:38.426294-05:00,Alive,1940,--,24172,M0,N0,Stage IIB,T4,6th,not reported,1631,da9d349f-ad6f-5705-847e-a01db4c303ef,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-G4-6304_diagnosis,No,Transverse colon,--,released,TCGA-G4-6304_treatment,d2c89e7b-599a-5007-be56-62179899b451,no,"Radiation Therapy, NOS",2019-07-31T18:28:38.426294-05:00,not reported,stage iib,2019-08-08T16:37:18.448891-05:00,2006
567ddc8e-2b00-417d-a326-479cb02e08dd,TCGA-G4-6304,TCGA-COAD,66,-24172,--,ffffa817-e120-5d64-83cb-898b0562f023,not hispanic or latino,female,white,released,TCGA-G4-6304_demographic,2019-07-31T18:28:38.426294-05:00,Alive,1940,--,24172,M0,N0,Stage IIB,T4,6th,not reported,1631,da9d349f-ad6f-5705-847e-a01db4c303ef,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-G4-6304_diagnosis,No,Transverse colon,2019-04-28T11:14:29.267943-05:00,released,TCGA-G4-6304_treatment_1,ab57b61f-2f3e-54fa-84b5-60e7bd3a5ae0,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:38.426294-05:00,not reported,stage iib,2019-08-08T16:37:18.448891-05:00,2006
ad440651-a2de-4bb1-90da-1e5e8975ab59,TCGA-AA-3521,TCGA-COAD,87,-31805,--,ec8b85ac-6080-5adc-b5ae-6b0bc24312e6,not reported,male,not reported,released,TCGA-AA-3521_demographic,2019-07-31T18:34:32.590059-05:00,Alive,1920,--,31805,M0,N0,Stage II,T3,5th,not reported,--,e946ce54-94a8-5339-a4d2-d88882a3a164,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3521_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:19:22.533035-05:00,released,TCGA-AA-3521_treatment_1,eaadd834-b435-55fc-9017-732f6ec5ae53,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:32.590059-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2007
ad440651-a2de-4bb1-90da-1e5e8975ab59,TCGA-AA-3521,TCGA-COAD,87,-31805,--,ec8b85ac-6080-5adc-b5ae-6b0bc24312e6,not reported,male,not reported,released,TCGA-AA-3521_demographic,2019-07-31T18:34:32.590059-05:00,Alive,1920,--,31805,M0,N0,Stage II,T3,5th,not reported,--,e946ce54-94a8-5339-a4d2-d88882a3a164,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3521_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3521_treatment,0a949d3f-fef3-545a-8358-dfa078ea6843,not reported,"Radiation Therapy, NOS",2019-07-31T18:34:32.590059-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2007
a9cb21d1-4c4a-4f30-ad4d-c54bed26f187,TCGA-AA-3975,TCGA-COAD,80,-29310,--,2c5c9f52-3b71-5d68-ae85-5eef14d5ec46,not reported,male,not reported,released,TCGA-AA-3975_demographic,2019-07-31T18:34:08.384120-05:00,Alive,1929,--,29310,M0,N0,Stage I,T2,6th,not reported,1036,ca3b040b-f890-5bab-8628-0b38d15b7ce8,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3975_diagnosis,No,"Colon, NOS",2019-04-28T11:19:03.033411-05:00,released,TCGA-AA-3975_treatment_1,f7e1fc36-d51a-5ab7-be15-b45c1a750d33,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:08.384120-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2009
a9cb21d1-4c4a-4f30-ad4d-c54bed26f187,TCGA-AA-3975,TCGA-COAD,80,-29310,--,2c5c9f52-3b71-5d68-ae85-5eef14d5ec46,not reported,male,not reported,released,TCGA-AA-3975_demographic,2019-07-31T18:34:08.384120-05:00,Alive,1929,--,29310,M0,N0,Stage I,T2,6th,not reported,1036,ca3b040b-f890-5bab-8628-0b38d15b7ce8,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3975_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3975_treatment,3e8dbb5f-0f97-5248-8e87-d4a58ee21eb0,no,"Radiation Therapy, NOS",2019-07-31T18:34:08.384120-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2009
1add38c2-df6f-47c9-9373-0bec0e40baf8,TCGA-AA-3851,TCGA-COAD,74,-27090,--,f862a375-2172-5d61-8e77-18cb120eb153,not reported,male,not reported,released,TCGA-AA-3851_demographic,2019-07-31T18:24:35.348656-05:00,Alive,1935,--,27090,M0,N0,Stage IIA,T3,6th,not reported,1006,0d6e956f-ff58-5fa5-a154-0a6ab36652eb,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3851_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3851_treatment,5b7db956-4654-5d90-9f54-a1e93ca8a23b,no,"Radiation Therapy, NOS",2019-07-31T18:24:35.348656-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
1add38c2-df6f-47c9-9373-0bec0e40baf8,TCGA-AA-3851,TCGA-COAD,74,-27090,--,f862a375-2172-5d61-8e77-18cb120eb153,not reported,male,not reported,released,TCGA-AA-3851_demographic,2019-07-31T18:24:35.348656-05:00,Alive,1935,--,27090,M0,N0,Stage IIA,T3,6th,not reported,1006,0d6e956f-ff58-5fa5-a154-0a6ab36652eb,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3851_diagnosis,No,"Colon, NOS",2019-04-28T11:11:06.272809-05:00,released,TCGA-AA-3851_treatment_1,e0a57900-1b2b-57e1-bef0-fbe171ce75ae,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:35.348656-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
8a84b03a-e37e-4827-98f0-4d480ec31037,TCGA-CK-6748,TCGA-COAD,45,-16529,--,5b0c8a8e-559d-5ac0-9559-46e532aeb796,not hispanic or latino,female,white,released,TCGA-CK-6748_demographic,2019-07-31T18:32:15.876999-05:00,Alive,1963,--,16529,M1,N1,Stage IV,T3,6th,not reported,61,f8151f1c-30b3-50db-b15a-84125aab16a8,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-CK-6748_diagnosis,No,Sigmoid colon,2019-04-28T11:17:31.269283-05:00,released,TCGA-CK-6748_treatment_1,8227691c-65bb-5068-b33c-48223ee866bd,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:15.876999-05:00,not reported,stage iv,2019-08-08T16:36:28.485406-05:00,2008
8a84b03a-e37e-4827-98f0-4d480ec31037,TCGA-CK-6748,TCGA-COAD,45,-16529,--,5b0c8a8e-559d-5ac0-9559-46e532aeb796,not hispanic or latino,female,white,released,TCGA-CK-6748_demographic,2019-07-31T18:32:15.876999-05:00,Alive,1963,--,16529,M1,N1,Stage IV,T3,6th,not reported,61,f8151f1c-30b3-50db-b15a-84125aab16a8,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-CK-6748_diagnosis,No,Sigmoid colon,--,released,TCGA-CK-6748_treatment,e6a0746c-98fd-560b-a671-701f509b4cf5,no,"Radiation Therapy, NOS",2019-07-31T18:32:15.876999-05:00,not reported,stage iv,2019-08-08T16:36:28.485406-05:00,2008
733d8b6a-ca9d-4a69-8c9c-1f88733e8b68,TCGA-AA-3970,TCGA-COAD,65,-23741,--,4ada10d4-3d0d-5a52-a6ae-891244572b4b,not reported,male,not reported,released,TCGA-AA-3970_demographic,2019-07-31T18:30:30.983631-05:00,Alive,1944,--,23741,M0,N0,Stage IIA,T3,6th,not reported,1096,744c1892-7d2b-5526-b8f2-8132b4f43322,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-AA-3970_diagnosis,No,Descending colon,2019-04-28T11:16:03.844070-05:00,released,TCGA-AA-3970_treatment_1,644d5687-950a-5d1b-ad32-7a868ebe31e7,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:30.983631-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
733d8b6a-ca9d-4a69-8c9c-1f88733e8b68,TCGA-AA-3970,TCGA-COAD,65,-23741,--,4ada10d4-3d0d-5a52-a6ae-891244572b4b,not reported,male,not reported,released,TCGA-AA-3970_demographic,2019-07-31T18:30:30.983631-05:00,Alive,1944,--,23741,M0,N0,Stage IIA,T3,6th,not reported,1096,744c1892-7d2b-5526-b8f2-8132b4f43322,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-AA-3970_diagnosis,No,Descending colon,--,released,TCGA-AA-3970_treatment,05375ca5-c32c-5d33-b5b5-7fa30f7bbbaf,no,"Radiation Therapy, NOS",2019-07-31T18:30:30.983631-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
565e2726-4942-4726-89d3-c5e3797f7204,TCGA-A6-2671,TCGA-COAD,85,-31329,1331,db0a1c10-92be-5471-abc0-abd5fcafc772,not hispanic or latino,male,white,released,TCGA-A6-2671_demographic,2019-07-31T18:28:35.448302-05:00,Dead,1924,--,31329,M1,N2,Stage IV,T3,6th,not reported,1126,791edec8-056b-5ce1-9b25-15c861f9c69c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-2671_diagnosis,No,Sigmoid colon,2019-04-28T11:14:26.848967-05:00,released,TCGA-A6-2671_treatment_1,7b46b686-89e3-568d-a285-6a5e9608c516,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:35.448302-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
565e2726-4942-4726-89d3-c5e3797f7204,TCGA-A6-2671,TCGA-COAD,85,-31329,1331,db0a1c10-92be-5471-abc0-abd5fcafc772,not hispanic or latino,male,white,released,TCGA-A6-2671_demographic,2019-07-31T18:28:35.448302-05:00,Dead,1924,--,31329,M1,N2,Stage IV,T3,6th,not reported,1126,791edec8-056b-5ce1-9b25-15c861f9c69c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-2671_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-2671_treatment,ba7bc9b5-32ac-56b5-ba45-3d4695bc2367,no,"Radiation Therapy, NOS",2019-07-31T18:28:35.448302-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
27d9c162-11bb-48fb-a41a-aa05fcb4c1c2,TCGA-G4-6293,TCGA-COAD,49,-18076,--,dc83e798-1ce2-5776-a90d-8e8fb1fe7821,not hispanic or latino,female,white,released,TCGA-G4-6293_demographic,2019-07-31T18:25:26.421513-05:00,Alive,1953,--,18076,M0,N1,Stage III,T3,5th,not reported,4051,8fbff4e8-b8c0-5bf5-9c0b-156568db1ca0,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-G4-6293_diagnosis,No,Transverse colon,2019-04-28T11:11:49.382829-05:00,released,TCGA-G4-6293_treatment_1,903fa7d1-0c66-5d38-a4a8-094a665788f2,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:26.421513-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2002
27d9c162-11bb-48fb-a41a-aa05fcb4c1c2,TCGA-G4-6293,TCGA-COAD,49,-18076,--,dc83e798-1ce2-5776-a90d-8e8fb1fe7821,not hispanic or latino,female,white,released,TCGA-G4-6293_demographic,2019-07-31T18:25:26.421513-05:00,Alive,1953,--,18076,M0,N1,Stage III,T3,5th,not reported,4051,8fbff4e8-b8c0-5bf5-9c0b-156568db1ca0,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-G4-6293_diagnosis,No,Transverse colon,--,released,TCGA-G4-6293_treatment,07989e07-a4ef-51a9-8ea6-9645f9cd4652,no,"Radiation Therapy, NOS",2019-07-31T18:25:26.421513-05:00,not reported,stage iii,2019-08-08T16:37:18.448891-05:00,2002
d651f9ba-8746-46c4-852c-6c2992c7d10e,TCGA-AA-3667,TCGA-COAD,36,-13302,--,bd0d8fb6-ae58-54a9-a631-5aa35a76f2fe,not reported,female,not reported,released,TCGA-AA-3667_demographic,2019-07-31T18:38:03.030838-05:00,Alive,1969,--,13302,M0,N0,Stage I,T2,5th,not reported,426,8909b7bd-0c4f-5604-b360-2175bb1340fa,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3667_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3667_treatment,7618f90b-e21e-559c-a294-826fa5d22b88,no,"Radiation Therapy, NOS",2019-07-31T18:38:03.030838-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2005
d651f9ba-8746-46c4-852c-6c2992c7d10e,TCGA-AA-3667,TCGA-COAD,36,-13302,--,bd0d8fb6-ae58-54a9-a631-5aa35a76f2fe,not reported,female,not reported,released,TCGA-AA-3667_demographic,2019-07-31T18:38:03.030838-05:00,Alive,1969,--,13302,M0,N0,Stage I,T2,5th,not reported,426,8909b7bd-0c4f-5604-b360-2175bb1340fa,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3667_diagnosis,No,"Colon, NOS",2019-04-28T11:22:17.488465-05:00,released,TCGA-AA-3667_treatment_1,bc443232-8611-5aee-8da0-a2365412797e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:03.030838-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2005
f3b9defb-88ed-4c95-9feb-7197d869676c,TCGA-AA-3680,TCGA-COAD,67,-24655,335,bfba3234-8ff1-5154-a5dd-775f5d87c0a3,not reported,female,not reported,released,TCGA-AA-3680_demographic,2019-07-31T18:40:23.581078-05:00,Dead,1939,--,24655,M1,N2,Stage IV,T4,6th,not reported,--,e90d31fe-1e81-543a-8639-31fce539a335,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3680_diagnosis,No,Cecum,--,released,TCGA-AA-3680_treatment,c889f7a4-047c-56c5-b879-ea036b69e768,no,"Radiation Therapy, NOS",2019-07-31T18:40:23.581078-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2006
f3b9defb-88ed-4c95-9feb-7197d869676c,TCGA-AA-3680,TCGA-COAD,67,-24655,335,bfba3234-8ff1-5154-a5dd-775f5d87c0a3,not reported,female,not reported,released,TCGA-AA-3680_demographic,2019-07-31T18:40:23.581078-05:00,Dead,1939,--,24655,M1,N2,Stage IV,T4,6th,not reported,--,e90d31fe-1e81-543a-8639-31fce539a335,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3680_diagnosis,No,Cecum,2019-04-28T11:24:16.700948-05:00,released,TCGA-AA-3680_treatment_1,93efa49d-db1f-5f06-a00c-aeedf13aec0b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:23.581078-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2006
e17959bd-045d-4540-b43a-c3863e8ff3c0,TCGA-G4-6295,TCGA-COAD,70,-25758,--,ee4b0c91-6b2b-5584-ab4a-dc92da503c5e,not hispanic or latino,female,white,released,TCGA-G4-6295_demographic,2019-07-31T18:38:56.588183-05:00,Alive,1934,--,25758,M0,N0,Stage II,T3,6th,not reported,254,01ca1ad9-a700-5741-a00d-afdd72529758,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-G4-6295_diagnosis,No,Cecum,--,released,TCGA-G4-6295_treatment,6872fe9b-8ba6-5910-a15a-db9a5b04da0c,no,"Radiation Therapy, NOS",2019-07-31T18:38:56.588183-05:00,not reported,stage ii,2019-08-08T16:37:18.448891-05:00,2004
e17959bd-045d-4540-b43a-c3863e8ff3c0,TCGA-G4-6295,TCGA-COAD,70,-25758,--,ee4b0c91-6b2b-5584-ab4a-dc92da503c5e,not hispanic or latino,female,white,released,TCGA-G4-6295_demographic,2019-07-31T18:38:56.588183-05:00,Alive,1934,--,25758,M0,N0,Stage II,T3,6th,not reported,254,01ca1ad9-a700-5741-a00d-afdd72529758,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-G4-6295_diagnosis,No,Cecum,2019-04-28T11:23:03.834449-05:00,released,TCGA-G4-6295_treatment_1,a66b6712-db10-5dbc-b4bc-f66453ff8c94,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:56.588183-05:00,not reported,stage ii,2019-08-08T16:37:18.448891-05:00,2004
4f601d7b-8db1-4c6d-9374-21dcd804980d,TCGA-AD-6895,TCGA-COAD,84,-30879,--,7a038c27-f3bb-5418-998f-df22a763bdbb,not hispanic or latino,male,white,released,TCGA-AD-6895_demographic,2019-07-31T18:28:08.017634-05:00,Alive,1927,--,30879,M0,N1a,Stage IIIB,T3,7th,not reported,763,63b14ab8-f769-59de-8461-511bb8940309,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AD-6895_diagnosis,Not Reported,Cecum,--,released,TCGA-AD-6895_treatment,1a3760ee-1f4c-54de-a549-014a4edc68df,no,"Radiation Therapy, NOS",2019-07-31T18:28:08.017634-05:00,not reported,stage iiib,2019-08-08T16:35:29.811838-05:00,2011
4f601d7b-8db1-4c6d-9374-21dcd804980d,TCGA-AD-6895,TCGA-COAD,84,-30879,--,7a038c27-f3bb-5418-998f-df22a763bdbb,not hispanic or latino,male,white,released,TCGA-AD-6895_demographic,2019-07-31T18:28:08.017634-05:00,Alive,1927,--,30879,M0,N1a,Stage IIIB,T3,7th,not reported,763,63b14ab8-f769-59de-8461-511bb8940309,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-AD-6895_diagnosis,Not Reported,Cecum,2019-04-28T11:14:04.360686-05:00,released,TCGA-AD-6895_treatment_1,6c22ae52-6ca4-5f87-8df9-96f0adf344ba,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:08.017634-05:00,not reported,stage iiib,2019-08-08T16:35:29.811838-05:00,2011
c293a148-a88c-4fb3-b2f4-e64e918044f9,TCGA-CK-4950,TCGA-COAD,68,-24944,--,b02b0b35-a340-5e4f-8a37-4a93bececb0e,not hispanic or latino,female,black or african american,released,TCGA-CK-4950_demographic,2019-07-31T18:36:13.474756-05:00,Alive,1940,--,24944,M0,N1,Stage IIIB,T3,6th,not reported,2599,3e667b75-e949-58db-af5c-047992f4b20d,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-CK-4950_diagnosis,No,Cecum,--,released,TCGA-CK-4950_treatment,008419f5-d88b-5d58-b879-d9c7c10ee97b,no,"Radiation Therapy, NOS",2019-07-31T18:36:13.474756-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2008
c293a148-a88c-4fb3-b2f4-e64e918044f9,TCGA-CK-4950,TCGA-COAD,68,-24944,--,b02b0b35-a340-5e4f-8a37-4a93bececb0e,not hispanic or latino,female,black or african american,released,TCGA-CK-4950_demographic,2019-07-31T18:36:13.474756-05:00,Alive,1940,--,24944,M0,N1,Stage IIIB,T3,6th,not reported,2599,3e667b75-e949-58db-af5c-047992f4b20d,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-CK-4950_diagnosis,No,Cecum,2019-04-28T11:20:46.482361-05:00,released,TCGA-CK-4950_treatment_1,4c4dec26-1843-5e01-852f-72e0de15eb5b,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:13.474756-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2008
4ad9784e-1edc-4186-9b45-4dfe0003f74b,TCGA-A6-6138,TCGA-COAD,61,-22523,--,a263f4ea-2d60-5667-ae69-9010c645c541,not hispanic or latino,male,white,released,TCGA-A6-6138_demographic,2019-07-31T18:27:59.292987-05:00,Alive,1949,--,22523,M0,N0,Stage I,T2,--,not reported,685,1263e084-7d11-5a43-8c6d-de6ce266ae62,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-6138_diagnosis,No,Cecum,2019-04-28T11:13:56.827181-05:00,released,TCGA-A6-6138_treatment_1,96871400-afc9-54b3-82bf-f537c41f8b04,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:59.292987-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2010
4ad9784e-1edc-4186-9b45-4dfe0003f74b,TCGA-A6-6138,TCGA-COAD,61,-22523,--,a263f4ea-2d60-5667-ae69-9010c645c541,not hispanic or latino,male,white,released,TCGA-A6-6138_demographic,2019-07-31T18:27:59.292987-05:00,Alive,1949,--,22523,M0,N0,Stage I,T2,--,not reported,685,1263e084-7d11-5a43-8c6d-de6ce266ae62,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-6138_diagnosis,No,Cecum,--,released,TCGA-A6-6138_treatment,777e3164-730e-5586-8cd0-2dd48cb9e836,no,"Radiation Therapy, NOS",2019-07-31T18:27:59.292987-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2010
7ad0617e-bc4a-4869-8419-744f04d9b7a3,TCGA-AZ-6601,TCGA-COAD,68,-25082,3042,d6dffc10-caa9-59b7-a55b-2925665135d3,not hispanic or latino,male,white,released,TCGA-AZ-6601_demographic,2019-07-31T18:31:15.962367-05:00,Dead,1933,2009,25082,M0,N0,Stage II,T3,5th,not reported,--,c84584a8-1d17-50ac-a3e1-1051e2889a4d,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AZ-6601_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AZ-6601_treatment,d58ea798-b0da-5e7f-aa5c-3b00f2b3d65e,no,"Radiation Therapy, NOS",2019-07-31T18:31:15.962367-05:00,not reported,stage ii,2019-08-08T16:35:57.350058-05:00,2001
7ad0617e-bc4a-4869-8419-744f04d9b7a3,TCGA-AZ-6601,TCGA-COAD,68,-25082,3042,d6dffc10-caa9-59b7-a55b-2925665135d3,not hispanic or latino,male,white,released,TCGA-AZ-6601_demographic,2019-07-31T18:31:15.962367-05:00,Dead,1933,2009,25082,M0,N0,Stage II,T3,5th,not reported,--,c84584a8-1d17-50ac-a3e1-1051e2889a4d,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AZ-6601_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:16:41.081909-05:00,released,TCGA-AZ-6601_treatment_1,862cb7c5-bbbb-5cd9-8bf8-cb67d190e399,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:15.962367-05:00,not reported,stage ii,2019-08-08T16:35:57.350058-05:00,2001
639e1050-088a-48fe-a0ef-4a01a3468cac,TCGA-AA-3496,TCGA-COAD,83,-30438,--,8d251dea-2604-56ff-8d3a-1189a3c6caaf,not reported,female,not reported,released,TCGA-AA-3496_demographic,2019-07-31T18:29:40.347522-05:00,Alive,1919,--,30438,M0,N0,Stage II,T3,5th,not reported,31,022fb21c-fd29-58e6-a679-db939bd10484,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3496_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3496_treatment,443096e0-f539-5796-9219-5f14ba1cf294,not reported,"Radiation Therapy, NOS",2019-07-31T18:29:40.347522-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2002
639e1050-088a-48fe-a0ef-4a01a3468cac,TCGA-AA-3496,TCGA-COAD,83,-30438,--,8d251dea-2604-56ff-8d3a-1189a3c6caaf,not reported,female,not reported,released,TCGA-AA-3496_demographic,2019-07-31T18:29:40.347522-05:00,Alive,1919,--,30438,M0,N0,Stage II,T3,5th,not reported,31,022fb21c-fd29-58e6-a679-db939bd10484,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3496_diagnosis,Not Reported,Ascending colon,2019-04-28T11:15:21.647420-05:00,released,TCGA-AA-3496_treatment_1,3a09db47-9fcd-5cd9-b500-c4a8548ce5a0,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:40.347522-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2002
5f6ed48b-3b5a-4d20-8fbf-c9aa3feea186,TCGA-RU-A8FL,TCGA-COAD,51,-18975,--,8f28c692-8fee-5f09-a7a7-ab38ab4b0213,not hispanic or latino,male,black or african american,released,TCGA-RU-A8FL_demographic,2019-07-31T18:41:44.848950-05:00,Alive,1960,--,18975,MX,N2a,Stage IIIB,T3,7th,not reported,1177,15be329f-b060-50bd-8af3-dcdd8805286c,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-RU-A8FL_diagnosis,No,Cecum,2019-04-28T11:25:25.797092-05:00,released,TCGA-RU-A8FL_treatment_1,7666f5fa-d10f-5803-89d9-49e5a3e9f1e8,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:44.848950-05:00,not reported,stage iiib,2019-08-08T16:37:44.165377-05:00,2011
5f6ed48b-3b5a-4d20-8fbf-c9aa3feea186,TCGA-RU-A8FL,TCGA-COAD,51,-18975,--,8f28c692-8fee-5f09-a7a7-ab38ab4b0213,not hispanic or latino,male,black or african american,released,TCGA-RU-A8FL_demographic,2019-07-31T18:41:44.848950-05:00,Alive,1960,--,18975,MX,N2a,Stage IIIB,T3,7th,not reported,1177,15be329f-b060-50bd-8af3-dcdd8805286c,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-RU-A8FL_diagnosis,No,Cecum,--,released,TCGA-RU-A8FL_treatment,e360d000-a09b-55af-997a-4139855cf582,no,"Radiation Therapy, NOS",2019-07-31T18:41:44.848950-05:00,not reported,stage iiib,2019-08-08T16:37:44.165377-05:00,2011
65ab030d-39f2-48ab-80ac-90cb1faa823a,TCGA-CA-5796,TCGA-COAD,52,-19353,--,d3c4ff05-2cc9-59e9-9bdd-70a7a9c1ff05,not hispanic or latino,female,asian,released,TCGA-CA-5796_demographic,2019-07-31T18:29:55.487314-05:00,Alive,1958,--,19353,M0,N0,Stage IIA,T3,6th,not reported,377,b3bb8c49-daa1-5991-b68c-8c75715ba024,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CA-5796_diagnosis,No,Ascending colon,--,released,TCGA-CA-5796_treatment,2179d619-94e7-5f63-a260-5a76d2bfcc38,no,"Radiation Therapy, NOS",2019-07-31T18:29:55.487314-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
65ab030d-39f2-48ab-80ac-90cb1faa823a,TCGA-CA-5796,TCGA-COAD,52,-19353,--,d3c4ff05-2cc9-59e9-9bdd-70a7a9c1ff05,not hispanic or latino,female,asian,released,TCGA-CA-5796_demographic,2019-07-31T18:29:55.487314-05:00,Alive,1958,--,19353,M0,N0,Stage IIA,T3,6th,not reported,377,b3bb8c49-daa1-5991-b68c-8c75715ba024,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-CA-5796_diagnosis,No,Ascending colon,2019-04-28T11:15:34.224079-05:00,released,TCGA-CA-5796_treatment_1,8b0ea12f-f1f9-5662-9933-21c1b79b432a,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:55.487314-05:00,not reported,stage iia,2019-08-08T16:35:57.350058-05:00,2010
f1e6ce83-b4a0-4643-8e8e-a1ef8a158a27,TCGA-AZ-6608,TCGA-COAD,55,-20094,59,1e200b1f-df0a-52ba-9f47-a2908d777fa4,not hispanic or latino,female,white,released,TCGA-AZ-6608_demographic,2019-07-31T18:40:12.911096-05:00,Dead,1954,2009,20094,M0,N1,Stage IIIA,T2,6th,not reported,--,9e0f85cf-055d-57cf-9d23-3d8920de8d0d,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AZ-6608_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AZ-6608_treatment,99ff5617-50c0-5cb8-9abe-cd90505a4482,no,"Radiation Therapy, NOS",2019-07-31T18:40:12.911096-05:00,not reported,stage iiia,2019-08-08T16:35:57.350058-05:00,2009
f1e6ce83-b4a0-4643-8e8e-a1ef8a158a27,TCGA-AZ-6608,TCGA-COAD,55,-20094,59,1e200b1f-df0a-52ba-9f47-a2908d777fa4,not hispanic or latino,female,white,released,TCGA-AZ-6608_demographic,2019-07-31T18:40:12.911096-05:00,Dead,1954,2009,20094,M0,N1,Stage IIIA,T2,6th,not reported,--,9e0f85cf-055d-57cf-9d23-3d8920de8d0d,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AZ-6608_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:24:09.211609-05:00,released,TCGA-AZ-6608_treatment_1,c7e899c7-4ec4-5b90-92b4-19dc340df99e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:12.911096-05:00,not reported,stage iiia,2019-08-08T16:35:57.350058-05:00,2009
23d0681a-912a-408f-b19a-0bbcf5ffc2f3,TCGA-AA-3695,TCGA-COAD,63,-23164,--,b00af9fd-1896-5ecb-8398-d06dd93b3ad8,not reported,female,not reported,released,TCGA-AA-3695_demographic,2019-07-31T18:25:02.792478-05:00,Alive,1946,--,23164,M1,N2,Stage IV,T3,6th,not reported,--,f5b507ce-101a-558b-a4a2-e15d51b9fe31,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3695_diagnosis,No,Cecum,--,released,TCGA-AA-3695_treatment,2839fc8c-2403-5f54-9e58-a8aacaf5b67f,not reported,"Radiation Therapy, NOS",2019-07-31T18:25:02.792478-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2009
23d0681a-912a-408f-b19a-0bbcf5ffc2f3,TCGA-AA-3695,TCGA-COAD,63,-23164,--,b00af9fd-1896-5ecb-8398-d06dd93b3ad8,not reported,female,not reported,released,TCGA-AA-3695_demographic,2019-07-31T18:25:02.792478-05:00,Alive,1946,--,23164,M1,N2,Stage IV,T3,6th,not reported,--,f5b507ce-101a-558b-a4a2-e15d51b9fe31,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3695_diagnosis,No,Cecum,2019-04-28T11:11:29.387474-05:00,released,TCGA-AA-3695_treatment_1,56ba9f11-e187-5a7d-9f4f-66be2d352615,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:02.792478-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2009
86d18004-9478-4e46-83b4-4fbe445ccb70,TCGA-AA-A01I,TCGA-COAD,76,-27759,--,e8e80639-f7e0-561c-900c-05cf53ad9aa5,not reported,male,not reported,released,TCGA-AA-A01I_demographic,2019-07-31T18:32:06.643442-05:00,Alive,1933,--,27759,M0,N0,Stage I,T2,6th,not reported,943,48944367-bc4c-53e6-8f72-85751945dd86,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01I_diagnosis,No,Sigmoid colon,2019-04-28T11:17:23.921596-05:00,released,TCGA-AA-A01I_treatment_1,d17654d0-9d75-5673-8998-ccfdebd8e692,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:06.643442-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2009
86d18004-9478-4e46-83b4-4fbe445ccb70,TCGA-AA-A01I,TCGA-COAD,76,-27759,--,e8e80639-f7e0-561c-900c-05cf53ad9aa5,not reported,male,not reported,released,TCGA-AA-A01I_demographic,2019-07-31T18:32:06.643442-05:00,Alive,1933,--,27759,M0,N0,Stage I,T2,6th,not reported,943,48944367-bc4c-53e6-8f72-85751945dd86,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A01I_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A01I_treatment,e8e7476c-a9b6-5dab-b95a-b3c843a2c0eb,no,"Radiation Therapy, NOS",2019-07-31T18:32:06.643442-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2009
41f8c9fd-ae52-4458-886b-faf37de77dd0,TCGA-G4-6294,TCGA-COAD,75,-27755,858,02f74806-d4b0-525d-82f3-d2cac8b5d3c6,not hispanic or latino,male,white,released,TCGA-G4-6294_demographic,2019-07-31T18:27:37.310055-05:00,Dead,1929,2006,27755,M1,N1,Stage IV,T3,6th,not reported,--,fd6c0b31-a612-5c24-805d-03fc880bc83a,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6294_diagnosis,Not Reported,Cecum,--,released,TCGA-G4-6294_treatment,3b20cf23-f65b-5744-bbe3-78fd7bc26c01,no,"Radiation Therapy, NOS",2019-07-31T18:27:37.310055-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2004
41f8c9fd-ae52-4458-886b-faf37de77dd0,TCGA-G4-6294,TCGA-COAD,75,-27755,858,02f74806-d4b0-525d-82f3-d2cac8b5d3c6,not hispanic or latino,male,white,released,TCGA-G4-6294_demographic,2019-07-31T18:27:37.310055-05:00,Dead,1929,2006,27755,M1,N1,Stage IV,T3,6th,not reported,--,fd6c0b31-a612-5c24-805d-03fc880bc83a,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6294_diagnosis,Not Reported,Cecum,2019-04-28T11:13:39.463922-05:00,released,TCGA-G4-6294_treatment_1,5b0ecbdf-8506-5d64-8595-23025d016c59,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:37.310055-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2004
022f39e9-57ee-4b2b-8b3a-8929e3d69a37,TCGA-DM-A28F,TCGA-COAD,73,-26856,1094,15f12adc-ad56-5179-a28c-c0c7e4b95656,not hispanic or latino,male,white,released,TCGA-DM-A28F_demographic,2019-07-31T18:22:25.357970-05:00,Dead,1929,2004,26856,M0,N1,Stage IIIB,T3,6th,not reported,1094,f2411a03-df9b-5862-aa49-a10da2d2bb4a,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A28F_diagnosis,No,Sigmoid colon,2019-04-28T11:09:20.182148-05:00,released,TCGA-DM-A28F_treatment_1,5556f18c-b28c-53f7-b8d1-29d333e5a359,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:25.357970-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2002
022f39e9-57ee-4b2b-8b3a-8929e3d69a37,TCGA-DM-A28F,TCGA-COAD,73,-26856,1094,15f12adc-ad56-5179-a28c-c0c7e4b95656,not hispanic or latino,male,white,released,TCGA-DM-A28F_demographic,2019-07-31T18:22:25.357970-05:00,Dead,1929,2004,26856,M0,N1,Stage IIIB,T3,6th,not reported,1094,f2411a03-df9b-5862-aa49-a10da2d2bb4a,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A28F_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A28F_treatment,faab77ea-5f40-5c10-ab77-49515e677f08,not reported,"Radiation Therapy, NOS",2019-07-31T18:22:25.357970-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2002
5b259d18-3976-4f44-967f-fe5fa8447c8b,TCGA-CM-5864,TCGA-COAD,60,-22219,--,5c0a9b6e-5576-56fe-aa39-baf91d019dad,not hispanic or latino,male,white,released,TCGA-CM-5864_demographic,2019-07-31T18:29:04.601818-05:00,Alive,1950,--,22219,M0,N0,Stage I,T2,7th,not reported,457,e08d5194-054d-5f61-bad5-43ffd4caa48a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5864_diagnosis,No,Cecum,--,released,TCGA-CM-5864_treatment,bb90e248-3295-57b1-ae49-cf3211ff33b4,no,"Radiation Therapy, NOS",2019-07-31T18:29:04.601818-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
5b259d18-3976-4f44-967f-fe5fa8447c8b,TCGA-CM-5864,TCGA-COAD,60,-22219,--,5c0a9b6e-5576-56fe-aa39-baf91d019dad,not hispanic or latino,male,white,released,TCGA-CM-5864_demographic,2019-07-31T18:29:04.601818-05:00,Alive,1950,--,22219,M0,N0,Stage I,T2,7th,not reported,457,e08d5194-054d-5f61-bad5-43ffd4caa48a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5864_diagnosis,No,Cecum,2019-04-28T11:14:51.935001-05:00,released,TCGA-CM-5864_treatment_1,985d0fd5-ca66-567a-a33b-705bbba8416e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:04.601818-05:00,not reported,stage i,2019-08-08T16:36:28.485406-05:00,2010
15b987ba-77ab-477b-a54a-65ec5c7c399e,TCGA-AA-3495,TCGA-COAD,79,-28886,--,5d338718-c0f9-5598-b720-3653fbdbb267,not reported,male,not reported,released,TCGA-AA-3495_demographic,2019-07-31T18:24:13.173721-05:00,Alive,1923,--,28886,M0,N0,Stage I,T2,5th,not reported,1127,4e7b68ee-a376-5503-a627-178a80426601,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AA-3495_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-AA-3495_treatment,35c62a5e-3512-5ea9-b361-e2a454c4b7ee,no,"Radiation Therapy, NOS",2019-07-31T18:24:13.173721-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2002
15b987ba-77ab-477b-a54a-65ec5c7c399e,TCGA-AA-3495,TCGA-COAD,79,-28886,--,5d338718-c0f9-5598-b720-3653fbdbb267,not reported,male,not reported,released,TCGA-AA-3495_demographic,2019-07-31T18:24:13.173721-05:00,Alive,1923,--,28886,M0,N0,Stage I,T2,5th,not reported,1127,4e7b68ee-a376-5503-a627-178a80426601,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AA-3495_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:10:48.937897-05:00,released,TCGA-AA-3495_treatment_1,a51ce2a9-27cc-596d-9c66-08914f346439,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:13.173721-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2002
65bb7520-f055-43a8-b735-1152fa2c9e04,TCGA-A6-2670,TCGA-COAD,45,-16512,--,54928794-22fd-56f0-a516-abbfe033226c,not hispanic or latino,male,white,released,TCGA-A6-2670_demographic,2019-07-31T18:29:58.295013-05:00,Alive,1964,--,16512,M0,N0,Stage IIA,T3,--,not reported,775,eb5ddb17-faf3-5cc9-8034-7b9ccc0dac05,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-2670_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-2670_treatment,1eb99c84-3ecf-5d09-bc7c-c1312d333435,no,"Radiation Therapy, NOS",2019-07-31T18:29:58.295013-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
65bb7520-f055-43a8-b735-1152fa2c9e04,TCGA-A6-2670,TCGA-COAD,45,-16512,--,54928794-22fd-56f0-a516-abbfe033226c,not hispanic or latino,male,white,released,TCGA-A6-2670_demographic,2019-07-31T18:29:58.295013-05:00,Alive,1964,--,16512,M0,N0,Stage IIA,T3,--,not reported,775,eb5ddb17-faf3-5cc9-8034-7b9ccc0dac05,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-2670_diagnosis,No,Sigmoid colon,2019-04-28T11:15:36.780000-05:00,released,TCGA-A6-2670_treatment_1,bedbe581-f430-5c0a-bddd-538b471e0ed6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:58.295013-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
401a37f3-6630-4400-a811-a262351e37de,TCGA-AA-3531,TCGA-COAD,75,-27514,--,f82406f5-f85f-50f4-a0f2-351ea8e1a71f,not reported,female,not reported,released,TCGA-AA-3531_demographic,2019-07-31T18:27:24.480618-05:00,Alive,1932,--,27514,M0,N0,Stage IIA,T3,6th,not reported,1035,129bff50-1598-5a43-883e-e17054d2e3cb,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3531_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3531_treatment,4da4570a-aa40-58fd-8a8a-4f5d6fb562a4,no,"Radiation Therapy, NOS",2019-07-31T18:27:24.480618-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
401a37f3-6630-4400-a811-a262351e37de,TCGA-AA-3531,TCGA-COAD,75,-27514,--,f82406f5-f85f-50f4-a0f2-351ea8e1a71f,not reported,female,not reported,released,TCGA-AA-3531_demographic,2019-07-31T18:27:24.480618-05:00,Alive,1932,--,27514,M0,N0,Stage IIA,T3,6th,not reported,1035,129bff50-1598-5a43-883e-e17054d2e3cb,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3531_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:13:29.918627-05:00,released,TCGA-AA-3531_treatment_1,cfc969c2-2757-5e97-ac1c-760506d41e6f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:24.480618-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
e76258b7-e13a-4b05-855b-d792701ffba1,TCGA-F4-6805,TCGA-COAD,58,-21241,--,1c11be25-708d-5494-9e6f-571e7be5b0f4,not hispanic or latino,female,white,released,TCGA-F4-6805_demographic,2019-07-31T18:39:34.296514-05:00,Alive,1953,--,21241,M0,N0,Stage IIA,T3,7th,not reported,1047,465c0b70-1e08-5eef-9b2f-b238a1148d71,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6805_diagnosis,No,"Colon, NOS",--,released,TCGA-F4-6805_treatment,f114d698-1483-5190-ab4b-cee6a3fd98f6,no,"Radiation Therapy, NOS",2019-07-31T18:39:34.296514-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
e76258b7-e13a-4b05-855b-d792701ffba1,TCGA-F4-6805,TCGA-COAD,58,-21241,--,1c11be25-708d-5494-9e6f-571e7be5b0f4,not hispanic or latino,female,white,released,TCGA-F4-6805_demographic,2019-07-31T18:39:34.296514-05:00,Alive,1953,--,21241,M0,N0,Stage IIA,T3,7th,not reported,1047,465c0b70-1e08-5eef-9b2f-b238a1148d71,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-F4-6805_diagnosis,No,"Colon, NOS",2019-04-28T11:23:36.440189-05:00,released,TCGA-F4-6805_treatment_1,349addac-5bd9-57a9-a98c-a40e0345aefa,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:34.296514-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2011
68801d41-535f-4b38-989b-ef4fe5f00039,TCGA-A6-6653,TCGA-COAD,82,-29996,--,c7402286-51bb-5fdc-ac48-c7b0db4971b0,not hispanic or latino,male,white,released,TCGA-A6-6653_demographic,2019-07-31T18:30:06.770749-05:00,Alive,1929,--,29996,M0,N0,Stage I,T2,7th,not reported,742,d2e67fea-1535-5854-a5e3-1a9ef88e8bed,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6653_diagnosis,No,"Colon, NOS",2019-04-28T11:15:44.180204-05:00,released,TCGA-A6-6653_treatment_1,dc70a6e0-f82d-5189-b928-92dab785a50f,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:06.770749-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2011
68801d41-535f-4b38-989b-ef4fe5f00039,TCGA-A6-6653,TCGA-COAD,82,-29996,--,c7402286-51bb-5fdc-ac48-c7b0db4971b0,not hispanic or latino,male,white,released,TCGA-A6-6653_demographic,2019-07-31T18:30:06.770749-05:00,Alive,1929,--,29996,M0,N0,Stage I,T2,7th,not reported,742,d2e67fea-1535-5854-a5e3-1a9ef88e8bed,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6653_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-6653_treatment,b1bc89be-c3f4-57ee-9fd1-db287fcaf39f,no,"Radiation Therapy, NOS",2019-07-31T18:30:06.770749-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2011
81e7cca8-2d71-4446-9692-872c2fe68d0a,TCGA-A6-6654,TCGA-COAD,65,-23953,--,c97a8797-54cd-5d36-aa03-5f5ac2f4680a,not hispanic or latino,female,white,released,TCGA-A6-6654_demographic,2019-07-31T18:31:37.040791-05:00,Alive,1946,--,23953,M0,N1,Stage IIIB,T3,7th,not reported,726,7d7d886b-e662-5e9b-873e-ae1de589ab48,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6654_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-6654_treatment,4b9b6635-7015-5680-b309-4aa51be2ac8e,no,"Radiation Therapy, NOS",2019-07-31T18:31:37.040791-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2011
81e7cca8-2d71-4446-9692-872c2fe68d0a,TCGA-A6-6654,TCGA-COAD,65,-23953,--,c97a8797-54cd-5d36-aa03-5f5ac2f4680a,not hispanic or latino,female,white,released,TCGA-A6-6654_demographic,2019-07-31T18:31:37.040791-05:00,Alive,1946,--,23953,M0,N1,Stage IIIB,T3,7th,not reported,726,7d7d886b-e662-5e9b-873e-ae1de589ab48,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-6654_diagnosis,No,"Colon, NOS",2019-04-28T11:16:58.316292-05:00,released,TCGA-A6-6654_treatment_1,5da00ef1-d864-54c4-8507-0862d19f29c7,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:37.040791-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2011
09942e9f-c178-44bc-9cd9-f5bfa350b23f,TCGA-AA-3519,TCGA-COAD,63,-23131,--,564a1e5d-b44d-5635-bcc7-2e5b14a2eb60,not reported,male,not reported,released,TCGA-AA-3519_demographic,2019-07-31T18:22:52.065030-05:00,Alive,1944,--,23131,M0,N1,Stage III,T3,5th,not reported,276,df2fc731-b831-5e6e-b2da-2c68b94f7fee,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3519_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3519_treatment,c0c679b4-aab2-5d29-af42-d3eaacfae877,no,"Radiation Therapy, NOS",2019-07-31T18:22:52.065030-05:00,not reported,stage iii,2019-08-08T16:34:13.342472-05:00,2007
09942e9f-c178-44bc-9cd9-f5bfa350b23f,TCGA-AA-3519,TCGA-COAD,63,-23131,--,564a1e5d-b44d-5635-bcc7-2e5b14a2eb60,not reported,male,not reported,released,TCGA-AA-3519_demographic,2019-07-31T18:22:52.065030-05:00,Alive,1944,--,23131,M0,N1,Stage III,T3,5th,not reported,276,df2fc731-b831-5e6e-b2da-2c68b94f7fee,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3519_diagnosis,No,"Colon, NOS",2019-04-28T11:09:43.154630-05:00,released,TCGA-AA-3519_treatment_1,d48e56a7-0075-50d2-9fec-97ad201b5d01,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:52.065030-05:00,not reported,stage iii,2019-08-08T16:34:13.342472-05:00,2007
b95720b1-aa00-4c6a-b202-3350d035829f,TCGA-AA-3489,TCGA-COAD,75,-27606,214,accd8202-6b47-5fc1-8da6-29808fcf414e,not reported,male,not reported,released,TCGA-AA-3489_demographic,2019-07-31T18:42:40.257002-05:00,Dead,1927,--,27606,M0,N0,Stage II,T3,5th,not reported,31,3dffb61a-79ee-56bd-a441-5c48acb6c95a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3489_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3489_treatment,50976603-643a-5cd0-95fc-f9efad4c46c2,no,"Radiation Therapy, NOS",2019-07-31T18:42:40.257002-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2002
b95720b1-aa00-4c6a-b202-3350d035829f,TCGA-AA-3489,TCGA-COAD,75,-27606,214,accd8202-6b47-5fc1-8da6-29808fcf414e,not reported,male,not reported,released,TCGA-AA-3489_demographic,2019-07-31T18:42:40.257002-05:00,Dead,1927,--,27606,M0,N0,Stage II,T3,5th,not reported,31,3dffb61a-79ee-56bd-a441-5c48acb6c95a,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3489_diagnosis,No,"Colon, NOS",2019-04-28T11:26:14.627653-05:00,released,TCGA-AA-3489_treatment_1,7498be12-6fdd-5035-a6d0-fc13093725cd,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:40.257002-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2002
f4a804d3-b5c4-4da5-800f-6e5757ecfa1c,TCGA-DM-A1DA,TCGA-COAD,71,-26169,228,b57aa224-9af5-573c-a131-c18e25b090e8,not hispanic or latino,female,white,released,TCGA-DM-A1DA_demographic,2019-07-31T18:43:07.381004-05:00,Dead,1928,1999,26169,M0,N2,Stage IIIC,T3,--,not reported,228,f23f4341-cbf3-534b-8ee8-ed834f0f794a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A1DA_diagnosis,No,Cecum,--,released,TCGA-DM-A1DA_treatment,4f819709-2ae0-50e6-9a00-7c83b5866884,not reported,"Radiation Therapy, NOS",2019-07-31T18:43:07.381004-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,1999
f4a804d3-b5c4-4da5-800f-6e5757ecfa1c,TCGA-DM-A1DA,TCGA-COAD,71,-26169,228,b57aa224-9af5-573c-a131-c18e25b090e8,not hispanic or latino,female,white,released,TCGA-DM-A1DA_demographic,2019-07-31T18:43:07.381004-05:00,Dead,1928,1999,26169,M0,N2,Stage IIIC,T3,--,not reported,228,f23f4341-cbf3-534b-8ee8-ed834f0f794a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A1DA_diagnosis,No,Cecum,2019-04-28T11:26:37.027504-05:00,released,TCGA-DM-A1DA_treatment_1,dd473b59-218b-532c-bdfb-73c4b1444c90,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:43:07.381004-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,1999
65056295-8fcd-4f82-a3c9-a5acd79521fe,TCGA-A6-6648,TCGA-COAD,56,-20641,--,b75e8e6f-d0bf-546f-bb9d-9da7966592bb,not hispanic or latino,male,white,released,TCGA-A6-6648_demographic,2019-07-31T17:41:08.852601-05:00,Alive,1954,--,20641,M1a,N0,Stage IVA,T3,7th,not reported,766,1696af00-6799-5195-b7c3-c4d387ffb446,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-A6-6648_diagnosis,No,Descending colon,2019-04-28T10:35:19.401502-05:00,released,TCGA-A6-6648_treatment_1,a488332e-7766-5795-a775-ae7e8d3f6f9d,yes,"Pharmaceutical Therapy, NOS",2019-07-31T17:41:08.852601-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2010
65056295-8fcd-4f82-a3c9-a5acd79521fe,TCGA-A6-6648,TCGA-COAD,56,-20641,--,b75e8e6f-d0bf-546f-bb9d-9da7966592bb,not hispanic or latino,male,white,released,TCGA-A6-6648_demographic,2019-07-31T17:41:08.852601-05:00,Alive,1954,--,20641,M1a,N0,Stage IVA,T3,7th,not reported,766,1696af00-6799-5195-b7c3-c4d387ffb446,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-A6-6648_diagnosis,No,Descending colon,--,released,TCGA-A6-6648_treatment,d0c291ec-1b69-5700-84b5-dda46e764343,no,"Radiation Therapy, NOS",2019-07-31T17:41:08.852601-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2010
beb63625-d9bf-4ccd-bc53-635b53d24240,TCGA-AA-3870,TCGA-COAD,71,-26086,--,d888e785-2468-5649-bd8b-a13079d8dcfa,not reported,female,not reported,released,TCGA-AA-3870_demographic,2019-07-31T18:35:50.030099-05:00,Alive,1938,--,26086,M1,N2,Stage IV,T3,6th,not reported,912,5ae6b887-9fb8-5b40-a18b-245f228df136,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3870_diagnosis,Not Reported,Ascending colon,2019-04-28T11:20:26.986057-05:00,released,TCGA-AA-3870_treatment_1,c4286bbc-bca3-50d6-913c-74e9aecf69cb,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:50.030099-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
beb63625-d9bf-4ccd-bc53-635b53d24240,TCGA-AA-3870,TCGA-COAD,71,-26086,--,d888e785-2468-5649-bd8b-a13079d8dcfa,not reported,female,not reported,released,TCGA-AA-3870_demographic,2019-07-31T18:35:50.030099-05:00,Alive,1938,--,26086,M1,N2,Stage IV,T3,6th,not reported,912,5ae6b887-9fb8-5b40-a18b-245f228df136,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3870_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3870_treatment,d5c5acf6-4aa5-5da0-92d0-a44d9c1b7db2,not reported,"Radiation Therapy, NOS",2019-07-31T18:35:50.030099-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
9fd08502-355b-4f5a-a25c-73ec7184f6d3,TCGA-F4-6459,TCGA-COAD,61,-22574,262,ba8d3bcd-9c11-51ac-8448-b7f7c6defbc0,not hispanic or latino,female,white,released,TCGA-F4-6459_demographic,2019-07-31T18:33:32.147903-05:00,Dead,1950,--,22574,M0,N2a,Stage IIIB,T3,7th,not reported,--,fc99d55d-25f4-5360-ac2f-9d3ca192a6dd,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6459_diagnosis,No,Sigmoid colon,2019-04-28T11:18:34.100822-05:00,released,TCGA-F4-6459_treatment_1,b6ee9731-024c-5ffd-9d55-0dfb6a42af3e,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:32.147903-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2011
9fd08502-355b-4f5a-a25c-73ec7184f6d3,TCGA-F4-6459,TCGA-COAD,61,-22574,262,ba8d3bcd-9c11-51ac-8448-b7f7c6defbc0,not hispanic or latino,female,white,released,TCGA-F4-6459_demographic,2019-07-31T18:33:32.147903-05:00,Dead,1950,--,22574,M0,N2a,Stage IIIB,T3,7th,not reported,--,fc99d55d-25f4-5360-ac2f-9d3ca192a6dd,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6459_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6459_treatment,1f72490f-e845-564e-8bc6-361b27094be3,no,"Radiation Therapy, NOS",2019-07-31T18:33:32.147903-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2011
2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2,TCGA-AA-3560,TCGA-COAD,72,-26359,--,bcd24e64-52f6-52ad-ae7b-07deba20179a,not reported,female,not reported,released,TCGA-AA-3560_demographic,2019-07-31T18:26:02.041607-05:00,Alive,1937,--,26359,M0,N2,Stage IIIC,T3,6th,not reported,608,454b8695-bcbc-570a-9570-9f64726ea716,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3560_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:12:19.565394-05:00,released,TCGA-AA-3560_treatment_1,50ff77fb-efc1-5841-a36c-5fd8e750319a,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:02.041607-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2009
2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2,TCGA-AA-3560,TCGA-COAD,72,-26359,--,bcd24e64-52f6-52ad-ae7b-07deba20179a,not reported,female,not reported,released,TCGA-AA-3560_demographic,2019-07-31T18:26:02.041607-05:00,Alive,1937,--,26359,M0,N2,Stage IIIC,T3,6th,not reported,608,454b8695-bcbc-570a-9570-9f64726ea716,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3560_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3560_treatment,bf69100d-9bd7-5d85-a83f-08c75afdea65,no,"Radiation Therapy, NOS",2019-07-31T18:26:02.041607-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2009
f88c0259-58ff-4bcc-a777-7705cdbd8213,TCGA-A6-5664,TCGA-COAD,80,-29426,--,bef09c3b-3401-507a-b8e3-86c22725bc67,not hispanic or latino,male,black or african american,released,TCGA-A6-5664_demographic,2019-07-31T18:40:41.458310-05:00,Alive,1930,--,29426,MX,N2a,Stage IIIC,T4a,7th,not reported,672,11b85bd5-0387-5dc4-86db-41d69a998d35,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-5664_diagnosis,No,"Colon, NOS",2019-04-28T11:24:32.013347-05:00,released,TCGA-A6-5664_treatment_1,b38e811d-e722-5178-8511-634f6eb956ad,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:41.458310-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2010
f88c0259-58ff-4bcc-a777-7705cdbd8213,TCGA-A6-5664,TCGA-COAD,80,-29426,--,bef09c3b-3401-507a-b8e3-86c22725bc67,not hispanic or latino,male,black or african american,released,TCGA-A6-5664_demographic,2019-07-31T18:40:41.458310-05:00,Alive,1930,--,29426,MX,N2a,Stage IIIC,T4a,7th,not reported,672,11b85bd5-0387-5dc4-86db-41d69a998d35,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-5664_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-5664_treatment,59a51205-f436-55fe-8812-4b5102e31b55,no,"Radiation Therapy, NOS",2019-07-31T18:40:41.458310-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2010
35c9264f-34ec-4d75-ab80-aaac86108fc8,TCGA-AY-6386,TCGA-COAD,66,-24453,--,c122234a-9a22-530f-8b6a-2ccbdbaa8ce1,not hispanic or latino,female,black or african american,released,TCGA-AY-6386_demographic,2019-07-31T18:26:43.033446-05:00,Alive,1944,--,24453,M0,N1a,Stage IIIB,T3,7th,not reported,542,62769a9a-72fb-5a7d-9e57-814ffdb0e32c,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-6386_diagnosis,No,Cecum,--,released,TCGA-AY-6386_treatment,7c0aeafa-7fec-5855-b1e7-e021e3f46a0d,no,"Radiation Therapy, NOS",2019-07-31T18:26:43.033446-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2010
35c9264f-34ec-4d75-ab80-aaac86108fc8,TCGA-AY-6386,TCGA-COAD,66,-24453,--,c122234a-9a22-530f-8b6a-2ccbdbaa8ce1,not hispanic or latino,female,black or african american,released,TCGA-AY-6386_demographic,2019-07-31T18:26:43.033446-05:00,Alive,1944,--,24453,M0,N1a,Stage IIIB,T3,7th,not reported,542,62769a9a-72fb-5a7d-9e57-814ffdb0e32c,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AY-6386_diagnosis,No,Cecum,2019-04-28T11:12:54.791331-05:00,released,TCGA-AY-6386_treatment_1,5f937753-b094-534d-b8b3-d29be5f3fbd3,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:43.033446-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2010
5f1399ef-8100-49e7-806f-9f532e55c0ba,TCGA-AA-3520,TCGA-COAD,86,-31531,--,fc343dcc-dd68-51d1-9b9d-e5fa12092e26,not reported,female,not reported,released,TCGA-AA-3520_demographic,2019-07-31T18:29:24.964523-05:00,Alive,1921,--,31531,M0,N0,Stage II,T3,5th,not reported,731,d8bf73cd-1bd9-5bb9-bb4f-9e6806d5b61a,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3520_diagnosis,Not Reported,Ascending colon,2019-04-28T11:15:09.320456-05:00,released,TCGA-AA-3520_treatment_1,260d65d8-d70d-5627-8619-a78c91dc63bd,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:24.964523-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2007
5f1399ef-8100-49e7-806f-9f532e55c0ba,TCGA-AA-3520,TCGA-COAD,86,-31531,--,fc343dcc-dd68-51d1-9b9d-e5fa12092e26,not reported,female,not reported,released,TCGA-AA-3520_demographic,2019-07-31T18:29:24.964523-05:00,Alive,1921,--,31531,M0,N0,Stage II,T3,5th,not reported,731,d8bf73cd-1bd9-5bb9-bb4f-9e6806d5b61a,C18.2,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Ascending colon,released,TCGA-AA-3520_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3520_treatment,182246ac-4214-5006-8637-8abf210611c6,no,"Radiation Therapy, NOS",2019-07-31T18:29:24.964523-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2007
b823d6e5-54b0-43d3-95e2-9be33dc6f734,TCGA-DM-A0XF,TCGA-COAD,68,-25032,1162,37960b18-d38e-555e-be9a-c48ee8634558,not hispanic or latino,female,white,released,TCGA-DM-A0XF_demographic,2019-07-31T18:35:23.614711-05:00,Dead,1931,2002,25032,M0,N2,Stage IIIC,T3,--,not reported,--,c1d318fc-aa50-5d72-8e89-7d7829c89012,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A0XF_diagnosis,No,Sigmoid colon,--,released,TCGA-DM-A0XF_treatment,0dcc39d4-34c8-57a9-a176-10aa781cce79,not reported,"Radiation Therapy, NOS",2019-07-31T18:35:23.614711-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,1999
b823d6e5-54b0-43d3-95e2-9be33dc6f734,TCGA-DM-A0XF,TCGA-COAD,68,-25032,1162,37960b18-d38e-555e-be9a-c48ee8634558,not hispanic or latino,female,white,released,TCGA-DM-A0XF_demographic,2019-07-31T18:35:23.614711-05:00,Dead,1931,2002,25032,M0,N2,Stage IIIC,T3,--,not reported,--,c1d318fc-aa50-5d72-8e89-7d7829c89012,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-DM-A0XF_diagnosis,No,Sigmoid colon,2019-04-28T11:20:04.368815-05:00,released,TCGA-DM-A0XF_treatment_1,67186e68-c4c7-5f58-b353-4281cba71754,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:23.614711-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,1999
fb9e7684-a7f7-4f17-bc5d-1f359e1b0d42,TCGA-CM-6680,TCGA-COAD,78,-28701,--,a2929f38-5986-5c72-b0d8-63c89e861ca8,not hispanic or latino,female,white,released,TCGA-CM-6680_demographic,2019-07-31T18:41:02.826547-05:00,Alive,1933,--,28701,M0,N2a,Stage IIIB,T3,7th,not reported,366,540db4e3-978b-5506-a239-e4148585e164,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6680_diagnosis,No,Cecum,--,released,TCGA-CM-6680_treatment,29212feb-d090-5645-a307-79d9bd3ca5d9,no,"Radiation Therapy, NOS",2019-07-31T18:41:02.826547-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2011
fb9e7684-a7f7-4f17-bc5d-1f359e1b0d42,TCGA-CM-6680,TCGA-COAD,78,-28701,--,a2929f38-5986-5c72-b0d8-63c89e861ca8,not hispanic or latino,female,white,released,TCGA-CM-6680_demographic,2019-07-31T18:41:02.826547-05:00,Alive,1933,--,28701,M0,N2a,Stage IIIB,T3,7th,not reported,366,540db4e3-978b-5506-a239-e4148585e164,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-6680_diagnosis,No,Cecum,2019-04-28T11:24:49.310536-05:00,released,TCGA-CM-6680_treatment_1,907f4c8b-e9c3-554a-9b81-9a7dd12a8819,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:02.826547-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2011
d4e1472a-7b5f-46f4-acb7-b961f634e28e,TCGA-AA-A024,TCGA-COAD,81,-29708,1188,bc5bb4ff-eabc-596f-a687-adccd45ead23,not reported,male,not reported,released,TCGA-AA-A024_demographic,2019-07-31T15:45:15.747517-05:00,Dead,1924,--,29708,M0,N0,Stage II,T3,5th,not reported,61,b6823fc5-592e-5907-8862-c1a83edc1fed,C18.6,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Descending colon,released,TCGA-AA-A024_diagnosis,Not Reported,Descending colon,2019-04-28T09:01:58.930861-05:00,released,TCGA-AA-A024_treatment_1,5fa087ad-55e5-5a53-8b18-8637814240dc,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:45:15.747517-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2005
d4e1472a-7b5f-46f4-acb7-b961f634e28e,TCGA-AA-A024,TCGA-COAD,81,-29708,1188,bc5bb4ff-eabc-596f-a687-adccd45ead23,not reported,male,not reported,released,TCGA-AA-A024_demographic,2019-07-31T15:45:15.747517-05:00,Dead,1924,--,29708,M0,N0,Stage II,T3,5th,not reported,61,b6823fc5-592e-5907-8862-c1a83edc1fed,C18.6,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Descending colon,released,TCGA-AA-A024_diagnosis,Not Reported,Descending colon,--,released,TCGA-AA-A024_treatment,d7324fba-0be7-52a3-be12-17c544075129,no,"Radiation Therapy, NOS",2019-07-31T15:45:15.747517-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2005
2c0a725a-e829-4d84-89d9-d0d47f6cfa37,TCGA-G4-6628,TCGA-COAD,78,-28772,--,3a9a2461-c45c-5de4-9967-df243fdbe251,not hispanic or latino,male,white,released,TCGA-G4-6628_demographic,2019-07-31T18:25:52.434359-05:00,Alive,1928,--,28772,M0,N0,Stage I,T2,6th,not reported,2424,844dca75-87ad-5020-92ac-ab1882d3f1d7,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6628_diagnosis,Not Reported,Cecum,2019-04-28T11:12:12.433000-05:00,released,TCGA-G4-6628_treatment_1,25de9556-787c-5354-a9d4-b1f7d9db87d0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:52.434359-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2006
2c0a725a-e829-4d84-89d9-d0d47f6cfa37,TCGA-G4-6628,TCGA-COAD,78,-28772,--,3a9a2461-c45c-5de4-9967-df243fdbe251,not hispanic or latino,male,white,released,TCGA-G4-6628_demographic,2019-07-31T18:25:52.434359-05:00,Alive,1928,--,28772,M0,N0,Stage I,T2,6th,not reported,2424,844dca75-87ad-5020-92ac-ab1882d3f1d7,C18.0,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Cecum,released,TCGA-G4-6628_diagnosis,Not Reported,Cecum,--,released,TCGA-G4-6628_treatment,4f92578b-39e8-55d9-b949-6ff1a90369d0,no,"Radiation Therapy, NOS",2019-07-31T18:25:52.434359-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2006
c113808a-773f-4179-82d6-9083518404b5,TCGA-AD-6548,TCGA-COAD,81,-29758,--,e5b843f8-f55c-5a5a-9f8f-1d787304d45b,not hispanic or latino,female,white,released,TCGA-AD-6548_demographic,2019-07-31T18:36:04.683125-05:00,Alive,1930,--,29758,M0,N0,Stage I,T2,7th,not reported,650,35e2c157-ad70-5279-bc82-3d4f9b5de27f,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-AD-6548_diagnosis,No,Splenic flexure of colon,2019-04-28T11:20:39.340126-05:00,released,TCGA-AD-6548_treatment_1,e6f90692-ac47-5714-8738-e0daefd06412,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:04.683125-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2011
c113808a-773f-4179-82d6-9083518404b5,TCGA-AD-6548,TCGA-COAD,81,-29758,--,e5b843f8-f55c-5a5a-9f8f-1d787304d45b,not hispanic or latino,female,white,released,TCGA-AD-6548_demographic,2019-07-31T18:36:04.683125-05:00,Alive,1930,--,29758,M0,N0,Stage I,T2,7th,not reported,650,35e2c157-ad70-5279-bc82-3d4f9b5de27f,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-AD-6548_diagnosis,No,Splenic flexure of colon,--,released,TCGA-AD-6548_treatment,f6820851-03cc-589c-be30-030210f09405,no,"Radiation Therapy, NOS",2019-07-31T18:36:04.683125-05:00,not reported,stage i,2019-08-08T16:35:29.811838-05:00,2011
3eb37b12-b8b4-40a3-bd8b-f89fc39c05fa,TCGA-A6-6782,TCGA-COAD,82,-30012,--,31158d20-ae53-56e6-be04-def249aaba84,not hispanic or latino,male,white,released,TCGA-A6-6782_demographic,2019-07-31T18:27:21.432362-05:00,Alive,1929,--,30012,MX,N0,Stage IIB,T4a,7th,not reported,617,f4335285-6749-56b7-9ecf-127b95b651a9,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-6782_diagnosis,No,Ascending colon,2019-04-28T11:13:27.495821-05:00,released,TCGA-A6-6782_treatment_1,62d941ea-58a6-58b1-a627-48f8a67812f0,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:21.432362-05:00,not reported,stage iib,2019-08-08T16:34:13.342472-05:00,2011
3eb37b12-b8b4-40a3-bd8b-f89fc39c05fa,TCGA-A6-6782,TCGA-COAD,82,-30012,--,31158d20-ae53-56e6-be04-def249aaba84,not hispanic or latino,male,white,released,TCGA-A6-6782_demographic,2019-07-31T18:27:21.432362-05:00,Alive,1929,--,30012,MX,N0,Stage IIB,T4a,7th,not reported,617,f4335285-6749-56b7-9ecf-127b95b651a9,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-A6-6782_diagnosis,No,Ascending colon,--,released,TCGA-A6-6782_treatment,95de20f7-d69f-5f3a-8196-2de0ebc385fc,no,"Radiation Therapy, NOS",2019-07-31T18:27:21.432362-05:00,not reported,stage iib,2019-08-08T16:34:13.342472-05:00,2011
57cdaa1c-4e94-4a28-ab3b-300c0457555f,TCGA-A6-2674,TCGA-COAD,71,-26292,--,ee266eaa-677e-590d-888f-f70c1e4d3a0e,not hispanic or latino,male,white,released,TCGA-A6-2674_demographic,2019-07-31T15:52:48.855988-05:00,Alive,1938,--,26292,M1,N2,Stage IV,T3,6th,not reported,1331,268702d9-6a0c-5b3d-ad95-8c2a73101503,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-A6-2674_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-2674_treatment,92289391-2c86-52d0-9b25-b56c02cc6e83,no,"Radiation Therapy, NOS",2019-07-31T15:52:48.855988-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
57cdaa1c-4e94-4a28-ab3b-300c0457555f,TCGA-A6-2674,TCGA-COAD,71,-26292,--,ee266eaa-677e-590d-888f-f70c1e4d3a0e,not hispanic or latino,male,white,released,TCGA-A6-2674_demographic,2019-07-31T15:52:48.855988-05:00,Alive,1938,--,26292,M1,N2,Stage IV,T3,6th,not reported,1331,268702d9-6a0c-5b3d-ad95-8c2a73101503,C18.7,8480/3,Mucinous adenocarcinoma,no,No,not reported,Sigmoid colon,released,TCGA-A6-2674_diagnosis,No,Sigmoid colon,2019-04-28T09:08:07.078944-05:00,released,TCGA-A6-2674_treatment_1,5b3df2f3-d2d0-57ac-b8b8-6c8cb4db6a74,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:52:48.855988-05:00,not reported,stage iv,2019-08-08T16:33:45.855164-05:00,2009
bfb07784-693b-4c25-874e-4ad6e04a5d46,TCGA-AA-3529,TCGA-COAD,78,-28609,--,d63f5e50-bac3-5ccf-b010-a1390a316f08,not reported,female,not reported,released,TCGA-AA-3529_demographic,2019-07-31T18:35:56.101376-05:00,Dead,1929,2007,28609,M0,N2,Stage IIIC,T3,6th,not reported,--,7c3c1f6a-6f55-55e5-becf-95381d49b5ec,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3529_diagnosis,No,Sigmoid colon,2019-04-28T11:20:31.988529-05:00,released,TCGA-AA-3529_treatment_1,69dd186b-2c44-5e9c-8d8e-82342fb05c31,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:56.101376-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2007
bfb07784-693b-4c25-874e-4ad6e04a5d46,TCGA-AA-3529,TCGA-COAD,78,-28609,--,d63f5e50-bac3-5ccf-b010-a1390a316f08,not reported,female,not reported,released,TCGA-AA-3529_demographic,2019-07-31T18:35:56.101376-05:00,Dead,1929,2007,28609,M0,N2,Stage IIIC,T3,6th,not reported,--,7c3c1f6a-6f55-55e5-becf-95381d49b5ec,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3529_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3529_treatment,f04aaef4-2486-526b-97a7-fa332423032e,not reported,"Radiation Therapy, NOS",2019-07-31T18:35:56.101376-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2007
0b8de222-119a-40f3-8beb-12b9d933225b,TCGA-AA-3856,TCGA-COAD,59,-21670,--,d355d109-cc34-5e1c-8114-e5a7aeeac355,not reported,male,not reported,released,TCGA-AA-3856_demographic,2019-07-31T18:23:01.410801-05:00,Alive,1950,--,21670,M0,N0,Stage IIA,T3,6th,not reported,30,f8717a06-4e06-5f14-9263-694a16b7d976,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3856_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3856_treatment,8239157e-e73e-520a-95c9-ca57bbf51b80,not reported,"Radiation Therapy, NOS",2019-07-31T18:23:01.410801-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
0b8de222-119a-40f3-8beb-12b9d933225b,TCGA-AA-3856,TCGA-COAD,59,-21670,--,d355d109-cc34-5e1c-8114-e5a7aeeac355,not reported,male,not reported,released,TCGA-AA-3856_demographic,2019-07-31T18:23:01.410801-05:00,Alive,1950,--,21670,M0,N0,Stage IIA,T3,6th,not reported,30,f8717a06-4e06-5f14-9263-694a16b7d976,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3856_diagnosis,No,"Colon, NOS",2019-04-28T11:09:50.933764-05:00,released,TCGA-AA-3856_treatment_1,b6577e43-026b-5936-908d-79ed96d8074f,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:01.410801-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
df228c56-89ac-4122-93b3-6c0740c4ec09,TCGA-AA-3534,TCGA-COAD,78,-28489,--,d473d166-82e4-576c-b0b6-5b9a1bf75669,not reported,female,not reported,released,TCGA-AA-3534_demographic,2019-07-31T18:38:50.680211-05:00,Alive,1929,--,28489,M0,N0,Stage IIA,T3,6th,not reported,882,9c9b25dc-fce6-59a3-badf-7de3fe927906,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3534_diagnosis,No,Ascending colon,--,released,TCGA-AA-3534_treatment,0c3d1e65-ec3f-505b-89c9-8e1f670b759b,no,"Radiation Therapy, NOS",2019-07-31T18:38:50.680211-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
df228c56-89ac-4122-93b3-6c0740c4ec09,TCGA-AA-3534,TCGA-COAD,78,-28489,--,d473d166-82e4-576c-b0b6-5b9a1bf75669,not reported,female,not reported,released,TCGA-AA-3534_demographic,2019-07-31T18:38:50.680211-05:00,Alive,1929,--,28489,M0,N0,Stage IIA,T3,6th,not reported,882,9c9b25dc-fce6-59a3-badf-7de3fe927906,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3534_diagnosis,No,Ascending colon,2019-04-28T11:22:58.624761-05:00,released,TCGA-AA-3534_treatment_1,89a50db4-c6f1-58b9-ad21-bac47d9653e2,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:38:50.680211-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
fbb69964-f962-4b89-b59b-dd05f8faf61a,TCGA-AZ-6599,TCGA-COAD,72,-26438,206,b4d07ba7-8724-5ddc-995e-19969ce70f1f,not hispanic or latino,male,white,released,TCGA-AZ-6599_demographic,2019-07-31T18:41:05.832319-05:00,Dead,1929,2001,26438,MX,N0,Stage I,T2,5th,not reported,--,b1b1cb67-2f2b-5837-a098-557a6d0309ee,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-6599_diagnosis,No,Cecum,--,released,TCGA-AZ-6599_treatment,71b2155f-0e03-53a3-82d7-145d4cb28690,no,"Radiation Therapy, NOS",2019-07-31T18:41:05.832319-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2001
fbb69964-f962-4b89-b59b-dd05f8faf61a,TCGA-AZ-6599,TCGA-COAD,72,-26438,206,b4d07ba7-8724-5ddc-995e-19969ce70f1f,not hispanic or latino,male,white,released,TCGA-AZ-6599_demographic,2019-07-31T18:41:05.832319-05:00,Dead,1929,2001,26438,MX,N0,Stage I,T2,5th,not reported,--,b1b1cb67-2f2b-5837-a098-557a6d0309ee,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-6599_diagnosis,No,Cecum,2019-04-28T11:24:51.817993-05:00,released,TCGA-AZ-6599_treatment_1,b00d73a9-1f10-50e4-ad87-12049b4ea591,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:05.832319-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2001
80809d79-92e1-4d6c-ba2e-0a9589997792,TCGA-AA-A01C,TCGA-COAD,75,-27729,--,d69a34fc-4056-5dd1-babe-62bdd77507fc,not reported,male,not reported,released,TCGA-AA-A01C_demographic,2019-07-31T18:31:30.570203-05:00,Alive,1934,--,27729,M0,N1,Stage IIIA,T2,6th,not reported,457,5c68297d-aedc-5c84-bb91-e57478f17b8d,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01C_diagnosis,No,Ascending colon,2019-04-28T11:16:53.363719-05:00,released,TCGA-AA-A01C_treatment_1,6d4ffedb-9c37-5b11-9d8b-ca53748f1fd1,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:30.570203-05:00,not reported,stage iiia,2019-08-08T16:35:29.811838-05:00,2009
80809d79-92e1-4d6c-ba2e-0a9589997792,TCGA-AA-A01C,TCGA-COAD,75,-27729,--,d69a34fc-4056-5dd1-babe-62bdd77507fc,not reported,male,not reported,released,TCGA-AA-A01C_demographic,2019-07-31T18:31:30.570203-05:00,Alive,1934,--,27729,M0,N1,Stage IIIA,T2,6th,not reported,457,5c68297d-aedc-5c84-bb91-e57478f17b8d,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A01C_diagnosis,No,Ascending colon,--,released,TCGA-AA-A01C_treatment,e6250378-c439-589f-a1e8-ed546015afe3,no,"Radiation Therapy, NOS",2019-07-31T18:31:30.570203-05:00,not reported,stage iiia,2019-08-08T16:35:29.811838-05:00,2009
74a0264d-1d31-430d-9a88-e7334c8aa96c,TCGA-A6-A56B,TCGA-COAD,57,-20903,1711,0f6a8815-5a77-5451-8333-3a2c6e9bed70,not hispanic or latino,male,black or african american,released,TCGA-A6-A56B_demographic,2019-07-31T18:30:19.067618-05:00,Dead,1951,--,20903,M0,N1,Stage IIIB,T3,6th,not reported,1595,7bf4bfb7-2f7a-5a0d-97ca-bf903dacbb97,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-A56B_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-A56B_treatment,5811d5b5-3217-5048-b7c6-020108d71944,no,"Radiation Therapy, NOS",2019-07-31T18:30:19.067618-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2008
74a0264d-1d31-430d-9a88-e7334c8aa96c,TCGA-A6-A56B,TCGA-COAD,57,-20903,1711,0f6a8815-5a77-5451-8333-3a2c6e9bed70,not hispanic or latino,male,black or african american,released,TCGA-A6-A56B_demographic,2019-07-31T18:30:19.067618-05:00,Dead,1951,--,20903,M0,N1,Stage IIIB,T3,6th,not reported,1595,7bf4bfb7-2f7a-5a0d-97ca-bf903dacbb97,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-A56B_diagnosis,No,Sigmoid colon,2019-04-28T11:15:54.083069-05:00,released,TCGA-A6-A56B_treatment_1,95ffffac-3cd5-5558-86f8-ef77f83ad01c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:19.067618-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2008
9b2c325c-1f03-43c7-ad5c-b49c6d205635,TCGA-DM-A28A,TCGA-COAD,78,-28833,805,2ad60444-0ab3-5f09-87ce-71a61fa6faa2,not hispanic or latino,male,white,released,TCGA-DM-A28A_demographic,2019-07-31T18:33:17.228357-05:00,Dead,1923,2003,28833,M0,N2,Stage IIIC,T3,6th,not reported,805,3b77e86c-3d32-5b27-9a02-d62c5c520e0d,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A28A_diagnosis,No,Cecum,--,released,TCGA-DM-A28A_treatment,a0026e18-79fe-5302-b864-65016f7ccb8c,not reported,"Radiation Therapy, NOS",2019-07-31T18:33:17.228357-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2001
9b2c325c-1f03-43c7-ad5c-b49c6d205635,TCGA-DM-A28A,TCGA-COAD,78,-28833,805,2ad60444-0ab3-5f09-87ce-71a61fa6faa2,not hispanic or latino,male,white,released,TCGA-DM-A28A_demographic,2019-07-31T18:33:17.228357-05:00,Dead,1923,2003,28833,M0,N2,Stage IIIC,T3,6th,not reported,805,3b77e86c-3d32-5b27-9a02-d62c5c520e0d,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-DM-A28A_diagnosis,No,Cecum,2019-04-28T11:18:21.438182-05:00,released,TCGA-DM-A28A_treatment_1,173aa44e-b7d9-56c7-a467-4dd3da3a62d2,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:17.228357-05:00,not reported,stage iiic,2019-08-08T16:36:52.154454-05:00,2001
912b61a1-6a5b-451c-b753-9c3dac03e8cb,TCGA-AA-3543,TCGA-COAD,84,-30772,--,91a4c943-e2d4-5a73-a2b7-b08e073c690e,not reported,male,not reported,released,TCGA-AA-3543_demographic,2019-07-31T18:32:28.631359-05:00,Alive,1924,--,30772,M0,N0,Stage I,T2,6th,not reported,30,8b69a3e9-9d2b-5646-8efc-a7fcdde1f915,C18.2,8480/3,Mucinous adenocarcinoma,yes,Yes,not reported,Ascending colon,released,TCGA-AA-3543_diagnosis,Not Reported,Ascending colon,2019-04-28T11:17:41.469238-05:00,released,TCGA-AA-3543_treatment_1,931e2b67-8e70-58db-b508-53213109d878,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:28.631359-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
912b61a1-6a5b-451c-b753-9c3dac03e8cb,TCGA-AA-3543,TCGA-COAD,84,-30772,--,91a4c943-e2d4-5a73-a2b7-b08e073c690e,not reported,male,not reported,released,TCGA-AA-3543_demographic,2019-07-31T18:32:28.631359-05:00,Alive,1924,--,30772,M0,N0,Stage I,T2,6th,not reported,30,8b69a3e9-9d2b-5646-8efc-a7fcdde1f915,C18.2,8480/3,Mucinous adenocarcinoma,yes,Yes,not reported,Ascending colon,released,TCGA-AA-3543_diagnosis,Not Reported,Ascending colon,--,released,TCGA-AA-3543_treatment,9b0d1f06-34d1-5bb7-8ef1-14ac50e29756,no,"Radiation Therapy, NOS",2019-07-31T18:32:28.631359-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
d5a1f43e-25a7-47f5-b63e-43714f9f732a,TCGA-QL-A97D,TCGA-COAD,84,-30914,--,e2139889-d05b-5cfb-a06f-ee7e0175cdc2,not reported,female,black or african american,released,TCGA-QL-A97D_demographic,2019-07-31T18:37:57.255154-05:00,Alive,1928,--,30914,MX,N0,Stage I,T2,7th,not reported,666,f7148392-d98f-59bb-b516-0a107c8a1e55,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-QL-A97D_diagnosis,No,Cecum,2019-04-28T11:22:12.922580-05:00,released,TCGA-QL-A97D_treatment_1,ba9d6ce9-523f-5c35-aba3-c05b7e3d5a2b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:37:57.255154-05:00,not reported,stage i,2019-08-08T16:37:44.165377-05:00,2012
d5a1f43e-25a7-47f5-b63e-43714f9f732a,TCGA-QL-A97D,TCGA-COAD,84,-30914,--,e2139889-d05b-5cfb-a06f-ee7e0175cdc2,not reported,female,black or african american,released,TCGA-QL-A97D_demographic,2019-07-31T18:37:57.255154-05:00,Alive,1928,--,30914,MX,N0,Stage I,T2,7th,not reported,666,f7148392-d98f-59bb-b516-0a107c8a1e55,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-QL-A97D_diagnosis,No,Cecum,--,released,TCGA-QL-A97D_treatment,0f0e5ba2-0629-51bf-b730-ec19b9778d93,no,"Radiation Therapy, NOS",2019-07-31T18:37:57.255154-05:00,not reported,stage i,2019-08-08T16:37:44.165377-05:00,2012
3aae5316-6a5d-4b83-9020-ad691d4edf99,TCGA-G4-6626,TCGA-COAD,90,-32871,1,565e5f56-6e18-5dee-9c80-2f1905680f8b,not hispanic or latino,male,white,released,TCGA-G4-6626_demographic,2019-07-31T18:27:09.600994-05:00,Dead,1916,2009,32871,M0,N0,Stage IIA,T3,6th,not reported,--,b6b850e3-6d12-5411-814c-a062478d40cf,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6626_diagnosis,No,Ascending colon,2019-04-28T11:13:17.469713-05:00,released,TCGA-G4-6626_treatment_1,877e6a97-ac4b-53eb-b2ae-4c6fdbdd5b78,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:09.600994-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2006
3aae5316-6a5d-4b83-9020-ad691d4edf99,TCGA-G4-6626,TCGA-COAD,90,-32871,1,565e5f56-6e18-5dee-9c80-2f1905680f8b,not hispanic or latino,male,white,released,TCGA-G4-6626_demographic,2019-07-31T18:27:09.600994-05:00,Dead,1916,2009,32871,M0,N0,Stage IIA,T3,6th,not reported,--,b6b850e3-6d12-5411-814c-a062478d40cf,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6626_diagnosis,No,Ascending colon,--,released,TCGA-G4-6626_treatment,0dbe4d91-ad2d-51cd-92d7-b0aa029bff72,no,"Radiation Therapy, NOS",2019-07-31T18:27:09.600994-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2006
40c217ee-429f-41f4-adc6-db9186622b17,TCGA-CM-6172,TCGA-COAD,70,-25902,--,aa732cd1-e089-5375-bc3e-e7938f39f8c1,not hispanic or latino,female,white,released,TCGA-CM-6172_demographic,2019-07-31T18:27:27.586608-05:00,Alive,1940,--,25902,M0,N1a,Stage IIIB,T3,7th,not reported,335,d6ef5216-b743-56ec-a13b-354f8ae7bc51,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6172_diagnosis,No,Sigmoid colon,2019-04-28T11:13:32.077786-05:00,released,TCGA-CM-6172_treatment_1,9aeb6eed-537d-5304-8c6e-4cc286c2f857,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:27.586608-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
40c217ee-429f-41f4-adc6-db9186622b17,TCGA-CM-6172,TCGA-COAD,70,-25902,--,aa732cd1-e089-5375-bc3e-e7938f39f8c1,not hispanic or latino,female,white,released,TCGA-CM-6172_demographic,2019-07-31T18:27:27.586608-05:00,Alive,1940,--,25902,M0,N1a,Stage IIIB,T3,7th,not reported,335,d6ef5216-b743-56ec-a13b-354f8ae7bc51,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CM-6172_diagnosis,No,Sigmoid colon,--,released,TCGA-CM-6172_treatment,9b84e044-34bf-52eb-96b9-02aa03965dbc,no,"Radiation Therapy, NOS",2019-07-31T18:27:27.586608-05:00,not reported,stage iiib,2019-08-08T16:36:28.485406-05:00,2010
55697871-b9aa-4acd-8dbe-dcd5391db8f0,TCGA-CM-6674,TCGA-COAD,39,-14368,--,25f7fc15-adc3-571d-8e40-7843749d1166,not hispanic or latino,male,white,released,TCGA-CM-6674_demographic,2019-07-31T18:28:28.526079-05:00,Alive,1972,--,14368,M0,N0,Stage IIA,T3,7th,not reported,394,1052f0f0-679d-58f6-a30e-fdb3cb2c44ea,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-CM-6674_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-CM-6674_treatment,5b917298-9c92-549b-bda3-1d1e2946bb4f,no,"Radiation Therapy, NOS",2019-07-31T18:28:28.526079-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2011
55697871-b9aa-4acd-8dbe-dcd5391db8f0,TCGA-CM-6674,TCGA-COAD,39,-14368,--,25f7fc15-adc3-571d-8e40-7843749d1166,not hispanic or latino,male,white,released,TCGA-CM-6674_demographic,2019-07-31T18:28:28.526079-05:00,Alive,1972,--,14368,M0,N0,Stage IIA,T3,7th,not reported,394,1052f0f0-679d-58f6-a30e-fdb3cb2c44ea,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-CM-6674_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:14:21.666088-05:00,released,TCGA-CM-6674_treatment_1,d0c0d2dc-c9dc-5f37-ad4c-f2efc25a79ae,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:28.526079-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2011
93ca8937-97c0-4f6e-bdec-66d32f2a7b3d,TCGA-AA-A029,TCGA-COAD,67,-24686,--,1a2d4260-4700-53f9-8836-8a8dc9282837,not reported,male,not reported,released,TCGA-AA-A029_demographic,2019-07-31T18:32:40.670924-05:00,Alive,1939,--,24686,M0,N0,Stage II,T3,5th,not reported,1581,8e260862-c849-5921-ba6b-0d5091be3e51,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A029_diagnosis,No,Cecum,2019-04-28T11:17:51.705777-05:00,released,TCGA-AA-A029_treatment_1,3082d0b4-f45f-523f-b928-d6d9f48bedd5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:40.670924-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2006
93ca8937-97c0-4f6e-bdec-66d32f2a7b3d,TCGA-AA-A029,TCGA-COAD,67,-24686,--,1a2d4260-4700-53f9-8836-8a8dc9282837,not reported,male,not reported,released,TCGA-AA-A029_demographic,2019-07-31T18:32:40.670924-05:00,Alive,1939,--,24686,M0,N0,Stage II,T3,5th,not reported,1581,8e260862-c849-5921-ba6b-0d5091be3e51,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A029_diagnosis,No,Cecum,--,released,TCGA-AA-A029_treatment,96bc55e8-061f-52be-85a9-1b61103a58ac,no,"Radiation Therapy, NOS",2019-07-31T18:32:40.670924-05:00,not reported,stage ii,2019-08-08T16:35:29.811838-05:00,2006
4f9775f2-b663-4daf-aa9e-50915cae9407,TCGA-A6-3808,TCGA-COAD,73,-26666,--,8d6616c9-1a0e-55f7-9dca-af6566e22e8c,not hispanic or latino,male,white,released,TCGA-A6-3808_demographic,2019-07-31T18:28:14.006935-05:00,Alive,1936,--,26666,M0,N0,Stage IIA,T3,--,not reported,1014,083ad5a3-7fa9-5124-b1f2-d4780d6ba559,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-3808_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-3808_treatment,2bb6f439-18cb-5186-9fcd-b854b464e9d7,no,"Radiation Therapy, NOS",2019-07-31T18:28:14.006935-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
4f9775f2-b663-4daf-aa9e-50915cae9407,TCGA-A6-3808,TCGA-COAD,73,-26666,--,8d6616c9-1a0e-55f7-9dca-af6566e22e8c,not hispanic or latino,male,white,released,TCGA-A6-3808_demographic,2019-07-31T18:28:14.006935-05:00,Alive,1936,--,26666,M0,N0,Stage IIA,T3,--,not reported,1014,083ad5a3-7fa9-5124-b1f2-d4780d6ba559,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-A6-3808_diagnosis,No,"Colon, NOS",2019-04-28T11:14:09.028236-05:00,released,TCGA-A6-3808_treatment_1,e93a1477-7e97-564d-8e30-755cfec02326,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:14.006935-05:00,not reported,stage iia,2019-08-08T16:33:45.855164-05:00,2009
c4d74653-d26b-4e51-aee0-82ee3d42f883,TCGA-AA-3517,TCGA-COAD,60,-22099,--,8bc103e1-8420-560c-bbb8-7ed5d66fe1f2,not reported,male,not reported,released,TCGA-AA-3517_demographic,2019-07-31T18:42:43.447747-05:00,Alive,1947,--,22099,M0,N0,Stage IIA,T3,6th,not reported,1186,47071a01-feef-5cea-bf23-447eac5ca7f3,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3517_diagnosis,No,"Colon, NOS",2019-04-28T11:26:17.108359-05:00,released,TCGA-AA-3517_treatment_1,9313ab45-9e47-58a2-a91d-ccb97b152c1f,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:43.447747-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
c4d74653-d26b-4e51-aee0-82ee3d42f883,TCGA-AA-3517,TCGA-COAD,60,-22099,--,8bc103e1-8420-560c-bbb8-7ed5d66fe1f2,not reported,male,not reported,released,TCGA-AA-3517_demographic,2019-07-31T18:42:43.447747-05:00,Alive,1947,--,22099,M0,N0,Stage IIA,T3,6th,not reported,1186,47071a01-feef-5cea-bf23-447eac5ca7f3,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3517_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3517_treatment,fa280838-9dff-5f29-860d-ca8f1b786a17,no,"Radiation Therapy, NOS",2019-07-31T18:42:43.447747-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
c5c4a0a5-900d-483d-9282-475654d63265,TCGA-AA-3518,TCGA-COAD,81,-29769,--,903ed848-e189-5c1b-aaf0-f828b355930f,not reported,female,not reported,released,TCGA-AA-3518_demographic,2019-07-31T18:36:28.849236-05:00,Alive,1926,--,29769,M0,N0,Stage IIA,T3,6th,not reported,31,5016de54-86e5-5fce-bd1a-791e378036ce,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3518_diagnosis,No,Cecum,--,released,TCGA-AA-3518_treatment,88e4ad58-0d68-5d69-a1da-8f8f91d1b71c,not reported,"Radiation Therapy, NOS",2019-07-31T18:36:28.849236-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
c5c4a0a5-900d-483d-9282-475654d63265,TCGA-AA-3518,TCGA-COAD,81,-29769,--,903ed848-e189-5c1b-aaf0-f828b355930f,not reported,female,not reported,released,TCGA-AA-3518_demographic,2019-07-31T18:36:28.849236-05:00,Alive,1926,--,29769,M0,N0,Stage IIA,T3,6th,not reported,31,5016de54-86e5-5fce-bd1a-791e378036ce,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3518_diagnosis,No,Cecum,2019-04-28T11:20:59.130655-05:00,released,TCGA-AA-3518_treatment_1,acffe9cb-84ce-5ecc-af1d-5f1f85f3ab91,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:28.849236-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
857a5889-19e7-4208-8362-f1377c408037,TCGA-A6-A567,TCGA-COAD,56,-20493,1881,92409641-aa68-53b4-8bb3-31da9009e457,not reported,male,black or african american,released,TCGA-A6-A567_demographic,2019-07-31T15:53:43.119098-05:00,Dead,1951,2012,20493,M1,N1,Stage IV,T3,6th,not reported,--,f77acdbc-3857-5ce7-a3f9-4e01e49f5ca7,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-A567_diagnosis,No,Sigmoid colon,--,released,TCGA-A6-A567_treatment,45f7034d-fefc-5a5b-abe2-1bf0f3fa7a9e,no,"Radiation Therapy, NOS",2019-07-31T15:53:43.119098-05:00,not reported,stage iv,2019-08-08T16:34:13.342472-05:00,2007
857a5889-19e7-4208-8362-f1377c408037,TCGA-A6-A567,TCGA-COAD,56,-20493,1881,92409641-aa68-53b4-8bb3-31da9009e457,not reported,male,black or african american,released,TCGA-A6-A567_demographic,2019-07-31T15:53:43.119098-05:00,Dead,1951,2012,20493,M1,N1,Stage IV,T3,6th,not reported,--,f77acdbc-3857-5ce7-a3f9-4e01e49f5ca7,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-A6-A567_diagnosis,No,Sigmoid colon,2019-04-28T09:08:52.418165-05:00,released,TCGA-A6-A567_treatment_1,60504bdb-16d8-5902-9eca-dba79816bde5,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:53:43.119098-05:00,not reported,stage iv,2019-08-08T16:34:13.342472-05:00,2007
bc02f801-081b-489b-87cb-d275c70299d5,TCGA-AA-3845,TCGA-COAD,86,-31593,--,9a0f4f32-4355-5367-9761-d3547e742f44,not reported,female,not reported,released,TCGA-AA-3845_demographic,2019-07-31T18:35:35.392478-05:00,Dead,1923,2009,31593,M0,N0,Stage IIA,T3,6th,not reported,--,421e4007-9275-5853-a691-117ab93e362e,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3845_diagnosis,No,Ascending colon,2019-04-28T11:20:14.415399-05:00,released,TCGA-AA-3845_treatment_1,6b2545f7-ed64-5da7-9006-0887611be839,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:35:35.392478-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
bc02f801-081b-489b-87cb-d275c70299d5,TCGA-AA-3845,TCGA-COAD,86,-31593,--,9a0f4f32-4355-5367-9761-d3547e742f44,not reported,female,not reported,released,TCGA-AA-3845_demographic,2019-07-31T18:35:35.392478-05:00,Dead,1923,2009,31593,M0,N0,Stage IIA,T3,6th,not reported,--,421e4007-9275-5853-a691-117ab93e362e,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3845_diagnosis,No,Ascending colon,--,released,TCGA-AA-3845_treatment,a18da306-da52-5b84-acb1-ecdf62fe86a5,not reported,"Radiation Therapy, NOS",2019-07-31T18:35:35.392478-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2009
f5c3bc61-1018-4351-bb23-aacc1459365f,TCGA-AA-3710,TCGA-COAD,80,-29465,--,95facda4-e37a-5e34-98bb-33048cffa3ec,not reported,female,not reported,released,TCGA-AA-3710_demographic,2019-07-31T18:40:29.958500-05:00,Alive,1928,--,29465,M0,N0,Stage IIA,T3,6th,not reported,821,bd242807-ccd1-5fe1-a565-56ac9c5e322d,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AA-3710_diagnosis,No,Ascending colon,2019-04-28T11:24:21.673826-05:00,released,TCGA-AA-3710_treatment_1,4cdc0dcc-f91c-5187-be2d-a296de00e566,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:40:29.958500-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
f5c3bc61-1018-4351-bb23-aacc1459365f,TCGA-AA-3710,TCGA-COAD,80,-29465,--,95facda4-e37a-5e34-98bb-33048cffa3ec,not reported,female,not reported,released,TCGA-AA-3710_demographic,2019-07-31T18:40:29.958500-05:00,Alive,1928,--,29465,M0,N0,Stage IIA,T3,6th,not reported,821,bd242807-ccd1-5fe1-a565-56ac9c5e322d,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-AA-3710_diagnosis,No,Ascending colon,--,released,TCGA-AA-3710_treatment,879ffd4e-ed8a-573f-ad07-804f4f3fab7a,no,"Radiation Therapy, NOS",2019-07-31T18:40:29.958500-05:00,not reported,stage iia,2019-08-08T16:34:38.138144-05:00,2008
960d278c-c87d-42dc-ad28-42e010d8f0f1,TCGA-A6-5662,TCGA-COAD,46,-16873,--,9800ce75-29d4-587e-bd09-d6361e0db69a,not hispanic or latino,male,white,released,TCGA-A6-5662_demographic,2019-07-31T18:32:58.601809-05:00,Alive,1964,--,16873,M1,N2,Stage IVA,T3,--,not reported,718,620ba2a2-9e69-5559-867b-82560e768dad,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-A6-5662_diagnosis,No,Splenic flexure of colon,2019-04-28T11:18:06.591180-05:00,released,TCGA-A6-5662_treatment_1,52996cae-9675-5cb3-965f-a37231ad81b0,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:58.601809-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2010
960d278c-c87d-42dc-ad28-42e010d8f0f1,TCGA-A6-5662,TCGA-COAD,46,-16873,--,9800ce75-29d4-587e-bd09-d6361e0db69a,not hispanic or latino,male,white,released,TCGA-A6-5662_demographic,2019-07-31T18:32:58.601809-05:00,Alive,1964,--,16873,M1,N2,Stage IVA,T3,--,not reported,718,620ba2a2-9e69-5559-867b-82560e768dad,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-A6-5662_diagnosis,No,Splenic flexure of colon,--,released,TCGA-A6-5662_treatment,8c4646ae-9012-5405-91ca-d41f3ad0973f,no,"Radiation Therapy, NOS",2019-07-31T18:32:58.601809-05:00,not reported,stage iva,2019-08-08T16:33:45.855164-05:00,2010
57b0f89f-1b75-453e-922c-01cd4d44ca49,TCGA-CK-5914,TCGA-COAD,81,-29586,--,75b84a7b-1f8b-53e4-a85c-5c7e0541e1fd,not hispanic or latino,male,white,released,TCGA-CK-5914_demographic,2019-07-31T18:28:55.830377-05:00,Alive,1927,--,29586,MX,N1,Stage IIIB,T3,6th,not reported,669,651d1d51-1225-5373-9443-8f287f2e2c43,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-5914_diagnosis,No,Sigmoid colon,--,released,TCGA-CK-5914_treatment,7de43578-535e-5f03-bead-cfb64c4e6253,not reported,"Radiation Therapy, NOS",2019-07-31T18:28:55.830377-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2008
57b0f89f-1b75-453e-922c-01cd4d44ca49,TCGA-CK-5914,TCGA-COAD,81,-29586,--,75b84a7b-1f8b-53e4-a85c-5c7e0541e1fd,not hispanic or latino,male,white,released,TCGA-CK-5914_demographic,2019-07-31T18:28:55.830377-05:00,Alive,1927,--,29586,MX,N1,Stage IIIB,T3,6th,not reported,669,651d1d51-1225-5373-9443-8f287f2e2c43,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-CK-5914_diagnosis,No,Sigmoid colon,2019-04-28T11:14:44.481846-05:00,released,TCGA-CK-5914_treatment_1,c9f215c0-1e90-5e97-86e9-81e8af8d5738,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:55.830377-05:00,not reported,stage iiib,2019-08-08T16:35:57.350058-05:00,2008
92554413-9ebc-4354-8e1b-9682f3a031d9,TCGA-4N-A93T,TCGA-COAD,67,-24523,--,77246ec3-e6c0-5ca5-b528-68b285a93ccb,not hispanic or latino,male,black or african american,released,TCGA-4N-A93T_demographic,2019-07-31T15:20:21.407951-05:00,Alive,1946,--,24523,M0,N1b,Stage IIIB,T4a,7th,not reported,146,1ff8c9c9-ea6c-51d6-897b-306ee9c8aae0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-4N-A93T_diagnosis,No,Ascending colon,--,released,TCGA-4N-A93T_treatment,41a84a30-1a47-5e41-a502-b8c75272a662,no,"Radiation Therapy, NOS",2019-07-31T15:20:21.407951-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2013
92554413-9ebc-4354-8e1b-9682f3a031d9,TCGA-4N-A93T,TCGA-COAD,67,-24523,--,77246ec3-e6c0-5ca5-b528-68b285a93ccb,not hispanic or latino,male,black or african american,released,TCGA-4N-A93T_demographic,2019-07-31T15:20:21.407951-05:00,Alive,1946,--,24523,M0,N1b,Stage IIIB,T4a,7th,not reported,146,1ff8c9c9-ea6c-51d6-897b-306ee9c8aae0,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-4N-A93T_diagnosis,No,Ascending colon,2019-04-28T08:40:30.407613-05:00,released,TCGA-4N-A93T_treatment_1,54d1059d-f94a-5190-a4fb-2a4db64d4107,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:20:21.407951-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2013
0687bea4-911a-4ef2-9fa2-531ef6ba7910,TCGA-NH-A6GC,TCGA-COAD,66,-24355,--,77b340a1-ad1d-5d00-8833-b36300232581,not hispanic or latino,female,black or african american,released,TCGA-NH-A6GC_demographic,2019-07-31T18:22:42.983694-05:00,Alive,1947,--,24355,M1b,N1b,Stage IVB,T4b,7th,not reported,389,cb1f5a7d-49ae-5f9c-a9ce-b4610a9723ba,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-NH-A6GC_diagnosis,No,Descending colon,--,released,TCGA-NH-A6GC_treatment,abc88233-23f7-5576-9649-2a3387ffe4e8,no,"Radiation Therapy, NOS",2019-07-31T18:22:42.983694-05:00,not reported,stage ivb,2019-08-08T16:37:18.448891-05:00,2013
0687bea4-911a-4ef2-9fa2-531ef6ba7910,TCGA-NH-A6GC,TCGA-COAD,66,-24355,--,77b340a1-ad1d-5d00-8833-b36300232581,not hispanic or latino,female,black or african american,released,TCGA-NH-A6GC_demographic,2019-07-31T18:22:42.983694-05:00,Alive,1947,--,24355,M1b,N1b,Stage IVB,T4b,7th,not reported,389,cb1f5a7d-49ae-5f9c-a9ce-b4610a9723ba,C18.6,8480/3,Mucinous adenocarcinoma,no,No,not reported,Descending colon,released,TCGA-NH-A6GC_diagnosis,No,Descending colon,2019-04-28T11:09:35.414597-05:00,released,TCGA-NH-A6GC_treatment_1,1dd37f47-5317-52da-84ed-843ee61c6d97,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:42.983694-05:00,not reported,stage ivb,2019-08-08T16:37:18.448891-05:00,2013
81a7184e-f9f5-4e3f-9603-5f5642386c1e,TCGA-T9-A92H,TCGA-COAD,82,-30058,--,a6313e01-a8ed-583c-a552-eb9054fb2b4e,not hispanic or latino,male,black or african american,released,TCGA-T9-A92H_demographic,2019-07-31T18:42:11.309001-05:00,Alive,1931,--,30058,M0,N0,Stage IIA,T3,7th,not reported,362,293b5207-b0ce-560f-8b25-e753ae538b67,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-T9-A92H_diagnosis,No,Sigmoid colon,2019-04-28T11:25:49.140717-05:00,released,TCGA-T9-A92H_treatment_1,637f28a2-bc93-5377-89ae-370a587f862b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:11.309001-05:00,not reported,stage iia,2019-08-08T16:37:44.165377-05:00,2013
81a7184e-f9f5-4e3f-9603-5f5642386c1e,TCGA-T9-A92H,TCGA-COAD,82,-30058,--,a6313e01-a8ed-583c-a552-eb9054fb2b4e,not hispanic or latino,male,black or african american,released,TCGA-T9-A92H_demographic,2019-07-31T18:42:11.309001-05:00,Alive,1931,--,30058,M0,N0,Stage IIA,T3,7th,not reported,362,293b5207-b0ce-560f-8b25-e753ae538b67,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-T9-A92H_diagnosis,No,Sigmoid colon,--,released,TCGA-T9-A92H_treatment,f594ad6b-b7d1-570a-ad05-3dfce027f4c4,no,"Radiation Therapy, NOS",2019-07-31T18:42:11.309001-05:00,not reported,stage iia,2019-08-08T16:37:44.165377-05:00,2013
73a142e1-8ac2-4cfe-b8cf-7e9dea64f488,TCGA-AA-A02J,TCGA-COAD,70,-25749,153,7810313c-bcbc-5bd0-a59b-6b4a56f9897c,not reported,female,not reported,released,TCGA-AA-A02J_demographic,2019-07-31T18:30:36.936132-05:00,Dead,1938,2008,25749,M1,N0,Stage IV,T3,6th,not reported,--,cedc5cfa-8af7-5813-abc3-4eeb47440e2c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02J_diagnosis,No,Sigmoid colon,2019-04-28T11:16:08.610751-05:00,released,TCGA-AA-A02J_treatment_1,9acc339a-aaa3-5f62-bb33-2b9cc9c7c806,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:36.936132-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2008
73a142e1-8ac2-4cfe-b8cf-7e9dea64f488,TCGA-AA-A02J,TCGA-COAD,70,-25749,153,7810313c-bcbc-5bd0-a59b-6b4a56f9897c,not reported,female,not reported,released,TCGA-AA-A02J_demographic,2019-07-31T18:30:36.936132-05:00,Dead,1938,2008,25749,M1,N0,Stage IV,T3,6th,not reported,--,cedc5cfa-8af7-5813-abc3-4eeb47440e2c,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02J_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A02J_treatment,57306cc6-a818-5c8a-9a0b-beb2f16a2e24,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:36.936132-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2008
326c1637-ea91-4006-b440-d38420af1ae5,TCGA-A6-6137,TCGA-COAD,55,-20095,--,78ad4489-2eb3-5ae4-907f-60b9845b4e79,not hispanic or latino,male,white,released,TCGA-A6-6137_demographic,2019-07-31T18:26:19.867596-05:00,Alive,1955,--,20095,M0,N1c,Stage IIIB,T3,--,not reported,824,1cc661f9-ce0c-514b-a349-8e07b9f29c93,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-A6-6137_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:12:34.234791-05:00,released,TCGA-A6-6137_treatment_1,601f391c-82e0-506d-a29b-3b5779337e07,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:19.867596-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
326c1637-ea91-4006-b440-d38420af1ae5,TCGA-A6-6137,TCGA-COAD,55,-20095,--,78ad4489-2eb3-5ae4-907f-60b9845b4e79,not hispanic or latino,male,white,released,TCGA-A6-6137_demographic,2019-07-31T18:26:19.867596-05:00,Alive,1955,--,20095,M0,N1c,Stage IIIB,T3,--,not reported,824,1cc661f9-ce0c-514b-a349-8e07b9f29c93,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-A6-6137_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-A6-6137_treatment,3a2e63d8-345e-5372-bef2-e132c26e3ed7,no,"Radiation Therapy, NOS",2019-07-31T18:26:19.867596-05:00,not reported,stage iiib,2019-08-08T16:33:45.855164-05:00,2010
e831369c-78c0-4c75-9cf3-f46ed669312e,TCGA-AA-3544,TCGA-COAD,68,-24959,--,7978a618-2850-59b4-b313-664a27dcac2f,not reported,male,not reported,released,TCGA-AA-3544_demographic,2019-07-31T18:39:40.543596-05:00,Alive,1940,--,24959,M0,N0,Stage I,T2,6th,not reported,426,7c882d37-d518-57b5-b061-61806aef5b6f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3544_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3544_treatment,39b643b7-b379-5bf9-b521-fda3dc823909,no,"Radiation Therapy, NOS",2019-07-31T18:39:40.543596-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
e831369c-78c0-4c75-9cf3-f46ed669312e,TCGA-AA-3544,TCGA-COAD,68,-24959,--,7978a618-2850-59b4-b313-664a27dcac2f,not reported,male,not reported,released,TCGA-AA-3544_demographic,2019-07-31T18:39:40.543596-05:00,Alive,1940,--,24959,M0,N0,Stage I,T2,6th,not reported,426,7c882d37-d518-57b5-b061-61806aef5b6f,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3544_diagnosis,No,"Colon, NOS",2019-04-28T11:23:41.728804-05:00,released,TCGA-AA-3544_treatment_1,980d3c68-da7b-5f92-93b6-93b243b3b797,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:40.543596-05:00,not reported,stage i,2019-08-08T16:34:13.342472-05:00,2008
20ccd267-74e5-4574-a8e1-028bcd74aaeb,TCGA-AA-3872,TCGA-COAD,45,-16651,--,1c53e6c8-fa22-5ff6-9074-3338af1b709f,not reported,male,not reported,released,TCGA-AA-3872_demographic,2019-07-31T18:24:47.746486-05:00,Alive,1964,--,16651,M1,N2,Stage IV,T4,6th,not reported,--,368d4ee6-74dd-534b-ba5f-6d4181e9495d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3872_diagnosis,No,"Colon, NOS",2019-04-28T11:11:15.924533-05:00,released,TCGA-AA-3872_treatment_1,50480b14-e548-55d9-b8f9-61100a937fa9,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:47.746486-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
20ccd267-74e5-4574-a8e1-028bcd74aaeb,TCGA-AA-3872,TCGA-COAD,45,-16651,--,1c53e6c8-fa22-5ff6-9074-3338af1b709f,not reported,male,not reported,released,TCGA-AA-3872_demographic,2019-07-31T18:24:47.746486-05:00,Alive,1964,--,16651,M1,N2,Stage IV,T4,6th,not reported,--,368d4ee6-74dd-534b-ba5f-6d4181e9495d,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3872_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3872_treatment,cb0f51e1-01a6-5792-ab09-83cbdfc90661,not reported,"Radiation Therapy, NOS",2019-07-31T18:24:47.746486-05:00,not reported,stage iv,2019-08-08T16:35:04.140343-05:00,2009
9dcb4e16-b582-4cd0-87cf-04f480ec2cec,TCGA-AA-3542,TCGA-COAD,69,-25324,--,802cd23d-1be6-57ae-98fb-f8d2cf3f03bd,not reported,male,not reported,released,TCGA-AA-3542_demographic,2019-07-31T18:33:29.141795-05:00,Alive,1939,--,25324,M0,N2,Stage IIIC,T3,6th,not reported,395,3e65f9a6-e7f3-5d3f-b56f-a64a91d1e051,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3542_diagnosis,No,Sigmoid colon,2019-04-28T11:18:31.608649-05:00,released,TCGA-AA-3542_treatment_1,ce901834-f0cf-527b-802d-292c2ba2bfd4,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:29.141795-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
9dcb4e16-b582-4cd0-87cf-04f480ec2cec,TCGA-AA-3542,TCGA-COAD,69,-25324,--,802cd23d-1be6-57ae-98fb-f8d2cf3f03bd,not reported,male,not reported,released,TCGA-AA-3542_demographic,2019-07-31T18:33:29.141795-05:00,Alive,1939,--,25324,M0,N2,Stage IIIC,T3,6th,not reported,395,3e65f9a6-e7f3-5d3f-b56f-a64a91d1e051,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3542_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3542_treatment,e7ccb412-5ed0-5d8b-8df9-7501ca9c78fa,no,"Radiation Therapy, NOS",2019-07-31T18:33:29.141795-05:00,not reported,stage iiic,2019-08-08T16:34:13.342472-05:00,2008
85a57cfe-f1c9-44d9-8b50-022c0d3438d1,TCGA-AZ-5403,TCGA-COAD,43,-15983,1910,fc2ecd20-4799-59d2-ad6c-d27a85f47f18,not hispanic or latino,male,white,released,TCGA-AZ-5403_demographic,2019-07-31T18:31:54.582690-05:00,Dead,1957,2005,15983,MX,N0,Stage II,T3,5th,not reported,--,1bce2230-ba60-54f4-a606-a2368f99ddc4,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-AZ-5403_diagnosis,No,Descending colon,2019-04-28T11:17:12.998377-05:00,released,TCGA-AZ-5403_treatment_1,1924957f-637a-54f6-80d7-4a35240a7b69,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:54.582690-05:00,not reported,stage ii,2019-08-08T16:35:57.350058-05:00,2000
85a57cfe-f1c9-44d9-8b50-022c0d3438d1,TCGA-AZ-5403,TCGA-COAD,43,-15983,1910,fc2ecd20-4799-59d2-ad6c-d27a85f47f18,not hispanic or latino,male,white,released,TCGA-AZ-5403_demographic,2019-07-31T18:31:54.582690-05:00,Dead,1957,2005,15983,MX,N0,Stage II,T3,5th,not reported,--,1bce2230-ba60-54f4-a606-a2368f99ddc4,C18.6,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Descending colon,released,TCGA-AZ-5403_diagnosis,No,Descending colon,--,released,TCGA-AZ-5403_treatment,55fac13e-f861-5c78-986a-8b73c943a118,no,"Radiation Therapy, NOS",2019-07-31T18:31:54.582690-05:00,not reported,stage ii,2019-08-08T16:35:57.350058-05:00,2000
654c6f5c-3e5c-49f0-b53f-87cd9797d7c9,TCGA-AA-3947,TCGA-COAD,60,-22035,--,46ed73b8-77ab-56cf-84c9-4be8e8f46a22,not reported,female,not reported,released,TCGA-AA-3947_demographic,2019-07-31T18:29:52.196010-05:00,Alive,1949,--,22035,M0,N0,Stage IIB,T4,6th,not reported,1004,288291d6-496d-5827-b688-649d277b4cbf,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3947_diagnosis,No,"Colon, NOS",2019-04-28T11:15:31.559748-05:00,released,TCGA-AA-3947_treatment_1,4666d992-2903-5a4b-9980-fe480a61e530,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:52.196010-05:00,not reported,stage iib,2019-08-08T16:35:04.140343-05:00,2009
654c6f5c-3e5c-49f0-b53f-87cd9797d7c9,TCGA-AA-3947,TCGA-COAD,60,-22035,--,46ed73b8-77ab-56cf-84c9-4be8e8f46a22,not reported,female,not reported,released,TCGA-AA-3947_demographic,2019-07-31T18:29:52.196010-05:00,Alive,1949,--,22035,M0,N0,Stage IIB,T4,6th,not reported,1004,288291d6-496d-5827-b688-649d277b4cbf,C18.9,8480/3,Mucinous adenocarcinoma,no,No,not reported,"Colon, NOS",released,TCGA-AA-3947_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3947_treatment,a6865dbb-4074-5861-881c-66664e2206f8,no,"Radiation Therapy, NOS",2019-07-31T18:29:52.196010-05:00,not reported,stage iib,2019-08-08T16:35:04.140343-05:00,2009
99c532b0-6b42-4925-a344-fc7262c415ee,TCGA-DM-A285,TCGA-COAD,71,-26021,179,4e639d5c-9263-564f-a5ae-cb359d4bb30b,not hispanic or latino,female,white,released,TCGA-DM-A285_demographic,2019-07-31T18:33:14.321712-05:00,Dead,1930,2001,26021,M1,N2,Stage IV,T3,6th,not reported,--,0e9a6a4c-5a00-5cdc-81fb-aa345358de6d,C18.2,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Ascending colon,released,TCGA-DM-A285_diagnosis,Not Reported,Ascending colon,2019-04-28T11:18:18.853727-05:00,released,TCGA-DM-A285_treatment_1,65cfcf22-e178-5ebe-8c2c-02a961361dc4,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:14.321712-05:00,not reported,stage iv,2019-08-08T16:36:52.154454-05:00,2001
99c532b0-6b42-4925-a344-fc7262c415ee,TCGA-DM-A285,TCGA-COAD,71,-26021,179,4e639d5c-9263-564f-a5ae-cb359d4bb30b,not hispanic or latino,female,white,released,TCGA-DM-A285_demographic,2019-07-31T18:33:14.321712-05:00,Dead,1930,2001,26021,M1,N2,Stage IV,T3,6th,not reported,--,0e9a6a4c-5a00-5cdc-81fb-aa345358de6d,C18.2,8480/3,Mucinous adenocarcinoma,yes,No,not reported,Ascending colon,released,TCGA-DM-A285_diagnosis,Not Reported,Ascending colon,--,released,TCGA-DM-A285_treatment,908c36c1-7bf9-57d9-8bf3-aae2302999aa,not reported,"Radiation Therapy, NOS",2019-07-31T18:33:14.321712-05:00,not reported,stage iv,2019-08-08T16:36:52.154454-05:00,2001
4881a390-c4e4-48b4-ae66-140c64a87614,TCGA-A6-A5ZU,TCGA-COAD,59,-21554,--,4800afca-5639-56ee-b442-1192b05eacde,not hispanic or latino,male,black or african american,released,TCGA-A6-A5ZU_demographic,2019-07-31T18:27:50.045973-05:00,Alive,1954,--,21554,M0,N1,Stage IIIB,T3,7th,not reported,293,e9157d8c-81b8-5557-a032-aa104bd60da5,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-A6-A5ZU_diagnosis,No,Transverse colon,2019-04-28T11:13:49.617689-05:00,released,TCGA-A6-A5ZU_treatment_1,fcc43e2e-159d-54b0-8bf5-fb4d9cf07ae0,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:50.045973-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2013
4881a390-c4e4-48b4-ae66-140c64a87614,TCGA-A6-A5ZU,TCGA-COAD,59,-21554,--,4800afca-5639-56ee-b442-1192b05eacde,not hispanic or latino,male,black or african american,released,TCGA-A6-A5ZU_demographic,2019-07-31T18:27:50.045973-05:00,Alive,1954,--,21554,M0,N1,Stage IIIB,T3,7th,not reported,293,e9157d8c-81b8-5557-a032-aa104bd60da5,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-A6-A5ZU_diagnosis,No,Transverse colon,--,released,TCGA-A6-A5ZU_treatment,56da4b98-29dc-51a7-a31e-08e7fa71758c,no,"Radiation Therapy, NOS",2019-07-31T18:27:50.045973-05:00,not reported,stage iiib,2019-08-08T16:34:13.342472-05:00,2013
9743d31a-ea8f-4847-87d2-ebf77cc5983d,TCGA-CM-5861,TCGA-COAD,63,-23253,--,48c59f57-baa9-5f76-88e0-934ee724089e,not hispanic or latino,female,white,released,TCGA-CM-5861_demographic,2019-07-31T18:33:08.112577-05:00,Alive,1947,--,23253,M0,N0,Stage IIA,T3,7th,not reported,457,c3846a84-f31b-5a11-b520-b347b8ddbe6a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5861_diagnosis,No,Cecum,--,released,TCGA-CM-5861_treatment,561a77ca-e6f5-562d-9ae4-ef8e045ad62a,no,"Radiation Therapy, NOS",2019-07-31T18:33:08.112577-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
9743d31a-ea8f-4847-87d2-ebf77cc5983d,TCGA-CM-5861,TCGA-COAD,63,-23253,--,48c59f57-baa9-5f76-88e0-934ee724089e,not hispanic or latino,female,white,released,TCGA-CM-5861_demographic,2019-07-31T18:33:08.112577-05:00,Alive,1947,--,23253,M0,N0,Stage IIA,T3,7th,not reported,457,c3846a84-f31b-5a11-b520-b347b8ddbe6a,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CM-5861_diagnosis,No,Cecum,2019-04-28T11:18:13.951051-05:00,released,TCGA-CM-5861_treatment_1,78b9392d-553b-5747-8b63-d0c97f58fb8b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:08.112577-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2010
64bd568d-0509-48fe-8d0a-aef2a85d5c57,TCGA-F4-6856,TCGA-COAD,45,-16519,--,f396ecf8-6adc-5d5f-8a6d-bf7bf5618f26,not hispanic or latino,male,white,released,TCGA-F4-6856_demographic,2019-07-31T18:29:46.135823-05:00,Alive,1966,--,16519,M0,N0,Stage I,T2,7th,not reported,1074,bb7c2216-884f-5f97-bea6-80d70c76e6cd,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-F4-6856_diagnosis,No,Cecum,2019-04-28T11:15:26.526049-05:00,released,TCGA-F4-6856_treatment_1,53751efe-7240-577c-9c98-e93c1bce5f9c,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:46.135823-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
64bd568d-0509-48fe-8d0a-aef2a85d5c57,TCGA-F4-6856,TCGA-COAD,45,-16519,--,f396ecf8-6adc-5d5f-8a6d-bf7bf5618f26,not hispanic or latino,male,white,released,TCGA-F4-6856_demographic,2019-07-31T18:29:46.135823-05:00,Alive,1966,--,16519,M0,N0,Stage I,T2,7th,not reported,1074,bb7c2216-884f-5f97-bea6-80d70c76e6cd,C18.0,8480/3,Mucinous adenocarcinoma,no,No,not reported,Cecum,released,TCGA-F4-6856_diagnosis,No,Cecum,--,released,TCGA-F4-6856_treatment,6f821e06-04b6-5d96-9c84-b73875ee3e48,no,"Radiation Therapy, NOS",2019-07-31T18:29:46.135823-05:00,not reported,stage i,2019-08-08T16:37:18.448891-05:00,2011
e7af286b-3dec-4cf2-8fbd-fa64b3efdf7f,TCGA-F4-6809,TCGA-COAD,52,-19039,403,42f3acd2-19a6-5d79-af1a-11742ac0d486,not hispanic or latino,female,white,released,TCGA-F4-6809_demographic,2019-07-31T18:42:58.720297-05:00,Dead,1959,--,19039,M1,N1,Stage IVA,T3,7th,not reported,39,149225df-1b96-52a4-b4ee-e7eb85670261,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6809_diagnosis,No,Sigmoid colon,2019-04-28T11:26:29.684603-05:00,released,TCGA-F4-6809_treatment_1,e2b5b67b-dfbc-55fb-bf24-554860278059,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:42:58.720297-05:00,not reported,stage iva,2019-08-08T16:37:18.448891-05:00,2011
e7af286b-3dec-4cf2-8fbd-fa64b3efdf7f,TCGA-F4-6809,TCGA-COAD,52,-19039,403,42f3acd2-19a6-5d79-af1a-11742ac0d486,not hispanic or latino,female,white,released,TCGA-F4-6809_demographic,2019-07-31T18:42:58.720297-05:00,Dead,1959,--,19039,M1,N1,Stage IVA,T3,7th,not reported,39,149225df-1b96-52a4-b4ee-e7eb85670261,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-F4-6809_diagnosis,No,Sigmoid colon,--,released,TCGA-F4-6809_treatment,df517a46-15b5-5f51-9656-7e83a2902563,no,"Radiation Therapy, NOS",2019-07-31T18:42:58.720297-05:00,not reported,stage iva,2019-08-08T16:37:18.448891-05:00,2011
57a2044d-20cc-4d02-b268-ce570a0fabe3,TCGA-AA-3713,TCGA-COAD,68,-24927,--,348a0787-b92b-52bb-a547-e8d4d30bd9a5,not reported,male,not reported,released,TCGA-AA-3713_demographic,2019-07-31T18:28:52.874345-05:00,Alive,1937,--,24927,M1,N0,Stage IV,T3,5th,not reported,579,9231d14e-e3d1-53f5-a137-341da3a9faa3,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3713_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:14:41.860652-05:00,released,TCGA-AA-3713_treatment_1,b2ca8b86-fa98-5de3-82d0-4b94d51c18bc,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:28:52.874345-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2005
57a2044d-20cc-4d02-b268-ce570a0fabe3,TCGA-AA-3713,TCGA-COAD,68,-24927,--,348a0787-b92b-52bb-a547-e8d4d30bd9a5,not reported,male,not reported,released,TCGA-AA-3713_demographic,2019-07-31T18:28:52.874345-05:00,Alive,1937,--,24927,M1,N0,Stage IV,T3,5th,not reported,579,9231d14e-e3d1-53f5-a137-341da3a9faa3,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3713_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3713_treatment,bf51a1f9-ed5a-5176-ace2-1b6abf655ade,yes,"Radiation Therapy, NOS",2019-07-31T18:28:52.874345-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2005
e4be17c8-0855-432c-bb80-28bb24b62f32,TCGA-G4-6309,TCGA-COAD,40,-14729,--,37ab61c0-0dda-543d-99fa-866db018754c,not hispanic or latino,female,black or african american,released,TCGA-G4-6309_demographic,2019-07-31T18:39:13.404207-05:00,Alive,1967,--,14729,M0,N1,Stage IIIB,T3,6th,not reported,2600,c58310a6-29d9-5420-b679-94adc4440ebc,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6309_diagnosis,No,Sigmoid colon,--,released,TCGA-G4-6309_treatment,20f95993-c1b1-579d-ba8a-7ef07a3cb65c,no,"Radiation Therapy, NOS",2019-07-31T18:39:13.404207-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2007
e4be17c8-0855-432c-bb80-28bb24b62f32,TCGA-G4-6309,TCGA-COAD,40,-14729,--,37ab61c0-0dda-543d-99fa-866db018754c,not hispanic or latino,female,black or african american,released,TCGA-G4-6309_demographic,2019-07-31T18:39:13.404207-05:00,Alive,1967,--,14729,M0,N1,Stage IIIB,T3,6th,not reported,2600,c58310a6-29d9-5420-b679-94adc4440ebc,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6309_diagnosis,No,Sigmoid colon,2019-04-28T11:23:18.980703-05:00,released,TCGA-G4-6309_treatment_1,1eee738d-d554-5ee2-9c01-7d5584196238,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:39:13.404207-05:00,not reported,stage iiib,2019-08-08T16:37:18.448891-05:00,2007
0dc41cd5-0672-407c-9b4a-0f5f3970aa54,TCGA-A6-5660,TCGA-COAD,73,-26803,--,37ded65d-bc00-51a5-a041-416592ee9f8d,not hispanic or latino,male,black or african american,released,TCGA-A6-5660_demographic,2019-07-31T18:23:20.183189-05:00,Alive,1937,--,26803,M0,N2b,Stage IIIC,T3,--,not reported,888,693ae9be-69c6-5238-8e90-27e8960b5d7b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-5660_diagnosis,No,"Colon, NOS",--,released,TCGA-A6-5660_treatment,f0a61184-ef55-578a-b605-e9bf240cbb3d,no,"Radiation Therapy, NOS",2019-07-31T18:23:20.183189-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2010
0dc41cd5-0672-407c-9b4a-0f5f3970aa54,TCGA-A6-5660,TCGA-COAD,73,-26803,--,37ded65d-bc00-51a5-a041-416592ee9f8d,not hispanic or latino,male,black or african american,released,TCGA-A6-5660_demographic,2019-07-31T18:23:20.183189-05:00,Alive,1937,--,26803,M0,N2b,Stage IIIC,T3,--,not reported,888,693ae9be-69c6-5238-8e90-27e8960b5d7b,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-A6-5660_diagnosis,No,"Colon, NOS",2019-04-28T11:10:05.602306-05:00,released,TCGA-A6-5660_treatment_1,6e14327d-c971-5b8e-8bcf-b2cb43118628,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:23:20.183189-05:00,not reported,stage iiic,2019-08-08T16:33:45.855164-05:00,2010
aa909ffb-03e1-4e3f-8888-2212b23d90b7,TCGA-AA-3696,TCGA-COAD,75,-27667,153,3e97bb2e-6772-5cb0-a72f-726a79bfbda6,not reported,female,not reported,released,TCGA-AA-3696_demographic,2019-07-31T18:34:14.946028-05:00,Dead,1934,--,27667,M1,N1,Stage IV,T3,6th,not reported,--,f771ee6f-f86e-5026-9f0c-8c7dfca1d897,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3696_diagnosis,No,Sigmoid colon,2019-04-28T11:19:07.742442-05:00,released,TCGA-AA-3696_treatment_1,a2394de9-8e05-5865-8c2c-a36fc3f16734,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:14.946028-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2009
aa909ffb-03e1-4e3f-8888-2212b23d90b7,TCGA-AA-3696,TCGA-COAD,75,-27667,153,3e97bb2e-6772-5cb0-a72f-726a79bfbda6,not reported,female,not reported,released,TCGA-AA-3696_demographic,2019-07-31T18:34:14.946028-05:00,Dead,1934,--,27667,M1,N1,Stage IV,T3,6th,not reported,--,f771ee6f-f86e-5026-9f0c-8c7dfca1d897,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3696_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3696_treatment,f89c667e-7841-5cb3-b5c5-942794960d14,no,"Radiation Therapy, NOS",2019-07-31T18:34:14.946028-05:00,not reported,stage iv,2019-08-08T16:34:38.138144-05:00,2009
c8d6fe73-3504-42a5-9723-e1916fba8208,TCGA-AZ-6606,TCGA-COAD,81,-29704,357,3fbd1fa7-10b1-5318-80e2-c8acbbcf4aa8,not hispanic or latino,male,white,released,TCGA-AZ-6606_demographic,2019-07-31T18:36:54.279903-05:00,Dead,1928,2009,29704,M1,N2,Stage IV,T4,6th,not reported,--,01f0bac9-2406-50e1-a1e2-30c80d8a1799,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-6606_diagnosis,No,Cecum,--,released,TCGA-AZ-6606_treatment,c2b1d1c8-f57b-5453-84ec-272080c77a5d,no,"Radiation Therapy, NOS",2019-07-31T18:36:54.279903-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2009
c8d6fe73-3504-42a5-9723-e1916fba8208,TCGA-AZ-6606,TCGA-COAD,81,-29704,357,3fbd1fa7-10b1-5318-80e2-c8acbbcf4aa8,not hispanic or latino,male,white,released,TCGA-AZ-6606_demographic,2019-07-31T18:36:54.279903-05:00,Dead,1928,2009,29704,M1,N2,Stage IV,T4,6th,not reported,--,01f0bac9-2406-50e1-a1e2-30c80d8a1799,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AZ-6606_diagnosis,No,Cecum,2019-04-28T11:21:19.082993-05:00,released,TCGA-AZ-6606_treatment_1,f48bc66b-a20a-5116-92c9-737941d8cb89,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:54.279903-05:00,not reported,stage iv,2019-08-08T16:35:57.350058-05:00,2009
85e95dda-6198-464a-9187-fd0832bebb72,TCGA-AA-3492,TCGA-COAD,90,-32871,1,5510c393-ea3d-5c99-954b-1a0ce69c8223,not reported,female,not reported,released,TCGA-AA-3492_demographic,2019-07-31T18:32:01.062696-05:00,Dead,1912,--,32871,M0,N0,Stage II,T3,5th,not reported,--,91c2b535-5036-5573-9d47-454320daa117,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3492_diagnosis,No,Ascending colon,2019-04-28T11:17:19.091909-05:00,released,TCGA-AA-3492_treatment_1,eac1a8c6-ad4c-5c8c-afa5-73402cb345ce,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:32:01.062696-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2002
85e95dda-6198-464a-9187-fd0832bebb72,TCGA-AA-3492,TCGA-COAD,90,-32871,1,5510c393-ea3d-5c99-954b-1a0ce69c8223,not reported,female,not reported,released,TCGA-AA-3492_demographic,2019-07-31T18:32:01.062696-05:00,Dead,1912,--,32871,M0,N0,Stage II,T3,5th,not reported,--,91c2b535-5036-5573-9d47-454320daa117,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-3492_diagnosis,No,Ascending colon,--,released,TCGA-AA-3492_treatment,f274c52b-5197-50b7-b260-ac4fac305422,no,"Radiation Therapy, NOS",2019-07-31T18:32:01.062696-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2002
5a195baa-2d05-4273-a7c4-64cc816b0406,TCGA-AA-3982,TCGA-COAD,75,-27608,--,3fe3952a-bed3-5ae3-806f-5771d345237e,not reported,male,not reported,released,TCGA-AA-3982_demographic,2019-07-31T18:29:01.508051-05:00,Alive,1934,--,27608,M0,N1,Stage IIIB,T3,6th,not reported,822,5c80fd57-6a94-55c1-b1b4-8b5a85c20d12,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3982_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3982_treatment,79c8626c-5e05-5c94-8fca-9f76f9b699ac,no,"Radiation Therapy, NOS",2019-07-31T18:29:01.508051-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
5a195baa-2d05-4273-a7c4-64cc816b0406,TCGA-AA-3982,TCGA-COAD,75,-27608,--,3fe3952a-bed3-5ae3-806f-5771d345237e,not reported,male,not reported,released,TCGA-AA-3982_demographic,2019-07-31T18:29:01.508051-05:00,Alive,1934,--,27608,M0,N1,Stage IIIB,T3,6th,not reported,822,5c80fd57-6a94-55c1-b1b4-8b5a85c20d12,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3982_diagnosis,No,"Colon, NOS",2019-04-28T11:14:49.298066-05:00,released,TCGA-AA-3982_treatment_1,9509fc0e-24d5-5386-bfa7-e1deeae43b53,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:29:01.508051-05:00,not reported,stage iiib,2019-08-08T16:35:04.140343-05:00,2009
c777a777-373a-4773-9566-6c373261f00a,TCGA-CM-4750,TCGA-COAD,34,-12478,--,42012379-e61c-518c-8d90-d27616f9c432,not hispanic or latino,female,white,released,TCGA-CM-4750_demographic,2019-07-31T18:36:40.687422-05:00,Alive,1976,--,12478,M0,N1b,Stage IIIA,T1,--,not reported,244,b6cdde95-e0d6-5e5b-ac4e-d9ecd9b281c4,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-CM-4750_diagnosis,No,Rectosigmoid junction,2019-04-28T11:21:09.085978-05:00,released,TCGA-CM-4750_treatment_1,a36cfc93-2090-509b-a463-557f05fcd318,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:36:40.687422-05:00,not reported,stage iiia,2019-08-08T16:36:28.485406-05:00,2010
c777a777-373a-4773-9566-6c373261f00a,TCGA-CM-4750,TCGA-COAD,34,-12478,--,42012379-e61c-518c-8d90-d27616f9c432,not hispanic or latino,female,white,released,TCGA-CM-4750_demographic,2019-07-31T18:36:40.687422-05:00,Alive,1976,--,12478,M0,N1b,Stage IIIA,T1,--,not reported,244,b6cdde95-e0d6-5e5b-ac4e-d9ecd9b281c4,C19,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Rectosigmoid junction,released,TCGA-CM-4750_diagnosis,No,Rectosigmoid junction,--,released,TCGA-CM-4750_treatment,2c7e08e6-2ca5-5511-a671-33a86734cddf,no,"Radiation Therapy, NOS",2019-07-31T18:36:40.687422-05:00,not reported,stage iiia,2019-08-08T16:36:28.485406-05:00,2010
264c0d45-078a-4207-a101-71f99bcd237e,TCGA-G4-6303,TCGA-COAD,54,-19800,2003,448a9f1a-c623-58e5-95a2-8d4fac835f1f,not hispanic or latino,female,white,released,TCGA-G4-6303_demographic,2019-07-31T18:25:08.525920-05:00,Dead,1952,--,19800,M1,N1,Stage IV,T3,6th,not reported,1882,a3a25d5b-92ce-508d-8a35-4019516fb689,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6303_diagnosis,No,Sigmoid colon,2019-04-28T11:11:34.238109-05:00,released,TCGA-G4-6303_treatment_1,3077a217-5511-589c-b4d6-5cae9e5ba3cc,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:08.525920-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2006
264c0d45-078a-4207-a101-71f99bcd237e,TCGA-G4-6303,TCGA-COAD,54,-19800,2003,448a9f1a-c623-58e5-95a2-8d4fac835f1f,not hispanic or latino,female,white,released,TCGA-G4-6303_demographic,2019-07-31T18:25:08.525920-05:00,Dead,1952,--,19800,M1,N1,Stage IV,T3,6th,not reported,1882,a3a25d5b-92ce-508d-8a35-4019516fb689,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-G4-6303_diagnosis,No,Sigmoid colon,--,released,TCGA-G4-6303_treatment,7bb28911-5b94-578d-af47-0d2db1234e0a,no,"Radiation Therapy, NOS",2019-07-31T18:25:08.525920-05:00,not reported,stage iv,2019-08-08T16:37:18.448891-05:00,2006
2c30dc20-18a8-44f9-ab10-558c1e5634dc,TCGA-AY-6196,TCGA-COAD,47,-17311,--,c1604047-82ee-59b4-bfee-b15a6078d13d,not hispanic or latino,male,white,released,TCGA-AY-6196_demographic,2019-07-31T18:25:55.324136-05:00,Alive,1963,--,17311,--,N2b,Stage IIIC,T3,7th,not reported,6,e13556ab-3ce9-5348-92e4-8dae94370c62,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AY-6196_diagnosis,No,Ascending colon,--,released,TCGA-AY-6196_treatment,c3dc1cbc-f707-537f-a1f4-b3293fcc6da4,not reported,"Radiation Therapy, NOS",2019-07-31T18:25:55.324136-05:00,not reported,stage iiic,2019-08-08T16:35:57.350058-05:00,2010
2c30dc20-18a8-44f9-ab10-558c1e5634dc,TCGA-AY-6196,TCGA-COAD,47,-17311,--,c1604047-82ee-59b4-bfee-b15a6078d13d,not hispanic or latino,male,white,released,TCGA-AY-6196_demographic,2019-07-31T18:25:55.324136-05:00,Alive,1963,--,17311,--,N2b,Stage IIIC,T3,7th,not reported,6,e13556ab-3ce9-5348-92e4-8dae94370c62,C18.2,8480/3,Mucinous adenocarcinoma,no,No,not reported,Ascending colon,released,TCGA-AY-6196_diagnosis,No,Ascending colon,2019-04-28T11:12:14.751032-05:00,released,TCGA-AY-6196_treatment_1,0d556875-fef1-5cd9-9879-1c31a5629385,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:55.324136-05:00,not reported,stage iiic,2019-08-08T16:35:57.350058-05:00,2010
10628a61-bd5e-4415-af97-631c5ca320cb,TCGA-AA-A00A,TCGA-COAD,80,-29463,--,277ec5bc-8dba-56e1-8cd8-f486fd41d990,not reported,male,not reported,released,TCGA-AA-A00A_demographic,2019-07-31T18:41:23.977708-05:00,Alive,1929,--,29463,M0,N0,Stage IIA,T3,6th,not reported,1157,203f17be-cef5-52b9-960a-3bf88691d47c,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00A_diagnosis,No,Ascending colon,--,released,TCGA-AA-A00A_treatment,6c1be5c5-9358-5dd6-a78e-605efb4e55b3,no,"Radiation Therapy, NOS",2019-07-31T18:41:23.977708-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
10628a61-bd5e-4415-af97-631c5ca320cb,TCGA-AA-A00A,TCGA-COAD,80,-29463,--,277ec5bc-8dba-56e1-8cd8-f486fd41d990,not reported,male,not reported,released,TCGA-AA-A00A_demographic,2019-07-31T18:41:23.977708-05:00,Alive,1929,--,29463,M0,N0,Stage IIA,T3,6th,not reported,1157,203f17be-cef5-52b9-960a-3bf88691d47c,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-AA-A00A_diagnosis,No,Ascending colon,2019-04-28T11:25:06.937014-05:00,released,TCGA-AA-A00A_treatment_1,2fbf44fb-063a-5228-9137-03e896afafaa,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:41:23.977708-05:00,not reported,stage iia,2019-08-08T16:35:04.140343-05:00,2009
39aec099-a33e-47a4-a602-cbf65ddd3830,TCGA-D5-6541,TCGA-COAD,49,-18029,--,27d7a515-cce9-52e5-9aed-fcb6a4d9c832,not hispanic or latino,male,white,released,TCGA-D5-6541_demographic,2019-07-31T18:26:55.424068-05:00,Alive,1961,--,18029,M0,N0,Stage IIA,T3,--,not reported,474,6ea1e532-5515-5898-9eb4-4795350668a2,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-D5-6541_diagnosis,No,Splenic flexure of colon,2019-04-28T11:13:05.015948-05:00,released,TCGA-D5-6541_treatment_1,a18147ec-1f1e-5f7e-a4f5-b6a8731b5f92,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:55.424068-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2010
39aec099-a33e-47a4-a602-cbf65ddd3830,TCGA-D5-6541,TCGA-COAD,49,-18029,--,27d7a515-cce9-52e5-9aed-fcb6a4d9c832,not hispanic or latino,male,white,released,TCGA-D5-6541_demographic,2019-07-31T18:26:55.424068-05:00,Alive,1961,--,18029,M0,N0,Stage IIA,T3,--,not reported,474,6ea1e532-5515-5898-9eb4-4795350668a2,C18.5,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Splenic flexure of colon,released,TCGA-D5-6541_diagnosis,No,Splenic flexure of colon,--,released,TCGA-D5-6541_treatment,419c940f-da8f-5aa5-9fc6-fb08deb33d0c,no,"Radiation Therapy, NOS",2019-07-31T18:26:55.424068-05:00,not reported,stage iia,2019-08-08T16:36:52.154454-05:00,2010
21bdad0d-c6a2-428c-b2b4-0de282b34abc,TCGA-AA-3850,TCGA-COAD,74,-27090,--,289a1a25-f514-5cff-a6e2-84d926403c8a,not reported,male,not reported,released,TCGA-AA-3850_demographic,2019-07-31T18:24:50.788746-05:00,Dead,1935,2009,27090,M0,N0,Stage I,T2,6th,not reported,--,757da2c2-3791-5a86-be8a-8f3c670fae93,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-3850_diagnosis,No,Transverse colon,2019-04-28T11:11:19.048506-05:00,released,TCGA-AA-3850_treatment_1,0d467c7f-aea1-50cb-a713-00f0489ea2b8,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:50.788746-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
21bdad0d-c6a2-428c-b2b4-0de282b34abc,TCGA-AA-3850,TCGA-COAD,74,-27090,--,289a1a25-f514-5cff-a6e2-84d926403c8a,not reported,male,not reported,released,TCGA-AA-3850_demographic,2019-07-31T18:24:50.788746-05:00,Dead,1935,2009,27090,M0,N0,Stage I,T2,6th,not reported,--,757da2c2-3791-5a86-be8a-8f3c670fae93,C18.4,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Transverse colon,released,TCGA-AA-3850_diagnosis,No,Transverse colon,--,released,TCGA-AA-3850_treatment,a5ba37f0-45c5-5041-bd94-1226906a8120,not reported,"Radiation Therapy, NOS",2019-07-31T18:24:50.788746-05:00,not reported,stage i,2019-08-08T16:34:38.138144-05:00,2009
a06c09a8-0951-49f4-a765-5147bbcae109,TCGA-AA-3664,TCGA-COAD,74,-27363,--,296c728d-da75-55d7-a04e-222d608e169a,not reported,female,not reported,released,TCGA-AA-3664_demographic,2019-07-31T18:33:35.305862-05:00,Alive,1931,--,27363,M0,N0,Stage II,T3,5th,not reported,1643,cd975e54-f000-5052-ad06-3230d7372424,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3664_diagnosis,No,Ascending colon,2019-04-28T11:18:36.664997-05:00,released,TCGA-AA-3664_treatment_1,2a5a0266-2ebe-5bc8-8082-1871e2aa1775,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:33:35.305862-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
a06c09a8-0951-49f4-a765-5147bbcae109,TCGA-AA-3664,TCGA-COAD,74,-27363,--,296c728d-da75-55d7-a04e-222d608e169a,not reported,female,not reported,released,TCGA-AA-3664_demographic,2019-07-31T18:33:35.305862-05:00,Alive,1931,--,27363,M0,N0,Stage II,T3,5th,not reported,1643,cd975e54-f000-5052-ad06-3230d7372424,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-3664_diagnosis,No,Ascending colon,--,released,TCGA-AA-3664_treatment,45948917-d0eb-50c0-8bb0-d40433c61e5f,no,"Radiation Therapy, NOS",2019-07-31T18:33:35.305862-05:00,not reported,stage ii,2019-08-08T16:34:38.138144-05:00,2005
a94e1279-a975-480a-93e9-7b1ff05cbcbf,TCGA-3L-AA1B,TCGA-COAD,61,-22379,--,2a3b1379-9507-580d-9628-4b502a720cc4,not hispanic or latino,female,black or african american,released,TCGA-3L-AA1B_demographic,2019-07-31T15:15:52.503550-05:00,Alive,1952,--,22379,M0,N0,Stage I,T2,7th,not reported,475,6eb0d5b6-cb00-519f-838e-119b548ac582,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-3L-AA1B_diagnosis,No,Cecum,--,released,TCGA-3L-AA1B_treatment,08bfaf92-3b30-5724-ac84-dac862df44bc,no,"Radiation Therapy, NOS",2019-07-31T15:15:52.503550-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2013
a94e1279-a975-480a-93e9-7b1ff05cbcbf,TCGA-3L-AA1B,TCGA-COAD,61,-22379,--,2a3b1379-9507-580d-9628-4b502a720cc4,not hispanic or latino,female,black or african american,released,TCGA-3L-AA1B_demographic,2019-07-31T15:15:52.503550-05:00,Alive,1952,--,22379,M0,N0,Stage I,T2,7th,not reported,475,6eb0d5b6-cb00-519f-838e-119b548ac582,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-3L-AA1B_diagnosis,No,Cecum,2019-04-28T08:36:39.871685-05:00,released,TCGA-3L-AA1B_treatment_1,83c97fdf-1c33-5854-b543-bd33c198cbb3,no,"Pharmaceutical Therapy, NOS",2019-07-31T15:15:52.503550-05:00,not reported,stage i,2019-08-08T16:33:45.855164-05:00,2013
26a12266-c6d8-42f9-bd4e-5093d827ac9a,TCGA-AM-5820,TCGA-COAD,59,-21902,--,2c82ec06-6211-5676-aabf-f28488b95b76,not hispanic or latino,female,white,released,TCGA-AM-5820_demographic,2019-07-31T18:25:21.002120-05:00,Alive,1951,--,21902,M1,N2,Stage IVA,T4a,7th,not reported,14,a08fe5fd-25ae-5d44-bece-70df63619ba3,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AM-5820_diagnosis,No,"Colon, NOS",--,released,TCGA-AM-5820_treatment,52b0689e-1710-5028-af88-2ce84368059f,not reported,"Radiation Therapy, NOS",2019-07-31T18:25:21.002120-05:00,not reported,stage iva,2019-08-08T16:35:29.811838-05:00,2010
26a12266-c6d8-42f9-bd4e-5093d827ac9a,TCGA-AM-5820,TCGA-COAD,59,-21902,--,2c82ec06-6211-5676-aabf-f28488b95b76,not hispanic or latino,female,white,released,TCGA-AM-5820_demographic,2019-07-31T18:25:21.002120-05:00,Alive,1951,--,21902,M1,N2,Stage IVA,T4a,7th,not reported,14,a08fe5fd-25ae-5d44-bece-70df63619ba3,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AM-5820_diagnosis,No,"Colon, NOS",2019-04-28T11:11:44.556081-05:00,released,TCGA-AM-5820_treatment_1,fa548586-d1cd-587d-857f-ac97f9012cd1,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:25:21.002120-05:00,not reported,stage iva,2019-08-08T16:35:29.811838-05:00,2010
19089ae0-b590-4649-9d94-a147fa506e32,TCGA-G4-6627,TCGA-COAD,84,-30697,--,ea0909b5-af0b-5e66-8c29-bd470497d278,not hispanic or latino,male,white,released,TCGA-G4-6627_demographic,2019-07-31T18:24:22.397560-05:00,Alive,1923,--,30697,M0,N0,Stage IIA,T3,6th,not reported,2175,25a93adf-21c3-5586-9282-ad56b22c06d2,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6627_diagnosis,No,Ascending colon,2019-04-28T11:10:56.352600-05:00,released,TCGA-G4-6627_treatment_1,781a8fe0-fc4c-5afc-a725-581dded27de9,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:24:22.397560-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2007
19089ae0-b590-4649-9d94-a147fa506e32,TCGA-G4-6627,TCGA-COAD,84,-30697,--,ea0909b5-af0b-5e66-8c29-bd470497d278,not hispanic or latino,male,white,released,TCGA-G4-6627_demographic,2019-07-31T18:24:22.397560-05:00,Alive,1923,--,30697,M0,N0,Stage IIA,T3,6th,not reported,2175,25a93adf-21c3-5586-9282-ad56b22c06d2,C18.2,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Ascending colon,released,TCGA-G4-6627_diagnosis,No,Ascending colon,--,released,TCGA-G4-6627_treatment,7b5c1d9c-052b-5770-b42f-36e9975b0385,no,"Radiation Therapy, NOS",2019-07-31T18:24:22.397560-05:00,not reported,stage iia,2019-08-08T16:37:18.448891-05:00,2007
dd4be58e-da22-4bcd-bf4c-2b9e60ffda19,TCGA-AA-A02F,TCGA-COAD,68,-25051,--,21534535-7efd-55d7-ac86-40ad29ab0a61,not reported,female,not reported,released,TCGA-AA-A02F_demographic,2019-07-31T15:55:16.564194-05:00,Alive,1939,--,25051,M1,N1,Stage IV,T3,6th,not reported,1216,29c6afa1-7f05-5685-bd79-8d813ccab593,C18.7,8010/3,"Carcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02F_diagnosis,No,Sigmoid colon,2019-04-28T09:10:09.241856-05:00,released,TCGA-AA-A02F_treatment_1,0d0098bf-0606-59a5-b86c-bf77d6901920,yes,"Pharmaceutical Therapy, NOS",2019-07-31T15:55:16.564194-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2007
dd4be58e-da22-4bcd-bf4c-2b9e60ffda19,TCGA-AA-A02F,TCGA-COAD,68,-25051,--,21534535-7efd-55d7-ac86-40ad29ab0a61,not reported,female,not reported,released,TCGA-AA-A02F_demographic,2019-07-31T15:55:16.564194-05:00,Alive,1939,--,25051,M1,N1,Stage IV,T3,6th,not reported,1216,29c6afa1-7f05-5685-bd79-8d813ccab593,C18.7,8010/3,"Carcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02F_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A02F_treatment,530ceea5-8bb2-53e2-a3e1-754114b26aa7,no,"Radiation Therapy, NOS",2019-07-31T15:55:16.564194-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2007
33e989b9-fac4-47d8-b429-269044ac772a,TCGA-AA-3977,TCGA-COAD,65,-23832,--,d605340a-0b06-5bac-b0f9-bd4e81068579,not reported,male,not reported,released,TCGA-AA-3977_demographic,2019-07-31T18:26:31.296004-05:00,Alive,1944,--,23832,--,N0,--,T2,6th,not reported,761,48f1359c-b897-5b62-b04d-31de46bc5dc2,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3977_diagnosis,No,Sigmoid colon,2019-04-28T11:12:44.490265-05:00,released,TCGA-AA-3977_treatment_1,701627c7-2026-565d-b8f0-a28da4a7928c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:31.296004-05:00,not reported,not reported,2019-08-08T16:35:04.140343-05:00,2009
33e989b9-fac4-47d8-b429-269044ac772a,TCGA-AA-3977,TCGA-COAD,65,-23832,--,d605340a-0b06-5bac-b0f9-bd4e81068579,not reported,male,not reported,released,TCGA-AA-3977_demographic,2019-07-31T18:26:31.296004-05:00,Alive,1944,--,23832,--,N0,--,T2,6th,not reported,761,48f1359c-b897-5b62-b04d-31de46bc5dc2,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-3977_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-3977_treatment,e9c60634-1f04-5aa2-8588-4f786247e7c8,no,"Radiation Therapy, NOS",2019-07-31T18:26:31.296004-05:00,not reported,not reported,2019-08-08T16:35:04.140343-05:00,2009
69fb431f-0caf-4cdd-9085-eda5b18ed15d,TCGA-AA-A02H,TCGA-COAD,74,-27362,61,24b8d727-e46d-5f96-a759-3cfc71be2a41,not reported,female,not reported,released,TCGA-AA-A02H_demographic,2019-07-31T18:30:09.946275-05:00,Dead,1933,2007,27362,M1,N2,Stage IV,T3,6th,not reported,--,d3960bc5-b93b-5bda-ac1f-12fb1e8791e0,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02H_diagnosis,No,Sigmoid colon,2019-04-28T11:15:46.591620-05:00,released,TCGA-AA-A02H_treatment_1,598c27e0-03a6-5ce8-ac72-db36523a5723,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:09.946275-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2007
69fb431f-0caf-4cdd-9085-eda5b18ed15d,TCGA-AA-A02H,TCGA-COAD,74,-27362,61,24b8d727-e46d-5f96-a759-3cfc71be2a41,not reported,female,not reported,released,TCGA-AA-A02H_demographic,2019-07-31T18:30:09.946275-05:00,Dead,1933,2007,27362,M1,N2,Stage IV,T3,6th,not reported,--,d3960bc5-b93b-5bda-ac1f-12fb1e8791e0,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AA-A02H_diagnosis,No,Sigmoid colon,--,released,TCGA-AA-A02H_treatment,9f8f3f08-fa82-5fe4-b674-33466412d981,not reported,"Radiation Therapy, NOS",2019-07-31T18:30:09.946275-05:00,not reported,stage iv,2019-08-08T16:35:29.811838-05:00,2007
03efbc94-a43d-4db0-9377-e397348430a6,TCGA-AA-3524,TCGA-COAD,85,-31197,--,7211941c-1e4a-5d51-995d-5b4a9d090ddc,not reported,male,not reported,released,TCGA-AA-3524_demographic,2019-07-31T18:22:31.425869-05:00,Alive,1922,--,31197,M0,N0,Stage II,T3,5th,not reported,1096,c0b7fcee-6565-5f22-ab1f-5315e60eecdc,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3524_diagnosis,Not Reported,Sigmoid colon,2019-04-28T11:09:25.530900-05:00,released,TCGA-AA-3524_treatment_1,3fd7c33a-9d71-53f0-9d68-fe2b4fb495f5,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:31.425869-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2007
03efbc94-a43d-4db0-9377-e397348430a6,TCGA-AA-3524,TCGA-COAD,85,-31197,--,7211941c-1e4a-5d51-995d-5b4a9d090ddc,not reported,male,not reported,released,TCGA-AA-3524_demographic,2019-07-31T18:22:31.425869-05:00,Alive,1922,--,31197,M0,N0,Stage II,T3,5th,not reported,1096,c0b7fcee-6565-5f22-ab1f-5315e60eecdc,C18.7,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,Sigmoid colon,released,TCGA-AA-3524_diagnosis,Not Reported,Sigmoid colon,--,released,TCGA-AA-3524_treatment,7fa2dfbe-eb97-570b-8d9b-48922b7420df,no,"Radiation Therapy, NOS",2019-07-31T18:22:31.425869-05:00,not reported,stage ii,2019-08-08T16:34:13.342472-05:00,2007
315ef7f6-ca21-4d87-8f19-40bd455885ec,TCGA-AY-4071,TCGA-COAD,63,-23320,29,8f7f8e04-2855-5ff6-9a4f-7dc3239abb62,not hispanic or latino,female,white,released,TCGA-AY-4071_demographic,2019-07-31T18:26:13.759502-05:00,Dead,1946,2009,23320,--,N0,Stage I,T1,6th,not reported,--,b8b06f8a-bcff-5056-a7e7-1d357f0c17a6,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AY-4071_diagnosis,No,Sigmoid colon,2019-04-28T11:12:29.365027-05:00,released,TCGA-AY-4071_treatment_1,41e247d8-54dd-503b-a8f0-217a03bd8aa6,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:26:13.759502-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2009
315ef7f6-ca21-4d87-8f19-40bd455885ec,TCGA-AY-4071,TCGA-COAD,63,-23320,29,8f7f8e04-2855-5ff6-9a4f-7dc3239abb62,not hispanic or latino,female,white,released,TCGA-AY-4071_demographic,2019-07-31T18:26:13.759502-05:00,Dead,1946,2009,23320,--,N0,Stage I,T1,6th,not reported,--,b8b06f8a-bcff-5056-a7e7-1d357f0c17a6,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-AY-4071_diagnosis,No,Sigmoid colon,--,released,TCGA-AY-4071_treatment,f1325ae3-5826-5759-882a-04b601a95988,no,"Radiation Therapy, NOS",2019-07-31T18:26:13.759502-05:00,not reported,stage i,2019-08-08T16:35:57.350058-05:00,2009
04d7a52f-a89b-4114-a608-a6254b4d604f,TCGA-AA-3986,TCGA-COAD,73,-26967,--,689679e5-88bb-5e39-87b3-ca6d88544950,not reported,male,not reported,released,TCGA-AA-3986_demographic,2019-07-31T18:22:37.215100-05:00,Alive,1934,--,26967,M0,N0,Stage I,T2,5th,not reported,580,f0e59fee-1a28-5c38-956f-e11790b530f6,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3986_diagnosis,Not Reported,"Colon, NOS",2019-04-28T11:09:30.521319-05:00,released,TCGA-AA-3986_treatment_1,4a7d2731-5beb-54f4-a065-679e10efdd4d,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:22:37.215100-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
04d7a52f-a89b-4114-a608-a6254b4d604f,TCGA-AA-3986,TCGA-COAD,73,-26967,--,689679e5-88bb-5e39-87b3-ca6d88544950,not reported,male,not reported,released,TCGA-AA-3986_demographic,2019-07-31T18:22:37.215100-05:00,Alive,1934,--,26967,M0,N0,Stage I,T2,5th,not reported,580,f0e59fee-1a28-5c38-956f-e11790b530f6,C18.9,8140/3,"Adenocarcinoma, NOS",yes,No,not reported,"Colon, NOS",released,TCGA-AA-3986_diagnosis,Not Reported,"Colon, NOS",--,released,TCGA-AA-3986_treatment,424d83a9-f04c-580c-915a-affa162ff1ea,no,"Radiation Therapy, NOS",2019-07-31T18:22:37.215100-05:00,not reported,stage i,2019-08-08T16:35:04.140343-05:00,2007
aa85d9e8-caa6-422c-95ce-780e4ac2a5e4,TCGA-AA-3532,TCGA-COAD,63,-23133,--,fe542858-ea36-5941-a1b6-b2eedad6ea20,not reported,male,not reported,released,TCGA-AA-3532_demographic,2019-07-31T18:34:11.924017-05:00,Alive,1944,--,23133,M0,N0,Stage IIA,T3,6th,not reported,882,296547dc-a1fc-57f1-9405-a025afd5f6a8,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3532_diagnosis,No,"Colon, NOS",2019-04-28T11:19:05.304919-05:00,released,TCGA-AA-3532_treatment_1,51f5678b-fb7a-5ceb-95e8-505064d85c3b,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:11.924017-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
aa85d9e8-caa6-422c-95ce-780e4ac2a5e4,TCGA-AA-3532,TCGA-COAD,63,-23133,--,fe542858-ea36-5941-a1b6-b2eedad6ea20,not reported,male,not reported,released,TCGA-AA-3532_demographic,2019-07-31T18:34:11.924017-05:00,Alive,1944,--,23133,M0,N0,Stage IIA,T3,6th,not reported,882,296547dc-a1fc-57f1-9405-a025afd5f6a8,C18.9,8140/3,"Adenocarcinoma, NOS",no,No,not reported,"Colon, NOS",released,TCGA-AA-3532_diagnosis,No,"Colon, NOS",--,released,TCGA-AA-3532_treatment,c70e1fdf-17db-5fe1-8f17-b6532c7f260c,no,"Radiation Therapy, NOS",2019-07-31T18:34:11.924017-05:00,not reported,stage iia,2019-08-08T16:34:13.342472-05:00,2007
755d3bde-76c3-45c1-8427-8e4d5d686dc1,TCGA-CK-6747,TCGA-COAD,87,-32052,--,6c8e6768-40a4-5ff7-88f3-fee221d84683,not hispanic or latino,female,white,released,TCGA-CK-6747_demographic,2019-07-31T18:30:45.769599-05:00,Alive,1921,--,32052,MX,N0,Stage IIA,T3,6th,not reported,820,cc52e6fe-e12f-594c-a588-cec6da6859c5,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CK-6747_diagnosis,No,Cecum,--,released,TCGA-CK-6747_treatment,757acc2f-3b62-5abb-9b0d-ef4330b40092,no,"Radiation Therapy, NOS",2019-07-31T18:30:45.769599-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2008
755d3bde-76c3-45c1-8427-8e4d5d686dc1,TCGA-CK-6747,TCGA-COAD,87,-32052,--,6c8e6768-40a4-5ff7-88f3-fee221d84683,not hispanic or latino,female,white,released,TCGA-CK-6747_demographic,2019-07-31T18:30:45.769599-05:00,Alive,1921,--,32052,MX,N0,Stage IIA,T3,6th,not reported,820,cc52e6fe-e12f-594c-a588-cec6da6859c5,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-CK-6747_diagnosis,No,Cecum,2019-04-28T11:16:16.124942-05:00,released,TCGA-CK-6747_treatment_1,dc0b3370-3bc7-5152-a509-85c8379ac038,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:30:45.769599-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2008
3a8ca50f-bc9f-4250-8c8d-22893763ea46,TCGA-D5-6926,TCGA-COAD,65,-23768,--,6cfccd74-2c17-5642-ac8e-2222296d9edc,not hispanic or latino,male,white,released,TCGA-D5-6926_demographic,2019-07-31T18:27:06.830152-05:00,Alive,1946,--,23768,M0,N1,Stage IIIB,T4a,7th,not reported,275,a870b13e-6340-54c5-b7aa-89ea5b082740,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6926_diagnosis,No,Sigmoid colon,--,released,TCGA-D5-6926_treatment,3cd53094-f6f2-56bd-a5cb-1a884d20ddde,yes,"Radiation Therapy, NOS",2019-07-31T18:27:06.830152-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2011
3a8ca50f-bc9f-4250-8c8d-22893763ea46,TCGA-D5-6926,TCGA-COAD,65,-23768,--,6cfccd74-2c17-5642-ac8e-2222296d9edc,not hispanic or latino,male,white,released,TCGA-D5-6926_demographic,2019-07-31T18:27:06.830152-05:00,Alive,1946,--,23768,M0,N1,Stage IIIB,T4a,7th,not reported,275,a870b13e-6340-54c5-b7aa-89ea5b082740,C18.7,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Sigmoid colon,released,TCGA-D5-6926_diagnosis,No,Sigmoid colon,2019-04-28T11:13:15.053576-05:00,released,TCGA-D5-6926_treatment_1,d8610333-04ea-5517-b5a9-e450d96735c1,yes,"Pharmaceutical Therapy, NOS",2019-07-31T18:27:06.830152-05:00,not reported,stage iiib,2019-08-08T16:36:52.154454-05:00,2011
764c97c9-01d3-45cb-86bd-f8a52b5468da,TCGA-AA-A02R,TCGA-COAD,84,-30834,670,fe66c971-d2d9-5e00-a7b1-2295df806682,not reported,female,not reported,released,TCGA-AA-A02R_demographic,2019-07-31T18:31:00.951174-05:00,Dead,1922,2007,30834,M0,N0,Stage IIA,T3,6th,not reported,--,4907ce6c-5a38-570b-afe8-46923c835176,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A02R_diagnosis,No,Cecum,--,released,TCGA-AA-A02R_treatment,8bd5b94b-11c8-581c-8de7-b0b52ab54a6e,not reported,"Radiation Therapy, NOS",2019-07-31T18:31:00.951174-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2006
764c97c9-01d3-45cb-86bd-f8a52b5468da,TCGA-AA-A02R,TCGA-COAD,84,-30834,670,fe66c971-d2d9-5e00-a7b1-2295df806682,not reported,female,not reported,released,TCGA-AA-A02R_demographic,2019-07-31T18:31:00.951174-05:00,Dead,1922,2007,30834,M0,N0,Stage IIA,T3,6th,not reported,--,4907ce6c-5a38-570b-afe8-46923c835176,C18.0,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Cecum,released,TCGA-AA-A02R_diagnosis,No,Cecum,2019-04-28T11:16:28.577950-05:00,released,TCGA-AA-A02R_treatment_1,98f1c95f-a595-50f8-bb35-51bcb3df2711,not reported,"Pharmaceutical Therapy, NOS",2019-07-31T18:31:00.951174-05:00,not reported,stage iia,2019-08-08T16:35:29.811838-05:00,2006
a85e8208-a6f5-4e91-8f35-ef574f4273fc,TCGA-CM-6677,TCGA-COAD,75,-27575,--,fe783940-c184-5e21-a3ef-3345406dc5e2,not hispanic or latino,female,white,released,TCGA-CM-6677_demographic,2019-07-31T18:34:02.522961-05:00,Alive,1936,--,27575,M0,N0,Stage IIA,T3,7th,not reported,337,0ab21d0f-b93e-5547-8adc-83fb0015fc47,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-CM-6677_diagnosis,No,Hepatic flexure of colon,2019-04-28T11:18:58.189468-05:00,released,TCGA-CM-6677_treatment_1,2c19d68a-c5dc-5095-8b4a-94fa5063652c,no,"Pharmaceutical Therapy, NOS",2019-07-31T18:34:02.522961-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2011
a85e8208-a6f5-4e91-8f35-ef574f4273fc,TCGA-CM-6677,TCGA-COAD,75,-27575,--,fe783940-c184-5e21-a3ef-3345406dc5e2,not hispanic or latino,female,white,released,TCGA-CM-6677_demographic,2019-07-31T18:34:02.522961-05:00,Alive,1936,--,27575,M0,N0,Stage IIA,T3,7th,not reported,337,0ab21d0f-b93e-5547-8adc-83fb0015fc47,C18.3,8140/3,"Adenocarcinoma, NOS",no,No,not reported,Hepatic flexure of colon,released,TCGA-CM-6677_diagnosis,No,Hepatic flexure of colon,--,released,TCGA-CM-6677_treatment,de7f0658-fee2-5d84-928c-99374ecbb1d2,no,"Radiation Therapy, NOS",2019-07-31T18:34:02.522961-05:00,not reported,stage iia,2019-08-08T16:36:28.485406-05:00,2011
